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ABSTRACT
The tachykinins substance P (SP) and neurokinin A (NKA) can be
released from fine somatosensory afferents into the spinal cord by noxious
cutaneous stimuli. This study assessed the role of their respective NKj and NK2
receptors and some putative intracellular mediators in both acute and sustained
nociceptive inputs to dorsal horn neurons:
(a) In anaesthetised rats, extracellular recordings were made from laminae
III-V multireceptive neurons. The ionophoretic administration of NKj antagonists
L-668,169, GR 82334 and [D-Pro4,D-Trp7.9»10Phe1 ^substance P-(4-ll) failed
to influence neuronal responses to noxious pinch or heat, but often enhanced
responses to innocuous brush, whilst the NK2 antagonist L-659,874 inhibited
responses to noxious heat, but not pinch or brush. Selective NKj and NK2
receptor agonists, [N-acetyl-Arg6,Sar9,Met(02)^]SP6_i ] and GR 64349
respectively, both excited dorsal horn neurons. The contribution of NKj and NK2
receptors to sustained neuronal activity induced by peripheral application of the C-
fibre selective algogen mustard oil was then investigated. The mustard oil-
induced activity was inhibited by the selective NK/? receptor antagonist L-659,874
but not by the selective NKj antagonists L-668,169 or GR 82334. The role of
NKj and NK2 receptors was further examined in the central neuronal sensitisation
of both innocuous and noxious inputs, induced by mustard oil. Prior to mustard
oil application, the NKj antagonists RP 67580 and GR 82334 selectively
enhanced neuronal responses to innocuous brush, whilst NK2 antagonists SR
48968 and L-659,874 selectively inhibited responses to noxious heat, however,
following repeated mustard oil application, the facilitated neuronal responses to
brush and heat were blocked by both selective NK] and NK2 antagonists.
(b) Evidence for a role of protein kinase C (PKC) in mediating sustained
nociceptive responses of rat dorsal horn neurons was provided by the blockade of
mustard oil-, but not brush-evoked neuronal activation by the PKC inhibitors GF
109203X and chelerythrine and by SR 48968-sensitive subcellular translocation of
[^HJphorbol 12,13-dibutyrate binding sites ipsilateral to mustard oil stimulation.
(c) In Situ hybridisation histochemistry (ISHH) demonstrated that
expression of c-fos mRNA, induced in the superficial dorsal horn by peripheral
application of mustard oil was inhibited by systemic administration of both RP
67580 and SR 48968.
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(d) The effects of intrathecally-applied NK \ and NK2 antagonists were
assessed on thermally-evoked tail-flick and paw-flick behavioural responses. GR
82334 and L-659,874 had no effect alone, but in combination inhibited paw-flick.
After inflammation induced by intraplantar injection of carrageenan, each was
effective individually.
These results provide evidence that spinal NK2 receptors are involved in
mediating both acute and sustained nociceptive transmission, probably acting
through phosphoinositide hydrolysis and stimulation of protein kinase C (PKC).
However, evidence for NK4 receptor involvement was only obtained in sustained
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In the early 19th Century, two opposing theories were proposed to explain
how the nervous system differentiates between the various forms of sensory
experience, these were the 'Intensity Theory' and the 'Specificity Theory':-
Goldscheider (1884) formulated the Intensity Theory which maintained
that pain has no separate receptors, but is produced in the nervous system as a
result of summation of impulses excited by the application of noxious pressure or
temperature to the skin. Thus weak stimulation would excite the cutaneous
sensory nerve endings to a low level, regarded as normal, but as stimulation
increased it would evoke pain.
This view was challenged by a strong body of opinion in favour of the
'Specificity Theory'. Charles Bell was the first to suggest that there was
'specificity' in the cutaneous nervous system (see Sinclair, 1967). However, this
theory is generally attributed to Muller derived from his law of 'specific sensory
energies'. Muller proposed that activity in a particular nerve would give rise to a
specific sensation regardless of the sensory stimulus used (Muller, 1842).
Evidence supporting this theory came from Blix (1884) who discovered that in
normal skin, stimulation of tiny 'spots' would react preferentially to touch, cold,
warm and pain. In 1895, Von Frey suggested that under the skin of each of these
sensory spots there lay one or more sense organs specialised to respond to a
particular type of stimulus. Von Frey, supporting the specificity theory proposed
that hair follicle endings in hairy skin and Meissner's corpuscles in glabrous skin
would respond to touch, Krause's end bulbs to cold, Ruffini endings to warmth
and free endings to pain. However, it has since been discovered that Ruffini
endings are identified with slowly adapting mechanoreceptors (Chambers et al,
1972); Krause's end bulbs are a variety of rapidly adapting mechanoreceptors
(Iggo and Ogawa, 1977) and thermal sensitivity depends on free nerve endings
(Andres and During, 1973).
In 1965, Melzack and Wall proposed the 'Gate Control Theory' for
nociceptive transmission within the spinal cord, suggesting that the spinal cord
substantia gelatinosa (SG) cells act as a gating mechanism between primary
afferents and higher brain areas. They proposed that the SG cells modulate
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afferent transmission before it affects the central transmission (T) cells which in
turn relay sensory information to higher levels of the brain. Activity in large and
small afferent fibres results in negative and positive feedback respectively onto the
substantia gelatinosa cells. Melzack and Wall stated that for pain to occur, there
would have to be (a) ongoing activity in small myelinated and unmyelinated fibres,
(b) stimulus-evoked activity and (c) a relative balance of activity in large and small
afferent fibres. The tonic activity in small myelinated and unmyelinted afferent
fibres would keep the gate partly open, whereas if large myelinated fibres were
activated the gate would close, limiting the discharge of T cells.
There have been many criticisms of the Gate Control Theory (Nathan,
1976; Cervero and Iggo, 1980) and although aspects of its original configuration
may not now be tenable, the idea of the substantia gelatinosa acting as a centre of
integration and regulation remains a useful hypothesis.
1.2 CUTANEOUS SENSORY AFFERENTS AND RECEPTORS
1.2.1 Cutaneous Sensory Afferents
In cutaneous nerves the Aa(3 class comprises the largest group of fibres
with the fastest conduction velocities (30-100 m/s) and innervate corpuscular
endings or hair follicle receptors. The small myelinated fibres belong to the A5 or
class III group which supply hair follicle receptors and mechanical nociceptors.
They conduct at 4-30 m/s, whereas the unmyelinated fibres (C-fibres) have the
smallest diameters which conduct at less than 2.5 m/s, innervating mechanical,
thermal and polymodal nociceptors as well as sensitive mechanoreceptors (hair),
warm receptors and are also present in sympathetic efferents. (Zimmerman, 1968;
Iggo, 1974). Most of the information about the nature and properties of
nociceptive afferent units has come from recordings of the activity of single
afferent fibres. It was Adrian (1931) and Zotterman (1939) who first
demonstrated that noxious stimulation evoked activity in unmyelinated C-fibres
and in slowly conducting myelinated A8 fibres. Torebjork and Hallin (1973,
1974) have confirmed these findings in conscious human studies, where they
demonstrated that the subject only felt pain when the cutaneous nerve was
stimulated at C-fibre but not at A-fibre intensity
1.2.2 Cutaneous Receptors
The terminal portions of the primary afferent neuron lying in the
peripheral tissue (skin and the adjacent subcutaneous connective tissue) constitute
15
the receptive or dendritic part of the cell (Bodian, 1962), which receive the
stimulus and translate it into nerve impulses which propagate along the afferent
fibre. As previously mentioned, on account of the methods developed by Adrian
and Zotterman in 1926, there has been rapid advancement in our understanding of
the nature and properties of individual afferent fibres. This method and others
have enabled a detailed study of cutaneous receptors which has generated three
sub-classes, mechanoreceptors, thermoreceptors and nociceptors. (Iggo, 1966;
Burgess and Perl, 1973; Hensel, 1973). See Figure 1.1 for a schematic
representation of the neuronal organisation of and afferent input of the superficial
dorsal horn.
(a) Mechanoreceptors
Cutaneous mechanoreceptors are most readily activated by mechanical
changes to the skin, they can also be affected by thermal changes (Iggo, 1966) but
this is thought to be insignificant physiologically (Duclaux and Kenshalo, 1972).
Burgess and Perl (1973) have classified 3 classes of cutaneous mechanoreceptors
on their ability to detect position, velocity or transients of stimulus.
Receptors Detecting Cutaneous Displacement and Velocity. There are
two sub-classes of receptors detecting cutaneous displacement and velocity which
are (i) slowly and (ii) rapidly adapting cutaneous mechanoreceptors (Iggo, 1966;
Brown and Iggo, 1967).
Receptors Detecting Velocity. There are at least 5 kinds of cutaneous
sensory receptors that detect velocity. Four are found in hairy skin (G2 hair
follicle receptors, D hair follicle receptors, field receptors and C
mechanoreceptors) and one in glabrous skin (Meissner's corpuscle), (Brown and
Iggo, 1967; Burgess and Perl, 1973).
Receptors Detecting Transient Movement. There are two types of
cutaneous receptors that are designed to detect transients : Hair Follicle
Receptors and Pacinian Corpuscles, both of which activate Aa(3 primary afferent
fibres (Burgess et al, 1968).
(b) Thermoreceptors
Hensel (1973) described the neurophysiological properties of cutaneous
thermoreceptors as having (a) a static discharge at constant temperatures, (b) a
dynamic response to temperature changes and (c) no excitatory response to
mechanical stimuli within reasonable intensity. There are 2 kinds of cutaneous
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Figure 1.1
Schematic diagram of the neuronal organisation of, and afferent input to the
superficial dorsal horn.
The diagram represents an imaginary transverse section of the dorsal horn and
illustrates the afferent fibre endings and neuronal elements present in the first four
laminae of the dorsal horn. To the left of the diagram the types of afferent fibre
and relevant receptor groups associated to them are listed. Fibre endings in the
dorsal horn are schematised diagrams taken from published morphological studies.
Neurons in the diagram represent standard types of neuron in the superficial dorsal
horn. The following types have been illustrated: (from top to bottom) a marginal
cell, an SG limiting cell, two SG central cells and two neurons of the nucleus
proprius, the most superficial of which has dendrites penetrating lamina II.
Indicated at the right of the diagram are the laminar division of the superficial
dorsal horn and corresponding nomenclature.
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receptors which signal innocuous changes in skin temperature, these are warm and
cold receptors.
Cold Receptors may be either myelinated (Hensel and Zotterman, 1951;
Iggo, 1969) or unmyelinated (Iggo, 1959; Douglas et al, 1960) and are found in
both hairy and glabrous skin (Iggo, 1969).
Warm Receptors are generally thought to be unmyelinated (Iggo, 1959;
Hensel et al, 1960). However, Hensel (1966) has reported studies demonstrating
myelinated warm fibres. Warm receptors are active at normal body temperature,
their discharge slows with cooling of the skin and increases with heating.
However, they are silenced by noxious levels of radiant heat (LaMotte and
Campbell, 1978).
(c) Nociceptors
Nociceptors were first described by Sherrington (1900) as sensory
endings that respond to stimuli that threaten or actually damage tissue. Since then,
sub-populations of primary afferent fibres that respond to excessive mechanical or
thermal stimuli have been described in animals (Burgess and Perl, 1967; Bessou
and Perl, 1969) and in man (Van Hees and Gybels, 1972). There are two main
groups of cutaneous nociceptors, the A8 mechanical nociceptor and the C-
polymodal nociceptor (see Figure 1.1 for a schematic diagram).
A8 Mechanoreceptors are nociceptors associated with A5 fibres which
are only excited by noxious mechanical stimulation (Burgess and Perl, 1967;
Burgess et al, 1968; Georgopoulis, 1976). They are referred to as high threshold
mechanoreceptors although thresholds do vary. They have reasonably large
receptive fields (1-2 cm diameter) comprising of several sensitive zones separated
by areas where mechanical stimulation is without effect. They are not activated by
thermal or chemical stimuli (Burgess and Perl, 1967).
Certain A5 nociceptors can be sensitised by repeated applications of
noxious heat to their receptive fields (Fitzgerald and Lynn, 1977; Lynn and
Carpenter, 1982; Treede et al, 1992). However, many A5 units will fatigue after a
repetitive application of the stimulus and if this is intense enough, cessation of
firing can occur (Fitzgerald and Lynn, 1977). Although rare, specific
mechanoreceptors associated with unmyelinated fibres have been described
(Georgopoulis, 1976).
C-Polymodal Nociceptors. Bessou and Perl (1969) originally described
polymodal nociceptors by their responsiveness to intense thermal and mechanical
stimuli as well as to irritant chemicals. In the absence of stimulation, these
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receptors do not produce any spontaneous activity, but they respond well to
noxious mechanical, thermal and chemical stimuli (Bessou and Perl, 1969). Their
receptive field area is generally small e.g. one digit of the ipsilateral paw, although
a degree of overlap exists between the receptive fields of several afferent fibres
(Torebjork, 1974). The most effective mechanical stimuli are those of greatest
noxious intensity applied by pointed objects and effective thermal stimuli are
noxious heat (greater than 45°C) (Bessou and Perl, 1969).
The nociceptors will increase Iheii discharge with intensity of stimulation,
after a large initial discharge, the response adapts and settles to a lesser level
which can continue after cessation of the stimulus (Adrian and Zotterman, 1926;
Torebjork and Hallin, 1974; Croze et al, 1976). Another characteristic of C
polymodal nociceptors consists of the appearance of 'fatigue' following the
repetition of a noxious stimulus to the same point on the receptive field (Bessou
and Perl, 1969; Van-Hees and Gybels, 1972; Torebjork and Hallin, 1974;
Kumazawa and Perl, 1977; Lynne and Carpenter, 1982).
C polymodal nociceptors can be sensitised by a prior nociceptive thermal
stimulus. Sensitisation can be manifest by several changes, a reduction in
threshold, a reduced response latency to a given thermal stimulus and the
appearance of spontaneous activity (Bessou and Perl, 1969; Croze et al, 1976;
Kumazawa and Perl, 1977; Lynn and Carpenter, 1982). This sensitisation is more
marked in hairy than glabrous skin (Campbell and Meyer, 1983).
Other Nociceptors have been described including:-
C Mechanical Nociceptors- C mechanical nociceptors have been
described by Iggo, 1960; Bessou and Perl, 1969; Beck et al, 1974; Georgopoulis,
1976; Kumazawa and Perl, 1977; LaMotte and Campbell, 1978; Lynn and
Carpenter, 1982). Intense mechanical stimuli can activate the cold and warm
thermoreceptors although their responses are often only moderate and variable. It
is possible that some of these receptors are the same as the C cold nociceptors
(Bessou and Perl, 1969).
A8 Mechanoheat Nociceptors- A5 Mechanoheat Nociceptors respond
well to both mechanical and thermal testing (Beck et al, 1974; Georgopoulis,
1976; Kumazawa and Perl, 1977; Treede et al, 1992), although the threshold for
thermal testing is much higher (51-53°C) than that of C polymodal nociceptors
(LaMotte et al, 1983). A5 and C cold nociceptors respond both to extreme cold
and to intense mechanical stimulation (Iggo, 1959; Bessou and Perl, 1969;
Georgopoulis, 1976).
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1.3 THE DORSAL HORN OF THE SPINAL CORD.
1.3.1 Laminar Organisation
In 1952, Rexed gave the first comprehensive and systematic account of
the histology of the spinal cord grey matter. This cytoarchitectonic laminar
scheme of the cat spinal cord presented by Rexed (1952,1954) has been
reproduced for the rat by Molander (1984,1986) (see Figure 1.2) and concentrates
on the shapes, sizes, density and distribution of the neuronal somata. It does not
take into consideration the dendritic trees of neurons or axonal projections and
terminations. There are 9 distinguishable cell layers (laminae) in the cord together
with a region around the central canal (lamina X) described by Rexed and extend
through the rostro-caudal length of the cord (see Figure 1.2). The dorsal horn
consists of
Lamina 1 is the most dorsal of the layers, covering the dorsal surface of
the dorsal horn it bends around its apex and tapers down the lateral side. It is a
relatively thin layer of predominantly small cells, although a few larger marginal
cells can be found overlying the gelatinosa with their major dendrites arranged
horizontally (Szentagothai, 1964; Scheibel and Scheibel, 1968; Waldeyer, 1988).
Although the smaller cells are more numerous, they have not been extensively
studied.
Lamina II lies immediately ventral to lamina I, as a well-defined layer
running from the medial, across and down the lateral side, and is known as the
substantia gelatinosa (Rolando, 1824). The substantia gelatinosa (SG) displays
closely packed small cells in the outer zone and a more loose arrangement in the
inner zone (Cervero and Iggo, 1980). Rexed (1952,1954) has equated the lamina
II layer with the substantia gelatinosa and it can be subdivided into laminae IIq and
Ilj (Gobel et al, 1980). Lamina IIq, the dorsal or outer part of the SG contains
stalk cells whose dendrites form a cone emanating from the cell body and passing
ventrally through laminae II-IV. Islet cells are located in lamina 11) (the inner or
ventral part of the SG) and dendritic trees extend from these cells to cover the
entire width of lamina II, (Gobel, 1978).
Lamina III lies ventral to lamina II and is characterised by densely
aggregated cells (Molander et al, 1984), being slightly larger and more widely
spaced than in lamina II. (Rexed, 1952), however the border between laminae II
and III is indistinct with a slightly transitional character.
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Figure 1.2
Schematic drawings of the cytoarchitectonic subdivisions of sements L1-L6
rat spinal cord laminae.
CC, column of Clarke; IL, intermedio-lateral nucleus; IM, intermedio-medial
nucleus; LSN, lateral spinal nucleus; Liss, Lissauer's tract; LG, lateral group of
large cells in the dorso-lateral part of the ventral hom; LM, latero-medial nucleus;
MG, medial group of large neurons in the intermediate zone. Note that LG, LM
and VM are parts of lamina IX.
(Taken from Molander et al, 1984)
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Lamina IV forms the upper part of the base of the head of the dorsal
horn. It is a relatively thick layer which extends across the dorsal horn with
neurons of varying sizes (Molander et al, 1984), easily distinguished from lamina
III, where the neuron size is more uniform. There are very large cells present
which have dendrites which pass laterally, dorsally and medially, but with a
general longitudinal orientation. Both Spinocervical Tract (SCT) and Postsynaptic
Dorsal Column (PSDC) projection cells are present in laminae IV.
Lamina V extends as a thick band across the narrowest part of the neck of
the dorsal horn. The presence of the lateral reticulated area with numerous
myelinated fibres makes lamina V distinctive and in comparison to laminae IV, it
is characterised by even larger cells (Molander et al, 1984) with a different shape
of dendritic field.
Lamina VI exists only in the cervical and lumbosacral enlargements of
the spinal cord (Rexed, 1952) and cells there were only occasionally encountered
in the present study. The cells are smaller, have a more homogenous distribution
than those in lamina III and are darker than those of lamina V (Molander et al,
1984).
1.3.2 Cutaneous Primary Afferent Input Into the Dorsal Horn
The morphology of the primary afferent input into the various laminae of
the dorsal horn is very important to understanding spinal sensory mechanisms.
There are various techniques used for investigation, classically these have involved
mainly Golgi and degeneration techniques (Fitzgerald, 1984). However more
recently one of the most successful techniques is that of intra-axonal injection of
the enzyme horseradish peroxidase (HRP) into single identified primary afferent
fibres (Brown, 1981a,b).
Fibres which enter the spinal cord via the dorsal roots all bifurcate into
ascending and descending branches close to the entrance zone (Rethelyi and
Szentagothai, 1973), with the exception of hair follicle afferents which only have
an ascending branch in the dorsal columns (Szentagothai, 1964; Brown, 198la,b;
Patterson et al, 1990).
The terminations of myelinated (A) and unmyelinated (C) primary afferent
fibres from the skin, differ in the superficial dorsal horn (Rethelyi, 1977, Light and
Perl, 1977,1979). Light and Perl have demonstrated that the fine fibres in the
lateral region of the dorsal root project predominantly to the superficial layers of
the dorsal horn (Lamina I, II), while the thick fibres project predominantly to
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deeper regions (Lamina II-V) of the spinal grey matter in cats and monkeys, in
agreement with other studies (LaMotte, 1977).
Although the collaterals from small myelinated (A5) and unmyelinated
(C) afferent fibres are generally associated with the superficial dorsal horn
(Fitzgerald, 1984; Fyffe, 1984; Retheyli and Szentagothai, 1973), there has been
some controversy over the precise distribution of fine afferent collaterals in this
region. Gobel's group have reported both the degenerative changes of dorsal root
afferents in lamina I and II (Gobel and Binck, 1977) and they have also observed
ultrafine axons and terminals (presumed to be of C fibre origin) in lamina I of the
spinal cord, following anterograde transport of HRP from cut dorsal roots (Gobel
et al, 1980). These findings imply that there are both C and A8 afferent fibres in
lamina I. However, by using Golgi techniques, (Retheyli, 1977) and degeneration
studies (LaMotte, 1977; Ralston and Ralston, 1979), it was concluded that C fibres
terminate in lamina II and AS axons in lamina I. This is in agreement with other
studies (Beal and Fox, 1976; Beal and Bicknell, 1981) who found that large axons
give rise to terminals in lamina I. Studies of individual fibres (Light and Perl,
1979) and functional studies (Kumazawa and Perl, 1977) have also confirmed
these results. Thus, although there may be an unmyelinated primary afferent input
into lamina I, it is clear that there is a major input into this region from small
myelinated AS fibres (Light and Perl, 1979; Fitzgerald, 1984; Fyffe, 1984).
Little experimental evidence supports a fine primary afferent input into
lamina IV and V, although Light and Perl (1979) found a few AS collaterals in
lamina V. However, many of the neurons in this lamina send dorsal dendrites
superficially and thus may receive direct input from primary afferent fibres that
enter more superficial laminae (Willis and Coggeshall, 1991).
Collaterals from large myelinated afferents originate from the lateral
dorsal white matter and either penetrate through the medial part of the substantia
gelatinosa or curve around the medial side of the dorsal horn and enter ventrally in
lamina IV, where they recurve and end in large flame-shaped arbors in lamina II
and III (Ramon y Cajal, 1909; Szentagothai, 1964; Scheibel and Scheibel, 1968).
More recently, the superficial level to which these flame shaped arborizations
reach has been a contentious issue. Degeneration studies (LaMotte, 1977) and
HRP labelling (Light and Perl, 1979) demonstrate that fibres terminate only as
superficial as lamina III. However, several other studies report that these
arborizations reach lamina II (Proshanky and Egger, 1977; Light and Perl, 1979).
It is now thought that this difference may be species dependent as it is clearly
observed in monkeys (Beal and Fox, 1976) but not in cat (Brown, 1981a,b). Many
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large myelinated primary afferent axons directly enter lamina IV. Scheibel and
Scheibel (1968) suggest that these fibres are a separate population to those which
send collaterals to the substantia gelatinosa. Szentagothai (1964) however,
suggests they all come from the same population of fibres.
In conclusion, the superficial layers appear to play a specific role in
nociception as they receive a major input from small diameter afferent fibres. The
deeper laminae on the other hand, receive inputs mainly from non-nociceptive
primary afferent fibres.
1.3.3 Classification of Dorsal Horn Neurons
The heterogenous population of dorsal horn neurons can be classified
according to their responsiveness towards electrical and natural cutaneous stimuli
(Iggo, 1974; Handwerker et al, 1975) into three broad categories.
(a) Non-Nociceptive Neurons
These cells are also known as Class 1 cells (Iggo, 1974), excited by low
threshold mechanoreceptors responding to touch, hair movement and other types
of innocuous tactile stimulation (Dubner and Bennet, 1983). As they reach
maximal discharge frequencies below noxious stimulus intensities (see Mense,
1990), it is unlikely that they are involved in the processing of nociceptive
information. They generally have small receptive fields with sharp boundaries,
each low threshold mechanoreceptor responding to input from different kinds and
combinations of primary afferent fibres.
(b) Multireceptive Neurons
These neurons are also known as Class II (Iggo, 1974) or wide dynamic
range (WDR) cells. They have a convergent input from both A(3 low threshold
mechanoreceptor afferents and small diameter (AS and C) nociceptive afferents
(Price et al, 1976,1978,1979). Accordingly they have a low mechanical threshold
responding to both noxious and innocuous stimulation with a higher (maximal)
firing frequency upon noxious stimulation.
Multireceptive neurons are abundant in lamina V of the dorsal horn, but
are also found in other lamina (Price et al, 1976,1978,1979; Bennet et al, 1981).
They have large receptive fields, organised in a complex manner, with a central
area responsive to both tactile and noxious stimulation surrounded by a larger area,
with ill-defined borders that is responsive only to noxious stimuli. The entire
excitatory receptive field may depend on anasthesia level and descending
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influences (Dubner and Bennet, 1983). Many of these neurons which are
prominent in lamina IV and V respond to input from sensitive, low threshold
mechanoreceptors only in the intact spinal cord, but become additionally
responsive to noxious stimuli when the influence of tracts descending from
supraspinal sites is blocked (Brown, 1971; Handwerker et al, 1975).
There is considerable evidence that multireceptive neurons have an
important function in pain mechanisms (see Dubner and Bennett, 1983 for a
review). These neurons respond to both noxious mechanical and noxious heat
stimulation with a frequency of discharge that is higher than that which can be
evoked by any form of innocuous stimulation (Price et al, 1976,1978,1979;
Hoffman et al, 1981). It has been suggested that the multireceptive neurons may
be particularly important for discrimination of different intensities of painful
stimulation (Dubner et al, 1989; Kenshalo et al, 1989). Also, human studies have
showed evidence that the selective stimulation of multireceptive neurons produced
pain (Mayer et al, 1975; Price and Dubner, 1977). In addition, many
multireceptive neurons can be antidromically activated from the contralateral
thalamus (Willis et al, 1974; Price et al, 1976).
(c) Nocispecific Neurons
These neurons are also known as Class 3 cells (Iggo, 1974) or nociceptive
specific (NS) (Price and Dubner, 1977). They respond exclusively to noxious
stimulation from impulses in slowly conducting (A5 and C) primary afferent fibres
(Cervero et al, 1976; Menetrey et al, 1977). They exist abundantly in the marginal
layer (Lamina 1) of the dorsal horn (Willis et al, 1974; Price and Mayer, 1975;
Cervero et al, 1976; Price et al, 1976; Menetrey et al, 1977), but are also found to
a lesser extent in lamina IV and V (Price et al, 1976;1978;1979; Menetrey et al,
1977; Kumazawa and Perl ,1977).
Receptive fields for nocispecific cells are usually smaller than those of
WDR cells (Cervero et al, 1976) and sometimes show a similar sensitivity pattern
of those of WDR cells (Dubner and Bennett, 1983). Two subclasses of
nocispecific cells have been described, Class 3a and 3b (Cervero et al, 1976).
Class 3a responds only to a noxious mechanical stimulus such as pinching and
appears to receive input from high threshold A8 mechanosensitive afferents
(Cervero et al, 1976). Class 3a responds only to a noxious mechanical stimulus
such as pinching and appears to receive exclusive input from high threshold A8
mechanosensitive afferents (Cervero et al, 1976; Price et al, 1976). Class 3b cells
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have input from C fibres in addition to A8 and respond to noxious mechanical and
thermal stimuli.
NS neurons do not seem to be able to detect very small changes in
noxious heat above 48°C (Price and Mayer, 1975; Price et al, 1976). It has been
suggested that NS cells are likely to be part of an ascending pathway for pain since
many nociceptive specific afferents can be antidromically activated from areas
anatomically associated with nociception.
Any of the cells in the latter two cell types may be important in the
transmission of nociceptive information and all 3 types may have some relevance
to the eventual perception of pain. Many of the 3 categories of spinal neurons
mentioned above are influenced by descending tracts from various parts of the
brain. Activity descending from the brainstem has been shown to preferentially
inhibit nociceptive responses of dorsal horn neurons. This can be demonstrated
experimentally using a reversible blockade of descending influence by local
cooling of the cord (Wall, 1967; Brown, 1971; Handwerker et al, 1975; Cervero et
al, 1976; Duggan et al, 1977). Recordings have been made from nociceptive
neurons affected by tonic descending inhibition in lamina I (Cervero et al, 1976)
and lamina IV-VI (Wall, 1967; Besson et al, 1975; Handwerker et al, 1975;
Duggan et al, 1981). Inhibition of dorsal horn nociceptive interneurons has been
demonstrated following focal electrical stimulation of various regions of the
brainstem (Fields et al, 1977; Morton et al, 1983,1984; Mokha et al, 1985,1986;
Light et al, 1986; Sandkhuler et al, 1988).
Many spinal neurons will relay information within propriospinal fibres,
however, these and a significant proportion relay in ascending projections to
various sites supraspinally.
1.4 ASCENDING SOMATOSENSORY PROJECTION TRACTS
After the information from skin receptors is processed in the dorsal horn it
is then transmitted to supraspinal regions. A number of distinct ascending
somatosensory pathways can transmit nociceptive information to supraspinal sites
The spinal location of neurons comprising the major tracts are outlined below.
1.4.1 The Spinothalamic Tract
A direct projection from the spinal cord to the thalamus was first
proposed by Edinger (1889), (see Willis and Coggeshall, 1991 for a review). The
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locations of spinal neurons giving rise to the spinothalamic tract in rat, cat and
monkey are known from investigations employing electrophysiological mapping
of neurons antidromically activated from a stimulating electrode placed in the
thalamus (Willis et al, 1974; Price et al, 1978; Craig and Kniffki, 1985; Palecek et
al, 1992; Dado et al, 1994a,b,c), and by retrograde labelling with horseradish
peroxidase (HRP) (Craig et al, 1989a,b; Willis et al, 1979) or fluorescent markers
(Craig et al, 1989a,b).
Spinothalamic tract neurons are found throughout the spinal grey matter
except for the motorneuron pools although there are concentrations of STT
neurons in laminae I and V in both rat (Dado et al, 1994a) and monkey (Price et
al, 1976,1979; Kumazawa and Perl, 1977; Willis et al, 1979). In the cat, the
distribution is different.
The input to STT cells has been investigated using both electrically-
evoked volleys (Foreman et al, 1975) and natural cutaneous stimulation (Willis et
al, 1974; Kenshalo et al, 1982; Dougherty and Willis, 1992; Palecek et al, 1992).
Many STT cells are activated by Aa(3, Ab and C fibres in cutaneous nerves,
however in some cases the input may be restricted to the smaller afferent fibre
group (Foreman et dl, 1975). The most common type of STT cell is the wide
dynamic range variety (Price et al, 1978; Kenshalo et al, 1979,1982; Palecek et al,
1992; Dado et al, 1994b), though others are found including those which respond
to noxious thermal stimulation of the skin (Willis et al, 1974; Price et al, 1978;
Kenshalo et al, 1979,1982; Palecek et al, 1992; Dado et al, 1994b). Some
respond to noxious cooling of the skin (Craig and Kniffki, 1985).
The STT has been regarded as a 'nociceptive pathway' for some years.
This view has been supported by clinical observations in which surgical
destruction (anterolateral cordotomy) of the area of the spinal cord white matter
where many STT axons ascend (Willis et al, 1979), reduces or eliminates pain and
temperature sensations below the lesion on the contralateral upper extremity
(White and Sweet, 1969). STT cells may participate in the development of
primary and secondary hyperalgesia. After a series of noxious heat stimuli
(culminating in a mild burn), the responses of primate STT cells to further noxious
heat was enhanced and the threshold decreased (Kenshalo et al, 1979). These
changes are presumably associated with the development of primary hyperalgesia
in humans. Further studies by Kenshalo et al, (1982) demonstrate that a mild burn
also enhances the response of primate STT cells to innocuous mechanical stimuli
in an area which was not subject to the burn, resembling the development of
secondary hyperalgesia in humans.
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Thus the evidence points to a role for the spinothalamic tract in
transmission of acute and chronic nociceptive information from the spinal cord.
1.4.2 The Spinoreticular Tract
The spinoreticular tract (SRT) comprises of neurons which project from
the spinal cord (mainly ascending in the ventrolateral white matter) to the
brainstem reticular formation (Kevetter and Willis, 1983).
SRT neurons have been retrogradely labelled using injections of HRP into
various parts of the reticular formation (Chaouch et al, 1983; Peschanski and
Besson, 1984; Kevetter and Willis, 1983; Kevetter et al, 1982). Labelled cells can
be seen throughout all levels of the spinal cord, generally most being contralateral
to the injection site (Kevetter and Willis, 1983; Kevetter et al, 1982; Chaouch et
al, 1983). In the rat, cat and monkey, most SRT neurons are located in lamina V
of the dorsal horn and laminae VII and VIII of the ventral horn (Kevetter et al,
1982; Chaouch et al, 1983; Kevetter and Willis, 1983). Broadly similar results
have been achieved using both True Blue (Nahin and Micevych, 1986) or
Wheatgerm Agglutinin (WGA) conjugated to HRP (Peschanski and Besson,
1984).
Using retrograde transport of HRP, Lima (1990) has demonstrated a
separate SRT which projects mainly ipsilaterally from lamina I and X of the spinal
cord and terminates in the dorsal reticular nucleus of the medulla, which has a
predominant population of nociceptive specific neurons (Villanueva et al, 1988).
SRT neurons are nociceptive (Fields et al, 1975,1977; Maunz et al, 1978)
and thus the SRT system may play a role in processing nociceptive inputs from the
spinal cord.
1.4.3 The Spinocervical Tract
The spinocervical tract (SCT) was first described in the cat by Morin in
1955. Since then, several studies have confirmed the existence of this system in
cats Brown et al, 1976,1977,1980a,b; Cervero et al, 1977; Craig, 1978; Hong et
al, 1979; Brown, 1981 a,b) as well as in humans, primates, dogs, rats, mice, guinea
pigs and rabbits (Truex et al, 1965; Mizuno et al, 1967; Giesler et al, 1979;
Downie et al, 1988).
SCT cells project into the ipsilateral dorsolateral funiculus and terminate
in the lateral cervical nucleus (Brodal and Rexed, 1953), which in turn projects to
the contralateral thalamus (Craig, 1978). The location of neurons of SCT origin
have been determined at all levels of the ipsilateral spinal cord (Brown et al,
30
1976,1977,1980a,b; Cervero et al, 1977); however, the great majority of SCT cells
occupy a band across the ipsilateral dorsal horn which is centred in lamina IV
(Craig, 1978; Brown et al, 1980a,b; Brown, 1981a).
It is generally held that the majority (70%) of SCT neurons are of the
WDR type (Brown, 1971; Cervero et al, 1977) with receptive fields on the hairy,
but not glabrous skin. Type 1 (LT) SCT neurons form the majority of the
remaining 30% and the nociceptive specific units make up usually less than 5%
(Brown, 1971; Cervero et al, 1977; Downie et al, 1988).
1.4.4 Postsynaptic Dorsal Columns
Using electrophysiological methods, Uddenberg (1968) first demonstrated
the existence of post-synaptic fibres in the dorsal columns (PSDC). Subsequently,
using both anatomical and electrophysiological methods, the PSDC has been
studied further in the cat (Angaut-Petit, 1975a,b; Fields et al, 1977; Rustioni and
Kaufman, 1977; Jankowska et al, 1979; Brown and Fyffe, 1981; Enevoldson and
Gordon, 1984; Kamogawa and Bennett, 1986); and rat (de Pommery et al, 1984;
Giesler et al, 1984; Giesler and Cliffer, 1985).
Using anatomical methods, the cells of origin of the PSDC pathway have
been shown to occur predominantly in the medial part of lamina IV of the
ipsilateral spinal cord (Rustioni and Kaufman, 1977; Brown and Fyffe, 1981;
Enevoldson and Gordon, 1984; Giesler et al, 1984; de Pommery et al, 1984).
Many PSDC neurons (50-77%) appear to be multireceptive, being excited
by the activation of both low-threshold mechanoreceptive and nociceptive primary
afferents (Uddenberg, 1968; Angaut-Petit, 1975b; Jankowska et al, 1979; Brown
and Fyffe, 1981; Brown et al, 1983; Kamogawa and Bennett, 1986). There are
small populations of non-nociceptive and nociceptive-specific PSDC neurons also
reported (Angaut-Petit, 1975b; Brown and Fyffe, 1981; Brown et al, 1983;
Kamogawa and Bennett, 1986).
Giesler and Cliffer (1985) tested the responses of PSDC neurons to
noxious heat after sensitisation to repeated noxious heating and found that 93% of
the sensitised neurons tested failed to respond to noxious heat. It was concluded
that these neurons do not play an important role in nociception in the rat, although




The spinomesencephalic tract (SMT) is a pathway from the spinal cord to
the midbrain (Willis et al, 1979; Menetrey et al, 1982; Liu, 1983; Wiberg and
Blomqvist, 1984; Swett et al, 1985). The primary targets of this pathway include
the Periaqueductal Grey (PAG) intercollicular nucleus, cuneiform nucleus,
pretectal nuclei and nucleus of Darkschewitson (Menetrey et al, 1982; Wiberg and
Blomqvist, 1984; Hylden et al, 1986) and often with branches to the thalamus
(Hylden et al, 1985). Retrograde transport localised the majority of SMT cells to
lamina I (the marginal layer) of the dorsal horn contralateral to the injection site
(Menetrey et al, 1982; Swett et al, 1985; Lima and Coimbra, 1989). However, not
all investigators have demonstrated a concentration from lamina I (Willis et al,
1979; Liu, 1983; Wiberg and Blomqvist, 1984; Yezierski and Mendez, 1991).
This difference may be attributed differences in the terminal zones accessed by
tracers (Wiberg and Blomqvist, 1984; Hylden et al, 1985,1986; Swett et al, 1985;
Lima and Coimbra, 1989; Yezierski and Mendez, 1991).
SMT cells can be of low threshold (LT), high threshold (HT) or wide
dynamic range (WDR) type (Menetrey et al, 1980; Yezierski and Schwartz, 1986),
with the majority of SMT cells displaying multireceptive properties (Yezierski and
Schwartz, 1986).
1.5 TACHYKININS
The tachykinin family of peptides is characterised by the carboxyl
terminal sequence Phe-X-Gly-Leu-Met-NH2, They are neurotransmitter and/or
neuromodulator substances in both the central and peripheral nervous systems.
The family includes substance P (SP), neurokinin A (NKA), neuropeptide K
(NPK), neuropeptide 7 (NP7) and neurokinin B (NKB), the amino acid sequences
of which are shown in Figure 1.3.
1.5.1 Synthesis of Tachykinin Peptides
Mammalian tachykinins are the products of two distinct genes. The
mRNAs that encode SP, NKA (as well as NPK and NPy) are derived from a single
gene, the PPT-1 (or PPT-A) gene (Nawa et al, 1984; Krause et al, 1987), whereas
NKB is encoded by a distinct gene, the PPT-II (or PPT-B) gene (Kotani et al,
1986; Bonner et al, 1987). As shown in Figure 1.4, alternative splicing of
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Figure 1.3
The mammalian tachykinin peptides.
The amino acid sequences of the five naturally occuring mammalian tachykinins,
substance P (SP); neurokinin A (NKA); neuropeptide K (NPK); neuropeptide 7
























Schematic diagram of the transcription and splicing of the PPT-1 gene
primary transcript, and of the translation and posttranslational processing of
the a-, (3- and y-PPT precursors.
The rat SP/NKA gene is depicted at the top, with the boxes denoting the exons
numbered 1-7 below each. Transcription of the gene and splicing of the primary
transcript yields a-, (3-or 7-PPT mRNA. The mRNAs are translated with
concomitant signal peptide cleavage, and the various peptides derrived from each
presursor are displayed below each PPT as discussed in the text. The numbers
above each PPT precursor represent the number of amino acids present in each.
The abbreviations used are: G, BgUI; B, BamHl; H, Hindlll; P, PstI; PPT,
preprotachykinin.
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primary transcripts of the PPT-I gene, results in the production of four SP-
encoding mRNAs differing in exon usage within the protein coding region,
designated a, (3 , 7 and 5 preprotachykinin-1 mRNA (Nawa et al, 1984; Krause et
al, 1987; Harmar et al, 1990): The [3-PPT is encoded by all seven exons of the
PPT-1 gene and contains sequences, which, upon post-translational processing,
produce both SP and NKA: The a-PPT is missing the NKA-containing region
encoded by exon 6 and thus produces SP, but not NKA : The 7-PPT is missing a
15 amino acid region encoded by exon 4 and produces both SP and NKA. The
ratio between SP and NKA will vary according to differential splicing of the PPT-
1 mRNA, however, SP can be derived from all three preprotachykinin mRNA
transcripts, whereas NKA can only be generated from (3 and 7 -PPT-1. NPK and
NP7 are N-terminally extended derivatives of NKA that appear to be final products
in the posttranslational processing of (3 and 7-PPT in some tissues (Arai and
Emson, 1986).
In the rat, tissues expressing the PPT-1 gene generally produce on
average about 80% 7-PPT mRNA and 20% of (3-PPT mRNA (with slight
variations in each tissue studied while a-PPT mRNA accounts for less than 1% of
the PPT gene derived RNA (Carter and Krause, 1990). The relative proportion of
a-, (3-, and 7-PPT mRNA production is markedly species-dependent, for example,
[3-PPT is the predominant form expressed in human basal ganglia (Bannon et al,
1992), while a-PPT prevails in the bovine brain (Nawa et al, 1984). Thus species-
specific splicing of the PPT primary transcript is observed, but within a given
species, tissue-specific splicing may or may not occur. The mechanism(s)
underlying alternative splicing of similar or identical transcripts in different
species and tissues is unknown, however, stimulus-induced alterations in splicing
could be of physiological importance.
1.5.2 Distribution of Tachykinins in the Spinal Cord and Dorsal Roots.
(ai) Distribution of Substance P
Substance P (SP) was isolated from equine brain and gut and was first
detected as a peptide by Von Euler and Gaddum (1931). It was structurally
characterised by Chang et al (1971) (see Figure 1.3) and the identity of the
material was confirmed as substance P by Otsuka and Konishi (1976). The
confirmed structure is Arg - Pro - Lys - Pro - Gin - Gin - Phe - Phe - Gly - Leu -
Met NH2.
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Immunohistochemical studies have demonstrated that SP is found in a
sub-population of dorsal root ganglion neurons (Hokfelt et al, 1975a,b, 1976; Salt
and Hill, 1983; Leah et al, 1985; Ju et al, 1987; Merighi et al., 1988; O'Brien et al,
1989), expressed in populations of small, dark cells, although there have also been
findings in large, light cells (O'Brien et al, 1989). The highest levels of SP has
been found in cervical and lumbar dorsal root ganglia (Smith et al, 1993).
Furthermore, it has been established that SP and SP-like immunoreactive
material is localised in dorsal horn (Hokfelt et al, 1975a,1976,1977; Ljungdahl et
al, 1978; Gibson et al, 1981; Charney et al, 1983; Ogawa et al, 1985; Hirakawa
and Kawata, 1992) and also in a proportion of small diameter, primary sensory
neurons (Hokfelt et al, 1975a,b; Jessell et al, 1979; Ju et al, 1987; Vedder and
Otten, 1991) which have more recently been identified as A fibre high threshold
mechanoreceptor units or glabrous skin C-mechanoheat units (Lawson et al,
1994). Surprisingly, in contrast to widely held assumptions, SP-LI was not
detectable in C polymodal nociceptor units located in hairy skin (Lawson et al,
1994).
SP fibres are found in abundance in lamina 1 and II (Hokfelt et al,
1975a,1976,1977; Cuello et al, 1977; Ljungdahl et al, 1978; Gibson et al, 1981;
Hunt et al, 1981), but they are also found in lesser abundance in lamina X, in the
medial parts of laminae VI and VII and in the ventral horns of the spinal cord
(Hokfelt et al, 1975a, 1976; Gibson et al, 1981). Approximately 50-60% of the SP
content of the dorsal horn is in primary afferent terminals and the remainder is in
intrinsic spinal neurons and bulbospinal projections (Ljungdahl et al, 1978;
Tessler et al, 1980), evidenced by the fact that a significant number of SP
immunoreactive fibres survive both surgical and chemical deafferentations and
supraspinal transections (Nagy et al, 1980; Hammond and Ruda, 1991). This
demonstrates that some of the SP is of intrinsic origin.
As assessed by bioassay, high concentrations of SP have been
demonstrated in the spinal cord (Ninkovic et al, 1985). This has been confirmed
by showing high levels of SP in dorsal horn by radioimmunoassay (Moussaoui et
al, 1992) and radioimmunoassay combined with high performance liquid
chromatography (Ogawa et al, 1985; Arai and Emson, 1986). However, these are
relatively crude techniques, using homogenised spinal cord and measuring basic
levels of the peptide. For a more detailed study, the distribution of SP within the
rat central nervous system has been studied extensively using
immunohistochemistry (Hokfelt et al, 1975a,b,1977; Ljungdahl et al, 1978;
Gibson et al, 1981; Hunt et al, 1981; Hirakawa and Kawata, 1992). In this
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technique, antisera raised against peptides conjugated to carrier proteins, such as
bovine serum albumin, are applied to tissue sections and visualised by fluorescent
or other types of markers. However this technique is not ideal for two reasons,
firstly, colchicine was frequently applied to raise the concentration of the peptide
in the cell body to detectable levels and although the method is known to have
reproducible results, Kiyama and Emson (1991) have suggested that in some cases
colchicine may alter the synthesis of peptides. Secondly, the antigen may cross-
react with structurally similar peptides, such as one of the neurokinins (Kanazawa
et al, 1984), hence the careful use of the term "SP-like immunoreactivity" rather
than "SP- immunoreactivity". After the sequences for rat prepro-SP mRNA
became available (Chang et al, 1971), a more specific approach became possible
with In Situ Hybridisation Histochemistry (ISHH) for localisation of cells that
contain the PPT-1 mRNA (Warden and Young, 1988). Using this method PPT-1
mRNA -positive cells have been localised in neocortex, hippocampus, medial
habenula, superior colliculus, central grey and dorsal horn of the spinal cord. In
the dorsal horn, PPT-1 mRNA- containing cells were prominent in laminae I, II
and V, dorsal root ganglia and lateral spinal nucleus.
(aii) Co-localisation of Substance P
Light microscopical studies on rat sensory ganglia have shown that many
SP-containing neurons also display immunoreactivity (IR) for other peptides
including calcitonin gene related peptide (CGRP) (Ju et al, 1987; Merighi et al,
1988); cholecystokinin (CCK) (Leah et al, 1985); galanin (GAL) (Ju et al, 1987);
bombesin (BB) (Cameron et al, 1988) and neurokinin A (NKA) (Dalsgaard et al,
1985). Whether or not SP and somatostatin (SS)-IR co-exist, however, has been a
matter of controversy. It was first reported that SS and SP exist in separate
populations of sensory neurons (Hokfelt et al, 1976) and in agreement,
radioimmunoassay techniques have shown that SP and SS have distinct
distributions (Smith et al, 1993). However, Ju et al (1987) and Merighi et al
(1988) have reported a small percentage of neurons with SP and SS co-localisation
in the rat, as have Leah et al (1985) in the cat.
Although most studies only report the existence of single co-localisations
(i.e. with only one other peptide), multiple co-localisations have been reported,
where SP is co-localised with two or three other peptides (Leah et al, 1985;
Cameron et al, 1988). Thus it may be possible that within a single secretory
neuron, different peptides may be selectively transported to central and/or
peripheral axonal branches.
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SP is also known to be co-localised with 'classical' transmitters in the
spinal cord. Almost all SP neurons contain enkephalin (Enk), both SP and Enk
are found in neurons in lamina I and II of the dorsal horn (Senba et al, 1988) and
are co-localised in axons and terminals of lamina I and II (Katoh et al, 1988). SP
is also co-localised in axons and terminals of lamina I and II with 5-HT (Tashiro
and Ruda, 1988) and glutamate (Glu) (DeBiasi and Rustioni, 1988).
(bi) Distribution ofNeurokinin A
For many years SP was the only known mammalian tachykinin, although
several tachykinins i.e. physalaemin, eledoisin and kassinin had been isolated from
non-mammalian tissues (see Erspamer, 1981). However, using an antiserum with
negligible crossreactivity to SP, physalaemin-like immunoreactivity was
demonstrated in mammalian tissues by Lazarus and colleagues (1980). Similarly,
Maggio et al (1983) used radioimmunoassay to provide evidence for a SP-like
peptide in extracts of spinal cord and called it substance K. This peptide is now
known to be neurokinin A (NKA; also known as neurokinin a or neuromedin L)
and has been isolated from porcine spinal cord and sequenced (Kangawa et al,
1983; Kimura et al, 1983; Minamino et al, 1984a) (see Figure 1.3). The sequence
is His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 which is a similar amino acid
sequence to substance P at the C terminus, except it has a kassinin-like valine at
position 7.
Like substance P, NKA synthesis occurs in the cell bodies of primary
afferents located in the dorsal root ganglia (drg). These elements express the PPT-
1 gene, thus producing SP, NKA as well as the N-terminally extended forms of
NKA mentioned above (Too et al, 1989; Helke et al, 1990). Indeed, high levels of
NKA-LI have been reported in the drg (Ogawa et al, 1985; Arai and Emson,
1986) and after intrathecal colchicine, NKA-LI has been observed in a population
of predominantly small size spinal ganglion bodies. (Dalsgaard et al, 1985), which
have been shown to incorporate radiolabelled amino acids into NKA in vitro
(Harmar and Keen, 1984). Capsaicin treatment has been shown to reduce NKA
levels in the drg by approximately 50% (Moussaoui et al, 1992), in agreement with
Maggio and Hunter (1984), who found similar results when using an antiserum
raised against kassinin. This confirms that cell bodies of capsaicin sensitive
neurons, whose central terminals are located in the dorsal horn, contain NKA, in
agreement with Moussaoui et al (1992) and Hua et al (1985), who reported the
presence of NKA in capsaicin-sensitive sensory neurons in rats and guinea-pigs
respectively.
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NKA is found in high levels in the dorsal horn of the spinal cord, by the
use of radioimmunoassay and high performance liquid chromatography combined
with radioimmunoassay (Kanazawa et al, 1984; Minamino et al, 1984a,b; Ogawa
et al, 1985; Shults et al, 1985; Arai and Emson, 1986; Tateishi et al, 1989; Franck
et al, 1991). NKA has been shown to have a similar distribution to SP in the
dorsal horn of the spinal cord (Ogawa et al, 1985), with higher amounts in lumbar
than cervical and thoracic segments (Moussaoui et al, 1992). However, these
methods only measure the overall amounts of NKA in the dorsal horn and give no
information about its precise distribution within the various laminae. Dalsgaard et
al (1985) have employed an immnohistochemical technique with a specific
antiserum to NKA and detected a dense pattern of NKA-LI predominantly in the
outer layers of the dorsal horn, corresponding to Rexed's laminae I and II which
was markedly reduced after dorsal rhizotomy. Warden and Young (1988) have
carried out in situ hybridisation to study the distribution of PPT-1 and PPT-2 in the
spinal cord of the rat, with high levels of PPT-I and PPT-2 labelled cell bodies
being found in laminae I and II of the dorsal horn i.e. where fine nociceptive
afferents terminate.
(bii) Co-Localisation ofNeurokinin A
In accordance with the existence of a common precursor for SP and
NKA, there is strong evidence that NKA is co-localised with SP in the dorsal horn
and dorsal root ganglia. Radioimmunoassay techniques demonstrated that SP and
NKA are generally distributed in a fairly consistent manner with relatively
invariant molar ratios (Ogawa et al, 1985; Arai and Emson, 1986) and after
unilateral cervical dorsal roots had been sectioned, SP and NKA were both
decreased, in a parallel fashion, in the dorsal horn. Similarly
immunohistochemical studies have demonstrated that NKA-like immunoreactivity
was detected in the spinal dorsal horn with a similar distribution pattern to SP,
both decreasing in a parallel fashion after dorsal root transection (Dalsgaard et al,
1985). Using colchicine pre-treatment, these investigators have demonstrated that
a population of NKA cell bodies in the dorsal root ganglia also display
immunoreactivity for substance P and hence it was concluded that these peptides
are co-localised in a population of primary sensory neurons. As both NKA and SP
can potentially be derived from (3-and y-PPT mRNA and SP has been shown to be
co-localised with many peptides and neurotransmitters, it is possible that NKA
also coexists with some or all of these substances but may remain undetected.
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(ci) Distribution ofNeurokinin B.
Neurokinin B (NKB; also known as neuromedin K or neurokinin (3) was
isolated from the spinal cord and then sequenced (Kangawa et al, 1983; Kimura et
al, 1983; Minamino et al, 1984b; Nawa et al, 1984). The isolated sequence is
Asp-Met-His-Asp-Phe-Phe-Ala-Gly-Leu-Met-NH2 (see Figure 1.3) which is
similar to the amino acid sequence of SP at the C-terminus.
NKB seems to have a different and non-overlapping distribution to NKA
and SP (Kanazawa et al, 1984; Ogawa et al, 1985; Arai and Emson, 1986; Helke
et al, 1990). Unlike the products of PPT-1, NKB is not detected in the dorsal root
ganglia by radioimmunoassay (Moussaoui et al, 1992); ISHH (Warden and
Young, 1988) or immunocytochemistry (Too and Maggio, 1992). It is also
unlikely that NKB, is localised in primary afferent terminals, as after dorsal root
section, there is a decrease in SP but no change in the concentration of NKB in the
dorsal horn (Ogawa et al, 1985). Similarly, neonatal capsaicin treatment did not
affect the NKB concentration in the spinal cord, while it reduced NKA and SP
concentrations by approximately 50% in the dorsal horn (Moussaoui et al, 1992).
As the content of NKB in the spinal cord was unaffected by dorsal root section, it
is reasonable to suppose that NKB in the dorsal horn is localised in nerve
terminals belonging to interneurons, descending or ascending fibres.
Using radioimmunoassay and high performance liquid chromatography
(HPLC), NKB has been demonstrated to be at highest concentrations in the dorsal
horn of the spinal cord (Ogawa et al, 1985; Arai and Emson, 1986; Tateishi et al,
1989; Moussaoui et al, 1992) and distributed all along the rostrocaudal axis of the
spinal cord (Moussaoui et al, 1992). ISHH has revealed that these NKB- positive
cells are present in a prominent band across lamina III, with a few cells in lamina I
and II (Warden and Young, 1988). However, different results were achieved
more recently when Too and Maggio (1992) carried out a double-labelling
immunofluorescence study in rat spinal cord using highly specific antisera raised
against SP or NKB. These investigators reported that NKB immunoreactive fibres
were concentrated mainly in lamina I and II, but it was not possible to localise
NKB-LI cells in the spinal cord. One possible answer to the discrepancy in the
results is that although cell bodies containing NKB mRNA have been localised
predominantly in lamina III (Warden and Young, 1988), perhaps these cells send
fibres into the more superficial layers.
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1.6 TACHYKININ RECEPTORS
There is evidence for three pharmacologically distinct mammalian
tachykinin receptors (Regoli et al, 1987). They have been termed neurokinin
NKq, NK2 and NK3 receptors and although all natural tachykinins are capable of
acting as full agonists at all of these 3 receptor sites (Regoli et al, 1987), each has
its own preferred ligand (Buck et al, 1986 Nakanishi et al, 1991; Maggi et al,
1993).
NK j- (SP has the highest affinity for this receptor).
NK/>- (NKA, NPK and NKy all act preferentially at this receptor).
NK3- (NKB is the preferred peptide).
Using molecular cloning techniques, 3 distinct genes encoding these
receptors, have been isolated and characterised. A cDNA clone for the NK/>
receptor was first isolated from bovine stomach (Masu et al, 1987) and then also
from rat stomach (Sasai and Nakanishi, 1989). Similarly, cDNA clones for NKj
and NK3 receptors were isolated from rat brain (Yokota et al, 1989; Shigemoto et
al, 1990). All 3 tachykinin receptors are members of a superfamily of G protein-
coupled rhodopsin-like receptors whose activation leads to stimulation of the
phosphoinositide (PI) pathway (Helke et al, 1990; Maggi et al, 1993).
1.6.1 The Distribution of Tachykinin Receptors in the Spinal Cord
The distribution of tachykinin receptors has been investigated using
pharmacological techniques, radioligand binding and autoradiography and more
recently by directly investigating expression of mRNA in tissues.
(ai) Distribution ofNKj Receptors.
By use of [^25i]_B0i^on Hunter-Substance P ([125i]_j3H-SP) it has been
demonstrated that NKj receptors are densely located in lamina I-II of the dorsal
horn, intermediolateral cell column and lamina X (Ninkovic et al, 1985; Helke et
al, 1986; Yashpal et al, 1990). This has been confirmed by measurement of
mRNA for NKq receptors which has consistently revealed high levels of
expression in the superficial spinal cord (Elde et al, 1990; Hershey and Krause,
1990; Tsuchida et al, 1990; Schafer et al, 1993). Using ISHH, Elde et al (1990)
have reported high levels of NKq receptor expression in neurons of the dorsal
horn, the area around the central canal and preganglionic autonomic neurons.
Using [125p]_BH-SP in combination with rhizotomy or lesioning, it has
been proposed that NK] receptor binding sites are located post-synaptically to
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primary afferent terminals, associated with both sensory and motor neurons (Helke
et al, 1986; Yashpal et al, 1991). Similar results have been achieved following
neonatal capsaicin (Mantyh and Hunt, 1985; Helke et al, 1986).
(aii) Heterogeneity ofNKj Receptors.
In spite of a general agreement in numerous binding studies, the
introduction of highly selective non-peptide NKj antagonists has highlighted some
important differences between species. The non-peptide NK^ antagonist CP-
96,345, has been shown to be about 100 times more potent in human, bovine and
guinea-pig tissues than in those of rat or mice (Beresford et al, 1991; Gitter et al,
1991; Watling et al, 1991; Petitet et al, 1993a). The converse picture is presented
by the non-peptide receptor antagonist RP 67,580, which possesses greater
potency in blocking the NK-1 receptor in the rat than guinea pig (Garrett et al,
1991; Petitet et al, 1993a). These results are surprising, since the structures of rat
and human receptors are veiy similar (95% homology) (Takeda and Krause 1991),
however, using these non-peptide antagonists, NK4 receptors can be differentiated
into two broad categories.
Heterogeneity of NK^ binding sites within the same species have also
been observed on the basis of differences in binding between central and
peripheral tissues (Lew et al, 1990; Fardin and Garret, 1991) and in the same
tissue (Petitet et al, 1992; Kage et al, 1991). These investigations have all
employed 'peptide' antagonists and therefore metabolic breakdown by peptidases
may account for some of the observed differences. A further study employing
newer non-peptide antagonists, has been carried out. Beresford et al, (1992),
measured the potencies of CP-96,345 and GR 82334 for NKj receptors in
preparations from guinea-pig, rabbit and rat. Both GR 82334 and CP-96,345 were
substantially less potent in rat tissues compared to guinea pig preparations and
rabbit aorta, also strongly suggestive of an intraspecies difference. Indeed,
behavioural studies have also suggested that there are indeed two subtypes of NKj
receptor in mouse spinal cord termed NK^ and NKjg (Sakurada et al, 1991).
The mechanism for generating two NKj receptors from one gene has yet to be
fully elucidated, however, two isoforms of the human NKj receptor thought to be
generated through alternative splicing mechanisms have been isolated (Fong et al,
1992), but are they functionally different?
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(hi) Distribution ofNK.2 Receptors.
The distribution of ligand binding to NK2 receptor sites in the spinal cord
has been studied using [125j]_bh_nka and it was found to be distinctly different
from NKj sites. Whereas the NKj sites are associated with both sensory and
motor neurons, the NK2 sites are associated only with the dorsal horn, presumably
the sensory afferent system (Buck et al, 1986) and are found in a distinct band in
lamina I and II of the dorsal horn (Mantyh et al, 1984a; Quirion and Dam, 1985;
Dam et al, 1990). However these results must be interpreted with caution as many
sites labelled with [1^1] BH-NKA may have been NK3 rather than NK2 sites
(Saffroy et al, 1988). Also it has been shown by Bergstrom et al (1987) that
addition of a Bolton Hunter group can affect the receptor specificity of certain
tachykinins. Finally, the NK] and NK2 receptors have very similar specificity of
certain tachykinin sequences (they show an overall similarity of 48%) (Yokota et
al, 1989) and so care must be taken in interpreting ligand binding results as there
may be a degree of cross-reactivity. However, when Yashpal et al (1990,1991)
used the more selective ligands [l^ij.hjsqdyl-NKA and eledoisin they also found
that NK2 receptors were present in the spinal dorsal horn. These sites are found to
be present in low quantities, mostly being concentrated along the dorsal and
ventromedial borders of the dorsal horn, and along the central canal of the lumbar
and sacral segments. After rhizotomy studies, Yashpal et al, (1991) concluded
that these NK2 sites are located postsynaptically to afferent fibre terminals.
There has been some controversy as to whether NK2 binding sites are
situated in the CNS. Some investigators have reported that NK2 sites are present
only in the periphery (Saffroy et al, 1988; Mantyh et al, 1989; Sasai and
Nakanishi, 1989) and using blot-hybridisation and RNAse protection analysis
Tsuchida et al (1990) reported that no NK2 binding sites can be found in either the
periphery or the CNS (Tsuchida et al, 1990). However, contradicting results were
achieved by both Takeda and Krause (1991) and Schafer and Weihe (unpublished
observations). Using nuclease protection analysis, Takeda and Krause (1991)
found low levels of NK2 receptors in the CNS and also, Schafer and Weihe
(unpublished observations) used ISHH to detect low levels of the NK2 receptor
mRNA in the spinal cord which was elevated after adjuvant-induced arthritis.
Thus, although there has been some controversy, both ligand binding
(using highly selective ligands for NK2 receptors), nuclease protection analysis
and ISHH suggest that NK2 receptors are present in the dorsal spinal cord in very
low quantities.
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(bii) Heterogeneity ofNK2 Receptors.
The first indication that NK2 receptors may be heterogeneous was
obtained by McKnight and co-workers (McKnight et al, 1988; Williams et al,
1988) who observed that L-659,874 potently antagonised NK2 agonists in the rat
vas deferens whilst it was weakly active in the guinea pig isolated trachea. More
recent in vitro studies have supported the existence of NK2 receptor heterogeneity
between species recognised by different NK2 receptor antagonists. The NK/>a
receptor subtype is characterised by high affinity for the heptapeptide antagonists
MEN 10207 and MEN 10376, and the selective NK2 ligand MDL28564. It is
preferentially expressed in rabbit pulmonary artery and bronchus, guinea pig
trachea, human ileum and colon and rat spinal cord (Buck et al, 1990; Maggi et al,
1990,1991,1992; Patacchini et al, 1991; Wiesenfeld-Hallin et al, 1994). The
NK2B receptor subtype is preferentially recognised by the antagonists R396 and
L-659,877 and is expressed in rat vas deferens and hamster trachea (Maggi et al,
1991,1992; Patacchini et al, 1991). This interspecies heterogeneity of NK2
receptors has been supported using radioligand binding studies (Van Giersbergen
et al, 1991).
Pharmacological and molecular binding studies have also demonstrated
tachykinin receptor subtypes expressed in rat tissues (Takeda and Krause, 1991;
Nimmo et al, 1992). Using ligand binding assays ([ 1 combined with
analysis of NK2 receptor mRNA levels by nuclease protection methods, Takeda
and Krause (1991) showed that the highest level of NK2 receptor mRNA
expression was found with urinary bladder RNA and relatively high expression
found with vas deferens and gastrointestinal tissue RNAs. Expression was also
detected in hippocampus, striatum and spinal cord RNA preparations but the
levels were about 500-fold lower than for urinary bladder. From these
observations, Takeda and Krause (1991) concluded that there are two distinct
NK2 receptor types in rat tissue membranes, one type expressed in duodenum and
another expressed in vas deferens and urinary bladder. However, two types of
NK2 receptor have been identified within rat urinary bladder by the displacement
of [125i]_nka with the NK2 receptor selective antagonist MEN 10207 (Nimmo
et al, 1992). The differences observed between studies may be due to the use of
different ligands, however, until two distinct receptor subtypes are molecularly
characterised, these results must be interpreted with caution.
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(ci) Distribution ofNKj Receptors.
Receptor binding assays and autoradiographic studies using
eledoisin demonstrate that NK3 sites are found in highest concentrations in the
dorsal horn especially in its dorsal borders; while there are low concentrations in
the lateral horn of the thoracic cord and around the central canal in lumbar and
sacral segments (Buck et al, 1986; Mantyh et al, 1989; Yashpal et al, 1990,1991).
Unfortunately it has been shown that this ligand can also bind to both NKj and
NK2 sub-types under certain assay conditions (Regoli et al, 1987; Quirion and
Dam, 1988) and so these results do not necessarily display specific binding for
NK3 receptors. However, using a highly selective synthetic agonist ligand
[^H]senktide, a similar distribution of binding has been observed in the primate
spinal cord (Guard and Watson, 1991), with specific binding concentrated in the
superficial layers of the dorsal horn and lower levels observed throughout the
dorsal and ventral horns.
(cii) Heterogeneity ofNKj Receptors.
The study of possible NK3 receptor subtypes has been hampered by the
lack of selective agonists and antagonists, however, most recently radioligand
binding studies have suggested the existence of interspecies NK3 receptor
subtypes.
Using displacement of the selective NK3 receptor radioligand [^5j]_
[MePhe^JNKB with the selective NK3 receptor agonists senktide, [MePhe^]NKB
and [Pro^JNKB in both guinea-pig and rat cerebral cortex membranes, differences
in binding can be observed. Whereas both senktide and [MePhe^JNKB potently
displace the radioactive ligand in both guinea pig and rat membranes, [Pro^JNKB
displays higher affinity for the rat compared to the guinea pig membranes (Watling
et al, 1994). Interestingly, the non-peptide NK2 antagonist SR 48968, whilst
possessing essentially no affinity for NK3 binding sites in the rat, is a moderately
potent displacer of NK3 binding sites in the guinea pig (Petitet et al, 1993b;
Watling et al, 1994). However, as is the case for the NK2 receptor, no
information is currently available concerning the molecular determinants which
underlie these apparent species variants of the NK3 receptor and thus results must
be interpreted with caution.
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1.7 THE INVOLVEMENT OF TACHYKININS IN ACUTE AND SUSTAINED
NOCICEPTION
The tachykinins SP and NKA are thought to play an important role in the
transmission of nociceptive information in the spinal cord due to the observation
that the greatest concentration of tachykinin-like immunoreactive terminals are
seen in the region of the substantia gelatinosa (Ogawa et al, 1985), an area where
fine nociceptive afferents predominantly terminate (Perl, 1984). In addition,
results from various experimental observations including electrophysiological,
flexor-reflex, transmitter release and behavioural studies indicate an important role
for these tachykinins in both acute and sustained nociceptive pain states.
1.7.1 Acute Nociceptive States and the Possible Involvement of
Tachykinins in their Production
Acute pain is that of short duration which normally occurs at the onset of
noxious stimulus, lasting over 10s of seconds, and in an unanaesthetised state will
evoke a withdrawal reflex from the source of injury. There are several lines of
evidence indicative of a role for the tachykinins SP and NKA in the spinally-
mediated transmission of acute pain.
(a) Substance P.
There is much evidence indicative of an important role for SP in
transmission of nociceptive information in the spinal cord. SP was first proposed
to mediate nociceptive inputs at the first sensory synapse in the spinal cord (Henry,
1976) on the basis of immunohistochemical evidence, for its presence in small
diameter sensory fibres (Hokfelt et al, 1975a), and electrophysiological evidence
for its excitation of nociceptive neurons in this region (Henry, 1976). This
contention has been supported by the following :-
(ai) Transmitter Release Studies.
Both sensitive antibody microprobe and push-pull cannula perfusion
techniques have been utilised to measure the release of SP-like immunoreactivity
(SP-LI) in the spinal cord in vivo and it has been demonstrated that SP-LI is
released from the spinal cord in response to noxious (but not non-noxious)
mechanical and cold stimulation of the ipsilateral hindpaw (Duggan et al,
1987,1988; Go and Yaksh, 1987; Kuraishi et al, 1989; Tiseo et al, 1990).
However, contradicting results have been obtained concerning SP release in
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response to noxious thermal stimulation. Whereas Duggan et al (1987,1988) have
demonstrated SP release in the spinal cord following a noxious thermal
stimulation to the ipsilateral hindpaw, other groups of investigators (Tiseo et al,
1990; Kuraishi et al, 1989) could not demonstrate a thermally-mediated SP release
even when behavioural signs were indicative of pain (Tiseo et al, 1990).
However, the thermal stimulus used by Duggan's group was greater than the
threshold for irreversible inflammatory damage, suggesting that SP is more likely
to be released in a 'sensitised' state. Indeed, spinal release of SP-IR has been
demonstrated following 'scalding' thermal stimulation (Go and Yaksh, 1987;
Kuraishi et al, 1989) in addition to more prolonged inflammatory conditions (Oku
et al, 1987; Kuraishi et al, 1989; Schaible et al, 1990; McCarson and Goldstein
1991).
Using electrical stimulation of the sciatic nerve, SP in the spinal cord has
been shown to be released from small, probably unmyelinated primary afferents
(Yaksh et al, 1980; Go and Yaksh, 1987) and the antibody microprobe detection
technique has found that this release is in a discrete, focal area around the
substantia gelatinosa (Duggan et al, 1987,1988). It should be noted that not all SP
in the dorsal horn is found in primary afferent fibres, approximately 20% is
thought to originate from intrinsic and descending neurons (Jessell et al, 1979).
However, the contribution to evoked release from these seems to be minimal as in
spinally-transected animals no change was observed in SP release due to noxious
pinch (McCarson and Goldstein, 1991).
Thus from release studies it cannot be concluded that SP is primarily
responsible for transmission of acute nociceptive responses. A certain element of
tissue damage seems necessary to provoke its release to noxious thermal stimuli
and so it may result in the activation of nociceptors that are not heat specific
(aii) Electrophysiological Studies.
In in vitro, intracellular recording studies, electrical stimulation of dorsal
roots at C fibre strength or bath application of SP to both adult rat transverse
spinal cord slices (Yoshimura et al, 1993; Urban and Randic, 1984) and neonatal
hemisected spinal cord (Nagy et al, 1993), produces a late, slow de.polarisat.ion in
dorsal horn neurons. This can be blocked by the SP antagonists Spantide
(Yoshimura et al, 1993) and (D-Argl, D-Pro^, D-Trp^-9, Leu^)-SP (Urban and
Randic, 1984). However, the evidence that these SP-evoked responses are
mediated by C-fibres is not compelling. Although the newly described NKj
antagonist CP-96,345 specifically blocked the excitation of cat dorsal horn
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neurons brought about by electrical stimulation of afferents at C-fibre strength
(Nagy et al, 1993), in capsaicin-sensitive fibres, the antagonist CP-96,345 did not
inhibit the capsaicin-evoked equivalent depolarisation. As capsaicin selectively
activates a subpopulation of primary afferent fibres, the majority of which are
polymodal nociceptors (Fitzgerald, 1983), these data suggest that NK] receptors
are not involved in the activation of capsaicin-sensitive C fibres.
In numerous in vivo studies, SP has been microionophoretically applied to
dorsal horn neurons in the spinal cord. Henry (1976) was one of the first to
suggest a role for SP in pain perception when he found that ionophoretic
application of this peptide to single neurons in laminae IV-VI of the cat spinal
cord excited about half of the cells tested. Its failure to excite all nociceptive
neurons was explained by the low rate of SP release from the micropipettes. Since
then, several groups have applied SP by microiononphoresis in the vicinity of
dorsal horn neurons and generally observed excitatory effects (Randic and Miletic,
1977; Sastry 1979; Zieglgansberger and Tulloch, 1979; Piercey et al, 1981;
Kellstein et al, 1990; Hill et al, 1985; Salter and Henry, 1991). The locally
ionophoresed SP can produce an excitatory effect that is slow in onset and of long
duration (Henry, 1976; Zieglgansberger and Tulloch, 1979; Salter and Henry,
1991), inhibited by the selective SP antagonist CP-96,345 (Radhakrishnan and
Henry, 1991) and some have found it to be selective for dorsal horn neurons that
respond to noxious stimulation (Henry, 1976; Salter and Henry, 1991). However,
in all these studies, heterogenous neuronal populations have been examined,
which may present considerable variation in the organisation of their cutaneous
afferent inputs. Furthermore, the predominant zone of fine afferent termination
and also of receptors for the released transmitters, is the substantia gelatinosa
(Perl, 1984), far away from most of the drug administration sites in the above
studies. In some cases, complex mixed excitatory and inhibitory effects have been
observed (Davies and Dray, 1980; Murase and Randic, 1984; Willcockson et al,
1984; Ryall and Pini, 1987) suggesting multiple sites or components of action.
Also very few studies have histologically identified the neurons and this may cause
a further level of variability.
There is a great deal of controversy over the role of SP in the spinal dorsal
horn. Whereas it has been reported by various workers that SP selectively excites
mechanically nociceptive neurons (Randic and Miletic, 1977), chemically
nociceptive neurons (Wright and Roberts, 1980) or thermally nociceptive neurons
(Henry, 1976; Piercey et al, 1980) in the dorsal horn, excitatory effects have also
been seen by some workers on non-nociceptive dorsal horn neurons
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(Zieglgansberger and Tulloch, 1979; Lawson et al, 1994). Indeed, other in vivo
experiments indicate that some inputs to a sub-population of dorsal horn neurons
are inhibited by SP, acting via an NKj receptor (Fleetwood-Walker et al,
1987,1990). Fleetwood-Walker et al, (1987) used a dual electrode protocol to
investigate the roles of tachykinins in somatosensory processing. This involved
administering drugs into the region of the substantia gelatinosa (SG) whilst
recording responses of laminae IV-V spinocervical tract (SCT) neurons. Results
showed that [Met-OMe^]-SP (a selective NKj agonist) was ineffective in
altering nociceptive responses, although it appeared to have an inhibitory influence
over a non-nociceptive input pathway. This was confirmed in later when
Fleetwood-Walker et al, (1990) examined effects of tachykinins on both
superficial and deep dorsal horn neurons. The responses of laminae III-V dorsal
horn neurons to innocuous cutaneous stimuli were attenuated by SP and the highly
selective NKj agonist [N-acetyl-Arg^,Sar9,Met(02)^]SP-(6-l I) whereas the
selective NKj receptor antagonists L-668,169, GR 82334 and [D-Pro4,D-
Trp7>9>10phelT]substance P-(4-ll) failed to influence neuronal responses to
cutaneous pinch or noxious heat but often enhanced responses to noxious brush.
However, Duggan et al, (1979) found that when SP was administered
ionophoretically into the substantia gelatinosa of cats it failed to affect excitation
of deeper spinal cord neurons elicited by non-noxious (brush) as well as noxious
(heat) cutaneous stimuli. The discrepancies seen are probably due to differences
in experimental procedure. In particular, differences in anaesthesia may be of
relevance, as substance P-induced excitations appear to be especially sensitive to
anaesthetics (Sastry, 1978).
In decerebrate, spinalised, unanaesthetised rats, intrathecal SP facilitates
the nociceptive flexion reflex to both mechanical and thermal stimulation of the
ipsilateral hindfoot (Wiesenfeld-Hallin, 1986; Woolf and Wiesenfeld-Hallin,
1986; Xu and Wiesenfeld-Hallin, 1992). However, the thermal stimulation is very
intense (80-100°C) and is most probably damaging causing local inflammatory
effects. The tachykinin antagonist spantide II selectively blocks the facilitatory
effect of intrathecal SP and C-afferent conditioning stimulation on spinal cord
reflex excitability without causing neural injury (Wiesenfeld-Hallin et al, 1990).
A similar inhibition of the flexor reflex has been achieved using the highly
selective non-peptide antagonists CP-96,345 (Xu et al, 1992a) and RP 67,580
(Laird et al, 1993). However, multiple sites of action inappropriate to the function
of endogenous nociception such as the ventral horn (Otsuka and Yangisawa,
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1980) may contribute to these results and thus this effect may not be entirely due to
the action of SP.
(aiii) Behavioural Studies.
Behavioural responses provide inconsistent evidence that NK] receptors
are involved in mediating nociceptive effects of tachykinins in the rat spinal cord.
Intrathecal administration of SP or selective NKj agonists results in dose-
dependent reciprocal hindlimb scratching, biting and licking responses directed to
the caudal part of the body (Hylden and Wilcox, 1981; Piercey et al, 1981;
Sweeney and Sawynok, 1986; Post and Folkers, 1985; Gamse and Saria, 1986;
Papir-Kricheli et al, 1990; Laneuville et al, 1988; Lecci et al, 1991). These
responses are thought to be a syndrome indicative of nociceptive stimulation and
supporting this, intrathecal injection of both SP and selective NKj agonists has
been shown to result in a dose-dependent reduction in both tail-flick latency
(Picard et al, 1993; Cridland and Henry, 1986,1988; Yashpal et al, 1993; Post and
Folkers, 1985) and paw-pressure latency (Sweeney and Sawynok, 1986), thus
facilitating nociceptive transmission and indeed, one report claims that SP causes
hyperalgesia after intrathecal administration (Akerman et al, 1982). However, not
all studies are in agreement with SP having a primary role in nociceptive
transmission, Doi and Jurna, (1981) demonstrated antinociception from 10 min
after intrathecal SP injection and others have reported that SP plays no role in the
behavioural responses to tail-flick and hot plate test in the mouse (Gamse and
Saria, 1986) or rat (Piercey et al, 1981). It may be that SP is a modulator rather
than a transmitter of noxious information as suggested by Sweeney and Sawynok,
(1986) after they observed that pre-treatment with two doses of intrathecal SP
produced complete desensitisation to the paw pressure test without altering the
baseline responsiveness.
Experiments with the peptide SP antagonists have further suggested a role
for SP in transmission of nociceptive input to the spinal cord. Intrathecal
administration of SP antagonists prevents the aversive responses (biting,
scratching and licking) induced by intrathecal SP and produces antinociception in
the hot plate and Tail-flick tests (Piercey et al, 1981; Lembeck et al, 1981; Post
and Folkers, 1985). However, the interpretation of these results is hampered by
the fact that several peptidergic SP antagonists also possess pharmacological
activities which are unrelated to blockade of SP receptors, for example
vasoconstriction, (Freedman et al, 1988).
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The more recent development of the selective non-peptide NK] receptor
antagonists CP-96,345 (Snider et al, 1991), CP-99,994 (McLean et al, 1993) and
RP 67580 (Garret et al, 1991) have provided new research tools with which to
investigate the role of tachykinins in nociception. In adult rats, CP-96,345 has
been shown to be active in both the hot plate (Lecci et al, 1991) and Tail-flick
(Picard et al, 1993; Yashpal et al, 1993) tests and in addition, it has been
demonstrated to specifically and dose-dependantly block both the behavioural
responses and the attenuation of the tail-flick response induced by i.t. SP agonist
(Picard et al, 1993). These results are at variance with those from Garces et al,
(1992) who reported no antinociceptive activity of CP-96,345 in paw-flick and
tail-flick tests or SP-mediated biting and scratching. The discrepancies between
these studies may be explained by the lesser affinity of CP-96,345 for rat and
mouse tissue, binding with 70-fold lower affinity to the NKj receptor than to that
in human, gerbil and guinea-pig tissue (Beresford et al, 1991). It is also known to
have non-specific cardiovascular depressant effects (Lembeck et al, 1992) and
calcium channel antagonist activity (Schmidt et al, 1992) which contribute to the
antinociceptive actions of this peptide compound (Nagahisa et al, 1992) and
demonstrate that it is not specific for NKj receptors. Indeed, there was no effect
on acute thermal (tail-flick and hot-plate) tests or against acetic acid induced
abdominal constriction, after administration of the more recently developed
selective NKj non-peptide antagonist CP-99,994 however in a tonic nociceptive
test CP-99,994 significantly reduced the second phase of the formalin-induced
paw-licking response following pre-treatment (Elliott et al, 1992), suggestive of a
role for NKj receptors in a tonic nociceptive state. RP 67580 binds with high
affinity to the rat NK j receptor (Garrett et al, 1991), however it has been
demonstrated to be inactive in the mouse tail-flick and rat paw-pressure tests
(Rupniak et al, 1993) and only effective in models producing a more sustained
level of nociception (Rupniak et al, 1993), in agreement with the above study with
CP,99 994.
(b) Neurokinin A
Although there is considerable evidence which suggests that SP plays a
role in nociceptive transmission, it is unlikely to be the only transmitter. There
may be many others, but NKA is a likely candidate for a transmitter in primary
afferents. It has been found that NKA is also present in primary sensory neurons
(Harmar and Keen, 1984) and is released by capsaicin from primary afferent
terminals (Saria et al, 1986). This and the observation that by radioimmunoassay
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similar distributions of NKA and SP are found in rat dorsal horn, dorsal roots and
dorsal root ganglia (Ogawa et al, 1985), suggests that NKA and SP may be co-
released from relevant afferents or may be released separately, depending on the
nature of the stimulus.
Compared to SP, fewer studies have been conducted on the possible
functional roles for NKA in primary sensory processing.
(bi) Transmitter Release Studies.
Studies using the antibody microprobe technique have been used to
examine the release of immunoreactive NKA in barbiturate anaesthetised spinal
cats following cutaneous thermal and mechanical stimulation (Duggan et al, 1990;
Hope et al, 1990; Lang et a., 1991). Noxious mechanical and noxious thermal
stimuli both increased the levels of immunoreactive NKA in a diffuse pattern
throughout the dorsal horn, which was not potentiated by tissue damage (Hope et
al, 1990). The immunoreactive NKA persisted beyond the duration of the noxious
stimulus (Duggan et al, 1990; Hope et al, 1990), taking 60 to 90 minutes to reach
pre-stimulus levels, suggesting that NKA is degraded slowly when released in the
spinal cord. This is a different pattern to that of SP, which is released focally into
the region of the SG, but only by damaging levels of stimuli (Duggan et al,
1987,1988) and is degraded rapidly by peptidases (Duggan et al, 1992).
Thus it is evident that SP and NKA have very different release (or
degradation) patterns and roles in the spinal cord. The diffuse release pattern and
persistence of NKA in the spinal cord are suggestive of a role for this transmitter
in prolonged spinal events and indeed its release has been observed after injection
of kaolin and carrageenan into the knee joint (Hope et al, 1990).
(bii) Electrophysiological Studies.
There is much evidence indicative of an important role for NK2 receptors
(and NKA) in the transmission of nociceptive information in the spinal cord.
These have included both in vitro as well as in vivo preparations.
After capsaicin excitation of C fibres in vitro, a post-synaptic
depolarisation of dorsal horn neurons has been demonstrated (Urban et al, 1992;
Nagy et al, 1993). The selective NK2 antagonist MEN 10376 reversibly reduced
the amplitude of this depolarisation to 30% of control (Urban et al, 1992).
Similarly, Nagy et al, (1993) have demonstrated that these dorsal horn neurons
which respond to capsaicin, were also excited by perfusion of both NKj and NK2
agonists, which were blocked by the selective antagonists CP-96,345 and MEN
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10376, respectively. However, capsaicin evoked- responses in the dorsal horn
were inhibited by the selective NK2 antagonist MEN 10376, but no change was
observed after perfusion with the NKj receptor antagonist CP-96,345. These data
suggest that the activation of dorsal horn neurons by C fibres involve mainly NK/?,
rather than NKj, receptors. Further evidence for the involvement of NKA and
NK2 receptors in capsaicin-sensitive nociceptive afferents was obtained following
infusion of the selective NK2 antagonists GR 98400 and MEN 10376 (Dougherty
et al, 1994). Both the NK3? antagonists reduced the responses of STT neurons to
intradermal capsaicin but not to noxious or innocuous mechanical stimulation.
In anaesthetised rats (Salter and Henry, 1991) and cats (Henry and Salter,
1987), ionophoretic administration of NKA has been shown to cause excitation of
both nociceptive and non-nociceptive dorsal horn neurons with a delayed, slow
and prolonged excitatory effect. However, these results are at variance with those
of Fleetwood-Walker et al, (1987,1990).
By using a dual electrode protocol in the cat, Fleetwood-Walker et al,
(1987,1990) demonstrated that NKA caused a marked and selective facilitation of
responses to noxious heat, but other activity and sensory responses (even to
noxious mechanical stimuli) were unaffected. A similar effect was seen when the
NK2 agonists NKA, kassinin and [Glp6,D-Pro9]SP, but not the NKj agonists SP
or spantide were applied ionophoretically into the region of the substantia
gelatinosa. A facilitation of the response of SCT neurons to noxious thermal, but
not mechanical nociception was found. In addition, when the NK2 antagonists
[D-Pro4, Fys6, D-Trp7'9'10, Phe11]SP(4-11) and [D-Tyr4, D-Trp7*9, Nle11] SP
(4-11) were ionophoresed at higher currents, both were alone able to attenuate
thermal nociceptive responses.
These results were more recently confirmed in the rat using a range of
recently developed agonists and antagonists, which have higher selectivity for the
NK2 receptors. Using a single electrode, extracellularly recording from rat
laminae III-V neurons whilst ionophoresing drugs nearby, has shown that the
highly selective NK2 receptor antagonist F-659,874 profoundly inhibited
responses to noxious heat, with no effect on the sensory responses to noxious
pinch or innocuous brush. A reciprocal effect was observed after ionophoresis of
NK2 agonists, NKA or GR 64349. Thus it is concluded that although both NKj
receptors clearly mediate excitation of dorsal horn neurons, it is not NKj, but NK2
receptors that are important as the physiological transducer of thermal nociceptive
inputs in this model.
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A role for NK2 tachykinin receptors in the regulation of the spinal flexor
reflex has also been suggested (Xu et al, 1991; Xu and Wiesenfeld-Hallin, 1992;
Wiesenfeld-Hallin et al, 1994). Xu et al, (1991) studied the effects of intrathecal
NKA, SP and MEN 10207 (a selective NK-2 receptor antagonist) on the spinal
nociceptive flexor reflex. The results showed that whilst both intrathecal NKA
and SP facilitate the flexor reflex in a similar manner, MEN 10207 only blocked
the facilitation to NKA but not to SP consistent with a role for NK-2 receptors in
the mediation of spinal reflex excitability. This group followed with an
investigation of the effect of intrathecal NKA on spinal reflex excitability in
response to cutaneous thermal and mechanical stimulation (Xu and Wiesenfeld-
Hallin, 1992). Both thermal and mechanical stimulation were substantially
facilitated by NKA, the thermal with a much greater facilitation response than
mechanical (although the thermal stimulus was at a damaging temperature of
80°C).
(biii) Behavioural Studies.
Although far fewer behavioural studies have been carried out for NKA
than for SP, evidence is accumulating to suggest that NK2 receptors are extremely
important in mediating nociceptive transmission in the spinal cord. Intrathecal
injection of NKA or a selective NK2 agonist caused similar reciprocal hindlimb
biting, licking and scratching responses to those described for SP (Gamse and
Saria, 1986) in addition to dose-dependent, transient decreases in the tail-flick and
paw-flick response latencies to a noxious thermal stimulus (Cridland and Henry,
1986; Laneuville et al, 1988; Fleetwood-Walker et al, 1990; Picard et al, 1993).
The inverse effect was seen with intrathecal injection of the NK2 antagonist [D-
Pro4, Lys6, D-Trp7>9>10, Phe11]SP(4-11)4 (D-Pro4) (Fleetwood-Walker et al,
1990), with an increased response latency in Tail-flick and hot-plate tests.
A more recent study examined the non-peptide NK2 antagonist SR 48968
as an inhibitor of the reaction time in the rat tail-flick and also on the decrease of
reaction time induced by the intrathecal injection of the selective NK2 agonist
NKA-(4-10) (Picard et al, 1993). The results show that there was a potent
decrease in tail-flick reaction time after administration of NKA-(4-10), which
persisted for an extended period of time (26 minutes) and was selectively blocked
by SR 48968, suggesting a role for NKA in transmission of prolonged facilitation
of nociception.
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1.7.2 Sustained Nociceptive States and the Possible Involvement of
Tachykinins in their Production.
Persistent pain and hyperalgesia occurs following peripheral tissue injury
which produces changes in the function of the nervous system. The
hypersensitivity which results as a consequence of tissue injury and inflammation
is due to a considerable extent of increased sensitivity of primary afferent
nociceptors that innervate the area of peripheral damage (Bessou and Perl, 1969;
LaMotte et al, 1992). This increased responsiveness in primary afferents, due to
an injuring stimulus in their receptive field area, may not affect responses in
central neurons (Treede et al, 1992). However, additional mechanisms can lead to
increased responses in the neurons within the spinal cord (central sensitisation:
Woolf, 1983; Treede et al, 1992) which may also contribute to the phenomenon of
a 'sustained' nociceptive state. The induction of central sensitisation is critically
dependent upon the activation of nociceptive afferent fibre inputs (Wall and
Woolf, 1984; Woolf and Wall, 1986) and has been observed following brief
electrical stimulation of high-threshold afferent fibres (Woolf and King; 1990), the
application of chemical irritants to skin (Dougherty and Willis, 1992; LaMotte et
al, 1992) and following peripheral inflammation (Schaible et al, 1990). There are
several lines of evidence indicative of a role for the tachykinins SP and NKA in
the spinally-mediated transmission of sustained nociception.
(a) Substance P.
(ai) Biosynthesis and Transmitter Release Studies.
Inflammatory models of formalin and CFA have been shown to increase
the biosynthesis of SP-IR and mRNA encoded by the preprotachykinin (PPT)-l
gene in the spinal dorsal horn and dorsal root ganglia of rats (Minami et al, 1989;
Donaldson et al, 1992; Noguchi and Ruda, 1992; McCarson and Krause, 1994).
Following bilateral injection of adjuvant into the rat hindpaws the levels
of PPT mRNA were significantly increased in both the dorsal root ganglia at L4-
L5 levels and also in the lumbar spinal cord (Minami et al, 1989). Similarly, after
unilateral injection of adjuvant or formalin, increase in PPT mRNA level was
observed only on the treated side of the spinal cord (Minami et al, 1989; Noguchi
and Ruda, 1992) and dorsal root ganglia (Minami et al, 1989; Donaldson et al,
1992; McCarson and Krause, 1994). Using ISHH, Noguchi and Ruda (1992)
have demonstrated in laminae I, II and V/VI ipsilateral to the inflammation there
was a differential increase in the number of neurons exhibiting PPT mRNA. In
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lamina I there was a greater than 200% increase in the number of spinal projection
neurons containing PPT mRNA and using fluorogold labelling 61% of these were
shown to be SMT neurons. It is possible that not only afferent, but also spinal
(local) SP neurons play a role in sustained nociception.
In addition to an increased biosynthesis of transmitter, an increase in the
NKj receptor gene expression and NKj binding sites have been observed after
induction of inflammation by formalin and CFA (Schafer et al, 1993; Stucky et al,
1993; McCarson and Krause, 1994). Four and eight days after unilateral CFA-
induced inflammation in rats, Stucky et al (1993) reported increases in BH-
[125jjsp binding in laminae I and II of the ipsilateral spinal cord, in agreement
with Schafer et al (1993) who used ISHH to detect an almost 200% increase in
NKj receptor gene expression within small to medium sized laminae I-II neurons
6 days after CFA injection. Similarly, using solution hybridisation-nuclease
protection techniques an almost two fold increase in NKq receptor mRNA was
detected in the rat lumbar dorsal horn 4 days after CFA or 2-4 hours after formalin
injection (McCarson and Krause, 1994).
Inflammatory and 'sensitising' models have also been demonstrated to
increase the release of SP in the dorsal horn. Spinal release of SP
immunoreactivity (SP-IR) has been demonstrated following a 'sensitising' thermal
stimulation (Go and Yaksh, 1987; Kuraishi et al, 1989) in addition to more
prolonged inflammatory conditions (Oku et al, 1987; Kuraishi et al, 1989;
Schaible et al, 1990; McCarson and Goldstein, 1991). In vitro immunochemical
studies have revealed that after intraplantar injection of formalin into the rat
hindpaw, there is a resulting increase in the release of SP-like immunoreactivity
(SP-LI) in the ipsilateral spinal cord (Kuraishi et al, 1989; McCarson and
Goldstein, 1989,1991). A biphasic release was observed by McCarson and
Goldstein (1991) with early (0-20 min) and late (20-60 min) increases in SP-LI
consistent with observations of two corresponding phases of nociceptive
hyperalgesic behaviour (Chapman and Dickenson, 1993).
Carrageenan- or carrageenan/kaolin- induced inflammation takes several
hours to develop and represents a useful tool to study acute inflammatory pain
states. Three hours after bilateral carrageenan injection, a significant increase in
both the spontaneous and capsaicin-evoked release of SP-LI has been detected in
the superfusates collected from the dorsal horn (Garry and Hargreaves, 1992),
indicating that an enhanced release of SP occurs in the dorsal during
inflammation. Similarly, release of SP in the dorsal horn occurred following
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innocuous mechanical stimulation of a carrageenan/kaolin-inflamed (Schaible et
al, 1990) or a CFA-inflamed (Oku et al, 1987) but not a normal knee joint.
Collectively these results suggest that biosynthesis of SP in the spinal cord
and primary sensory neurons and NKj receptors in the dorsal horn can be
increased by a sustained and inflammatory pain state.
(aii) Electrophysiological Studies.
When C-fibres are repetitively stimulated at high frequencies, the
phenomenon of 'wind-up', a progressive increase in the number of action
potentials evoked per stimulus, occurs in dorsal horn neurons (Mendell, 1966). In
addition to causing wind-up, brief repetitive stimulation of C-afferents also
induces prolonged increase of spinal cord excitability (Wall and Woolf, 1984).
Substance P may be involved to some extent in wind-up as it has been shown that
ionophoresis of SP enhances the response of dorsal horn neurons to C-fibre input
(Zieglzansberger and Tulloch, 1979; Kellstein et al, 1990), and causes a long-
lasting slow depolarisation (Murase and Randic, 1984) which resembles the slow
prolonged depolarisation produced by repetitive stimulation of C afferent fibres.
This is strengthened by the observation that SP enhanced, whilst the SP antagonist
[D-Pro2,D-Trp7'9]-SP (DPDT) attenuated 'wind-up' caused by repeated simulation
of C, but not A afferents (Kellstein et al, 1990) and further that responses to
electrical stimulation of C afferents and 'wind-up' of the flexor reflex were blocked
the NKi antagonist RP 67,580 in a dose-dependent manner without affecting the
baseline reflex (Laird et al, 1993). This is also consistent with the results of
McNeill et al (1989), who observed that administration of capsaicin to rats at birth
caused a depletion of IR-SP in the dorsal horn and a corresponding reduction in
the number of cells exhibiting 'wind-up'. The exact mechanism by which SP
produces the slow depolarisation in dorsal horn neurons has yet to be elucidated;
however there has been a report which suggests that SP produces a prolonged (up
to 4 mins) increase in intracellular calcium release from intracellular stores
(Womack et al, 1988).
A spinal role for NKj receptors in the response of dorsal horn nociceptive
neurons to peripheral inflammation has also been demonstrated, using the formalin
model (Chapman and Dickenson, 1993). The selective non-peptide NK[ receptor
antagonist RP 67,580 had mimimal effects on the response to acute C-fibre
stimulation, however using the same dose, RP 67580 produced marked and dose-
dependent inhibitions of both phases of the formalin response of dorsal horn
neurons which could be clearly separated from vehicle effects (Chapman and
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Dickenson, 1993). However, it should be noted that RP 67580 was dissolved in a
very acidic solution (lOmM HC1) which would be likely to produce damaging
effects.
Recently, a novel model of peripheral injury induced by UV irradiation
has been utilised (Thompson et al, 1994). Behavioural hyperalgesia (both thermal
and mechanical) was induced in neonatal rat pups 1-3 days following UV
irradiation of one hind-paw and the spinal cord was subsequently removed,
hemisected and maintained in vitro at 4°C. A and C-fibre evoked ventral root
potential (VRP) responses were examined in these isolated in vitro spinal cord
preparations and compared with those in naive untreated animals. Following UV
irradiation, it was observed that both A- and C- fibre evoked responses were
enhanced. The contribution of NKq receptors was then assessed using bath
perfusion of the selective antagonists CP-96,345 and RP 67580 and it was
observed that although the prolonged C-fibre evoked VRPs were not affected by
NK] antagonists under normal conditions, the enhanced A- and C- evoked VRPs
following UV injury showed a significant NKq component that was associated
with behavioural hyperalgesia. These results suggest that NKj receptors may
contribute to the phenomenon of 'central sensitisation' and relate to the behavioural
hypersensitivity observed.
The excitability of spinal flexor reflexes in experimental animals has been
shown to be increased by injury or inflammation in the periphery (Woolf, 1983;
Ferrell et al, 1988). Similar, though more transient increases in flexor reflex
excitability can be induced by high intensity electrical conditioning stimuli to C
afferent (but not A8 or A(3 afferent) fibres (Wall and Woolf, 1984; Woolf and
Wiesenfeld-Hallin, 1986). This effect may be analogous to the 'wind-up' seen in
dorsal horn cells after repeated C-fibre afferent stimulation to their receptive fields
(Mendell and Wall, 1965). Pre-treatment of the sciatic nerve with capsaicin
abolishes this facilitation (Woolf and Wall, 1986), suggestive of a role of
neuropeptides. Indeed, intrathecal administration of SP is shown to mimic the
electrical conditioning stimuli by facilitating the nociceptive flexor reflex for 4-5
minutes (Woolf and Wiesenfeld-Hallin; 1986; Wiesenfeld-Hallin et al, 1990; Xu
et al, 1992). Intrathecal pre-treatment with the selective NKq antagonists spantide
II (Wiesenfeld-Hallin et al, 1990), CP-96,345 (Xu et al, 1992) and RP 67,580
(Laird et al, 1993) effectively antagonise the facilitatory effect of SP on the flexor
reflex. The non-peptide antagonist CP-96,345, at effective doses, not only
attenuated facilitation evoked by the electrical conditioning stimulus, but also
depressed the reflex response such that the conditioned response was considerably
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smaller that the baseline response seen immediately before the conditioning
response (Xu et al, 1992). As CP-96,345 is active at calcium channels (Schmidt et
al, 1992), non-specific activity at these channels may account for the differences
observed on the baseline reflex and thus suggests that the facilitation of the spinal
flexor reflex is mediated NKj receptors whilst the baseline reflex is not.
(aiii) Behavioural Studies.
Many different models are used to simulate sustained or chronic pain
associated with inflammation without major tissue damage. Immersion of the rat's
distal tail region in hot water results in a sustained noxious cutaneous stimulation
characterised by a reduction in tail-flick reaction time which both peptide and non-
peptide NKq antagonists have been shown to dose-dependently increase (Cridland
and Henry, 1988; Yashpal et al, 1993) suggesting a role for SP in a sensitised
model of pain.
Intraplantar injection of formalin is associated with a characteristic
biphasic licking and biting behaviour pattern. Early SP antagonists only inhibited
the first phase of the formalin response (Ohkubo et al, 1990), but this could have
resulted from degradation of these drugs prior to the second phase of the formalin
response. More recently, non-peptide NKq antagonists have been used. CP-
96,345 inhibited the late phase of the response in a dose dependent manner
(Yamamoto and Yaksh, 1991; Birch et al, 1992; Nagahisa et al, 1992; Yashpal et
al, 1993). Yashpal et al, (1993) demonstrated stereospecificity of CP-96,345 as its
inactive isomer CP 96,344 was ineffective in the formalin test. However, others
have found that CP 96,344 attenuated the second phase of the formalin-induced
paw-licking response with a potency equal to its active isomer (Nagahisa et al,
1992). RP 67,580 binds with higher affinity to rat tissues than CP-96,345 but
again there are discrepancies in the formalin tests between groups. Whereas some
groups (Chapman and Dickenson, 1993; Garrett et al, 1991) have shown RP
67580 produces marked inhibitions in both phases of formalin response in both
mice and rats, Rupniak et al, (1993) have shown that it inhibited both phases in
mice and gerbils, but not rats and guinea pigs. This is a peculiar result as RP
67580 was able to attenuate the response to formalin in gerbils, but not guinea-
pigs, both species bearing the human-type NKq receptor as defined using CP
96345 (Rupniak et al, 1993). These authors have shown evidence for calcium
channel antagonist activity of RP 67580 in vitro and thus the discrepancy may not
be attributable to a specific interaction with NKq receptors but mediated in
significant part by calcium channel blockade.
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Intraplantar injection of carrageenan is associated with a rapid
oedematous increase in paw volume and a reduction in nociceptive pressure
threshold 3-5 hours after the injection. Although the racemic mixture of CP-
96,345 has been reported to show antinociceptive and anti-oedema activity in the
carrageenan-induced hyperalgesia in the rat (Birch et al, 1992) the inactive isomer
CP 96,344 can attenuate the carrageenan-induced paw oedema and hyperalgesia
with a potency equal to its active isomer (Nagahisa et al, 1992). This suggests that
SP may not be a mediator in this inflammatory model or that Ca^+ channels play
an overriding role. However it has been shown that CP-96,345 stereospecifically
inhibited mustard oil-induced rat foot oedema in rats and acetic acid induced
writhing in mice (Lembeck et al, 1992; Nagahisai et al, 1992) suggesting a role
for NKq receptors in these models of pain.
In more long-term pain states, such as caused by sciatic nerve constriction
injury in a model of neuropathic pain (Yamamoto and Yaksh, 1992) or CFA
(Hylden et al, 1992), thermal hyperalgesia was unaffected by capsaicin treatment
given two days after sciatic nerve constriction, despite a significant depletion of
SP-IR in the dorsal horn in both of these studies. However, neonatal
administration of capsaicin was able to prevent the hyperalgesia produced in a
model of neuropathic pain (Meller et al, 1992) suggesting that neuropathic pain
state is mediated by capsaicin-sensitive afferents. This does not necessarily imply
a role for SP as capsaicin-sensitive afferents may contain other putative
transmitters. Also, Basbaum et al, (1991) have shown that after sciatic nerve
constriction there is a dramatic loss of large myelinated fibres with a smaller but
significant reduction in the small unmyelinated population and as capsaicin is
known to destroy mainly small, unmyelinated fibres there is still an element of
uncertainty.
(b) Neurokinin A.
(bi) Biosynthesis and Transmitter Release Studies.
As adjuvant or formalin induced inflammation and hyperalgesia leads to
increased biosynthesis of SP-IR and mRNA encoded by the PPT-1 gene (Minami
et al, 1989; Donaldson et al, 1992; Noguchi and Ruda, 1992, McCarson and
Krause, 1994), then there is also the potential for NKA to respond similarly.
However, there is as yet no direct evidence for an increase in NKA or NK2
receptor biosynthesis due to inflammation and hyperalgesia. Nonetheless,
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increased release of NKA has been observed in the spinal cord after injection of
kaolin and carrageenan into the knee joint (Hope et al, 1990).
(bii) Electrophysiological Studies.
Although there is evidence that SP is involved in wind-up (Kellstein et al,
1990), as yet there is no evidence for the involvement of NKA in wind-up.
However, since both SP and NKA can be produced together (Nawa et al, 1984)
then it is possible either SP or NKA or both are involved in 'wind-up'. Indeed, in
the in vitro, hemisected spinal cord model (Thompson et al, 1994) both the
amplitude and area of prolonged C fibre-evoked ventral root responses (VRP),
(which underlie the phenomenon of wind-up) were demonstrated to be
significantly reduced by the selective NK2 antagonist MEN 10376 but not the
NKj receptor antagonists CP-96,345 or RP 67580 in naive animals. However,
following peripheral hyperalgesia induced by UV irradiation, the enhanced,
prolonged VRP evoked by C-fibre stimulation was significantly reduced by both
NKj and NK2 receptor antagonists (Thompson et al, 1994) demonstrating a role
for NK^ receptors in the facilitatory effect produced.
In decerebrate, spinalized, unanaesthetised rats, stimulation of both
cutaneous afferent fibres in the sural nerve and muscle afferent fibres in the
gastrocnemius-soleus nerve at C fibre intensity will elicit a flexor reflex response
in posterior biceps femoris/semitendinosus muscles (Wall and Woolf, 1984; Xu et
al, 1991). Administration of a conditioning stimulus (CS) (20s at 1 Hz) to the
gastrocnemius nerve at an intensity that activates unmyelinated axons produces a
marked increase in the excitability of the reflex, peaking at 20-30 minutes and
lasting for up to 100 minutes (Wall and Woolf, 1984; Xu et al, 1991). Pre-
treatment with the selective NK2 antagonist [TyrA D-Trp,6>8'9ArglC)] neurokinin
A-(4-10) (MEN 10207) (Maggi et al, 1990) effectively blocked the long-term
reflex facilitation to the gastrocnemius nerve stimulation (Xu et al, 1991). The
facilitation of the flexor reflex was totally abolished with no recovery for up to two
hours suggesting a potent role for NK2 receptors in the facilitation of the flexor
reflex response.
(biii) Behavioural Studies.
As yet there are no reports of the behavioural responses mediated by NK2
receptors in sustained nociceptive states.
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1.8 BIOCHEMICAL CHANGES IN SPINAL CORD NEURONS DURING
SUSTAINED NOCICEPTIVE INPUT.
As outlined above, a role for tachykinins in contributing to a sustained
nociceptive state has been suggested, however, the intracellular mechanisms by
which tachykinins might bring about a sensitisation of dorsal horn neurons are not
clear. It is possible that tachykinins trigger alterations in membrane excitability
through interactions with second messenger systems and protein kinases which
phosphorylate membrane bound proteins (Nestler and Greengard, 1983).
Phospholipase (PLC) is an enzyme which catalyses the hydrolysis of
polyphosphatidylinositol into the intracellular messengers inositol triphosphate
(IP3) and diacylglycerol (DAG). Following its production, IP3 stimulates the
release of Ca^+ from internal stores; on the other hand DAG stimulates the
translocation and activation of protein kinase C (PKC). When activated by DAG,
PKC phosphorylates specific substrate proteins that contribute to various cellular
processes, including neurotransmitter release and transduction (Nishizuka, 1986).
Noxious stimulus-induced sensitisation of dorsal horn neurons may
depend, in part, on the PLC second messenger system. Consistent with a role in
sensitisation of dorsal horn neurons, stimulation of PKC with phorbol esters and
synthetic DAG, or the intracellular microinjection of PKC has been found to
enhance Ca^+ currents (De Riemer et al, 1985) which may increase neuronal
excitability as well as presynaptic transmitter release and to reduce both Ca^+-
dependent K+ currents (Alkon et al, 1986) and CI" currents (Madison et al, 1986)
and thereby result in the prolongation of depolarisation and afterdischarges
associated with an inhibition of spike number.
Indeed, it has recently been suggested that PKC might play a role in
excitation of polymodal nociceptors as activation of PKC leads to the
depolarisation of the C-fibres of the rat vagus (Rang and Ritchie, 1988) and
excitation of the capsaicin-sensitive C-fibres in the tail of the neonatal rat spinal
cord and tail preparation (Bettaney et al, 1988; Dray et al, 1988). Supporting this,
the nociceptive behaviour in rats following intraplantar injection of formalin was
promoted by intrathecal administration of a phorbol ester or SC-10 which
stimulate PKC and reduced by a non-selective kinase inhibitor H7 (Coderre, 1992;
Coderre et al, 1993; Yashpal and Coderre, 1993) or the selective PKC inhibitor,
chelerythrine (Coderre et al, 1994). In addition, after application of bradykinin (a
potent pain-producing peptide that stimulates sensory afferent fibres including
polymodal nociceptors (Erdos, 1979)) to the neonatal rat dorsal root ganglion
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neurons, the resulting electrophysiological response, as well as an associated
increase in ^Ca^+ uptake, could be mimicked by phorbol esters and inhibited
both by a down-regulation of PKC and by staurosporine (a PKC inhibitor)
(Burgess et al, 1989).
The involvement of PKC in long-term central changes has been
implicated by the use of models of peripheral mononeuropathy (Hayes et al, 1992;
Mao et al, 1993) and monoarthritis induced by Complete Freund's Adjuvant (Tolle
et al, 1994). In the peripheral mononeuropathy model designed by Bennett and
Xie, (1988), Hayes et al, (1992) have demonstrated that monosialoganglioside
(which, they report can inhibit the translocation of PKC) reduces behavioural
hyperalgesia associated with the chronic constriction injury (CCI). More recently,
Mao et al, (1993) used [^HjPDBu to examine the three dimensional spatial
patterns of changes in membrane bound PKC in the lumbar spinal cords of rats
with peripheral mononeuropathy. Consistent with behavioural thermal
hyperalgesia, CCI rats examined 3 or 10 days after sciatic nerve ligation produced
a 3D pattern of increased membrane bound PKC on the ipsilateral lumbar spinal
cord, mainly within spinal cord laminae I-IV and V-VI of lumbar segments L2-L5.
On the contralateral lumbar spinal cord a much smaller increase was also
associated with laminae I-IV and V-VI of lumbar segments L2-L5. After
treatment with GM1 ganglioside (a glycosphingolipid which was reported to
prevent PKC translocation/activation) both the 3D increases in spinal cord
membrane-bound PKC and nociceptive behaviours were reliably reduced. Using
a model of experimental monoarthritis, Tolle et al, (1994) revealed a bilateral
increase of [20-^H(N)]-phorbol,12,13-dibutyrate ([^HjPDBu) binding and an
expansion of [3H]PDBu binding to deeper laminae of the dorsal horn following
unilateral inflammation. Whether the increased binding of [^HjPDBu resembles
de novo target-gene derived synthesis of PKC or functional activation of present
but inactive forms of PKC is yet to be elucidated.
PKC involvement has also been implicated in another model of synaptic
enhancement. Long term potentiation (LTP), a stable form of long-lasting
synaptic plasticity, evoked by brief high-frequency stimulation (Bliss and Lomo,
1973). There is a large body of evidence that PKC has a critical role in the
mediation of LTP (Akers et al, 1986; Reymann et al, 1988; Malinow et al, 1989;
Huang et al, 1992; Wang and Feng, 1992; Meberg et al, 1993). Akers and co¬
workers (1986) proposed that PKC is translocated from the cytosol to the cell
membrane after LTP induction and persistently activates substrate proteins to
maintain LTP (Akers et al, 1986). Consistent with this hypothesis, extracellular
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application of PKC inhibitors during LTP induction blocks LTP maintenance,
leaving the induction relatively unaffected (Reyman et al, 1988). Also, Meberg et
al, (1993) measured mRNA levels of PKC subtypes 3 days after induction of LTP
(long term enhancement of synaptic transmission) in the hippocampus. Altered
mRNA levels correlated significantly with alterations in synaptic efficacy, rats
with greater synaptic enhancement having a lowered gene expression of both (3-
PKC and 7-PKC but not a-PKC. Other data suggest that PKC is involved in the
induction of LTP, as intracellular injection of PKC inhibitors into CA1 pyramidal
cells reduced the initial LTP magnitude and shortened the duration (Malinow et al,
1989; Huang et al, 1992; Wang and Feng, 1992). Using intracellular
administration of the specific PKC inhibitor peptide PKC (19-31), the initial LTP
was reduced to about half the normal size (Malinow et al, 1988; Wang and Feng,
1992), indicating a requirement of PKC for the induction phase of LTP.
A role for NKj and NK2 receptor agonists in PKC-induced sustained
neuronal activation is quite possible since both NKj and NK2 receptors appear to
act largely through phosphoinositide hydrolysis (Hanley et al, 1980; Bristow et al,
1987). Rusin et al, (1992,1993) have investigated this possibility by examining
the effects of tachykinins and phorbol esters on cytosolic calcium concentration in
acutely isolated neurons from the dorsal horn of the spinal cord. They found that
PDBu (a phorbol ester PKC activator) and forskolin (an adenylate cyclase
activator) applied for 4 minutes, mimicked the effects of tachykinins by producing
a marked and prolonged potentiation of the NMDA-induced current responses of
the isolated dorsal horn neurons. Staurosporine (an agent known to inhibit both
protein kinase C and cAMP-dependent protein kinase) reduced the tachykinin
evoked potentiation of the NMDA response. These results have been further
substantiated by the unpublished observations from Carter and Krause that phorbol
ester can activate transcription of the SP/NKA gene (Helke et al, 1990). In
addition, expression of a cloned cDNA encoding the human NK2 receptor in
CHO cells, mediates powerful NKA-stimulated arachadonic acid (AA) liberation
required influx of extracellular Ca^+ in addition to a concomitant PKC activation
(Arkinstall et al, 1994). The PKC species involved was identified as the PKCa
isoform by employing specific antibodies for immunoblot analysis. Preincubation
with pertussis toxin had no effect on Ca^+ mobilisation but, it partially inhibited
AA release and completely blocked PKCa translocation, demonstrating that NK2
receptor activation may regulate two distinct but converging signal transduction
pathways regulated by different G protein species and involving Ca^+ influx and
PKCa activation.
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Interestingly, the increased expression of preprodynorphin mRNA in
ipsilateral superficial dorsal horn elicited by intraplantar carrageenan, is blocked
by NK2 receptor antagonists (Parker et al, 1993), again consistent with a role of a
signal resulting from phosphoinositide hydrolysis such as PKC activation.
1.9 MOLECULAR MECHANISMS OF NEURONAL PLASTICITY INDUCED
BY SYNAPTIC INPUT
Increases in intracellular Ca^+ and the activation of PKC result in the
increased expression of immediate early genes such as c-fos (Morgan and Curran,
1986), whose transcription is activated rapidly and transiently within minutes of
stimulation. The expression of late response genes is induced more slowly (Merlie
et al, 1984), the products of which are thought to serve more specific effector
functions in the neuronal response. The protein products of immediate early genes
(e.g. c-fos) act as third messengers that are believed to be involved in the
transcriptional control of genes that encode a variety of neuropeptides including
tachykinins.
1.9.1 Noxious Stimulus-Induced Expression of c-fos.
Noxious stimulation leads to the expression of immediate early genes
(IEGs) and their protein products. C-fos can be rapidly induced in rat spinal
neurons by brief primary afferent stimulation (Hunt et al, 1987; Bullit, 1989; Leah
et al, 1992). After activation of small diameter cutaneous sensory afferents with a
brief noxious heat (Hunt et al, 1987) or noxious mechanical pinch (Bullit, 1989;
Leah et al, 1992) there was a rapid appearance (within 30-120 minutes) of the c-
fos protein-like immunoreactivity (Hunt et al, 1987; Bullit, 1989; Leah et al, 1992)
in both superficial (laminae I-II) and deeper (III-VII) laminae of the appropriate
ipsilateral lumbar dorsal hom segment.
Local treatment with mustard oil, formalin or carrageenan provide
experimental models of short term hyperalgesia and in general have also been
found to generate a very rapid increase in the levels of the protein product of the c-
fos proto-oncogene (Hunt et al, 1987; Draisci and Iadarola, 1989; Presley et al,
1990; Williams et al, 1990; Pretel and Piekut, 1991; Noguchi et al, 1991,1992;
Leah et al, 1992). Both cutaneous application and intramuscular injection of the
chemical irritant mustard oil (known to selectively activate C fibres) resulted in the
rapid appearance of c-fos protein -LI in nuclei of postsynaptic dorsal horn neurons
67
of adult (Hunt et al, 1987; Pretel and Piekut, 1991), but not neonatal rats
(Williams et al, 1990), suggesting that mustard oil can stimulate small diameter
fibres in the rat only when there is mature functional connectivity in the spinal
cord. In the adult, 2 hours after cutaneous application of mustard oil to the
hindlimb, c-fos-LI was localised to nuclei predominantly in laminae I and II of
lumbar segments with only a few labelled neurons in the deeper layers; in
agreement with the distribution of nociceptive primary afferents (Light and Perl,
1979). However, injection of 5% mustard oil into the medial gastrocnemius
muscle evoked c-fos-LI in nuclei largely in the marginal layer I and layers IV-VII
of lumbar segments 4-5 (Hunt et al, 1987). Again this expression is consistent
with the somatotopic representation of this muscle in the dorsal horn and with
major terminations of small diameter nociceptive afferents of muscle in layer I
rather than layer II (Molander and Grant, 1986) and suggests that in the dorsal
horn, primary afferent input generates transsynaptic expression of c-fos-LI whose
laminar distribution is related to the nature of the sensory stimulus.
In agreement, a pattern of Fos-LI consistent with the known nociceptive
primary afferent input from the hindpaw was observed following subcutaneous
administration of formalin in both awake, freely moving and anaesthetised rats
(Presley et al, 1990; Leah et al, 1992). In the ipsilateral L4-5 dorsal horn, dense
labelling was recorded in the superficial layers (laminae I and II) and in deeper
layers (lam IV and V); (areas that contain large populations of nociceptive
neurons), whereas moderate labelling was found in deeper laminae. The pattern
of increased Fos-LI was time-dependent, reaching a maximum level at 2-3 hours,
decaying to basal levels within 6 hours after the stimulus. However, upon
sensitisation of the dorsal horn neurons, induced by prior peripheral noxious
stimuli administered to the contralateral paw, the number of Fos-LI nuclei
produced in both the ipsilateral and contralateral cord was significantly greater and
outlasted the stimulus for several hours (Leah et al, 1992). This suggests that Fos
may switch on genes coding for proteins that increase the sensitivity of the spinal
neurons to further afferent input.
Indeed, the participation of c-fos in the peripheral sensitisation associated
with intraplantar injection of carrageenan has been documented. By Northern
Blotting, Draisci and Iadarola, (1989) demonstrated that a rapid increase in c-fos
mRNA occurred in the lumbar spinal cord within 30 minutes of carrageenan
injection. The content of c-fos mRNA rose dramatically and remained at peak
elevation for at least 2 hours after injection of the inflammatory agent, returning to
control levels by 8 hours. By using ISHH and immunocytochemistry methods to
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label Fos and Fos-related proteins, 3 days after carrageenan injection, the induced
Fos-IR was found in the nuclei of spinal cord neurons located predominantly in
laminae I-II and V-VI (Noguchi et al, 1991,1992).
The expression of Fos has also been demonstrated in rat spinal dorsal
horn after induction of longer-term hyperalgesic states, such as adjuvant induced
arthritis (Menetrey et al, 1989; Hylden et al, 1992; Abbadie and Besson, 1993;
Tolle et al, 1994) and the development of a neuroma following nerve injury (Chi
et al, 1993).
In an acute study of adjuvant-induced arthritis in the rat, 16 hours after
unilateral injection of CFA, the subcutaneous inflammation was accompanied by
an increased concentration of c-fos-IR neurons in laminae I and II, around the
base of the dorsal horn and in deeper laminae VII, VIII and X (Menetrey et al,
1989). After capsaicin treatment, this inflammation-induced increase was shown
to be greatly attenuated (Hylden et al, 1992) indicating the input from small
diameter afferents is important for the stimulus- induced increase in Fos-LI. More
recently, the c-fos expression has been studied in a model of chronic CFA-
induced polyarthritic rats for up to 22 weeks (Abbadie and Besson, 1993). C-fos
expression followed the time course of arthritis and peaked simultaneously with
hyperalgesia 3 weeks after innoculation, However, these results are in
disagreement with those of Tolle et al, (1994), who showed in a monoarthric
model, that c-fos-IR neurons were completely absent after 2 weeks when
hyperalgesia was still demonstrable, suggesting that c-fos is vital in the initial
stages but not in the maintenance of the inflammatory state. However, there is a
strong correlation between pain behaviour and the number of cells expressing Fos
(Presley et al, 1990). Moreover, morphine pre-treatment produces a dose-
dependent suppression of Fos expression which corresponds with its analgesic
effects (Presley et al, 1990; Tolle et al, 1991). Although these observations do not
necessarily mean that c-fos is involved, there is growing evidence for an
association in central sensitisation and persistent nociception, the noxious stimuli
producing Fos expression also induces behavioural hyperalgesia (Coderre and
Melzack, 1987; Coderre et al, 1990), coinciding with the time course of Fos
expression induced by carrageenan (Draisci and Iadarola, 1989). The concurrence
of Fos expression and behavioural hyperalgesia is also evident in cases where a
peripheral stimulus initiates but does not apparently maintain the hyperalgesia, e.g.
heat injury of a rat's hindpaw (Coderre and Melzack, 1987) which produces an
initial hyperalgesia in the ipsilateral hindpaw after injury in addition to a delayed
hyperalgesia (after 4-24 hrs) in the contralateral hindpaw, coinciding with two
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'waves' of Fos expression (Williams et al, 1990), also suggestive of a role of Fos
expression in neural plasticity. This is supported by the observation that both the
contralateral hyperalgesia (Coderre and Melzack, 1987) and the Fos expression in
the contralateral dorsal horn (Williams et al, 1990) still develop when the injured
limb was locally anaesthetised shortly after the injury.
After peripheral nerve injury induced by sciatic nerve transection, a
persistent elevation in Fos-LI was induced predominantly in laminae I-II and V-
VII of the ipsilateral lumbar enlargement of the spinal cord (Chi et al, 1993),
demonstrating that peripheral nerve injury, induces a prolonged increase in Fos
expression in neurons predominantly in those regions of the spinal cord that are
associated with the transmission of nociceptive messages and thus this pattern of
Fos-LI is probably the result of persistent neuronal activity in the spinal cord.
1.9.2 Consequences of c-fos Expression.
The Fos protein forms a heterodimer with Jun which binds to AP-1 like
elements to form a DNA binding site in the promotor region of its target gene
(Morgan and Curran, 1989). Several late onset (peptide precursor) genes have
been reported to be activated by nociceptive inputs to dorsal horn neurons and it
seems likely that the early induction of c-fos expression in these cells may fulfil
some role in mediating these responses. Peripheral inflammation, noxious thermal
stimulation, trigeminal nerve stimulation or nerve lesions result in the increase in
the expression of mRNA encoding dynorphin (Draisci and Iadarola, 1989; Ruda et
al, 1989; Naranjo et al, 1991; Hylden et al, 1992), enkephalin (Iadarola et al,
1988; Noguchi et al, 1992), SP (Noguchi et al, 1988; Minami et al, 1989; Pretel
and Piekut, 1991) and glutamate (Kehl et al, 1991) in the dorsal horn or dorsal
root ganglion.
The preprodynorphin gene encodes a family of structurally-related opioid
peptides that have a high affinity for the k opiate receptor (Corbett et al, 1982).
Dynorphin-expressing neurons are thought to be involved in mechanisms that
modulate pain sensations (Iadarola et al, 1988) in rostrally projecting neurons that
transmit nociceptive signals e.g. SMT and perhaps STT. Furthermore, there is
strong evidence suggesting that the preprodynorphin gene is a target for c-fos, co-
induction of c-fos and preprodynorphin genes is reported to occur in the same
neuronal elements predominantly in laminae I-II and V-VI of the spinal cord after
noxious thermal stimulation (Naranjo et al, 1991; Draisci and Iadarola, 19898)
and inflammation (Draisci and Iadarola, 1989; Hylden et al, 1992). Iadarola and
colleagues (1988) have also found that the increase in Fos protein which peaks 2
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hours after peripheral inflammation is followed by a large increase in
preprodynorphin mRNA peaking at 3 days, followed by a subsequent increase in
dynorphin peptide. Over 80% of the neurons in the superficial laminae and deeper
dorsal horn which express preprodynorphin co-localise Fos-IR, which has been
taken as evidence that Fos mediated signalling is coupled to dynorphin gene
transcription (Dubner and Ruda, 1992). It has also been shown that phorbol esters
which activate PKC, lead to a rapid induction of c-fos mRNA (within 30 minutes)
and a later increase in the level of preprodynorphin mRNA (between 1.5 and 6
hours) in neuronal cells in culture (Naranjo et al, 1991). Also an AP-1 site has
been identified in the preprodynorphin (Naranjo et al, 1991) promotor that binds
fos/jun proteins which may therefore function as third messengers in the signal
transduction mechanisms of pain processes.
Another possible target of c-fos is the preproenkephalin gene, but
evidence is much more controversial than for dynorphin. While White and Gall,
(1987) found a positive relationship between c-fos mRNA and the expression of
the preproenkephalin gene in the rat hippocampus following seizure activity,
others (Iadarola et al, 1988; Draisci and Iadarola, 1989) showed only a very small
increase in preproenkephalin mRNA with c-fos protein in the spinal dorsal horn
after peripheral inflammation, which did not produce measurable increases in
enkephalin peptide content (Iadarola et al, 1988). The difficulty in measuring
changes in preproenkephalin may be because there are high basal levels in the
normal state and therefore it is difficult to detect any increase. However, more
recently, it was found that peripheral inflammation induced an increase in
preproenkephalin mRNA levels in spinal cord neurons and most neurons also
localised Fos and Fos-related immunoreactivity (Noguchi et al, 1992).
Furthermore, it has also been shown that Fos and Jun proteins bind to form an AP-
1 like site in the promotor regions of the rat preproenkephalin gene (Sonnenberg et
al, 1989).
Therefore it is possible that dynorphin and perhaps enkephalin are
involved to some extent in noxious stimulus induced plasticity. As enkephalin
typically produces inhibitory effects (Vaught et al, 1982) it may provide a
mechanism by which central plasticity and hyperalgesia are minimised (Dubner,
1991; Sullivan and Dickenson, 1991). Dynorphin which is typically found to
produce moderate antinociceptive effects (Hayes et al, 1987) has complex, dual
effects in the spinal cord (Hylden et al, 1991) leading to the suggestion that it may
produce direct excitatory effects on spinal projection neurons whilst producing
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inhibition by a negative feedback mechanism on dynorphin containing neurons
(Dubner and Ruda, 1992).
Substance P is one of several transmitters which might provide input to
modulate and regulate the expression of c-fos. SP is known to be present in small
diameter primary afferents (Hokfelt et al, 1975b) and after cutaneous mustard oil
application, which stimulates small diameter afferents, c-fos expression was
evoked in laminae I and II of the lumbar spinal cord (Pretel and Piekut, 1991).
Double label immunocytochemistry revealed that the majority of these c-fos like
immunoreactive neurons received input from SP immunoreactive neurons (and
also 5-HT and enkephalin neurons) (Pretel and Piekut, 1991).
Another potential candidate for the regulation of c-fos is the neuropeptide
NKA. As SP and NKA are derived from the same gene (DeBiasi and Rustioni,
1988), are thought to be co-localised, are distributed in a similar manner
throughout the spinal cord (Ogawa et al, 1985) and NKA is also believed to be
involved in nociception (see section 1.7), it is feasible that NKA on its own or in
conjunction with glutamate or other factors, may regulate the expression of c-fos
in the spinal cord.
The involvement of glutamate in the modulation and regulation of c-fos is
not so clear. Sharp et al, (1990) showed that the NMDA receptor agonist
quinolinic acid induced c-fos mRNA and Fos-related antigens throughout the
ipsilateral adult brain cortex in similar patterns and suggested that NMDA
receptors mediate induction of Fos following cortical injury. This was supported
by the demonstration that pre-treatment with the NMDA antagonist MK-801
significantly suppressed formalin-induced Fos-like immunoreactivity in the
superficial dorsal horn (Kehl et al, 1991). However, others have found that the
NMDA antagonists ketamine and MK-801 did not affect the distribution of Fos
labelled neurons in the spinal cord following noxious heat stimulation (Tolle et al,
1991), indicating that in these circumstances, at least, other factors play a greater
role.
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1.10 AIMS OF CURRENT WORK
This study aims to investigate the potential role of tachykinins that
activate NKj and NK2 receptors in models of both acute and sustained excitation
of spinal dorsal horn neurons. In addition, the changes in intracellular signalling
and gene expression by which tachykinins might bring about sensitisation of
dorsal horn neurons are also investigated. Various experimental models have been
employed
(1) Electrophysiological Techniques
(a) Extracellular recordings were made from rat laminae III-V
multireceptive dorsal horn neurons. Ionophoresis of selective NKj and NK/>
agonists and antagonists was used to investigate the action of tachykinins on
responses to brief noxious and innocuous stimuli.
(b) An investigation was carried out on the contribution of NKq and NK2
receptors in dorsal horn to the sustained neuronal activity in C afferents induced by
the peripheral application of the chemical algogen mustard oil (reported to be a
selective activator of C afferents).
(c) Using extracellular recordings from laminae III-V multireceptive
dorsal horn neurons, the effects of NK] and NK2 antagonists on sensory
responses (both noxious and innocuous) were examined before and after
cutaneous application of mustard oil, which induces central sensitisation and
hyperalgesia.
(2) Biochemical Techniques
The intracellular mechanisms involved in the sensitisation of dorsal horn
neurons are unknown. Experiments were conducted to address any role of protein
kinase C (PKC) in sustained nociceptive responses of dorsal horn neurons using
the following techniques
(a) Extracellular recordings were made from multireceptive laminae IV/V
dorsal horn neurons. PKC inhibitors were ionophoretically administered whilst
recording activity evoked by repeated cutaneous application of mustard oil.
(b) The subcellular translocation of PKC evoked in the spinal cord by
cutaneous application of mustard oil was examined. In addition, the involvement
of NK2 receptors was assessed using systemic administration of selective
antagonists.
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(3) In Situ Hybridisation Histochemistry
By use of in situ hybridisation histochemsitry, the induction of mRNA for
the immediate early gene c-fos was used as a molecular marker to assess genomic
responses of dorsal horn neurons. Repetitive cutaneous application of the C-fibre
selective chemical algogen, mustard oil, was used to elicit sustained neuronal
activity of dorsal horn neurons and the ensuing changes in induction of c-fos
mRNA noted. The contribution of NKj and NK2 receptors to this model of short-
term sensitisation was assessed by intravenous administration of selective non-
peptide antagonists.
(4) Behavioural Studies
A short study was undertaken to assess the role of NK^ and NK2
receptors in acute behavioural nociceptive models of tail-flick and paw-flick.




Electrophysiological Examination of Sensory Responses in
Laminae III-V Rat Dorsal Horn Neurons.
2.1 AIMS
The tachykinins, substance P and neurokinin A are both present in fine
somatosensory afferents and for some time substance P has been a candidate
transmitter of nociception. However, there is increasing evidence that neurokinin
A (and NK2 receptors) play a crucial role in mediating spinal nociceptive
transmission. Using the technique of local ionophoretic application of selective
tachykinin receptor agonists and antagonists, whilst extracellularly recording from
single superficial dorsal horn neurons, the possible role of NKq and NK2
receptors in mediating brief cutaneous sensory responses was investigated.
2.2 MATERIALS
Animals: Male Wistar rats were obtained from Charles River UK Ltd,
Margate, Kent, UK.
Anaesthetics: Alpha-chloralose and urethane were obtained from Sigma
Chemical Company, Poole, Dorset, UK; Halothane (flurothane) was obtained
from ICI Pharmaceuticals, Macclesfield, Cheshire, UK.
Laboratory Chemicals: Standard laboratory chemicals were of Analar
grade and from the following suppliers: Sodium chloride (NaCl), DLH (D, L,
homocysteic acid) and Pontamine Sky Blue (PSB) were obtained from Sigma
Chemical Company, Poole, Dorset, UK; Agar was obtained from Oxoid Ltd,
Basingstoke, Hampshire, UK.
Drugs: The tachykinin agonists, neurokinin A (NKA) & [Met-O Me^]
SP (SPOMe) were obtained from Cambridge Research Biochemicals, [N-acetyl-
Arg6,Sar9,Met(02)]SP6.n (Sar-9) was a gift from Professor D Regoli and
[Lys3,Gly8-R-7-lactam-Leu9]neurokinin-(3-10), (GR 64349) from Glaxo Group
Research.
The tachykinin antagonists, acetyl-Leu,Met,Gln,Trp,Phe-NH2 (L-
659,874); cyclo(Gln,D-Trp,Me-Phe,(R)Gly[ANC-2]Leu,Met)2, (L-668,169) and
cyclo(Gln,Trp,Phe,Gly,Leu,Met), (L-659,877) were obtained from Cambridge
Research Biochemicals & [D-Pro9[spiro-y-lactam]-LeulO,Trpl l]physalaemin-(l-
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11), (GR 82334) was a gift from Glaxo Group Research; Ac-Leu-Asp-Gln-Trp-
Phe-Gly-NH2, (R396) was a gift from Professor D Regoli.
2.3 METHODS
2.3.1 Animals
Adult male Wistar rats (250-300g) were housed in standard rat cages in
groups of 3 or 4, maintained under controlled lighting conditions (12 hour light :
12 hour dark); temperature (22-23°C) and allowed free access to food (rat and
mouse standard maintenance diet) and tap water.
2.3.2 Surgery
The animals were briefly anaesthetised with halothane and following
cannulation of the jugular vein, this was changed to an a-chloralose and urethane
mixture (a-chloralose 60mg/kg and 1.2g/kg urethane: intravenous). The
anaesthetic level was continuously monitored and supplemental doses given in
0.2ml aliquots as required on testing blink reflex and paw withdrawal. A tracheal
cannula was inserted and secured by ties and the spinal cord was exposed by
removal of surrounding muscle.
The animal was placed in a stereotaxic frame and secured in place by
means of a mouth piece, earbars, a tail-bar and 3 pairs of swan-neck clamps placed
carefully under the lateral processes of alternate vertebrae to support the vertebral
column (see Figure 2.1). A laminectomy was performed under x20 magnification
to expose T12-L4 for recording, the surrounding skin flaps were then tied to the
frame in order to create a 'pool' (see Figures 2.1 and 2.2). A 2% agar solution at
40°C was then injected under the spinal bone at the rostral end of the laminectomy
and poured over into the 'pool'. Once set, a section of agar was removed from over
the spinal cord and the dura carefully removed. Paraffin at 37°C was then poured
over the exposed cord to protect the surface once the dura had been extracted, (see
Figure 2.2).
When surgery was completed the anaesthetic was changed to a-chloralose
(60mg/kg) and 0.1ml aliquots were given as required. Rectal temperature and
occasionally arterial blood pressure were continuously monitored throughout the
experiments and maintained within physiological limits i.e. 37°C and 100-
150mmHg respectively. Rats were allowed to respire spontaneously but
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Figure 2.1
An outline of the methods used for extracellular recording from the dorsal
horn of the spinal cord from anaesthetised rats.
A thoracolumbar laminectomy was performed under x20 magnification to expose
T12-L4 for recording, 3 pairs of swan neck clamps supported the vertebral
column. The surrounding skin flaps were then tied to the frame in order to create
a 'pool'. A 2% agar solution was then injected under the bone at the rostral end of
the laminectomy, which created a stable preparation (see Figure 2.2 for details).
Extracellular recordings from single neurons were made via the central barrel of a
7-barrelled glass microelectrode filled with 4M NaCl. Multireceptive neurons
(which had responses to both noxious and innouous stimuli) were used. Their
cutaneous excitatory receptive fields were located on the ipsilateral hindlimb,
paws and toes. The innocuous cutaneous stimulus used was a rotating brush,
whereas the noxious cutaneous stimulus was provided by either a calibrated pinch
or thermocouple-controlled radiant heat-lamp (see Figure 2.3 for details of
cutaneous stimulators used). Mustard oil (8% in paraffin oil) was applied to the
receptive field area using a paintbrush and the sensory responses then repeated.
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A schematic diagram of (A) a dorsal view and (B) a transverse view of the rat
thoraco-lumbar laminectomy and the preparative surgery used for extracellular
neuronal recording.
A laminectomy was performed to expose T12-L4 for recording, 3 pairs of swan
neck clamps supported the vertebral column. A 2% agar solution was carefully
injected 0.5-1.Ocm beyond the spinal cord and intact dura and further agar covered
the exposed spinal cord and filled the pool surrounding the laminectomy. This
procedure improved the stability of the spinal cord, facilitating maintained
extracellular recordings from dorsal horn neurones. Once set, a section of agar
was removed from over the spinal cord and the dura carefully removed. Paraffin
oil at 37°C was then poured over the exposed cord to protect the surface.
Extracellular recordings were made from single neurons in the superficial dorsal
horn found at depths below dorsal surface between 0-650|itm (as stated on the
microdrive) via the central barrel of a 7-barrelled glass microelectrode filled with
4M NaCl. The other 6 barrels were used for ionophoresis and contained various







Spinal Clamps' Pool made by skin flaps
filled with 2% agar solution
B
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humidified oxygen was supplied to the area of the tracheal cannula to enrich the
inspired air.
2.3.3 Recording and Ionophoresis
Extracellular recordings from single neurons found at depths below dorsal
surface between 0-650|im (as stated on the microdrive) were made via the central
barrel of a 7-barrelled glass microelectrode filled with 4M NaCl, (pH 4.0-4.5),
(see Figures 2.1 and 2.2). Electrode tip sizes were 4.0-4.5|im and DC resistances
were 5-8MQ. The band-width of the recording amplifier was 1Hz -7 kElz. The
electrode was secured in place by a metal arch placed over the preparation and
moved by means of a microdrive system in 2 or 4|im steps until a suitable
recording was obtained.
Raw data recorded from this central barrel was displayed on
oscilloscopes. The other 6 barrels were used for ionophoresis and contained :- 1M
NaCl (pH 4.0-4.5) for automatic current balancing and current controls
(Neurophore Ionophoresis System, Medical Systems Corporation); Pontamine Sky
Blue (2% in 0.5M sodium acetate) for marking recording sites by ejection at 100)i
A for 10-13 minutes. (The laminar locations of recorded neurons were assessed
from Pontamine Sky Blue Spots on cryostat sections, see later); DLH (lOOmM, pH
8.0-8.5), an internal control of neuron stability and responsiveness and a selection
of the following dmgs:-
Tachykinin Agonists
Neurokinin A, (NKA) (ImM, pH4.0-4.5); [Met-O-MeHjSP (SPOMe); (O.lmM
in 0.3% dimethylformamide (DMF), pH 4.0-4.5): [N-acetyl-Arg6,Sar9,Met(02)]
SP6-n(Sar-9) (O.lmM in 0.3% DMF, pH 4.0-4.5) GR 64349 (ImM in distilled
H20, pH 4.0-4.5).
Tachykinin Antagonists
F-659,874; F-668,169 and F-659,877 (O.lmM in 0.3% DMF, pH 4.0-4.5):GR
82334 (ImM in distilled H20, pH 4.0-4.5): R396 (O.lmM in 0.3% DMF, pH 4.0-
4.5).
Drugs were either freshly made or stored at -20°C over dessicant and
solutions once thawed, were not re-frozen, or used again. All drugs were applied
with cathodal currents. Retaining currents of -lOnA were used to minimise drug
leakage between tests.
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2.3.4 Histological Determination of Laminar Location
At the end of each experiment, the cord was carefully removed using a
scalpel, watchmaker forceps and iris scissors. It was placed in a plastic
weighboat, orientation marked and frozen with an aerosol spot-freezing spray. It
was then fixed overnight in 10% formal saline and oriented to approximately 90°
to the horizontal plane in 0.25% agar solution in a freezing microtome. 52pm
sections were cut and collected in 0.1M phosphate buffer (pH 7.4). Once the
Pontamine Sky Blue spot had been visually located, the appropriate section (with
the blue spot on it) was mounted in phosphate buffer on a slide and sealed under a
coverslip with varnish. It was left overnight to dry and then photographed. The
section was then removed from the slide and remounted on a subbed slide, dried
overnight in formalin vapour to ensure adhesion and then stained with neutral red
and mounted under Depex Mounting Medium.
2.3.5 Quantification of Sensory Responses
Multireceptive neurons were used in these studies i.e. those which
displayed responses to both noxious and innocuous stimuli. Neurons were initially
found by their responsiveness to widespread manual brushing of the ipsilateral
hindlimb. Cutaneous receptive fields of the neurons were first localised by
excitatory responses to manual brush, then more restricted pinch and noxious heat
receptive fields were located within this innocuous field, (see Figures 2.1 and 2.3).
All the multireceptive neurons used had excitatory receptive fields on the
ipsilateral hindlimb, paws and toes (for an example see Figure 2.3). The
controlled noxious and innocuous stimuli were applied to adjacent sites within the
ipsilateral cutaneous field. The innocuous cutaneous stimulus used was either a
motorised, rotating brush or occasionally manual brushing using a small soft
paintbrush (10-15 second period). The noxious cutaneous stimuli were provided
by either a calibrated pinch (serrated forceps with a graduated controlled
displacement) or a thermocouple-controlled radiant heat lamp, precisely raising
skin surface temperature from 30°C to 46-48°C usually over 3 seconds rise time,
for a controlled period of 5-10 seconds (see Figure 2.3).
The foot was fixed in position by attachment to a clamp such that the
cutaneous stimulators remained in exactly the same position for the duration of the
test. Each set of stimuli was cycled over a minimum 3 minute period to allow full
recovery of the neuron between tests and to avoid unnecessary sensitisation of any
82
Figure 2.3
Diagram of cutaneous stimulators used and mustard oil application
(a) Innocuous Brush- This was provided by either a soft motorised, rotating brush
or occasionally manual brushing using a small soft paintbrush for a 10-15 second
period.
(b) Noxious Pinch- This was quantifiable by means of a graded scale which
directly allowed the pincher to be closed to the same level on each test, for a
duration of 10 seconds.
(c) Noxious Radiant Heat- This was provided by a thermistor-controlled radiant
heat lamp. The surface temperature was measured by a thermocouple, in the
centre of the heated area, placed within 1-2 cm of the cutaneous receptive field.
The temperature was raised from 30°C to 46°C to 48°C within 5 seconds and held
at 46 to 48°C for a duration of 5 to 10 seconds.
(d) Mustard Oil Application- The algogen (usually 8% in paraffin oil) was










Ivv Hairy surface of paw
Low threshold receptive field
for mustard oil application.
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of the responses (see Figure 2.4). Throughout the tests, care was taken to ensure
that the recorded spike height remained significantly greater than the field
potentials; occasionally this meant moving the position of the recording electrode
by a few |im in order to get closer to the neuron during the testing procedure.
First, control responses to each of the cutaneous stimuli were assessed.
This was repeated once or twice and only if the degree of variability was very
small (10% maximum) were the tests continued. Each drug was ionophoresed for
1 minute before the start of each test cycle and continued throughout the cycle,
starting at a low ejection current and increasing usually by lOnA, stepwise, each
cycle. After each drug application, full recovery of responses was achieved (from
5-30 min) before the next drug was tested (see Figure 2.4 for a diagramatic
representation).
2.3.6 Analysis
The neuronal firing was continuously recorded on FM tape (Racal) and
firing rates were plotted on-line by computer (IBM PS/2-70-121) together with
stimulator and ionophoresis markers. The data was stored on the hard-disc of the
computer and was analysed off-line by integrating the number of stimulus-induced
action potentials in selected constant time intervals, taking spontaneous activity
prior to the responses into account (by its subtraction from each sensory response
recorded). Responses to mechanical brush and pinch were integrated over the 5-
10 second stimulus times whereas responses to noxious thermal stimuli were
integrated over 25-30 seconds from the start of the 48°C plateau, to include the
long-latency activity often evoked by this stimulus (see Figure 2.4). These
responses were expressed as percentages of control values. Ionophoresis of the
direct excitant, D, L-homocysteic Acid (DLH) at the same currents used for
ionophoresis of agonists/antagonists was used to ensure that any drug responses
were not due to movement of the recording electrode away from or closer to the
neuron under study. The response to ionophoresis (at the same current) of DLF1
remained constant throughout the experiment.
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Figure 2.4
A typical example of the analysis technique used to study the ongoing firing
frequency records achieved during electrophysiological recording from a
lamina III-IV multireceptive neuron.
(a) shows the typical, well-matched control responses for the sensory stimuli under
investigation. For each of brush and heat, the number of stimulus-induced action
potentials in selected constant time intervals (10-15 seconds for brush and 25-30
seconds for heat) were integrated. This procedure was repeated after ionophoresis











2.4.1 Characteristics and Receptive Field Properties of Neurons
The present results were obtained from 61 neurons located in laminae III-
V of the dorsal horn. Their position was generally at a depth of 300-800|im as
read on the microdrive and their laminar position was confirmed by histological
identification in transverse sections of the spinal cord. The positions of Pontamine
Sky Blue (PSB) marks are shown in Figure 2.5. Occasionally the PSB histological
identification could not be found, this is most probably due to poor extraction of
the spinal cord, causing damage or alternatively the ionophoretic apparatus was
defective.
All neurons described were multireceptive i.e. responded to both noxious
and non-noxious stimuli (noxious heat, noxious pinch and non-noxious brush).
Care was taken not to overheat the noxious heat receptive field site as this could
lead to sensitisation and damage. Neurons which had mismatched responses to
stimuli (i.e. a very strong response to one stimulus and a very weak response to
another) were discarded as these could not be relied upon to give accurate results.
Also, neurons which did not give constant responses over the control testing were
not used.
Generally, the spontaneous activity of the cells under examination was
very low (less than or equal to 1 Hz) but on occasions it was a little higher (5-8
Hz). With these cells, care had to be taken that the sensory responses were clearly
distinguishable from background activity. All neurons had cutaneous receptive
fields located on either the paws (hairy or glabrous skin), toes or flank of the
ipsilateral hindlimb (see Figures 2.1 and 2.3). These were mapped using
innocuous stimuli and monitored continuously throughout the experiment to
ensure no change in size ensued, generally they remained topographically constant
throughout the recording period. The size of the receptive fields varied
considerably between different neurons under examination, from the nail-bed of
one toe to the whole flank of the ipsilateral limb, however, this did not seem to
have any detectable effect on the recording characteristics of neurons (or the drug
effect thereafter). Ionophoresis of the direct excitant, D, L-homocysteic Acid
(DLH) at the same currents used for ionophoresis of agonists/antagonists was used
to ensure that any drug responses were not due to movement of the recording
electrode away from or closer to the neuron under study. The response to




Camera lucida plot of the recording sites of dorsal horn neurons studied
Extracellular recording sites were marked with Pontamine Sky Blue at the end of
each experiment; a typical exmple is depicted by an asterix in the photograph. A
transverse section was taken for histological examination and a camera lucida
drawing was made of the location of some of these neurons, as represented in the
diagram by black circles.
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2.4.2 Current and Vehicle Controls
Neurons under consideration were routinely tested with vehicle and
current controls. They were examined under identical conditions to the agonists
and antagonists under study with ejection for at least 1 minute increasing the
current in a 10-20 nA stepwise manner every consecutive minute.
The vehicle required for certain compounds (0.3% DMF in water), had no
effect in 3 out of 3 neurons when ejected at up to 80nA for 12 minutes.
2.4.3 Control Responses to Sensory Stimuli
Before the drug effect on a neuron could be tested, a reproducible set of
control responses to sensory stimuli had to be achieved. A minimum of two
consistent cycles of sensory responses was always achieved before testing was
started. It was always important to ensure that the sensory stimulators were in
stable positions and were unlikely to move during the course of the experiment. A
three minute cycle of responses was generally followed to minimise any
sensitisation of responses to repetitive stimulation. On occasions this was
increased to 4 or 5 minutes depending upon the neuron under study.
2.4.4 Effects of Ionophoretically Applied Neurokinin Antagonists
(a) Ionophoretically Applied NKj Antagonists
The effects of three ionophoretically-applied NKj antagonists ejected
close to multireceptive dorsal horn neurons in laminae III-V of the spinal cord
were assessed. The highly-selective NKq antagonists used were L-668,169, GR
82334 and [D-Pro4,D-Trp7'9>10,PhelIjsubstance P-(4-11), which were tested as
previously described. Once the control responses had been tested, the drug under
study was ionophoresed for 1 minute before the sensory responses were tested and
then currents used to release the drug was increased in a stepwise manner.
In the majority of neurons tested* there were consistent results with no
discernible effect on spontaneous activity but with a clear increase in innocuous
*
brush and no significant change in responses to either noxious pinch or heat. (12/14)
Ionoplioresis ofL-668,169
Eight multireceptive dorsal horn neurons in laminae III-V were tested
with L-668,169 (Regoli et al, 1987). Figure 2.6 shows the ongoing firing records
showing typical effects of ionophoretically-applied L-668,169 on somatosensory
responses of these neurons. In 6/8 neurons tested, ionophoresis of the NKq
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Figure 2.6
Ongoing firing frequency records showing typical effects of the NKq receptor
antagonist L-668,169 on somatosensory responses of laminae III-V neuron.
A modest facilitation of responses to innocuous brush was observed in 6 out of 8
neurons tested, with no other consistent changes. Recovery from drug effects was
not examined closely, but in 3 out of 4 cells examined, responses to brush had
recovered to within ± 15% of control levels within 9-24 min after stopping
ionophoresis of the drug. The fourth cell showed approximately 50% recovery
within 4 min. The inset shows the position of the cutaneous receptive field on the
ipsilateral hind-limb. The duration of each of the stimuli is indicated, in the case
of noxious heat, this representing the period for which the skin temperature
exceeded the generally accepted noxious threshold of 45°C.
This diagram represents ongoing firing frequency records from a single laminae
III-V dorsal horn neuron, a five minute recovery period was attained before
ionophoresis of L669-169 was initiated. Full recovery was observed 12 minutes

































receptor antagonist at 20nA for 6 minutes resulted in a small but consistent
enhancement of activity evoked by innocuous brush to 141 ± 9% of mean pre-drug
control (mean ± s.e.m., P<0.05, Wilcoxon Test). There was little effect on
background (spontaneous) activity (which was 95 ± 7% of pre-drug activity) or
responses to noxious pinch or heat (which had stimulus-evoked neuronal firing
rates of 105 ± 10 and 82 ± 9% of mean pre-drug controls respectively). In the
remaining two cells, ionophoresis of L-668,169 at 20nA for 6 minutes resulted in
no detectable changes. In 4 cells where recovery was assessed there was 50%
(n=l) and over 85% (n=3) reversal of the effect of L-668,169 on brush responses
by 4 and 9-24 minutes respectively after cessation of ionophoresis. The vehicle
(0.3% DMF in water) had no effect in 3 out of 3 neurons when ejected at 80nA for
12 minutes. Records such as those shown in Figure 2.6 were analysed off-line by
integrating the number of stimulus-induced action potentials in selected constant
time intervals, taking spontaneous activity into account. The values were
calculated as a percentage of the mean pre-drug control value and are expressed as
the mean control value. Statistical significance of the changes was assessed by the
Wilcoxon test and the data is summarised in Figure 2.7.
Ionophoresis of GR 82334
The ionophoretic effects of the NKj receptor antagonist GR 82334
(Hagan et al, 1991) were investigated in 6 multireceptive neurons in laminae III-V
of the spinal dorsal horn. In 5/6 cells tested with a mean ejection current of 32 ±
4nA over 6 minutes there was a small but significant increase in innocuous brush
to 131 ± 8% of pre-drug control levels (P<0.05, as assessed by the Wilcoxon Test)
with no significant effect on spontaneous activity (103 ± 8% of pre-drug
spontaneous activity) or noxious heat, (after 1 minute of GR 82334 ejection the
response to noxious heat was 91 + 11% of pre-drug control value). Noxious pinch
was not examined in this set of experiments, (see Figure 2.8 for a summary of the
results). In the four cells tested, recovery of the response to innocuous brush was
observed 3 minutes after termination of ionophoresis in all cells. Figure 2.9 shows
ongoing firing frequency records demonstrating typical effects of the NKq
receptor antagonist GR 82334 on somatosensory responses of a laminae III-V
neuron, with recovery observed after 3 minutes.
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Figure 2.7
Summary of the effects of neurokinin receptor antagonists and agonists on
laminae III-V neurons.
All values are calculated as a percentage of the mean pre-drug control value and
are expressed as the mean ± s.e.m. Responses were designated as being
essentially unchanged if they remained within 20% of the mean control value.
Neurons in the population tested which were not influenced in the characteristic
predominant fashion illustrated, all showed no (or no consistent) changes in their
responses. For the sub populations of neurons affected by the drugs, the statistical
significance of changes was assessed by Wilcoxon test (a = p<0.05).
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Time dependence of the effects of neurokinin receptor antagonists on thermal
nociceptive responses.
All values represent evoked activity (corrected for background) and are shown as
percentages of the mean stimulus-induced activity occurring during the stimulus.
Values are expressed as mean ± s.e.m.
97



























Ongoing firing frequency records showing typical effects of the NKq receptor
antagonist GR 82334 on somatosensory responses of a laminae III-V neuron.
Facilitation of responses to innocuous brush (with no other consistent change) was
observed in 5 out of 6 cells examined. The lower trace shows recovery 3 min after
termination of ionophoresis. Similar effects were observed in 3 further cells
where recovery was assessed. The inset shows the position of the cutaneous field
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Ionophoresis of [D-Pro^,D-Trp70Phe^] substance P-(4-ll)
The action of NK ] receptor antagonists on multireceptive laminae TTT-V
dorsal horn neurons was confirmed with a brief study using a further selective
NKi antagonist [D-Pro4,D-Trp7'9'10,Phell] substance P(4-ll) (Regoli et al,
1987). Only 2 neurons were investigated, however the action of this NKj
antagonist mirrored that of the two other NK j antagonists studied (L-668,169 and
GR 82334).
In 2 out of 2 neurons tested with [D-Pro4,D-Trp7'9'10,Phell] substance
P-(4-ll) (30-40nA, 6 min), the somatosensory responses to brush were increased
by 33 and 41% of pre-drug activity with no consistent change in spontaneous
activity, noxious heat or pinch.
Ionophoretic currents of up to 50, 45 and 80nA were tested for L-
668,169, GR 82334 and [D-Pro4,D-Trp7>9'10,Phe1 ^substance P-(4-ll)
respectively, until either spike reduction or technical factors prevented further
study. The effects on sensory responses at these currents were similar to those at
lower currents, notably there still being no consistent inhibition of responses to
noxious heat.
(b) Ionophoretically-Applied NK2 Antagonists
The peptide antagonist L-659,874 (which is highly selective for NK2
receptors (McKnight et al, 1988)) was tested by ionophoresis close to the recorded
cells. The rather more potent cyclic analogue of L-659,874, L-659,877 could not
be tested because of its low solubility in acceptable vehicles. Effects of L-659,874
were tested on multireceptive neurons as previously described in the methods
section. Once the control responses had been obtained for both noxious and
innocuous cutaneous stimuli, the NK2 antagonist was ionophoresed for 1 minute
before and during the cutaneous somatosensory tests which followed. Recovery
was observed before further testing was continued.
Ionophoresis of L-659,874
L-659,874 produced a very different response from the NKj antagonists
tested. A typical response to ionophoresis of L-659,874 is depicted in Figure 2.10;
a highly selective inhibition of responses to noxious thermal stimuli without
altering responses to noxious pinch, innocuous brush or spontaneous activity. This
was seen in 8/10 neurons tested by ejection of lOnA of L-659,874 for 6 minutes.
By analysing records off-line and assessing the values as a percentage of
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Figure 2.10
Ongoing firing frequency records showing typical effects of the NK2 receptor
antagonist L-659,874 on somatosensory responses of a laminae III-V neuron.
A marked attenuation of responses to noxious heat but not other stimuli or
spontaneous activity was seen in all 11 neurons tested at currents of 15-20nA.
Recovery from drug effects was not examined closely, but in 3 out of 3 cells
examined there was recovery of the noxious heat response to within 50-85% of
control at 6-15 min after terminating ionophoresis of the drug. The inset shows
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the mean pre-drug control value it was calculated that lOnA of L-659,874 caused a
49% inhibition of the responses to noxious heat in responsive cells (see Figure
2.7) with no detectable effect in noxious pinch (99 ± 8% of pre-drug control),
innocuous brush (103 ± 9% of control) or spontaneous activity (93 ± 7% of pre-
drug activity). At a higher ejection current of 20nA, the selective inhibition of
noxious heat response was seen in all cells tested (9 out of 9) and this was of a
greater degree (mean 66% inhibition), than the lower ejection current. Again there
was no significant change in the responses to noxious pinch (85 ± 11%),
innocuous brush (104 ± 6%) or spontaneous activity (95 ± 12% of pre-drug
activity). In 4 cases, where both currents were tested on the same cell this
apparent dose-dependence was particularly clear.
In 3 neurons where recovery was investigated, the inhibition of heat
responses by L-659,874 had partially recovered (to 50-85% of controls) within 6-
15 minutes after cessation of ionophoresis. In the majority of cells tested here,
responses to noxious heat declined rapidly on cessation of the stimulus (to less
than 20% of the response during the stimulus, within the subsequent 10 seconds).
For each of the drugs tested there were, however, examples of relatively prolonged
after-discharges, retaining around 50% of the peak activity during the first 10
second post-stimulus period. There was no evidence that effects of any of the
drugs were greater (or in any way different) in post-stimulus periods than during
application of the heat stimulus (Figure 2.8).
2.4.5 Effects of Ionophoretically Applied Neurokinin Agonists
The effects of ionophoretically applied NK] and NK2 receptor agonists
on multireceptive dorsal horn neurons were assessed as previously described.
Control responses were tested and then the dmg under study was ionophoresed for
1 minute before the sensory responses were tested.
(a) Ionophoretically Applied NKj Agonist
The highly-selective NKq receptor agonist [N-acetyl-Arg6,Sar9Met
(C>2)^]substance P-(6-11) (Regoli et al, 1988) was tested on neuronal responses
to cycled cutaneous stimuli either at low (31 ± 4nA) or higher (57 ± 5nA)
ionophoretic currents.
Ionophoresis of [N-acetyl-Arg^, Sar^Met (02)^]substance P-(6-ll)
The effects of the highly-selective NKq receptor agonist [N-acetyl-Arg^,
Sar9Met(C>2)U]substance P-(6-ll) were investigated in 13 multireceptive neurons
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in laminae III-V of the spinal dorsal horn. When ejected at a low current range,
there generally was no effect on the spontaneous activity in the neurons examined.
There was a very slight increase in the basal activity to 121 ± 13 % of pre-drug
control when ejected at 31 ± 4nA for a mean time of 5 ± 1 minutes (P>0.05
Wilcoxon Test).
However, in 9/13 neurons tested, when this NKj agonist was ejected at
31+ 4nA there was a marked inhibition of the activity evoked by innocuous brush
in comparison with pre-drug controls (to 52 ± 5% of mean pre-drug control). (The
results were analysed off-line and taking spontaneous activity into account the
values were calculated as a percentage of mean pre-drug control value.) There
was no significant change to either noxious pinch or noxious heat responses after
ionophoresis of low currents of the NKp the noxious heat response was 98 ± 5%
of control and likewise the noxious pinch response was 92 ± 6% of the mean pre-
drug control. The summary, Figure 2.7 shows that whereas the responses to
spontaneous activity and noxious pinch and heat were not significantly different
from control values (P>0.05), the response to innocuous brush was significantly
decreased from mean pre-drug control (P>0.05).
Six neurons were additionally tested with a higher current range and
showed similar results to the low current range in 6 out of 6 neurons tested over a
mean ejection current of 57 ± 5nA for 6 ± 2 minutes of [N-acetyl-Arg^, Sar^Met
(C>2)11]substance P-(6-11). There was no significant change in either noxious
pinch or noxious heat (91 ± 14% and 106 ± 11% of mean pre-drug control
respectively) but in an analogous manner to the lower dose range, there was a
significant decrease in the response to innocuous brush. The higher ejection
current, nevertheless, did cause a marked increase in the spontaneous activity to
536 ± 88% of the control level. Current and vehicle control tests were carried out
and were found not to replicate the drug effect in any way.
(b) Ionophoretically-Applied NK2 Agonists
Two NK2 agonists were tested in these studies, the endogenous ligand
neurokinin A (NKA) and the highly-selective agonist at NK2 receptors, GR 64349
(Hagan et al, 1991). Both agonists elicited similar responses when ejected at
higher currents onto the multireceptive dorsal horn neurons.
Ionophoresis ofNeurokinin A
The effect of ionophoresis of neurokinin A was investigated in a total of 8
multireceptive neurons in laminae III-V of the spinal dorsal horn. Two dose
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ranges were investigated, the lower range had an ejection current of 11 ± 5nA and
was maintained for 7 ± 1 minutes (mean ± s.e.m.). At this low ejection current
there was no significant change in the level of spontaneous activity compared to
control levels (112 ± 10% of mean pre-drug control). There was however a
selective facilitation of the responses to noxious thermal stimuli; in 6/8 cells tested
there was a facilitation to 155 ± 13% of mean pre-drug control (mean ± s.e.m.,
P<0.05). The responses to innocuous brush and noxious pinch remained
essentially unaltered (89 ±11% and 108 ± 10% of pre-drug controls respectively)
and although one cell showed a 30% increase in noxious pinch response, this was
not reproduced in the other examples. The ongoing firing frequency record shown
in Figure 2.11 shows the typical effect of low ejection currents of the NK2 agonist
NKA on the spontaneous activity and cutaneous sensory responses.
When ejected over a higher current range of 44 ± 4nA for a mean time of
6+1 minutes, the outcome was a different set of influences on spontaneous
activity and sensory responses in comparison with the lower ejection current
range. The spontaneous activity was significantly increased in a consistent manner
to 354 ± 61% of the pre-drug spontaneous activity (P<0.05) in 6 out of 8 cases.
However, when corrected for the elevated baseline, it was seen that noxious heat
responses were attenuated to 64 ± 16% of the mean pre-drug control values whilst
the responses to noxious pinch and innocuous brush were essentially unaltered (79
± 19% and 120 ± 21% of pre-drug control values respectively; no significant
changes). After ionophoresis of NKA, in 2 cases the increment in spontaneous
activity was equivalent to the magnitude of reduction in heat responses. However,
in all other cases this NKA-induced reduction in heat responses was much greater
than the actual increase in spontaneous activity. Recovery was observed within 6-
12 minutes after terminating ionophoresis and none of the effects were reproduced
in current control tests. In 4 cells where [N-acetyl-Arg^, Sar^Met
(02)H]substance P-(6-ll) and NKA were each tested, there were clear excitatory
responses to both NKj and NK2 receptor agonists.
Ionophoresis of GR 64349
Ionophoresis of the selective NK2 agonist GR 64349 was studied in 5
multireceptive laminae III-V dorsal horn neurons. At a mean ejection current of
66 ± 5nA, the agonist produced similar results to the higher dose range of the
endogenous ligand NKA. When the agonist was ejected for a mean time of 7 ± 1
minute, spontaneous activity was clearly increased from baseline levels to 398 ±
54% of the mean pre-drug control (P<0.05, Wilcoxon Test). Innocuous brush
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Figure 2.11
Ongoing firing frequency records showing typical effects of the NK2 receptor
agonist neurokinin A in the absence or presence of the NK2 receptor
antagonist L-659,874 on the somatosensory responses of a laminae III-V
neuron.
Neurokinin A caused a selective facilitation of responses to thermal but not
mechanical noxious stimuli. Responses to innocuous brush (not shown here) were
also unaltered (see Figure 2.7). Results were typical of 6 neurons tested with low
currents of neurokinin A. After the middle trace had been recorded, ioiioplioresis
of L-659,874 was begun in addition to neurokinin A. A marked attenuation of the
neurokinin A-amplified response to noxious heat to below control levels was
observed in all 3 cells so tested. The inset shows the position of the cutaneous
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and noxious pinch responses were essentially unaltered (111 ± 13 and 88 ± 20% of
mean pre-drug control), the noxious heat response, when normalised for the
elevated baseline, was diminished to 75 ± 11% of control values (P>0.05).
Recovery of the spontaneous activity and the heat response was observed within 6
to 12 minutes of terminating ionophoresis; the responses returning close to
baseline levels.
2.4.6 Co-Ionophoresis of Both NKj Agonist and Antagonist.
The response to co-administration of both NK \ agonist and antagonist
was assessed in 3 laminae III-V multireceptive dorsal horn neurons. Initial
ejection of low currents of the highly selective NKj agonist [N-acetyl-Arg^,
Sar^Met (02)^] substance P-(6-ll) resulted in responses typical of the 13 cells
examined in total; there was a clear inhibition of the response to innocuous brush
with no discernible effect on either spontaneous activity or to noxious pinch and
heat responses. Once a stable response to the agonist had been achieved, co-
ionophoresis with the specific NKj antagonist GR 82334 was initiated. In 3 out
of 3 neurons, ionophoresis of GR 82334 reversed the [N-acetyl-Arg^, Sar^Met
(02)H]substance P-(6-11) - induced decrease in brush responses, with no
significant effect on the noxious pinch and heat responses. The effect of GR
82334 on the increase in spontaneous activity brought about by high ejection
currents of [N-acetyl-Arg^, Sar^Met (02)^] substance P-(6-ll) was not
investigated in this series of experiments.
2.4.7 Co-Ionophoresis of Both NK2 Agonist and Antagonist.
Three multireceptive dorsal horn laminae III-V neurons were used to
investigate the action of co-administration of both NK2 agonist and antagonist by
an ionophoretic route. The response to a low ejection current of NKA was
determined and a further 3 out of 3 cells where there was a selective facilitation of
the thermal nociceptive responses, with no apparent effect on spontaneous activity,
noxious pinch or innocuous brush. This response is typical of the neurons tested
with low currents of NKA,(see Figure 2.11). Once a strong and stable response to
the NK2 agonist had been achieved, co-ionophoresis with the highly selective-
NK2 antagonist L-659,874 was initiated. Figure 2.11 demonstrates the typical
effects achieved with first, low currents of NKA followed by a co-ionophoresis
with the NK2 antagonist L-659,874. The NKA induced facilitation of the noxious
heat response was markedly attenuated to below control levels after co-
ionophoresis with L-659,874. This is consistent with reversal of the effect of
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exogenous NKA by the selective NK/? receptor antagonist but cannot be
unequivocal, since the antagonist alone had inhibitory effects on thermal
nociceptive responses (Figure 2.10). The effect of L-659,874 on the increase in
spontaneous activity brought about by high ejection currents of NKA was not
investigated in the present study.
2.5 DISCUSSION
Multireceptive dorsal horn neurons from laminae III-V of the rat dorsal
horn spinal cord were identified using both depth measurements (taken from the
microdrive) in combination with Pontamine Sky Blue histology. Mulitreceptive
neurons were chosen to be studied as they can integrate both nociceptive and non-
nociceptive information (Iggo, 1974; Flandwerker et al, 1975) and allow ready
comparison of the processing of these inputs. Ionophoresis of the direct excitant
D,L-homocysteic acid (DLH) at the same currents used for ionophoresis of
agonists/antagonists caused reproducible excitation throughout each experiment,
reducing the possibility that recordings were from primary afferent fibres
(Goodchild et al, 1982) or that any drug responses were due to movement of the
recording electrode away from or closer to the recording site. Current and vehicle
controls were routinely carried out using ejection of NaCl and DMF (0.3%
dimethylformamide in water) respectively and were unable to reproduce any of the
observed drug actions described below.
Although SP is known to cause excitation of nociceptive dorsal horn
neurons (Henry, 1976; Randic and Miletic, 1977; Zieglgansberger and Tulloch,
1979), these experiments provided no clear evidence that NKj receptors
participate in transducing brief nociceptive inputs to laminae III-V neurons of rat
spinal dorsal horn under the present conditions. The highly selective NKq
antagonist, L-668,169 was used. However, as its potency is reported to be
reduced in rodent bioassays compared to those in other species (Pattachini et al,
1992), two other NKj antagonists were also tested; GR 82334 which retains high
potency at rat NKj receptors (Beresford et al, 1992) and [D-Pro4,D-
Trp7'9>10,Phell] substance P-(4-ll), which is effectively antinociceptive in the
mouse formalin paw model (Murray et al, 1991). From the results it can be seen
that ionophoretic application of GR 82334, L-668,169 or [D-Pro4,D-
Trp7'9>K),Phell] substance P-(4-ll), to laminae III-V dorsal horn neurons, at
pharmacologically effective currents, induced no significant effects on
spontaneous activity nor on the responses to noxious pinch and noxious heat. In
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contrast, each NKq receptor antagonist caused a modest facilitation of their
responses to innocuous brush in the majority of cells. As ionophoresis of the NKq
receptor antagonists regularly facilitated the responses to innocuous cutaneous
stimuli, this suggests that their lack of effect on nociceptive responses was not due
to failure to reach the relevant sites at the concentrations used, nor for technical
reasons. Further support that this effect of L-668,169, GR 82334 and [D-Pro4,D-
Trp7'9'lC),Phel 1]substance P-(4-11) on non-nociceptive responses was due to
NKq receptor antagonism is strengthened by the observation that the NKj
antagonists used are all structurally quite distinct compounds but yet ionophoresis
of low currents of each has similar consequences. These observations are
substantiated by the precisely inverse results obtained with the highly selective
NKq agonist [N-acetyl-Arg6,Sar9Met(02)H substance P-(6-11). At low ejection
currents, ionophoresis of [N-acetyl-Arg^,Sar9Met(02)^ substance P-(6-11) to rat
laminae III-V dorsal horn neurons, generally induced no significant effects on their
spontaneous activity nor on the responses to noxious cutaneous stimulation, but
there was a marked inhibition of the activity evoked by innocuous brush in
comparison to pre-drug controls. However, when ionophoresed at a higher current
range, [N-acetyl-Arg6,Sar9]Vlet(C)2)l ^ substance P-(6-11) likewise did not affect
the responses to noxious cutaneous stimulation but in an analogous manner to the
lower dose range, significantly decreased the response to innocuous brush. The
higher ejection current nevertheless, did cause a marked increase in the
spontaneous activity consistent with the possibility of a distinct population of NKq
receptors causing relatively direct excitation of laminae III/V neurons, in addition
to the population which appears to modulate their non-nociceptive inputs.
Nevertheless, it is possible that the antagonists have unknown side effects or that
more complex interactions are occurring.
Co-ionophoresis of both NKq receptor-selective agonist and antagonist
further strengthens the possibility that NKq receptors are involved selectively in
non-nociceptive responses. Once a stable response to the agonist had been
achieved, co-ionophoresis with the specific NKq antagonist was initiated. The
results show that GR 82334 reversed the [N-acetyl-Arg6,Sar^,Met(02)^]
substance P-(6-l l)-induced selective decrease in brush response.
The observations that ionophoretic administration of NKq receptor
antagonists selectively facilitate the response to innocuous brush (with no
significant effect on responses to noxious pinch and heat), suggests that NKq
receptors are responsible for an attenuating influence on non-nociceptive inputs to
these cells and that the antagonist is acting to reverse the action of the endogenous
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receptor agonist, substance P, which has been released during the course of our
experimental procedure. Although the factors responsible for substance P release
are unclear, it does not appear to be responsible for acutely mediating the
increased activity elicited by brief thermal or mechanical noxious stimuli. This
data is entirely consistent with previous experiments carried out using cats
(Fleetwood-Walker et al, 1990) and in agreement, other groups have reported a
similar lack of involvement of NK4 receptors in mediating brief nociceptive inputs
(both thermal and mechanical) to deeper dorsal horn neurons (Duggan et al, 1979;
Willcockson et al, 1984). However, these effects are at variance with the results
of others. It has been reported that administration of the non-peptide NKj
antagonist CP-96,345 results in inhibition of responses of nociceptive dorsal horn
neurons to C-fibre strength electrical simulation or of the after-discharge responses
to brief noxious pinch and heat stimuli (De Koninck and Henry, 1991;
Radhakrishnan and Henry, 1991). There was little effect on the initial phase of
excitatory responses to brief heat stimuli and inconsistent effects on pinch-evoked
excitation. It is possible that CP-96,345 is effective only on late components of
nociceptive responses, however the use of an extremely profound pinch stimulus
as well as evidence that CP-96,345 is a potent antagonist of 'L'-type Ca^+ channels
(Schmidt et al, 1992) and furthermore that such compounds are effective
antinociceptive agents (Miranda et al, 1992) suggest that actions of this compound
other that on NKj receptors may be involved. Although both peptide and non-
peptide NK] receptor antagonists have been reported to block the late prolonged
but not the brief excitatory postsynaptic potentials induced in dorsal horn neurons
by stimulation of afferents at C-fibre strength or by noxious stimuli (Urban and
Randic, 1984; De Koninck and Henry, 1991), in our experiments, there was no
evidence that NK j receptor antagonists were any more effective in the 20s of after
discharge following a noxious heat stimulus than they were during the response
itself (Figure 2.8).
In contrast to the results concerning NKj receptors, the highly selective
NK2 receptor antagonist L-659,874 caused a marked and highly consistent
inhibition of thermal nociceptive responses without affecting spontaneous activity
or responses to innocuous brush and noxious pinch. Inhibition by the NK2
receptor antagonist showed a striking selectivity for thermal rather than
mechanical nociceptive stimuli, a result also noted in cat with the moderately
selective NK2 receptor antagonist [D-Pro4,Lys6,D-Trp7'9>l(),Phel 1] substance P
-(4-11) (Fleetwood-Walker et al, 1990).
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Consistent with a role of an NK2 receptor agonist such as neurokinin A in
thermal, but not mechanical nociception, ionophoretic administration of NKA to
laminae III-V dorsal horn neurons caused a selective facilitation of thermal
nociceptive responses with no significant effect on background (spontaneous)
activity, or responses to innocuous bmsh and noxious pinch (Figure 2.11), a result
also seen in cat with neurokinin A and other agonists with NK2 receptor
selectivity (Fleetwood-Walker et al, 1990)). Although NKA is the preferred
ligand for the NK2 receptor, it also shows a slight affinity for both NKj and NK3
receptors present in spinal cord tissue (see Maggi et al, 1993). However, the NK2
receptor selective agonist GR 64349 was also used in this set of experiments and
administration of this agonist resulted in an equivalent selective facilitation of
thermal nociceptive responses. Further substantiating that NK2 receptors are
selectively involved in thermal nociceptive responses is the observation that the
selective NKA-induced facilitation of the response to noxious heat is markedly
attenuated when both NKA and the selective NK2 receptor antagonist L-659,874
are co-ionophoresed.
In the current experiments, both neurokinin A and GR 64349 further
caused marked and consistent increases in spontaneous activity of laminae III-V
dorsal horn neurons, consistent with the idea that NK2 receptor activation is an
important element in the transduction of thermal nociceptive inputs. It is of course
possible that co-released transmitters may also subserve an important role.
Interestingly, although both NK 1 and NK2 receptor agonists increase the
spontaneous activity in laminae III-V cells, the situation is quite different in lamina
I where only NK2 but not NK] receptor agonists are effective (Fleetwood-Walker
et al, 1992).
These results would thus appear to suggest that for these tachykinin
receptors, it is actually the NK2 receptor which plays an important role in
mediating brief thermal noxious responses within laminae III-V of the spinal
dorsal horn. The mechanistic basis for this is unclear, since polymodal C-afferents
are reported to contain tachykinins, (Leah et al, 1985) and are likely to contribute
greatly to both responses. However, subpopulations specifically sensitive to either
thermal or mechanical nociceptive stimuli may exist (Perl, 1984; Besson and
Chaouch, 1987; Treede et al, 1992). Small dorsal root ganglion neurons are very
heterogenous in terms of their neuropeptide content (Leah et al, 1985; O'Brien et
al, 1989; Levine et al, 1993) and there is evidence that thermal/mechanical
noxious stimuli can differentially elicit release of neuropeptides into spinal
perfusates (Duggan et al, 1987, 1988; Kuraishi et al, 1989; Tiseo et al, 1990).
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Although SP and NKA originate from a single gene, differential RNA processing
can result in mature transcripts either encoding or lacking the NKA sequence
(Nawa et al, 1984; Krause et al, 1987). This may be a cell-specific phenomenon
occurring differentially in certain functional sub-populations of small dorsal root
ganglion cells. Substance P release in the spinal cord has been reported following
noxious pinch, intraplantar formalin, topical methylene chloride and flexion of a
kaolin/carrageenan knee-joint (Duggan et al, 1988; Kuraishi et al, 1989; Schaible
et al, 1990; McCarson and Goldstein, 1991). Thermal cutaneous stimuli,
however, were only effective at damaging skin temperatures considered to result in
irreversible inflammatory cutaneous lesions (Go and Yaksh, 1987; Duggan et al,
1988; Kuraishi et al, 1989). SP release was localised to a discrete focal area of the
SG (Duggan et al, 1988) where it is degraded rapidly (Duggan et al, 1992). In
contrast, both noxious mechanical stimuli and noxious thermal stimuli (at skin
temperatures below those producing inflammatory damage), but not innocuous
stimuli, were effective in releasing neurokinin A (Duggan et al, 1990) which
persisted and spread diffusely thoughout the dorsal horn. Furthermore, the
selective NK2 antagonist MEN 10376 was a potent antagonist of capsaicin-
evoked C fibre excitation of dorsal horn neurons (Urban et al, 1992; Nagy et al,
1993), whereas the NKj receptor antagonist CP-96,345 did not inhibit capsaicin-
evoked responses (Nagy et al, 1993). As capsaicin is believed to selectively
activate polymodal nociceptors (Fitzgerald, 1983), these results suggest that
activation of dorsal horn neurons by polymodal nociceptors involve mainly NK2
rather than NKj receptors. Also, Xu et al, (1991) described that the NK2 receptor
antagonist, [Tyr5,D-Trp6>8,95Argl0]neurokinin A-(4-10) (MEN 10207)
selectively reversed the facilitation by neurokinin A to the sural nerve of the spinal
nociceptive flexor reflex. In agreement, the NK2 receptor selective antagonist
MEN 10376 inhibited the ventral root potentials (VRPs) evoked by C fibre
strength electrical stimulation of the ipsilateral dorsal roots, whereas the NKj
receptor antagonists RP 67580 and CP-96,345 were ineffective (Thompson et al,
1993). However, in a condition of UV-induced hyperalgesia, the facilitated VRPs
were significantly reduced by both NKj and NK2 receptor antagonists (Thompson
et al, 1993) suggesting that NKj receptors are of greater importance in mediating
responses to noxious stimuli in more prolonged pain states. Correspondingly, only
the facilitation of nociceptive flexor reflex by substance P or C-afferent
conditioning stimuli and conditioning stimulation of the gastrocnemius nerve (and
not the reflex itself) was inhibited by the NKj receptor antagonist spantide II
(Wiesenfeld-Hallin et al, 1990).
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The data from behavioural experiments also point towards the
involvement of substance P in mediating inflammation-supported nociception
rather than responses to brief noxious stimuli. In acute behavioural nociceptive
studies, the evidence for involvement of NKj receptors is poor. Although some
groups have demonstrated a reduction in hot-plate and paw-pressure thresholds
following intrathecal administration of SP or a selective NK \ agonist (Post and
Folkers, 1985; Cridland and Henry, 1986,1988; Picard et al, 1993; Yashpal et al,
1993), others demonstrated antinociception (Doi and Jurna, 1981) or evidence
suggesting that NKj receptor plays no iole in behavioural nociceptive responses
(Piercey et al, 1981; Gamse and Saria, 1986; Elliott et al, 1992; Garces et al,
1992). However, behavioural reports indicate that NKj receptors are of greater
importance in mediating responses to noxious stimuli in more prolonged pain
states. In a tonic nociceptive test, pre-treatment with the selective NK4
antagonists CP 99994 (Elliott et al, 1992) and CP-96,345 (Yamamoto and Yaksh,
1991; Birch et al, 1992; Yashpal et al, 1993) significantly reduced the second
(inflammation-supported) phase of the formalin-induced response to intraplantar
formalin. Similarly, the racemic mixture of CP-96,345 has shown antinocieptive
and anti-oedema activity in carrageenan-induced hyperalgesia (Birch et al, 1992)
and mustard oil-induced foot oedema (Lembeck et al, 1992) in rats as well as in
acetic acid writhing in mice (Nagahisi et al, 1992).
Thus these results provide evidence for the involvement of NK2 but not
NKj receptors in acute nociceptive transmission. However, the evidence is
accumulating that NK| receptors are of greater importance in mediating responses
to noxious stimuli in more prolonged pain states. Therefore it was decided to




The Effects of Neurokinin Antagonists on Mustard Oil-Evoked
Activation of Rat Dorsal Horn Neurons.
3.1 AIMS
The present experiments were designed to compare the contribution of
NKj and NK2 receptors in dorsal horn to the sustained neuronal activity induced
by the peripheral application of the chemical algogen mustard oil (reported to be a
selective activator of C afferents).
3.2 MATERIALS
Animals: Male Wistar rats were obtained from Charles River UK Ltd,
Margate, Kent, UK.
Anaesthetics: Alpha-chloralose and urethane were obtained from Sigma
Chemical Company, Poole, Dorset, UK; Halothane (flurothane) was obtained
from ICI Pharmaceuticals, Macclesfield, Cheshire, UK.
Laboratory Chemicals: Standard laboratory chemicals were of Analar
grade and from the following suppliers: Sodium chloride (NaCl), DLH (D, L,
homocysteic acid) and Pontamine Sky Blue (PSB) were obtained from Sigma
Chemical Company, Poole, Dorset, UK; allyl-isothiocyanate (mustard oil) was
purchased from Aldrich Chemical Company Ltd, Gillingham, Dorset, UK;
Halothane (Flurothane) was obtained from ICI Pharmaceuticals, Macclesfield,
Cheshire, UK. Agar was obtained from Oxoid Ltd, Basingstoke, Hampshire, UK
and paraffin was purchased from Scotlab, Lanarkshire, UK.
Drugs: The tachykinin antagonists, acetyl-Leu,Met,Gln,Trp,Phe-NH2 (L-
659,874) and cyclo(Gln,D-Trp,Me-Phe,(R)Gly[ANC-2]Leu,Met)2, (L-668,169)
were obtained from Cambridge Research Biochemicals & [D-Pro^fspinxy-
lactam]-LeulO,Trpl l]physalaemin-(l-ll), (GR 82334) was a gift from Glaxo
Group Research; 2-[l-imino-2-(2-methoxyphenyl)ethyl]-7,7 diphenyl-4
perhydroisoindolone (RP 67580) was a gift from Dr C Garret, Rhone-Poulenc
Recherche-Development, France and (S)-N-methyl-N[4-(4-acetylamino-4-phenyl
piperidino)-2-(3,4-dichloro phenyl)butyl] benzamide (SR 48968) a gift from Dr X




See Chapter 2 for details of animals, surgical techniques, histological
determination of laminar location and general procedures for recording &
ionophoresis. Extracellular recordings from single laminae III-V dorsal horn
neurons, were made through the central barrel of a 7-barrelled microelectrode
containing 4M NaCl, pH 4.0-4.5. Drugs were ionophoresed from the side barrels.
One side barrel contained 1M NaCl (pH 4.5-5.0), for automatic current balancing,
another barrel was filled with PSB for marking the position of recording sites and
the other electrode barrels contained various combinations of the following
selective NKq and NK2 antagonists:- L-659,874; L-668,196 and L-659,877
(0.1 mM in 0.3% DMF, pH 4.0-4.5); GR 82334 (ImM in distilled H20, pH 4.0-
4.5); R396 (O.lmM in 0.3% DMF, pH 4.0-4.5); RP 67580 and SR 48968 (ImM in
distilled H20, pH 4.0-4.5).
3.3.2 Application of Mustard Oil and Quantification of Drug Responses
All of the neurons recorded had cutaneous receptive fields on the
ipsilateral hindlimb which were multireceptive. Neurons were initially located by
their responsiveness to widespread manual brushing of the ipsilateral hindlimb and
cutaneous fields localised as described in Chapter 2. However, only neurons
which had a robust response to noxious heat were used, as these were more
susceptible to showing a prolonged increase in firing rate upon application of
mustard oil. The receptive field of each neuron was carefully mapped out on the
ipsilateral limb using a marker pen. Mustard oil (3-isothiocyanato-prop-l-ene)
was diluted to 5-20% (usually 8%) in paraffin oil and applied to the receptive field
area using a paintbrush. This procedure was repeated every 5 minutes until a
sufficient increase in discharge was maintained over a substantial period of time
(over tens of minutes). The mustard oil could influence the neurons in one of two
ways, either firstly with an immediate increase in discharge upon cutaneous
application which remained sustained; or secondly it took several applications of
the algogen to increase the firing rate. Drugs were tested only after mustard oil-
evoked activity was stable and had been continuous for at least 1-2 minutes. The
effect of drugs on the mustard oil induced activity was tested and in these studies,
the ionophoretic currents of the antagonists were increased stepwise from 10-
80nA. Each drug was ejected for 1-2 minutes unless excitation occurred, in which
case, the drug was switched off and the neuron allowed to recover fully before the
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next drug. At the end of each experiment, Pontamine Sky Blue was ejected to
mark recording sites for identification by histology as described earlier.
3.3.3 Analysis
Before the application of mustard oil, the cutaneous sensory responses
were analysed as described in Chapter 2. The mustard oil-increased firing rate
was also recorded on-line by computer (IBM PS/2-70-121) and the percentage
increase in activity after mustard oil application was analysed over a three minute
period, from a section of data in which the activity of the cell had reached a stable
level. This was achieved by integrating the number of action potentials in 5
second intervals every 20 seconds throughout the 3 minute period. The percentage
inhibition of firing caused by antagonists was analysed by integrating the number
of action potentials in a 60 second period, immediately before and following the
administration of antagonists.
3.4 RESULTS
3.4.1 Characteristics and Receptive Field Properties of Neurons
The present results were obtained from 35 neurons located in laminae III-
V in the dorsal horn of 33 rats. Laminar location was estimated as the depth
recording on the microdrive which for laminae III-V was 250-600pm. Very
occasionally recording took place from cells located slightly more superficially to
this depth but recording from cells found deeper than 600|im was only occasional
since there appeared to be a tendency for unresponsiveness below this depth.
Upon cessation of recording, each cell was marked by ejection of Pontamine Sky
Blue (PSB) for 10-15 minutes and at the end of the experiment, the spinal cord
was removed and histologically treated to enable identification of the recording
electrode position on transverse sections of the cord (see Figure 2.5).
All the neurons studied had cutaneous receptive fields located on the hairy
side of the foot and toes or the flank of the ipsilateral hindlimb. It was important
that the receptive field of the neuron was not located on the glabrous skin of the
foot as poor penetration by mustard oil resulted in the neuron under examination
not being activated by the algogen. The neurons were initially identified by
widespread manual brushing over the ipsilateral hindlimb and foot; the receptive
field was then mapped with an innocuous brush stimulus and the receptive field
area marked with waterproof ink. The size of the receptive field area varied
considerably between the neurons, from as small as a single digit to the whole
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flank of the ipsilateral limb and lower body; throughout the experiment the
receptive field size was continually monitored and any changes were noted.
All the neurons were multireceptive (responded to both innocuous and
noxious stimuli). It was particularly important that the neuron had a robust
response to noxious heat, as any neurons tested without this were generally not
activated by mustard oil. The noxious heat response is derived mainly from the C
fibres and evidence has been presented that mustard oil elicits activation of largely
C afferents (Heapy et al, 1987; Woolf and Wall, 1986), although it is possible that
some AS activation also occurs transiently (Harris and Ryall, 1988). Generally
before application of the mustard oil, the background activity of the neurons
examined was very low (less than 1Hz). If the background activity was too high
before application of mustard oil, then it masked the facilitatory response and so
these neurons were not used.
In some experiments, ionophoresis of D, L-homocysteic acid (DLH) was
carried out to ensure that any apparent changes were not due to movement of the
recording electrode relative to the neuron in that excitatory responses to this agent
remained relatively constant. The response to ionophoresis (at the same current)
of DLH remained constant throughout the experiment.
3.4.2 Control Responses
Neurons under consideration were tested with NaCl current controls.
They were examined under identical conditions to the antagonists under study,
with ejection for at least 1 minute, increasing the current in a 10-20 nA step-wise
manner every consecutive minute. In 2 out of 2 neurons tested at up to 80nA,
there was no effect after ionophoresis of NaCl, whereas L-659,874 promptly
caused greater than 50% inhibition of evoked-activity. See Figure 3.2a for a
typical example.
3.4.3 Cutaneous Application of Mustard Oil
Following mustard oil (allyl isothiocyanate) application to the receptive
field area, 34 out of 35 multireceptive laminae III-V dorsal horn neurons had a
significant and large increase in activity with firing rates of 138 ± 33 fold of
background (mean ± s.e.m.). In the majority of cases examined (28 out of 35
cells), this increased activity was consistently maintained for at least 28 minutes.
There were two general patterns which the increased mustard oil activity
followed; some cells had an immediate increase in activity after one application of
mustard oil which remained sustained for at least 7 minutes (Figures 3.1, 3.2b and
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3.3a). However, in most cases (n=22), the steady elevated firing rate was only
achieved by repeated application of mustard oil (3-5 times to the same site over a
period of 10-15 minutes), see Figure 3.4. This apparent different sensitivity to
mustard oil had no obvious effects on the pharmacological results obtained.
Records such as those shown in Figure 3.2 were analysed off-line to
calculate the percentage inhibition by the tachykinin antagonists of the mustard oil
evoked baseline. Before analysis it was important to ensure that the elevated
mustard oil-induced activity had remained at a constant level for at least 2 minutes.
The number of mustard oil- induced action potentials in 3 separate 30 second
periods were integrated and an average value calculated (taking spontaneous
activity prior to mustard oil activity into account). After ionophoresis of the drug
under study, a second average value was calculated and this was expressed as a
percentage of the mean pre-mustard oil control value. Statistical significance of
drug effects was calculated using the Mann Whitney U-test. Where recovery was
observed, the results were calculated as a percentage of the initial mustard oil
activity.
3.4.4 Mustard Oil-Induced Peripheral Effects
After cutaneous application of mustard oil, over the course of the
experiment, the receptive field area became pink and slightly swollen. After
recording from one neuron on the ipsilateral side of the cord, this side of the
animal was not used again even if the cell did not respond to peripheral
application of mustard oil. Care was taken to ensure that the mustard oil was not
transferred to the contralateral limb by wrapping the limb in waterproof tape after
each application. No peripheral effects due to mustard oil application were
observed on the contralateral side.
3.4.5 Effect NK2 Antagonists on Mustard Oil Induced Activity.
The effect of NK2 antagonists on the mustard oil-evoked activity was
investigated using two methods of administration.
(a) Effect of Ionophoretically Applied NK2 Antagonists.
The drugs were tested only after the mustard oil-elevated activity was
stable and had been continuous for at least 1-2 minutes. When the highly-selective
peptide NK2 antagonist, L-659,874, was ionophoresed at 10-80nA, in 23 out of 24
cells tested there was a clear and relatively maintained inhibition of mustard oil-
evoked activity (see Figures 3.1, 3.2 and 3.3) to 50 ± 7% (mean ± s.e.m.) of prior
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control activity (P<0.05, Mann-Whitney U-test). Inhibition began after an onset
delay of 0-120 seconds (mean = 38 + 9 seconds, n=23). In 19 cases where
currents of > 40nA were tested, clear inhibition was always apparent within 30
seconds. Recovery was observed in 13 out of 17 cases examined after terminating
ionophoresis of L-659,874 (Figure 3.2a) and in about half of these cases (n=6),
inhibition was maintained at its maximal level for no more than 30-60 seconds
(mean = 48 ± 6 seconds) even in the continued presence of L-659,874 (Figures
3.2b and 3.3a). Increasing the ejection currents however, produced a more
marked inhibition in 15 out of 19 neurons tested, with a typical example showing
17, 33 and 85% inhibition at 20, 30 and 40nA respectively (see Figure 3.2b).
Similar results were achieved when using the highly selective non-peptide
antagonist SR 48968. Figure 3.5b shows a typical example of one of the 3/4 cells
tested with ionophoretic currents of 15-70nA, there was a similar pattern of
sustained inhibition of the mustard oil-induced firing rate to 52.8 ± 7.8 % (P<0.05,
Mann-Whitney U-test) of prior control activity. Recovery was observed in each of
the cases tested.
Analysis was carried out off-line and the effect of L-659,874 on the
mustard oil-evoked activity was calculated for each 1 minute ionophoresis period.
The number of spikes integrated into each 1 minute ionophoresis period were
expressed as a percentage of the pre-drug mustard oil-evoked activity.
Recovery was assessed every minute after the termination of ionophoresis.
The number of spikes integrated in each 30 second period were calculated and
expressed as a percentage of pre-mustard oil- evoked activity. Once the neuron
had sufficiently recovered, the next drug was ionophoresed. Statistical
significance of drug effects was calculated using the Mann Whitney U-test.
(b) Effect of Intravenous Application of NK2 Antagonists
The non-peptide NK2 antagonist SR 48968 (Emonds-Alt et al, 1992),
when intravenously injected, gave entirely similar results to ionophoresis of the
peptide drug L-659,874. Figure 3.5d demonstrates when SR 48968 was
intravenously injected at a dose of lmg/kg and in 5/5 neurons tested there was a
marked decrease in the mustard oil-induced firing rate to 38.1 ± 3.1% of pre-drug
control levels (mean ± s.e.m.) (P<0.05, Mann-Whitney U-test). The maximum
inhibition of mustard oil-evoked activity usually occurred 2-3 minutes after
intravenous administration of the non-peptide drug and full recovery was observed
in only 2 out of the 5 cells examined after 5-12 minutes, however in a further 2
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Figure 3.1
Typical example of original oscilloscope records showing increased firing of
the neuron in response to mustard oil and its inhibition by the NK2
antagonist L-659,874.
The trace shows background spontaneous activity of this (multireceptive) neuron
prior to testing. B shows activity 5 min after topical application of 7% mustard oil
across the extent of the brush receptive field of the cell as determined by
innocuous brush-evoked firing. In this example, mustard oil-evoked activity was
sustained at this elevated level for a prolonged period without re-application. C
shows activity 2 min after ionophoresis of L-659,874 was initiated, 18 min
following the application of mustard oil. D shows recovery, 10 min after L-







Typical inhibitory effects of the NK2 antagonist L-659,874 on mustard oil-
evoked activity of laminae IV/V dorsal horn neurons.
The records display firing frequency of the neuron (as spikes per sec) and its
activation by either a single application (Fig. IB), or 3 consecutive prior
applications (Fig. 1A) of mustard oil. In the upper trace it can be observed that
ionophoretic application of NaCl had no effect whereas L-659,874 promptly
caused greater than 50% inhibition of evoked activity. After terminating
ionophoresis of L-659,874 rapid recovery was observed and the cell readily
responded to D, L-homocysteic acid (DLH) used as a presumed direct excitatory
stimulus. In the lower trace it can be seen that mustard oil-evoked activity was
progressively inhibited (and the inhibition maintained for longer periods) by




Typical examples of the lack of effect of NKj antagonists, generally-observed
on the mustard oil-evoked activity of laminae IV/V dorsal horn neurons.
The large increases in firing frequency elicited by mustard oil were unaffected by
the NKq antagonists L-668,169 (A) and GR 82334 (B) applied after the mustard
oil-induced activity had reached a steady state. In each case, the NK2 antagonist
L-659,874 caused inhibition. This effect was transient in example (A) and more














Typical example of a neuron responding to cutaneous application of mustard
oil with a slow build up in firing frequency.
An example of a neuron which responded to cutaneous application of 5-20%
mustard oil with a slow build up in firing frequency. The steady elevated firing
rate was achieved by repeated application of mustard oil (3-5 times to the same




Typical effects of ionophoretic or intravenous administration of NKj and
NK2 non-peptide antagonist.
Effects of the NKj antagonist, RP 67580 and the NK2 antagonist, SR 48968 on
ionophoretic application in (a) and (b) respectively, or on intravenous
administration in (c) and (d) respectively on the mustard oil-induced activity of








cells there was a partial recovery to approximately 50 % of pre-drug controls.
Analysis was carried out off-line and the effect of SR 48968 on the
mustard oil-evoked activity was calculated for each 1 minute ionophoresis period.
The number of spikes integrated into each 1 minute ionophoresis period were
expressed as a percentage of the pre-drug mustard oil-evoked activity (again
calculated over 1 minute). No other drug was tested after intravenous injection of
SR 48968.
3.4.6 Effect of NKj Antagonists on the Mustard Oil-Induced Activity.
The effect of NKq antagonists on the mustard oil-evoked activity was
investigated using again two methods of administration.
(a) Effect of Ionophoretically-Applied NKq Antagonists
The effect of two selective NKq selective peptide antagonists L-668,169
(Regoli et al, 1987) and GR 82334 (Hagan et al, 1991) and one highly selective
non-peptide antagonist RP 67580 were investigated (Garret et al, 1991) on
mustard oil induced activity. L-668,169 and GR 82334 when ionophoresed at 20-
80nA, rarely inhibited mustard oil-evoked activity (in 1 out of 11 and 3 out of 11
cases respectively). L-668,169 is reported to show 80-fold and 25-fold selectivity
for NKj over NK2 and NK3 receptors respectively (McKnight et al, 1988) and
equivalent values for GR 82334 are greater than 170-fold in each case (Hagan et
al, 1991) Although L-668,169 is undoubtedly less rat selective than GR 82334
and RP 67580 (Beresford et al, 1992) it has been shown to have effects on the
responses of dorsal horn neurons in rats (Fleetwood-Walker et al, 1991). In 17
cells tested with both NKj and NK/? antagonist, there was only one example
where both were clearly effective. The mustard oil-evoked activity in many cells
(n=15) was unaffected by NKq antagonists, but inhibited by the NK2 antagonist
L-659,874 (Figure 3.3). In a small number of examples (n=4) there was
unequivocal inhibition of activity by NKq antagonists (Figure 3.6), although in the
one effective example with L-668,169, inhibition was not well related to the time
of administration of the drug (Figure 3.6b). In this example the cell was lost while
waiting for recovery.
In contrast to the two peptide antagonists investigated, the highly selective
non-peptide antagonist RP 67580, which was ionopohoretically administered in an
identical manner, in a current range of 30-85nA, gave entirely dissimilar results.
In 3/4 cells examined, there was a 78.2 ± 11.3% decrease in the mustard oil-
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Figure 3.6
Examples of the occasionally-observed inhibitory effect of NKj antagonists
on mustard oil-evoked activity of laminae IV/V dorsal horn neurons.
A clear-cut inhibition of mustard oil-evoked firing was seen in 3 out of 11 cases
with GR 82334, as in example (A). Delayed recovery over 30-60 minutes was
observed. In only one example, (B), was there any evidence for inhibitory effects














evoked activity (mean ± s.e.m.) (P<0.05, Mann-Whitney U-test) from pre-drug
controls with no observable recovery in any of the three neurons examined. The
apparent discrepancy in results between peptide and non-peptide antagonists may
be due to the small sample used in the study of the non-peptide antagonist.
Analysis was carried out 'off-line' and the effect of L-668,169, GR 82334
and RP 67580 on mustard oil-induced activity calculated as in section 3.3.2.
(b) Effect of Intravenous Application of NKj Antagonists
The non-peptide NKj antagonist RP 67580, when intravenously injected,
gave entirely similar results to its ionophoretic administration. Intravenous
administration was unfortunately examined in only two neurons, but both showed
that a 1 mg/kg intravenous injection of the non-peptide antagonist resulted in a
marked inhibition of mustard oil-facilitated background activity to 32.25% of the
pre-drug control levels (see Figure 3.5). The maximum inhibition of mustard oil-
evoked activity usually occurred 2-3 minutes after intravenous administration of
the non-peptide drug, but recovery was not observed in either of the two cells
examined
Analysis was carried out off-line and was similar to the methods
described (section 3.3.2).
3.5 DISCUSSION
An in vivo experimental model of short-term sustained activation of C-
fibre nociceptive afferents was employed using unilateral cutaneous application of
the chemical algogen mustard oil. It provided a clear and reproducible model of
behavioural nociception (see Cleland et al, 1994), with which to assess the effects
of locally administered tachykinin receptor antagonists.
The neurons studied were all of a multireceptive nature, being responsive
to both innocuous brush as well as noxious pinch and heat stimulation. There
seemed to be a correlation between the ability of mustard oil to excite nociceptive
neurons and the manner in which they respond to noxious heating of the skin.
Those neurons which had a robust response to noxious cutaneous heat stimulation
were used as these were more susceptible to showing a prolonged increase in
firing upon cutaneous application of mustard oil. Their position was substantiated
by both depth measurements and blue spot histology and correspond to laminae
IV/V of the dorsal horn. Control studies demonstrated that the drug effects seen
were not due to any potential adverse effects of vehicle (0.3%
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dimethylformamide). The general excitant DLH also caused clear excitation,
reducing the possibility that recordings were from primary afferent fibres
(Goodchild et al, 1982) and NaCl current control experiments were unable to
reproduce any of the drug-induced responses described below (see Figure 3.2).
The laminae IV/V neurons generally exhibited a low level of background
activity (less than 1Hz) before application of mustard oil. This was an important
consideration as higher levels would have masked any response to mustard oil.
Following the repeated application of this chemical algogen (diluted to 8% in
paraffin oil) onto the outlined receptive field area, the multireceptive neurons
displayed a marked, facilitated increase in background firing activity resulting in a
medium-term sustained nociceptive state. The background was consistently
maintained at a steady level before the pharmacological testing was carried out.
Some cells had an immediate increase in firing rate after one application of
mustard oil which remained sustained for a prolonged period; however, in most
cases, the steady elevated firing rate was achieved by repeated application of the
algogen 3-5 times to the same site over a period of 10-15 minutes. The reason(s)
for this differing sensitivity between neurons is unclear, perhaps neurons that are
initially only slightly responsive are then sensitised to mustard oil (see Kress et al,
1992). However, this apparent different sensitivity to mustard oil had no obvious
effects on the pharmacological results obtained.
In contrast, when mustard oil, at dilutions of up to 20%, was applied to
the receptive fields on glabrous skin there was a minimal effect on the firing rates
of multireceptive neurons. This lack of effect of mustard oil on glabrous skin has
been attributed to a failure of mustard oil to penetrate the skin adequately (Harris
and Ryall, 1988) and consequently, only neurons with receptive fields on the
thinner hairy skin were used in these studies. Infrequently, there was no increase
in firing rates after cutaneous mustard oil application to hairy skin, even in cells
with nociceptive heat responses, suggestive that there may be sub-populations of
multireceptive C fibres that are unresponsive to this chemical algogen or
alternatively lack of access to the appropriate sites. Importantly, on no occasion
was a decrease in firing rate seen following the topical application of mustard oil.
In the present experiments, despite careful mapping of the receptive field for each
neuron, there was no clear evidence for receptive field expansion following
peripheral application of mustard oil, as described by Woolf and King, (1990);
Woolf and Thompson, (1991). This perhaps be explained by the slight differences
between experimental designs. In contrast to the present experiments, Woolf and
King, (1990) applied mustard oil to regions close to but outwith the overt firing
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zones or alternatively, the mustard oil activity was studied over prolonged periods
of up to 90 minutes (Woolf and Thompson, 1991).
The results presented here show that NK2 but not NK j receptors, play a
crucial role in mediating the sustained excitation of laminae IV/V neurons elicited
by cutaneous application of mustard oil. The evidence suggests that this is
specifically an NK2 receptor-mediated event as the selective peptide and non-
peptide NK2 antagonists, L-659,874 and SR 48968 respectively show extremely
good selectivity for NK2 over NKj and NK3 receptors (McKnight et al, 1988;
Williams et al, 1988; Advenier et al, 1992; Emonds-Alt et al, 1992,1993).
However the possibility of unidentified side effects playing a role cannot be ruled
out.
A stable and continuous mustard oil-induced increase in background
activity was attained before ionophoresis of antagonists was initiated.
Ionophoresis of the highly selective NK2 antagonist L-659,874 resulted in a
marked and relatively maintained inhibition in the mustard oil-induced activity,
which began after a variable onset delay, sometimes immediate but more regularly
taking a period of up to two minutes before maximum inhibition was achieved.
The difference between neurons is possibly due to inconsistency in the distances
required for the antagonist to reach its site of action. As L-659,874 is a peptide
antagonist, it may be degraded, thus these results were further substantiated using
both ionophoretic and intravenous administration of the highly potent non-peptide
antagonist SR 48968 (Emonds-Alt et al, 1992). Both regimes yielded results
entirely similar to those achieved with L-659,874, with an identical pattern of
sustained yet recoverable inhibition of the mustard-oil induced firing rate, the only
difference being the longer recovery time required after intravenous
administration.
Conversely, there were mixed results (both excitatory and inhibitory)
following administration of NK] receptor antagonists. Ionophoretic
administration of each of the two selective peptide NKj receptor antagonists, L-
668,169 and GR 82334, rarely inhibited the mustard oil-induced activity. GR
82334 does show higher affinity for the rat NKj receptor site (Beresford et al,
1992) than L-668,169 (McKnight et al, 1988). However these observations show
that ionophoresis of both antagonists lead to a similar outcome suggesting that
NK j receptors generally do not play a role in the acute facilitatory response to
mustard oil. Nevertheless, in a small number of examples there was unmistakable
inhibition of activity by NKj antagonists. Indeed, although this was relatively rare
with L-668,169, which shows low potency at the rat NKj receptor (Patacchini et
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al, 1992), GR 82334, which shows high selectivity for the rat NK ] over NK/? and
NK3 receptors (Hagan et al, 1991), was more effective in yielding an inhibition
following its ionophoretic administration. The reasons for this discrepancy are
unclear, however it may be that NK] receptors are of greater importance in
mediating responses to noxious stimuli in more prolonged, and inflammatory pain
states which have been unwittingly attained in this small sample of neurons.
Moreover, in accord with these results are those attained with both ionophoretic
and intravenous administration of the potent non-peptide NKj receptor antagonist,
RP 67580 (Garret et al, 1991). Both administration techniques resulted in a
significant decrease in the mustard oil-evoked activity with no observable
recovery. Only a small population of neurons was sampled which may be the
reason for the apparent discrepancy between these results and the majority
obtained using peptide NKq antagonists.
It is of course also possible that the localised route of administration of
drugs here did not allow the NKj antagonists to access their (perhaps slightly
more distant) sites of action. SP is a potent excitant of laminae IV/V nociceptive
neurons (Henry, 1976) and on intrathecal administration SP produces behaviour
suggestive of noxious irritation (Hylden and Wilcox, 1981). In addition,
intrathecal injection of certain peptide and non-peptide NKq antagonists elevate
behavioural response thresholds (Cridland and Henry, 1986, 1988; Garrett et al,
1991; Murray et al, 1991; Yamamoto and Yaksh, 1991; Yashpal et al, 1993).
However, other studies find no role for SP as a primary transmitter of nociceptive
information (Doi and Jurna, 1981; Piercey et al, 1981; Gamse and Saria, 1986.
These and further observations that pinch rather than noxious heat stimuli release
SP into dorsal horn (Duggan et al, 1988; Kuraishi et al, 1989) and that SP-like
immunoreactivity is localised in a proportion of small diameter primary sensory
units which have more recently been identified as A fibre high threshold
mechanoreceptor units or glabrous skin C-mechanoheat units (Lawson et al,
1994). Surprisingly, in contrast to widely held assumptions, SP-LI was not
detectable in C polymodal nociceptor units located in hairy skin (Lawson et al,
1994). This is consistent with the possibility that a somewhat different subset of
nociceptive afferents is involved in pinch-evoked SP release from those in the
heat- and mustard oil-evoked neuronal activity we have observed to be sensitive to
NK2 antagonists.
Nevertheless, neither brief neuronal responses to pinch (Fleetwood-
Walker et al, 1990, 1991, 1992); nociceptive flexor reflexes (Wiesenfeld-Hallin et
al, 1990), nor capsaicin-induced responses in an in vitro spinal cord-dorsal root
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ganglion preparation (Nagy et al, 1993) appear to be directly prevented by NK ]
antagonists. Instead the facilitation of nociceptive flexor reflex elicited by
conditioning C-fibre stimulation of the sural nerve is inhibited by the antagonist
spantide II which shows a modest selectivity for NK] over NK/> receptors (Maggi
et al, 1991). This is consistent with evidence that SP (NK]) antagonists prevent
the secondary behavioural hyperalgesia following heat injury (Coderre and
Melzack, 1991) and the late prolonged but not the brief epsps induced in dorsal
horn neurons by C-fibre activation or noxious stimuli (Urban and Randic, 1984;
De Koninck and Henry, 1991).
In view of evidence for differences in the absolute potency of certain NK]
antagonists between species, we tested GR 82334, which in contrast to L-668,169
(and indeed also spantide II) shows only slightly reduced potency in the rat bladder
compared to guinea-pig and rabbit tissue bioassays (Beresford et al, 1992;
Patacchini et al, 1992). Nevertheless, the present results with a medium-term
prolonged chemical algogenic stimulus support previous observations on
responses to brief noxious thermal stimuli (Fleetwood-Walker et al, 1990, 1991,
1992) in their marked sensitivity to NK2 rather than NK] receptor agents; thereby
suggesting that somewhat different inputs or circumstances are involved here from
those in experiments showing NK] sensitivity. Consistent with this theme, the
facilitation of a nociceptive reflex induced by intrathecal administration of NKA
or by conditioning stimulation of the gastrocnemius nerves at C-fibre intensity (Xu
et al, 1991) and the excitation of dorsal horn neurons evoked by application of
capsaicin to the dorsal root ganglia (Urban et al, 1992) are all inhibited by
selective NK2 receptor antagonists. The detailed characteristics and precise
location of this NK2-like receptor in dorsal horn remain to be ascertained.
The results presented here show that the NK25 but not the NK] receptors,
play a crucial role in mediating the sustained excitation of laminae IV/V neurons
elicited by cutaneous application of mustard oil; a medium-term prolonged
activation of nociceptive C and perhaps A5 afferents (Woolf et al, 1986; Heapy et
al, 1987; Harris and Ryall, 1988).
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CHAPTER 4:
Electrophysiological Examination of Evoked Sensory Responses in
Laminae III-V Rat Dorsal Horn Neurons Before and After
Application of Mustard Oil.
4.1 AIMS
The aim of these experiments was, (using the technique of extracellular
recordings from laminae III-V multireceptive dorsal horn neurons), to examine the
effects of local ionophoresis of NKq and NK2 antagonists on sensory responses
(both noxious and innocuous) before and after prolonged cutaneous application of
mustard oil, which induces central sensitisation and hyperalgesia.
4.2 MATERIALS
Animals: Male Wistar rats were obtained from Charles River UK Ltd,
Margate, Kent, UK.
Anaesthetics: Alpha-chloralose and urethane were obtained from Sigma
Chemical Company, Poole, Dorset, UK; Halothane (flurothane) was obtained
from ICI Pharmaceuticals, Macclesfield, Cheshire, UK.
Laboratory Chemicals: Standard laboratory chemicals were of Analar
grade and from the following suppliers: Sodium chloride (NaCl), DLH (D, L,
homocysteic acid) and Pontamine Sky Blue (PSB) were obtained from Sigma
Chemical Company, Poole, Dorset, UK; allyl-isothiocyanate (mustard oil) was
purchased from Aldrich Chemical Company Ltd, Gillingham, Dorset, UK;
Halothane (Flurothane) was obtained from ICI Pharmaceuticals, Macclesfield,
Cheshire, UK. Agar was obtained from Oxoid Ltd, Basingstoke, Hampshire, UK
and paraffin was purchased from Scotlab, Lanarkshire, UK.
Drugs: The tachykinin antagonists, acetyl-Leu,Met,Gln,Trp,Phe-NH2 (L-
659,874) and cyclo(Gln,D-Trp,Me-Phe,(R)Gly[ANC-2]Leu,Met)2, (L-668,169)
were obtained from Cambridge Research Biochemicals & [D-Prc>9[spiro-7-
lactam]-LeulO,Trpll]physalaemin-(l-ll), (GR 82334) was a gift from Glaxo
Group Research; 2-[l-imino-2-(2-methoxyphenyl)ethyl]-7,7 diphenyl-4
perhydroisoindolone (RP 67580) was a gift from Dr C Garret, Rhone-Poulenc
Recherche-Development, France and (S)-N-methyl-N[4-(4-acetylamino-4-phenyl
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piperidino)-2-(3,4-dichloro phenyl)butyl] benzamide (SR 48968) was a gift from
Dr X Emonds-Alt, Sanofi Recherche, France.
4.3 METHODS
4.3.1 General Methods
See Chapter 2 for details of animals, surgical techniques histological
determination of laminar location and general procedures for recording &
ionophoresis. Extracellular recordings from single laminae III-V dorsal horn
neurons were made through the central barrel of a 7-barrelled microelectrode
containing 4M NaCl, pH 4.0-4.5 and drugs were ionophoresed from the side
barrels. One side barrel contained 1M NaCl (pH 4.5-5.0), for automatic current
balancing, another barrel was filled with PSB for marking the position of
recording sites and the other electrode barrels contained various combinations of
the following selective NKq and NK2 antagonists:- L-659,874 and L-668,196
(0.1 mM in 0.3% DMF, pH 4.0-4.5); GR 82334 (ImM in distilled H20, pH 4.0-
4.5); RP 67580 and SR 48968 (ImM in distilled H20, pH 4.0-4.5).
4.3.2 Quantification of Sensory Responses Before and After Application of
Mustard Oil.
Neurons under examination all had multireceptive cutaneous receptive
fields on the ipsilateral hindlimb. Neurons were initially detected by widespread
manual brushing of the ipsilateral hindlimb whilst moving the recording electrode
with the microdrive up and down the track under examination. Once an excitatory
response to manual innocuous brush was detected the often more restricted
noxious heat receptive field was localised. Neurons were used only when equally
matched responses were attained for both innocuous brush and noxious heat.
All of the multireceptive neurons used had excitatory receptive fields on
the ipsilateral hindlimb, paws and toes and the controlled noxious and innocuous
stimuli used were applied to adjacent sites within the ipsilateral cutaneous field
(see Figure 2.1). The innocuous cutaneous stimulus used was a manually
operated, soft, paintbrush which was rotated for a 10 - 15 second period. The
noxious thermal stimulus used was a thermocouple-controlled radiant heat lamp,
precisely raising skin temperature from 30°C - 48°C (the exact maximum
temperature could be set for different neurons) over a 3 second rise time and
maintained at the maximum temperature for a further 5-10 seconds. A lesser
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duration was used for noxious heat than innocuous brush to avoid any
sensitisation.
As testing was to be carried out for a considerable time it was important
that the limb under study was held in exactly the same position. This was
achieved by fixing the position of the limb with a clamp which ensured that the
cutaneous stimuli remained in the same position for the duration of the test. The
brash and heat stimuli were then cycled over 3 minute time periods to allow full
recovery of the neuron between tests and to avoid any unnecessary sensitisation of
the responses.
Throughout the tests, care was taken to ensure that the recorded spike
height remained significantly greater than the background noise, occasionally this
meant moving the position of the recording electrode by a few pm in order to get
closer to the neuron during the testing procedure.
First, the control responses to brush and heat were carried out. At least
two well-matched sets of brush and heat responses were achieved before any
further testing. The testing was abandoned at this stage if well-matched brash and
heat responses could not be found. The drag under study was ionophoresed for 1
minute before the start of each test cycle and continued throughout the cycle,
starting at a low ejection current and increasing by 10 or 20 nA stepwise each
cycle. After the drug application, full recovery of responses was achieved (from 5
to 30 minutes) before the next drug under study was tested.
Once all the drags had been tested in this manner, the cell was left for 30
minutes to fully recover before application of the chemical algogen mustard oil.
An 8% solution of mustard oil (in paraffin oil) was painted onto the receptive field
area of the hindlimb and foot using a soft paintbrush every 5 minutes until the
activity had sufficiently increased as described in section 3.3. The control sensory
responses to brush and heat were then completed in duplicate or triplicate until 2
matched sets of sensory responses were achieved in a similar fashion to that
previously described. The drug under study was then ionophoresed for 1 minute
before the sensory responses were tested once again and then this process was
repeated, increasing the ionophoretic current in a stepwise manner by lOnA each
cycle. After each drag application full recovery of responses was achieved before
the next drag was tested.
4.3.3 Analysis
The neuronal firing was continuously monitored on FM tape (Racal) and
firing rates were plotted on-line by computer (IBM PS/2-70-121) together with
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stimulator and ionophoresis markers. The data was stored on the hard disk of the
computer and analysed off-line by integrating the number of stimulus-induced
action potentials in selected constant time intervals. Responses to mechanical
brush were integrated over 10 second stimulus times, whereas responses to
noxious thermal stimuli were integrated over a 10-15 second interval. The
spontaneous activity prior to the response was always taken into account and, once
removed from the control brush and heat values, these served as the 'normalised'
controls and were expressed as a value of 100%. After drug treatment, again the
brush and heat responses were normalised and expressed as a percentage of the
control value.
After peripheral application of mustard oil to the receptive field, sensory
responses to brush and heat were monitored firstly to elucidate the effect of the
peripheral mustard oil itself and secondly to determine the drug effect on the
mustard oil sensitised brush and heat responses. After application of the algogen
the spontaneous activity was much higher than before but similarly, the
background activity was subtracted from the responses to brush and heat to
normalise the results. The drug effect on each of the mustard oil-sensitised brush
and heat was expressed as a percentage of the control responses before mustard oil
application. These can be seen in Figures 4.1, 4.2 and 4.3.
4.4 RESULTS
4.4.1 Characteristics and Receptive Field Properties of Neurons
Tested
The present results were obtained from 18 neurons located in laminae III-
V of the dorsal horn of 18 rats as identified by histological determination with
PSB spots on transverse sections of the spinal cord. Laminar location was
estimated as the depth recording on the microdrive which for laminae III-V was
250-600|im. Similar to Chapter 3, recording from neurons deeper than 600pm was
rarely pursued as they normally resulted in an unsuccessful response to mustard
oil.
All neurons recorded were multireceptive (responded to both innocuous
brush and noxious heat and pinch). It was particularly important that the
magnitude of responses to both noxious and innocuous stimuli were well matched
where possible, in order to avoid any potential artefacts due to a differential
sensitivity of submaximal and near-maximal responses to drugs. Thus only
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responses which met this criterion were used. Additionally, a strong response to
noxious heat appeared to be a prerequisite for a good response to mustard oil.
The cutaneous receptive fields of the mustard oil-activated neurons were
always located on the foot, toes or flank of the ipsilateral hindlimb. It was
important that the receptive field was located on hairy and not the glabrous skin as
no 'sensitisation' of the neurons followed application of mustard oil to this,
presumably as a result of poorer penetration of the latter region by the mustard oil.
Receptive field size varied greatly between neurons, although this had no apparent
influence on the responsiveness of the neuron to cutaneous application of mustard
oil.
4.4.2 Control Responses To Sensory Stimuli
Two sets of stable control responses were achieved for both brush and
heat. It was an essential requirement that the activity remained stable and that,
where possible, responses to brush and heat were well matched in size.
4.4.3 Effects of Ionophoretically-Applied Neurokinin Antagonists on
Sensory Responses Before and After Application of Mustard Oil.
Sensory responses to innocuous brush and noxious heat were compared
both before and after the peripheral application of mustard oil. The effects of
highly selective NKq antagonists GR 82334 and RP 67580 (Garret et al, 1991)
and NK2 antagonists L-659,874 and SR 48968 (Emonds-Alt et al, 1992) were
also tested on the responses of these multireceptive neurons both before and after
mustard oil.
(a) Pre-Mustard Oil Responses
The pre-mustard oil sensory responses were assessed in a similar protocol
design to those described in Chapter 2. Briefly, once the receptive field had been
found by widespread manual brushing, the sensory stimulators were set up in such
a way that they would not move from the original position throughout the duration
of the experiment. Once two sets of control responses had been attained, the drug
under investigation was ionophoresed. The drug was ejected at a low current
initially for 1 minute before the sensory responses were repeated, this cycling of
responses was repeated every 3 minutes, each time increasing the ejection current
by 10 or 20 nA until an effect of the drug was seen.
Records such as those shown in Figures 4.1, 4.2 and 4.3 were analysed
off-line by integrating the number of stimulus-induced action potentials in selected
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time intervals, which were kept constant for a particular response taking the
spontaneous activity value from the spontaneous values. Results were expressed
as a percentage of the pre-drug control value, which itself was expressed as 100%,
for innocuous brush the responses were analysed over a 10 second period and the
noxious heat was analysed over a 20-30 second period taking into account any
long train of after-discharge. Statistical significance of the changes was assessed
by the Wilcoxon Test.
The Effect ofNKj Antagonists on Pre-Mustard Oil Responses.
The results were entirely consistent with previous studies using NKj
antagonists (see Chapter 2). The responses to spontaneous activity and responses
to noxious heat were not significantly different from control values (P>0.05) for
either of the selective NKj antagonists. The vehicle (0.3% DMF in water) had no
effect in 3 out of 3 neurons when ejected at up to 80nA for 12 minutes. However,
in 6/7 and 6/8 neurons for GR 82334 and RP 67580 respectively, ionophoresis of
these selective NKj antagonists resulted in a small but reliable enhancement of
activity evoked by innocuous brush. Ionophoresis of GR 82334 at 30-80nA
resulted in a significant enhancement of activity evoked by innocuous brush by
+54 ±7% ( n = 9) from the control value (see Figures 4.1, 4.3a and 4.4); in the
remaining cell there were no detectable changes. Similarly, ionophoresis of RP
67580 at 30-85nA caused a small, but reliable enhancement of innocuous brush
activity to 136 ± 8 (n = 5) of the control value (see Figures 4.2, 4.3b and 4.4) and
in the remaining 2 cells there was no detectable change in activity due to
ionophoresis of the antagonist.
The Effect ofNK2 Antagonists on Pre-Mustard Oil Responses
Before application of mustard oil to the receptive field area, both the NK2
antagonists under study (L-659,874 and SR 48968) gave similar results (see
Figures 4.3c,d and 4.4). Neither antagonist produced any significant change in the
response to innocuous brush. lonophoresis of L-659,874, over a current range of
15-55nA resulted in a brush response of 104 ± 5% mean ± s.e.m. (n = 8)
compared to control. Similarly, over a current range of 40-65nA, ionophoresis of
the non-peptide NK2 antagonist SR 48968 resulted in an insignificant change in
innocuous brush at 98 ± 8% mean ± s.e.m (n = 5) compared to pre-drug control.
Neither drug produced any significant change in the background (spontaneous)
activity. However, as previously described (Chapter 2), both the NK2 drugs under
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Figure 4.1
The effects of GR 82334 on sensory responses of corresponding laminae IV/V
neurons before and after mustard oil application
A typical examples of the effects of the NK] tachykinin antagonist, GR 82334 on
(a) brief sensory responses of laminae IV/V neurons, and (b) sensory responses of
laminae IV/V neurons following sensitisation of neuronal responsiveness as a




























The effects of RP 67580 on sensory responses of a laminae IV/V neuron
before and after mustard oil application
The complete recording sequence from a laminae IV/V neurons demonstrating the
effect of the NKj antagonist RP 67580 on (a) brief sensory responses of this
neuron, and (b) sensory responses following sensitisation of neuronal




























The effects of tachykinin antagonists on sensory responses of laminae IV/V
neurons before and after mustard oil application, expressed as values
normalised to corresponding controls.
Mustard oil caused mean increases in responses of 212 ± 27% (n=17) for
innocuous brush and 219 ± 27% (n=18) for noxious heat (to 48°C). The drugs
administered ionophoretically were as follows :
(a) GR 82334: 30-80nA prior to mustard oil (n=6-7), 25-85nA following
mustard oil (n=5-6).
(b) RP 67580: 30-85nA prior to mustard oil (n=4-7), 40-85nA following
mustard oil (n=4).
(c) L-659,874: 15-60nA prior to mustard oil (n=5-8), 15-95nA following
mustard oil (n=3-5).
(d) SR 48968: 40-65nA prior to mustard oil (n=4-5), 40-70nA following
mustard oil (n=4).
There was no consistent difference in the currents required for the effects
described prior to mustard oil. The statistical significance of drug effects
compared to their concurrent controls was assessed by the Wilcoxon Signed
Ranks test (* P< 0.05). The statistical significance of differences in drug effects
prior to, or following mustard oil was assessed by Mann-Whitney U-test (t P<
0.05).
Due to the practical difficulties ensuing from the complex and prolonged protocol
it was possible only in a limited number of cases to obtain complete recording
sequences of any given neuron, both before and after mustard oil. Each result was
































































Histogram demonstrating the effect of tachykinin antagonists on sensory
responses before and after cutaneous application of mustard oil.
Sensory responses to innocuous brush and noxious heat were compared before and
after the peripheral application of mustard oil. The effects of the highly selective
NKq antagonists GR 82334 and RP 67580 and NK2 antagonists L-659,874 and
SR 48968 were also tested on these multireceptive neurons both before and after
mustard oil.
Before mustard oil, ionophoretic application of selective NKj antagonists resulted
in a small, but reliable enhancement of activity evoked by innocuous brush with no
apparent effect on noxious heat or spontaneous activity in 6/7 and 6/8 cases for
GR 82334 and RP 67580 respectively. Similar application of NK2 antagonists
resulted in a pronounced decrease in the response to noxious heat with no
significant change in spontaneous or innocuous brush activation in 8/8 and 5/5
cases for L-659,874 and SR 48968 respectively.
A very different situation resulted after peripheral sensitisation to mustard oil. The
spontaneous activity increased on average by approximately 400% and
ionophoresis of both NK4 and NK2 antagonists caused a marked decrease in both
innocuous brush and noxious heat responses in this sensitised state.
There was no consistent difference in the currents required for the effects
described prior to/following mustard oil. The statistical significance of drug
effects compared to their concurrent control was expressed by the Wilcoxon
Signed Ranks Test (* P<0.05). The statistical significance of differences in drug
















study produced a pronounced and significant decrease in the response to noxious
heat. For L-659,874, over a current range of 15-55nA there was a 45 ± 10%,
mean ± s.e.m., (n = 5) decrease and for SR 48968, a 34 ± 3%, mean + s.e.m.
decrease from control values.
(b) Post-Mustard Oil Responses
After mustard oil (8% in paraffin oil) was painted over the receptive field
area on the foot and hind limb over 1-20 minutes, 23/24 cells tested had
pronounced and prolonged increases in activity with firing rates at 400 ± 19% of
background levels. A further 2 cells also had a high activity level after mustard oil
application, but this could not be compared with pre-mustard oil spontaneous
activity as this had not been recorded for technical reasons. Figure 4.1 shows a
typical example of the increased firing rate, post-mustard oil. Before any sensory
responses could be tested following mustard oil, it was ensured that the elevated
mustard oil-induced activity had remained at a constant level for at least two
minutes.
The post-mustard oil sensory responses (brush and heat) were analysed in
a similar manner to the pre-mustard oil sensory responses. The values for the
stimulus-evoked responses were then normalised by taking the spontaneous
background value from each sensory response value and expressing as a
percentage of the mean pre-drug control value.
The protocol for drug testing following mustard oil was identical to that
prior to mustard oil but usually with allowance for a prolonged period of recovery
from previous drugs (> 30 minutes). The results of the drug effects were
compared for both before and after mustard oil application also the statistical
significance of differences in drug effects prior to or following mustard oil was
assessed by Mann Whitney U-Test, and a comparison with the corresponding pre-
or post- mustard oil controls was made The statistical significance of drag effects
compared to their concurrent control was assessed by Wilcoxon Signed Ranks
Test.
The peripheral application of mustard oil to the receptive field area over a
period of 5 - 20 minutes caused a sensitisation of the sensory responses compared
to the pre-mustard oil control values. During this period, the receptive field area
became red and slightly swollen. The responses to innocuous brash and noxious
heat increased by 212 ± 27% (n=17) and 219 ± 27% (n=19) respectively reflecting
the same degree of sensitisation of these responses.
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The Effect ofNKj Antagonists on Post-Mustard Oil Responses.
In the sensitised state, ionophoresis of NKj antagonists GR 82334 and
RP 67580 produced an entirely different effect on the sensory responses, (noxious
heat and innocuous brush) compared to the pre-mustard oil controls. In 7 out of 7
neurons studied, ionophoresis of GR 82334 at 25-85nA caused a marked and
sustained decrease in responses to both innocuous brush and noxious heat to 69 ±
12% and 69 ± 4% respectively (mean ± s.e.m.) (P<0.05) (see Figures 4.1, 4.3a and
4.4). In 4 out of 4 neurons studied, ionophoresis of the non-peptide antagonist RP
67580 reproduced these effects with a decrease of 31 ± 4% (mean ± s.e.m.) in the
response to innocuous brush and 45 ± 15% (mean ± s.e.m) in the response to
noxious heat, expressed as a percentage of the control pre-mustard oil values (see
Figures 4.2, 4.3b and 4.4). This is entirely different to the pre-sensitised state
where both NK| antagonists produced a significant increase in the response to
innocuous brush with no discernible effect on the noxious heat. These changes
cannot be attributed to differences in ejection currents between pre- and sensitised
state, as there was no significant difference (P > 0.05) between them.
In the case of GR 82334, it was possible to test sufficient neurons in a
strictly matched design both before and after mustard oil, so that a precise
assessment could be made of drug effect on the mustard oil-induced increment in
the sensory responses, over and above any changes in basal activity (see Figure
4.1).
In these experiments, prior to mustard oil, GR 82334 had no effect on the
heat responses (98 ± 12% of control, mean ± s.e.m. n = 5). However, mustard oil
elicited an increase in drug-free heat responses to a mean value of 223 ± 62% of
control. The increment brought about in heat responses by mustard oil was
significantly inhibited by GR 82334, to a value of 16 ± 18% of the drug-free,
mustard oil induced increment (P<0.05, by Wilcoxon test). GR 82334 had a
significantly different effect on the increment in heat responses brought about by
mustard oil, than it did on pre-mustard oil heat responses (P>0.05, Mann Whitney
U-test).
Prior to mustard oil application, ionophoresis of GR 82334 (30-80nA),
caused a marked and significant increase in the response to innocuous brush (to
148 ± 7% of control, p<0.05, by Wilcoxon test). After recovery from the NKj
antagonist mustard oil application resulted in a significant increase in the brush
response to 212 ± 27% of control (mean ± s.e.m., P>0.05). This increment
brought about in brush responses by mustard oil was significantly inhibited by GR
82334, to a value of 69 ± 12% of the control (P<0.05, by Wilcoxon test).
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The Effect ofNK2 Antagonists on Post-Mustard Oil Responses.
Ionophoresis of both the peptide NK2 antagonist L-659,874 and the non-
peptide antagonist SR 48968 produced similar changes in the sensory responses
after peripheral application of mustard oil to the receptive field area (see Figures
4.3b,c and 4.4). In this sensitised state, L-659,874 caused a marked decrease in
both brush and heat responses to 68 ± 6% (3/5 neurons) and 55 ± 8% (5/5
neurons) of the control values. Similarly, SR 48968 caused a decrease in both the
innocuous and noxious responses to 58 ± 9% (4/5 neurons) and 54 ± 6% (4/4
neurons) of the pre-mustard oil control. These results are surprisingly different to
those in the pre-mustard oil non-sensitised state where the NK2 antagonists had no
apparent effect on the innocuous bmsh, whilst inhibiting the noxious heat
responses. Again this cannot be attributed to any differences in the current levels
between control and sensitised states as there was no significant difference
(P>0.05).
4.4 DISCUSSION
Stimulation of cutaneous nociceptors with mustard oil has been described
to lead to central sensitisation of dorsal horn neurons and expansion of their
effective receptive fields (Woolf and King, 1990; Woolf and Thompson, 1991).
Central sensitisation is the phenomenon whereby neurons in the dorsal horn
undergo prolonged alterations in their response properties (Woolf, 1991). It is
triggered by activation of nociceptive afferents by noxious stimuli (Wall and
Woolf, 1984; Woolf and Wall, 1986) or following their sensitisation, by low
intensity stimuli, produce activity dependent alterations in dorsal horn neurons
such that they begin to respond in an abnormal or exaggerated way to A [3 afferent
inputs (Woolf and King, 1990; Woolf, 1991). The result of such central sensitised
states is a prolonged reduction in the threshold, an expansion in the extent and an
increased responsiveness of the cutaneous receptive fields of dorsal horn neurons
(Campbell et al, 1979; LaMotte et al, 1983; Cervero et al, 1988; Hylden et al,
1989; Simone et al, 1991; Woolf and King, 1990). Although NK2 rather than
NKj receptors seem important in mustard oil-evoked increases in spontaneous
activity here, it is not clear whether NK j receptors may play a role in central
sensitisation.
The present experiments thus specifically addressed the role of NK] and
NK2 receptors in central sensitisation. The neuronal population sampled here had
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similar electrophysiological characteristics and receptive field locations as the cells
reported in Chapter 3. Only multireceptive neurons were studied because of their
ability to integrate both noxious and innocuous information (Iggo, 1974;
Handwerker et al, 1975). Their position was substantiated by depth measurements
and blue spot histology and correspond to laminae III-V of dorsal horn as defined
in rats by Molander et al, (1984). Control studies demonstrated that whilst DLH
ejection caused clear excitation, ejection of NaCl and vehicle were unable to
reproduce any of the observed actions described below. The cutaneous receptive
field of each neuron under examination was located on the 'hairy' foot, toes or
flank of the ipsilateral hindlimb. Neurons with receptive fields on the glabrous
skin were not used due to poor penetration of the chemical algogen mustard oil
(Harris and Ryall, 1988).
Ionophoresis of the highly selective NKj and NK2 antagonists around the
laminae III-V dorsal horn neurons produced results entirely consistent with those
obtained in Chapter 2. The selective peptide and non-peptide NKq antagonists
used were GR 82334 (Hagan et al, 1991) and RP 67580 (Garret et al, 1991)
respectively. Local application of each drug around laminae III-V dorsal horn
neurons resulted in a consistent facilitation of the response to innocuous brush
with no apparent change in the sensory responses to noxious pinch and heat. Also
analogous to Chapter 2 are the consequences after ionophoretic administration of
the highly selective NK2 antagonists L-659,874 (McKnight et al, 1988) and SR
48968 (Emonds-Alt et al, 1992), a selective attenuation of the noxious heat
response with no significant effect on innocuous brush or noxious pinch.
Following repeated cutaneous application of mustard oil to the neuronal
receptive field, there was a significant, facilitated increase in the background firing
rate. As described in Chapter 3, some cells had an immediate increase in firing
rate after a single application of this chemical algogen, however, in most cases, the
steady elevated firing rate was achieved by repeated application of the algogen.
However, a crucial dissimilarity between the experiments carried out here and
those in Chapter 3 was the length of time each neuron was exposed to mustard oil
before ionophoresis of selective antagonists. As each set of brush and heat
responses were cycled over a minimum period of 3 minutes and at least three
consecutive sets of control sensory responses were carried out here before drug
testing, then the latency between the initial mustard oil application and the
ionophoresis of selective antagonists was on average much greater.
This prolonged exposure to the selective C fibre stimulant was critical to
the responsiveness of each neuron as consequently the responses to both
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innocuous brush and noxious heat were markedly and significantly increased
taking background activity into account. Furthermore, consistent monitoring of
the receptive field size throughout each experiment revealed that whereas in the
last series of experiments there was no observed differences consequent to
mustard oil exposure, here an increase was frequently observed suggestive of the
involvement of a central alteration (Woolf, 1991). This may be simply due to the
increased exposure to mustard oil, although another possible explanation is the
application of repeated control sensory responses to a mustard oil-facilitated
neuron. Although in a non-mustard oil treated condition, cycling of the brush and
heat sensory responses at 3 minute intervals has never resulted in an observed
sensitisation of the dorsal horn neurons studied (Fleetwood-Walker et al, 1990),
perhaps in a system which has been 'primed' by cutaneous application of mustard
oil this can easily occur.
Correspondingly, in this 'sensitised' state, the balance of NKj and NK/?
receptor involvement in the sensory responses to innocuous brush and noxious
heat appeared to be altered. Although ionophoresis of both the highly selective
NK2 antagonists L-659,874 and SR 48968 resulted in a selective attenuation of
the response to noxious heat in both the pre-mustard oil and sensitised states, in
the sensitised state there was additional inhibition of the facilitated innocuous
brush sensory response. Furthermore, administration of selective NK] antagonists
had different consequences in each case. Whereas in the pre-mustard oil state,
ionophoretic administration of both GR 82334 and RP 67580 close to the laminae
III-V neurons resulted in a marked and selective facilitation of the response to
innocuous brush with no significant effect on noxious heat responses; in the
sensitised state the facilitation of neuronal responses to both brush and heat was
blocked by the NKq antagonists.
Interest was primarily in the influence of the selective tachykinin
antagonists on the cutaneous sensory responses in this 'sensitised' state and in
general any corresponding effect on the background activity was not calculated.
However, from the examples of neuronal activity shown in Figures 4.1, 4.2 and
4.3 it can be seen that although the mustard oil-facilitated background activity was
low, following ionophoretic administration of both selective peptide and non-
peptide NKq (GR 82334 and RP 67580 respectively) and NK2 receptor
antagonists (L-659,874 and SR 48968 respectively), there was attenuation of the
facilitated background activity for each example. These results were in contrast to
those described in Chapter 3 whereby although ionophoresis of the selective
peptide and non-peptide NK2 receptor antagonists L-659,874 and SR 48968
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resulted in a similar, marked attenuation of the mustard oil-facilitated background
activity in both series of experiments, the results obtained following ionophoretic
administration of selective NKj antagonists was entirely different. In Chapter 3
following acute nociceptive chemical stimulation of dorsal horn neurons, the
mustard oil-facilitated background was generally unaltered following ionophoretic
administration of selective peptide (GR 82334 and L-668,169) NKj receptor
antagonists but in a few examples where the selective non-peptide NKj receptor
antagonist RP 67580 was either ionophoretically or intravenously given, there was
attenuation of the amplified response to mustard oil.
These differences are likely to be due to the development of sensitisation
following the prolonged exposure of the neurons to mustard oil. Although the
background activity was sometimes very low following prolonged exposure to the
algogen, the fact that the receptive field size increased and the sensory responses
were facilitated, demonstrated that after prolonged application of the C fibre
stimulant mustard oil to a cutaneous receptive field, central sensitisation occurred,
in agreement with previous studies using mustard oil (Woolf and Wall, 1986;
Woolf and King, 1990) and also the C-fibre neurotoxin capsaicin (Simone et al,
1991; Dougherty and Willis, 1992; LaMotte et al, 1992). Central sensitisation is a
phenomenon known to occur following activation of nociceptive afferents by
sustained noxious or inflammatory stimuli that lead to hyperalgesia and allodynia
resulting in changes in the excitability of the spinal cord dorsal neurons (Woolf,
1991; Treede et al, 1992). In close agreement with the results described, central
sensitisation is characterised by a reduction in threshold, an increased
responsiveness of dorsal horn neurons to thermal (Kenshalo et al, 1979; Simone et
al, 1991) and mechanical stimuli (Kenshalo et al, 1979; Simone et al, 1991;
Woolf and King, 1990) and an expansion in the extent of the receptive field
(Treede et al, 1992). Many of these changes (especially secondary hyperalgesia
outwith the primary zone of injury) cannot be adequately explained by peripheral
changes, and therefore must be due to central sensitisation (Woolf, 1991; Treede
et al, 1992).
It therefore is apparent that although NKj receptors appear to be less
involved in acute nociception, they may have a role in mediating 'sensitised'
nociceptive responses. Consistent with this idea, inflammatory models of
sustained nociception induced by formalin and CFA have been shown to increase
the biosynthesis of SP-IR and mRNA encoded by the PPT-1 gene in both the
spinal dorsal horn and dorsal root ganglia of rats (Minami et al, 1989; Donaldson
et al, 1992; Noguchi and Ruda, 1992; McCarson and Krause, 1994). Following
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induction of these inflammatory states, an increase in the NKj receptor gene
expression and NK4 binding sites have also been observed (Schafer et al, 1993;
Stucky et al, 1993; McCarson and Krause, 1994). Furthermore, 'sensitising'
models of sustained C-fibre activity have demonstrated the increased release of
SP-IR into the spinal dorsal horn following a potential damaging thermal
stimulation (Go and Yaksh, 1987; Kuraishi et al, 1989) in addition to the more
prolonged inflammatory models of formalin, CFA or carrageenan/kaolin injection
(Oku et al, 1987; Kuraishi et al, 1989; Schaible et al, 1990; McCarson and
Goldstein, 1991; Garry and Hargreaves, 1992).
In addition, repetitive electrical stimulation of afferents at intensities
sufficient to activate C-fibres, correspondingly elicits the sensitised responsiveness
of dorsal horn neurons that is known as 'wind-up' (Mendell, 1966) and is thought
to contribute to central hyperalgesic states (Woolf, 1983; Dickenson, 1990; Woolf
and Thompson, 1991). Accordingly, SP was able to enhance, whilst a NKj
receptor antagonist was able to inhibit the responses of nociceptive dorsal horn
neurons to wind-up (Kellstein et al, 1990), in addition to the underlying long-
duration excitatory postsynaptic dorsal root potentials (Urban and Randic, 1989).
Furthermore, using an in vitro spinal cord-skin preparation, these long-duration
epsps have also been recorded extracellularly as ventral root potentials in the
recently developed ultraviolet (UV) burn hyperalgesic model. It was demonstrated
that the NKj receptor antagonist CP,96,345 was able to reduce C-fibre evoked
ventral root potentials in the UV-treated state yet was ineffective in naive rats
(Thompson et al, 1993) demonstrating a role for NK] receptors in this model of
central sensitisation. In addition, the facilitation of the flexion-reflex induced by
C-fibre strength conditioning stimulation to the sural nerve, believed to lead to
central sensitisation, was mimicked by intrathecal administration of SP (Woolf and
Wiesenfeld-Hallin, 1986; Wiesenfeld-Hallin et al, 1990; Xu et al, 1992) and
effectively antagonised by selective NKj receptor antagonists (Wiesenfeld-Hallin
et al, 1990; Xu et al, 1992; Laird et al, 1993). However, the baseline reflex
remained unaffected following pre-treatment with NK} receptor antagonist (Laird
et al, 1993).
Behavioural studies have further substantiated a role for NKj receptors in
sustained or inflammatory nociceptive models. The reduction in tail-flick latency
following sensitisation of the rat's tail in hot water can be reversed following NKj
receptor antagonist (Cridland and Henry, 1988; Yashpal et al, 1993). Similarly,
both the NK[ receptor antagonists RP 67580 and CP-96,345 were antinociceptive
in the formalin model of inflammation and hyperalgesia (Garrett et al, 1991;
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Yamamoto and Yaksh, 1991; Birch et al, 1992; Nagahisa et al, 1992; Chapman
and Dickenson, 1993; Yashpal et al, 1993) although there are reports of non-NKj
receptor mediated effects (Nagahisa et al, 1992; Rupniak et al, 1993). Likewise,
the carrageenan-induced oedema and hyperalgesia can be attenuated following
(±)CP-96,345 (Birch et al, 1992) although again, spurious non-NKj receptor-
mediated effects have been suggested (Nagahisa et al, 1992). However, CP-
96,345 has been shown to stereospecifically inhibit mustard oil-evoked oedema
and acetic acid-induced writhing (Lembeck et al, 1992; Nagahisi et al, 1992)
further substantiating a role for NKj receptors in inflammatory and hyperalgesic
conditions.
In the periphery, there is further evidence suggesting that NK^ receptor
effects are highlighted following induction of inflamed or sustained nociceptive
conditions. The non-peptide receptor antagonists RP 67580 and CP-96,345 dose-
dependently reduced plasma extravasation produced by electrical stimulation of
the trigeminal ganglion (Shepheard et al, 1993), intravenous injection of SP
(Lembeck et al, 1992; Nicolau et al, 1993; Moussaoui et al, 1993) or antidromic
sciatic nerve stimulation (Xu et al, 1992). Moreover, brief capsaicin treatment of
rabbit skin nerves leads to a reduction in the neurogenic, inflammatory response to
mustard oil and also in the SP content of the skin (Lynn and Shakhanbeh, 1988)
further supporting a role for SP in plasma extravasation and inflammation.
In contrast to the NKj receptors, NKA (and corresponding NK2
receptors) clearly play a functional central role in, brief thermal nociceptive
responses (see Chapter 2); medium-term sustained C-fibre activity following acute
cutaneous application of mustard oil (see Chapter 3); in addition to the sensitised
neuronal responses to brush and heat following prolonged exposure to the
chemical algogen mustard oil. It is therefore apparent that, unlike NKj receptors
which appear to only be functional in inflammatory and hyperalgesic conditions,
NK/> receptors play a role in mediating models of both acute and sustained,
inflammatory pain. However, following central neuronal sensitisation, this role
seems to be modified with NK2 receptors mediating both noxious and innocuous
neuronal responses. In support of the role of NK2 receptors in mediating
sustained, sensitised spinal nociceptive processing, other studies have shown that
adjuvant or formalin-induced inflammation and hyperalgesia leads to an increased
biosynthesis of PPT-1 mRNA (and therefore possibly NKA too) (Minami et al,
1989; Donaldson et al, 1992) and although there is as yet no direct evidence for an
increase in NK2 receptor biosynthesis due to inflammation and hyperalgesia,
increased release of NKA was seen following kaolin and carrageenan injection
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into the knee joint (Hope et al, 1990). Furthermore, molecular biology techniques
have also been utilised to provide powerful evidence that NK2 receptors play a
role in longer-term genomic responses to inflammation. Using in situ
hybridisation histochemistry, the contribution of NK2 receptors to the
carrageenan-induced expression of preprodynorphin mRNA in superficial dorsal
horn neurons was assessed (Parker et al, 1993). Locally applied NK2 antagonists
effectively reduced the response to carrageenan, both in terms of number of
expressing cells and density of expression. Electrophysiological studies provide
further support for a role of NK2 receptors in mediating sensitised responses, the
flexor reflex facilitation evoked by damaging cutaneous thermal stimuli (80°C for
0.5 seconds) was significantly potentiated by intrathecal NKA (Xu and
Wiesenfeld-Hallin, 1992). Likewise, pre-treatment with the selective NK2
receptor antagonist, MEN 10207 effectively blocked the long-term flexor reflex
facilitation due to gastrocnemius nerve conditioning at C fibre strength (Xu et al,
1991). Correspondingly, in the ultraviolet burn model using an in vitro, spinal
cord-skin preparation (Thompson et al, 1994), the selective NK2 antagonist MEN
10376, significantly reduced the C-fibre evoked ventral root potential both pre-
and post-inflammation, again providing evidence that NK/> receptors are important
in both acute and prolonged nociceptive states.
It is not yet clear whether the role in sensitisation of NKq receptors that
emerges after inflammation is simply due to extra production, output and spread of
SP to NKq sites some way from the release site or whether some distinct enabling
signal has been received which permits the receptors to modify cellular function.
Their influence, however, extends beyond the mediation of nociceptive input since
they also sensitise with respect to non-nociceptive inputs, emphasising an effective
role as sensitiser rather that just input mediator. Whilst a full elucidation of these
regulatory mechanisms presents a considerable research task, it is possible, with




The Role of Protein Kinase C (PKC) In Sustained
Nociceptive Responses of Rat Dorsal Horn Neurons
5.1 AIMS
The present experiments addressed any role of protein kinase (PKC) in
sustained nociceptive responses of rat dorsal horn neurons by (i) ionophoretic
administration of PKC inhibitors whilst recording activity evoked by repeated
cutaneous application of mustard oil; and (ii) assessing subcellular translocation of
PKC evoked in spinal cord by cutaneous application of mustard oil. In addition,
the involvement of NK2 receptors was assessed using systemic administration of
selective antagonists.
5.2 MATERIALS
Animals: Male Wistar rats were obtained from Charles River UK Ltd,
Margate, Kent, UK.
Anaesthetics: Alpha-chloralose and urethane were obtained from Sigma
Chemical Company, Poole, Dorset, UK; Halothane (flurothane) was obtained
from ICI Pharmaceuticals, Macclesfield, Cheshire, UK.
Laboratory Chemicals: Standard laboratory chemicals were of Analar
grade and from the following suppliers: Sodium chloride (NaCl), DLH (D, L,
homocysteic acid) and Pontamine Sky Blue (PSB) were obtained from Sigma
Chemical Company, Poole, Dorset, UK; allyl-isothiocyanate (mustard oil) was
purchased from Aldrich Chemical Company Ltd, Gillingham, Dorset, UK;
Halothane (Flurothane) was obtained from ICI Pharmaceuticals, Macclesfield,
Cheshire, UK. Agar was obtained from Oxoid Ltd, Basingstoke, Hampshire, UK
and paraffin was purchased from Scotlab, Lanarkshire, UK. [20-3h(N)]-
phorbol,12,13-dibutyrate ([3h]-PDBu) (specific activity 19.1 Ci/mmol) was
supplied by Du Pont, Dreiech, Germany. Bovine serum albumin (essential fatty
acid free), PDBu, 2-mercaptoethanol and phosphatidylserine were all purchased
from Sigma Chemical Company Ltd, Poole, Dorset, UK.
Drugs: The protein kinase C inhibitors, chelerythrine and 2-[-(3-
dimethylaminopropyl)-indol-3yl]-3-(-indol-3yl)maleimide, (GF109203X) were
obtained from Novabiochem, Nottingham, UK); (S)-N-methyl-N[4-(4-
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acetylamino-4-phenyl piperidino)-2-(3,4-dichloro phenyl)butyl] benzamide (SR




See Chapter 2 for details of animals; surgical techniques; procedures for
histological determination of laminar location and recording & ionophoresis
methods used. Extracellular recordings from single laminae III-V dorsal horn
neurons, were made through the central barrel of a 7-barrelled microelectrode
containing 4M NaCl, pH 4.0-4.5. Drugs were ionophoresed from the side barrels.
One side barrel contained 1M NaCl (pH 4.5-5.0) for automatic current balancing,
another barrel was filled with PSB for marking the position of recording sites and
the other electrode barrels contained the following selective PKC inhibitors:-
Chelerythrine (ImM, pH 4.5-5.0); GF 109203X (0.2mM in 0.2% DMF, pH 4.5-
5.0).
5.4 Methods:- [3h]phorbol 12,13-dibutyrate Binding Studies
5.4.1 Animals
Adult male Wistar rats (250-360g) were housed in groups of 3 or 4 in
standard plastic cages, maintained on a 12 hour light to 12 hour dark cycle at 22-
23°C; food and water available ad libitum throughout the experiments.
5.4.2 Drugs
The non-peptide NK2 receptor antagonist SR 48968 and the inactive
isomer SR 48965 were used in these experiments. Each was dissolved in a few
drops of ethanol, then saline (0.9% NaCl) to give lmg/ml solutions and injected as
a 1.0 mg/kg solution by an intraperitoneal (i.p.) route. Both drugs were made
fresh on the day of the experiment and were not frozen or reused.
5.4.3 Experimental Protocol
If an antagonist or vehicle was under study, the rats were injected by the
i.p. route 15 minutes prior to administration of anaesthetic, during which time they
remained in the cage with free access to both food and water.
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Figure 5.1 shows a summary diagram of the methods employed. The rats
were lightly anaesthetised with flurothane and both hind legs were shaved.
Mustard oil (allyl isothiocyanate) was diluted to 8% in paraffin oil and painted
onto the left hind-paw and limb using a paintbrush and covering up to the knee
joint. The stopwatch was started and at 5 and 10 minutes this procedure was
repeated. After the final application of mustard oil, the treated limb was carefully
covered with cling film and tape to avoid any cross-contamination of the
contralateral limb. The rat was placed in a restraining cage made from wire mesh
and cushioned with foam. It was then left to recover from the anaesthetic and
during this period the animal was closely monitored to ensure that the bandage did
not come off.
At 30 minutes post-mustard oil treatment, the animal was killed by
cervical dislocation and the spinal cord was removed as rapidly as possible, within
2-4 minutes. Following a laminectomy using sterile dissection instruments, the
T12-L6 area was exposed and the dura was carefully removed to allow easier
removal of the cord. Using a sterile surgical blade (No. 22), the cord was very
carefully hemisected along the midline and most of the dorsal roots were
removed; only the L2-L5 area was taken for the assay.
Each half of the cord was separately homogenised in 450pl of ice-cold
buffer (20mM Tris-HCl (pH 7.5) with 50mM 2-mercaptoethanol, 2mM EDTA
and ImM phenylmethylsulphonyl fluoride) containing 0.01% leupeptin and 20pM
transepoxysuccinyl-L-leucylamido-(4-guanidino)- butane (E-64) ("Kuo-PI") using
hand-held lml glass homogenisers. The samples were than ultracentrifuged
(38,000 x g , 20min, 4°C) to separate membranes and cytosol. The cytosolic
fractions (supernatant) were carefully removed using fine glass pipettes and
equilibrium ligand binding assays carried out as follows:-
The membranes were resuspended, using an Ystral polytron homogeniser,
in 300pl 50mM Tris HC1 (pH 7.4) with 4mg/ml bovine serum albumin (essential
fatty acid-free) (BSA). The membrane suspension (50ul) was aliquoted into tubes
on ice containing: 200pl 50mM Tris HC1 (pH 7.4) with 4mg/ml BSA; 25pl of [3H]
PDBu and 2.5pl dimethylformamide or 2.5|il of ImM PDBu in
dimethylformamide for measurement of total or non-specific binding levels
respectively. Tubes were capped, vortexed and placed in a waterbath at 37°C for
30 minutes. The tubes were then placed on ice and protein was precipitated by
addition of 300pl of 'Tris-PEG' (50mM Tris-ElCl (pH 7.4) with 24% polyethylene
glycol 8000 and lOOjil of'Tris-BGG' (50mM Tris-FICl (pFl 7.4) with 12mg/ml of
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Figure 5.1
Summary diagram of the procedures used in [^H]phorbol ester binding
studies in the rat spinal cord.
Male rats were anaesthetised and mustard oil (8%) applied 3x5 min intervals to
an extensive area of shaved skin distal from the thigh on one hindlimb. After 30
minutes, spinal segments L2-L5 were carefully removed and hemisected on the
midline for analysis. Tissue was homogenised and centrifuged before specific
binding of [3h]PDBu was determined as outlined.
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[3H]PDBu Binding In Rat Spinal Cord.
Adult male rat.
I
Anaesthetised, both legs shaved.
I
Left hindpaw and foot painted with 8%
M Oil 3x over 15 minutes.
I
Treated leg bandaged to prevent cross-
contamination.
I
Rat transferred to restraining cage for 30 mins.
i
Rat killed, spinal cord hemisected.
14 Si
Left (treated) hemisection Right (control) hemisection
SI 14
Each hemisect separately homogenised in 400|il ice-cold buffer
(20mM Tris-HCL (pH 7.5) with 50mM 2-mercaptoethanol, 2mM EDTA & ImM




250,000g, 30 mins 4°C.
SI
Supernatant Membranes
50pl/tube Pellet resuspended in Tris 50mM HCL Fatty
Acid Free (FAF) Bovine Serum Albumin
(BSA) 4mg/ml in pH 7.0 50[ol/tube
i 1
Additons to each tube Additons to each tube
200pl 1.25mg/ml PS in buffer (containing 200|oJ TBSA; 25|il PDBu
50mM Tris HC1, 4mg/ml BSA, ImM in TBSA (10(0.1 in 1 ml);
CaCl2, 75mM Mg Acetate); 25pl PDBu 2.5(0.1 DMF (total binding) or
in TBSA (1 Opil/ml); 2.5(0,1 DMF (total) or 2.5)0,1 PDBu (non-specific).
2.5p.l PDBu (non-specific)
SI 14
Cap, vortex 37°C 30 mins.
1
Proteins precipitated on ice with 12mg/ml bovine gamma globulin






Centrifuge 12,000g, 5min 4°C.
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bovine gamma globulin (BGG)) to each tube. The tubes were capped, vortexed
and left on ice for 20 minutes before being centrifuged (12,000 x g, 5 minutes,
4°C) and the supernatant aspirated. The tip of each tube was cut off and left to
dissolve overnight in 4ml scintillation fluid (Emulsifier-Safe, Packard Ltd.,
Groningen, Netherlands). The radioactivity in each pellet was determined by
counting in a Beckman LS 1801 liquid scintillation counter.
The cytosolic [^HJPDBu binding assay was performed in a method
similar to that described by Leach et al, (1983). The supernatant removed after
ultra-centrifugation was regarded as the cytosolic fraction, 50pi was aliquoted into
tubes on ice containing 200pl of a micellar preparation of phosphatidylserine
(sodium salt) in assay buffer (1.25 mg/ml final concentration), 25pl [^HJPDBu (10
|il/ml final concentration) and 2.5|il dimethylformamide or 2.5ul of ImM PDBu in
dimethylformamide for measurement of total or non-specific binding levels
respectively. The assay buffer ("Blumberg cytosol buffer") contained 50mM Tris
HC1; 4mg/ml BSA, ImM CaCl2; 75mM magnesium acetate. Phosphatidyl serine
micelles were prepared by sonication, assay tubes capped, vortexed and incubated
at 37°C for 30 minutes. Protein was precipitated on ice by addition of lOOpl of
12 mg/ml bovine gamma-globulin and 300pl of 24% polyetheneglycol 8,000 in
50mM Tris HC1 (pH 7.4), capped and vortexed vigorously. After 20 min (4°C),
assay tubes were spun (12,000 x g, 5 min, 4°C), aspirated and the radioactivity in
each pellet was determined by solution overnight in scintillation fluid, then
counting as described above for membrane assays.
5.4.4 Analysis
After each hemisected piece of spinal cord had been homogenised and
centrifuged, the resulting cytosol and membrane components were each
transferred into 4 tubes. Thus for each of cytosolic and membraneous components
there were 2 tubes for measurement of total binding and a further 2 for non¬
specific binding measurement. After completion of the assay, each tube was
counted for p-radiation and the results were expressed graphically (see Ligures 5.3
and 5.4). Each pair of results were averaged, and the difference between the mean
total and mean non-specific binding was regarded as the specific binding.
The subcellular translocation of [20-3H(N)]phorbo 1 12,13-dibutyrate
([3h]PDBu) binding sites from cytosolic to membrane compartments, can be
taken as an index of PKC activation in response to stimulation of cell surface
receptors (Lutz et al, 1993). Thus by comparing the cytosolic and membrane
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components from each hemisected piece of cord, it could be calculated whether
PKC translocation / activation had occurred.
Statistical significance of changes was assessed by Mann-Whitney U-test.
This is a nonparametric statistical analysis test which makes no assumptions of a
normal distribution of data and errors. It is therefore a convenient statistical test to
analyse both raw data, and data which is transformed (e.g., ratioed to some control
value) as is mostly presented here. Although the Mann-Whitney U-test is not the
most powerful test to detect small differences, it does demand the constraints on
data distribution of the Student's t-test, which can be violated easily in practice.
To apply the test, all the data have to be assigned a rank order of magnitude (e.g.
number 1 for lowest value to number n for the highest value (n = total number of
values in both data groups being compared)). The rank orders in both groups are
summed, and the statistical significance for the appropriate number of values in
each group, can be determined using a Mann-Whitney or Wilcoxon significance
table. Significance was accepted at probability values of P < 0.05.
5.5 RESULTS- ELECTROPHYSIOLOGY
5.5.1 Characteristics and Receptive Field Properties of Neurons Tested
The present results were obtained from 11 neurons located in laminae IV-
V in the spinal cord dorsal horn. Laminar location was estimated as the depth
recording on the microdrive which for laminae IV-V was 350-600pm. Very
occasionally recording took place from cells located slightly superficial to this
depth but recording from cells deeper than 600pm was very uncommon due to a
tendency for unresponsiveness to the chemical algogen mustard oil at this depth.
Upon cessation of recording each cell was marked by ejection of Pontamine Sky
Blue (PSB) for 10-15 minutes and when the experiment terminated, the spinal
cord was removed and histologically treated to enable identification of the
recording electrode position on transverse sections of the cord (see Figure 2.5).
All the neurons studied had cutaneous receptive fields located on the hairy
side of the foot and toes or the flank of the ipsilateral hindlimb. It was important
that the receptive field was not on the glabrous skin of the plantar surface of the
foot as there was poor penetration by mustard oil on this type of skin and the result
was that the neuron under examination was not activated by the algogen. The
neurons were initially identified by widespread manual brushing over the
ipsilateral hindlimb and foot; the receptive field was then mapped with an
innocuous brush stimulus and the receptive field area marked with waterproof ink.
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The size of the receptive field area varied considerably between neurons, from as
small as a single digit to the whole flank of the ipsilateral limb and lower body;
throughout the experiment the receptive field size was continually monitored and
any changes were noted.
All the neurons were multireceptive (responded to both innocuous and
noxious stimuli). It was particularly important that the neuron had a notably strong
response to noxious heat as any neurons tested without this were generally not
activated by mustard oil. Heat-evoked sensory responses are derived mainly from
C fibres with threshold skin-surface temperature usually in the range of 44-50°C
(Perl, 1984) however, temperatures above 48°C are generally considered to be
damaging (Duggan et al, 1988) and evidence has been presented that mustard oil
elicits activation of largely C afferents (Woolf and Wall, 1986; Heapy et al, 1987),
although it is possible that some A5 activation also occurs transiently (Harris and
Ryall, 1988). Generally before application of the mustard oil, the background
activity of the neurons examined was very low (less than 1Hz). If the background
activity was too high before application of mustard oil then it masked the
facilitatory response and so these neurons were not used.
Ionophoresis of D,L homocysteic acid (DLH) was used to ensure that any
drug responses were not due to movement of the recording electrode relative to the
neuron. The response to ionophoresis (at the same current) of DLH remained
constant throughout the experiment.
5.5.2 Current and Vehicle Controls
Neurons under consideration were routinely tested with vehicle or current
controls. They were examined under identical conditions to the inhibitors under
study with ejection for at least 1 minute increasing the current in a 10-20nA
stepwise manner every consecutive minute. The effect of vehicle (0.2% DMF) or
NaCl at up to 80nA was investigated in 3 neurons. In 3 out of 3 cells tested,
ionophoresis of vehicle or NaCl at up to 80nA had no detectable effect on
neuronal responses to cutaneous stimuli.
5.5.3 Effect of Cutaneous Application of Mustard Oil
The receptive field area of the neuron under study was characterised
manually with a soft paintbrush and mapped out with waterproof ink. After a 8%
solution of mustard oil (allyl isothiocyanate) in paraffin oil was painted onto the
restricted area, all the multireceptive neurons tested (9/11) had a large and
prolonged increase in activity with firing rates of 324.3 ± 75.8 fold of background
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(mean ± S.E.M.) which remained sustained for a minimum period of 5-6 minutes
after peripheral application.
Similar to the results achieved in Chapter 3, there were two general
patterns of mustard oil-induced activation; either an immediate increase in firing
rate after application of the algogen or, more commonly, the steady elevated firing
rate was achieved by repeated application of mustard oil to the receptive field.
Records such as those shown in Figure 5.2 were analysed off-line to
calculate the percentage inhibition by the protein kinase C inhibitors of the
mustard oil increased baseline. It was important to ensure that the elevated
mustard oil-induced activity had remained at a constant level for at least 2 minutes
before ionophoresis of the inhibitors. To calculate the drug-induced inhibition of
mustard oil-facilitated baseline activity, the number of mustard oil- induced action
potentials in 3 separate 30 second periods was integrated and an average value
calculated (taking spontaneous activity into account) as a percentage of the
corresponding mean pre-drug mustard oil baseline value. Statistical significance
was calculated using the Wilcoxon test.
5.5.4 Effect of Ionophoretically Applied Protein Kinase C Inhibitors
The effects of two ionophoretically-applied PKC inhibitors ejected close
to multireceptive dorsal horn neurons in laminae IV-V of the spinal cord were
assessed. The highly selective PKC inhibitors used were chelerythrine (Herbert et
al, 1990) and GF109203X (Toullec et al, 1990) which were tested first on mustard
oil-facilitated background activity and secondly on continuous brush activity (see
Figure 5.2).
(a) Effect ofProtein Kinase C Inhibitors on Mustard Oil-Induced Activity
The PKC antagonists profoundly inhibited the mustard oil evoked activity
of dorsal horn neurons, generally within 1 minute of ionophoresis (see Figure 5.2
for a typical example). In 8 out of 9 cells tested with GF109203X at 20-60nA,
marked inhibition of the mustard oil-evoked activity was seen (58 ± 9% inhibition
(mean ± s.e.m.)). Similarly in 8 out of 8 cells tested with chelerythrine at 10-
80nA, mustard oil evoked activity was inhibited by 70 ± 10% (mean ± s.e.m.).
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Figure 5.2
Typical effects of protein kinase C (PKC) inhibitors, chelerythrine and GF
109203X on stimulus-evoked activation of multireceptive dorsal horn
neurons.
Continuous records of firing frequency (responses/s; R/S, bin width 1000 ms) are
plotted against time. Prior to testing, all neurons examined showed a low
spontaneous firing rate (<0.1 Hz). Activity was evoked in (a) and (b) by mustard
oil (8% in paraffin oil) applied to the receptive field 4x5 min intervals until a
steady elevated firing rate was maintained or in (c) by motorised brush applied
continuously to an equivalent receptive field without mustard oil treatment. Drugs
were applied ionophoretically at the indicated currents (maintained until the
subsequent marker) and at all other times were subject to a retention current of -10
nA. Results are typical of 8 out of 8 cells and 4 out of 5 cells tested with GF
109203X (GF) in (a) and (c) respectively, and of 8 out of 9 cells tested with
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(b) Effect ofProtein Kinase C Inhibitors on Continuous Brush-Induced
Activity.
A continuous brush activity was maintained for a minimum period of 1
minute before ionophoresis of the highly selective PKC inhibitors was initiated.
The drugs were ionophoresed for minute at each current and the ejection current
increased by 10-20nA in a stepwise manner until there was a drug-induced effect.
In 4 out of 5 cells where GF109203X was tested on continuous brush-
evoked activity, there was no discernible effect, with only a small inhibition
(<15%) in the fifth cell.
5.6 RESULTS - PDBU BINDING STUDIES
5.6.1 The Effect of Mustard Oil on PDBu Binding in Rat Spinal Cord.
Tissue was successfully obtained from 9 preparations and demonstrated a
marked translocation of [^HJPDBu binding sites from cytosolic to membrane
fractions on the side ipsilateral to mustard oil compared to contralateral control
(Figure 5.3). For each hemisected piece of cord, the specific binding i.e. dpm per
assay tube (total minus non specific binding) was calculated for both membrane
and cytosolic fractions. The percentage of the recovered specific binding found in
the membrane fraction (i.e. specific binding in the membrane fraction/ specific
binding in membrane fraction + specific binding in cytosolic fraction) was
calculated and compared on ipsilateral mustard oil side with the corresponding
control side (see Figure 5.3). The percentage of specific binding in the membrane
fraction in mustard oil versus control and in mustard oil and drug versus mustard
oil alone (Figure 5.3) were then analysed by Mann-Whitney U-Test to assess
significant changes.
5.6.2 The Effect of SR 48968 on Mustard Oil-Induced PKC Translocation
in Rat Spinal Cord.
Administration of SR 48968 i.v. prevented the ipsilateral mustard oil-
induced translocation of [^HjPDBu binding sites from cytosolic to membrane
fraction (Figure 5.4). In 10 animals treated with SR 48968 the percentage of
[3H]PDBu binding associated with the membrane fraction was 31.1 ± 4.2 on the
mustard oil side compared to 28.6 ± 3.0 on the control (untreated) side. In animals
not treated with neurokinin antagonist, corresponding values were 51.9 ± 5.9 and
26.3 ± 2.4% respectively. Thus SR 48968 prevented mustard oil-induced
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Figure 5.3
The effect of unilateral mustard oil application to the skin of a distal
hindlimb on the subcellular distribution of ([^H]PDBu) binding sites in
spinal cord.
Specific binding of [^HJPDBu was determined in homogenates of hemisected
spinal cord (segments L2-L5). On the control side of spinal cord (contralateral to
mustard oil) this represented 12,000-15,000 dpm/assay (>85% specific) in the
cytosolic fraction and 4000-5000 dpm/assay (>75% specific) in the membrane
fraction. On the test side of spinal cord (ipsilateral to mustard oil application),
the absolute specific binding in the membrane fraction was increased on average
by 55 ± 15% (mean ± s.e.m.. n=9) and that in the cytosolic binding was only
slightly reduced (<10%) from that on the control side. The proportion of specific
binding recovered in the membrane fraction on the test side was significantly


















The effect of the NK2 tachykinin antagonist SR 48,968 on the mustard oil-
induced PKC translocation in rat spinal cord
Specific binding of [^H]PDBu was determined in homogenates of hemisected
spinal cord (segments L2-L5). Administration of SR 48,968 i.v. prevented the
ipsilateral mustard oil-induced translocation of [^H] binding associated with
membrane fraction in 10 animals. The % of [3H]PDBu binding associated with
membrane fraction was 31.1 ± 4.2 on the mustard oil compared to 28.6 ±3.0 on
the control side. In animals not treated with neurokinin antagonist,
corresponding values were 51.9 ± 5.9 and 26.3 ± 2.4% respectively.
The inactive isomer SR 48,965 failed to reproduce the suppression of [3]PDBu
binding site translocation seen with SR 48,968. In 9 animals the % of [3H]PDBu
binding sites found in membrane fraction were 42.4 ± 2.4 and 28.7 ±3.6 on the







Mustard Oil Mustard Oil
& SR 48968 & SR 48965
181
translocation of PKC in these preparations. In one other animal, the PKC
translocation was unaffected by SR 48968, in 4 other animals both the control and
mustard oil-treated side showed a raised percentage of [3H]PDBu binding sites in
the membrane fraction and insufficient data was obtained from another 7 animals
due to technical problems. It is possible that the cases of elevated [3H]PDBu
binding on both control and mustard oil-treated sides were due to an alternative
drug-induced effect, but technical artefacts cannot be excluded at this stage. The
inactive isomer SR 48965 failed to reproduce the marked suppression of mustard
oil-induced [^HjPDBu binding site translocation seen with SR 48968. In 9
animals the percentage of [3H]PDBu binding sites found in the membrane fraction
were 42.4 ± 2.9 and 28.7 ±3.6 on the mustard oil treated and control sides
respectively (Figure 5.4). Data from 2 further animals was unacceptable due to
technical problems. Thus the mustard oil-induced translocation of PKC was only
slightly attenuated by the inactive isomer SR 48965 whereas it was completely
suppressed by the active NK2 receptor antagonist SR 48968.
5.7 Discussion
Two experimental models were employed to address whether protein
kinase C (PKC) played any role in the sustained nociceptive responses of rat
dorsal horn neurons. In the first, PKC inhibitors were ionophoretically
administered whilst recording activity evoked by repeated cutaneous application of
mustard oil. This in vivo experimental model of short-term sustained activation of
C fibre nociceptive afferents has been described in Chapter 3.
All of the neurons recorded had cutaneous receptive fields on the
ipsilateral hairy skin of the hindlimb, toes or foot which were multireceptive.
Multireceptive neurons were always studied due to their ability to integrate both
noxious and innocuous information (Iggo, 1974; Handwerker et al, 1975) and
were identified as being located in laminae III-V using both depth measurements
in combination with blue spot histology. Ejection of NaCl or vehicle were unable
to reproduce any of the observed drug actions described below.
Neurons were initially located by their responsiveness to widespread
manual brushing of the ipsilateral hindlimb and cutaneous fields were localised.
However, only neurons which had a robust response to noxious heat were used, as
these were more susceptible to showing a prolonged increase in firing rate upon
application of mustard oil. Neurons were first subjected to a continuous brush-
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induced activity which was maintained for a minimum period of 1 minute before
ionophoresis of the highly selective PKC inhibitors was initiated and full recovery
was observed before cutaneous application of the chemical algogen mustard oil.
Consequent to several cutaneous applications of mustard oil (8% in paraffin oil)
there was a marked increase in the background activity. Inhibitors were tested
only after mustard oil-evoked activity was stable and had been continuous for at
least 1-2 minutes.
From the results it can be seen that ionophoresis of each of the highly
selective PKC inhibitors chelerythrine (Herbert et al, 1990) and GF 109203X
(Toullec et al, 1990) profoundly and consistently reversed the mustard oil-evoked
activity of dorsal horn neurons, beginning after a variable onset delay but generally
within 1 minute of ionophoresis. In contrast however, GF 109203X had no
discernible effect on the continuous brush evoked activity induced in a small
number of multireceptive neurons.
The second experimental model employed was that of a [20-3h(N)]
phorbol 12,12-dibutyrate ([^HjPDBu) binding assay used to assess subcellular
translocation of PKC evoked in spinal cord by cutaneous application of mustard
oil. PKC is activated by one of the products of inositol phospholipid metabolism,
1,2-diacylglyerol (DAG) (Nishizuka, 1989) which is mimicked by membrane-
permeant, tumour-promoting phorbol esters (Castagna et al, 1982; Blumberg et al,
1984). The finding that the spinal dorsal horn contains high levels of binding sites
for phorbol esters (Mantyh et al, 1984) and that PKC is present in the rat spinal
dorsal horn (Worley et al, 1986; Mochly-Rosen et al, 1987) raised the possibility
that PKC may play a functional role in sensory transmission, both in the release of
putative neurotransmitters and also in signal transduction at tachykinin receptors.
As we have previously demonstrated a functional role for NKA and NK2
receptors in both acute and sustained nociceptive processing (see Chapters 2, 3
and 4) the involvement of NK2 receptors in this process was further assessed
using systemic administration of selective antagonists.
Activation of Ca^+-sensitive PKC results in its intracellular redistribution
(translocation) from the cytosol to the membrane (Nishizuka, 1989).
Translocation/activation of PKC has been implicated in a number of sustained
neuronal activated states, such those seen in long-term potentiation (e.g. Akers et
al, 1986; Meberg et al, 1993), behavioural responses to formalin-induced
nociception (Coderre, 1992) and the neuropathic pain after nerve injury (Mao et
al, 1993). Therefore the biochemical experiments were carried out to examine
subcellular translocation of [^HJPDBu binding sites following cutaneous
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application of the selective C-fibre stimulant mustard oil. Specific binding of
[3H]PDBu was determined in homogenates of hemisected spinal cord (segments
L2-L5) and by comparing the cytosolic and membrane components from each
hemisected piece of cord, it could be calculated whether PKC translocation/
activation had occurred.
The present results demonstrate that cutaneous stimulation with mustard
oil leads to translocation/activation of PKC from cytosolic to membrane
compartments in ipsilateral but not the contralateral (untreated, control) side of the
spinal cord. However, intravenous administration of the highly selective non-
peptide NK2 antagonist SR 48968 prevented the ipsilateral mustard oil-induced
translocation of [^HjPDBu binding sites form the cytosolic to the membrane
fraction. This is a suggestive of a selective NK2 effect as SR 49868 has been
demonstrated to be a highly potent and selective antagonist of NK2 receptors
(Advenier et al, 1992; Emonds-Alt et al, 1992,1993). Supporting this, systemic
administration of the inactive (R) enantiomer of SR 48968, SR 48965 (Emonds-
Alt et al, 1992) failed to reproduce the marked suppression of mustard oil-induced
[^HjPDBu binding site translocation seen with SR 48968.
Evidence has been provided consistent with a role of PKC in central
sensitisation. Behavioural nociceptive responses to subcutaneous formalin
injection are enhanced by activators of PKC and PKC inhibitors (Coderre, 1992),
whereas low affinity blockers of phospholipase A2 and of protein kinase A (PKA)
were ineffective. In the presence of a permeabilising agent, a PKC
pseudosubstrate inhibitory peptide was also effective (Coderre and Yashpal,
1994), although none of the agents modified acute thermal or mechanical flexion
reflexes in normal animals. Moreover, infusion of a PKC activator (the phorbol
ester TPA) into the dorsal horn facilitates neuronal responses to NMDA in the
dorsal horn in vitro (Gerber et al, 1989) and produces an increase in the
background activity of spinothalamic tract (STT) neurons and a delayed
facilitation of neuronal non-nociceptive mechanical responses in vivo (Palecek et
al, 1994). When a phorbol ester which does not activate PKC (a-TPA) was
applied, no significant changes in background or evoked activity of STT cells were
observed providing evidence that PKC may play an important role in the process
of sensitisation of dorsal horn neurons to innocuous stimuli.
Use of the models of peripheral mononeuropathy and monoarthritis has
further implicated the involvement of PKC in long-term central changes elicited
by inflammation (Hayes et al, 1992; Mao et al, 1993; Tolle et al, 1994). Both the
pattern of increased membrane bound PKC and behavioural nociceptive responses
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associated with the loose ligation neuropathy model were reliably reduced
following administration of PKC inhibitors (Hayes et al, 1992; Mao et al, 1993).
Likewise, Tolle et al, (1994) observed increased [^HJPDBu binding coinciding
with monoarthritis-induced inflammation. Moreover, evidence suggests that PKC
has a critical role in the mediation of another model of synaptic enhancement, that
of LTP (Akers et al, 1986; Reymann et al, 1988; Malinow et al, 1989; Huang et
al, 1992; Wang and Feng, 1992; Meberg et al, 1993). Interestingly, the increased
expression of preprodynorphin mRNA elicited in ipsilateral superficial dorsal horn
by intraplantar carrageenan (like mustard oil-induced activation here (see Chapter
3), is blocked by NK2 receptor antagonists (Parker et al, 1993), again consistent
with a role of a signal resulting from phosphoinositide hydrolysis such as PKC
activation.
This study demonstrated a role for NK2 receptor agonists in the PKC-
induced sustained neuronal activation following cutaneous application of mustard
oil. However, other mediators are likely to contribute additionally to mustard oil-
induced PKC activation and sensitisation of dorsal horn neurons, for example
NKj, and metabotropic glutamate receptors have both been shown to be involved
in the mustard oil-induced sustained activation of C fibres (see Chapter 4 and
Young et al, 1994) and are therefore likely to contribute to similar subcellular
transduction mechanisms. The NK receptors and probably the metabotropic
glutamate receptor subtype involved in sensitisation, act through phosphoinositide
hydrolysis, calcium mobilisation and stimulation of protein kinase C (PKC)
(Hanley et al, 1980; Bristow et al, 1987; Thomson et al, 1994).
In agreement, various other studies have indicated a role for tachykinins
as well as metabotropic glutamate receptors in the PKC-induced sensitisation. In
dorsal horn slices in vitro, activation of PKC by phorbol esters facilitated neuronal
depolarising responses to NMDA (in the presence of tetrodotoxin) and also
increased the release of excitatory (and other) amino acids evoked by dorsal root
stimulation (Gerber et al, 1989). Moreover, the potentiation of NMDA currents
produced by neurokinins in isolated dorsal horn neurons can be inhibited by the
non-selective kinase inhibitor staurosporine; mimicked by the PKC activator
PDBu and (although PKA activation is not likely to be a prominent direct
consequence of SP action) can also be mimicked by activators of PKA (Gerber et
al, 1989; Rusin et al, 1992; Cerne et al, 1993). However, in the neonatal spinal
cord/tail preparation, staurosporine blocked the NK2 but not the NKj agonist-
induced VRP and the neurokinin A enhancement of excitatory amino acid
response (Urban et al, 1994) suggesting that NK2 but not NKj receptor-induced
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depolarisation involves activation of PKC. This is surprising as both NKj and
NK2 receptors are linked to the phosphoinositide pathway, although it is possible
that they influence other second messenger systems to somewhat different extents.
Nevertheless, this is not in agreement with the results obtained from Coderre and
Yashpal (1994). In this study, the enhancement of formalin-induced nociceptive
behaviour elicited by glutamate or SP, was also reversed by pre-treatment with a
highly selective PKC inhibitor, PKC( 19-26), (Coderre and Yashpal, 1994). The
analgesic effects of this PKC inhibitor were restricted to the tonic intermediate and
late phases of the formalin test and did not affect the acute early phase. In
agreement with our results, this suggests that the intracellular events triggered by
these second messengers are critically involved in mediating the plasticity or
central sensitisation that leads to persistent nociception. Recent experiments have
shown that the facilitation of dorsal horn activity elicited by metabotropic
glutamate agonist is similarly blocked by selective PKC inhibitors (Young et al,
unpublished observations).
A molecular mechanism whereby PKC activation could act to promote
the function of NMDA receptor channels has been described, where receptor
phosphorylation results in diminished Mg^+ block and increased conductance at a
given membrane potential (Chen et al, 1992; Tingley et al, 1993). Clearly either
neurokinin receptors or phosphoinositide-hydrolysing metabotropic glutamate
receptors could initiate such a mechanism, perhaps underpinning the synergistic
contribution they make, with NMDA receptors, to dorsal horn sensitisation.
Consistent with this body of evidence for a role of PKC in sensitisation, is a recent
report that the ongoing basal levels of inositol 1,4,5-triphosphate are elevated in
the spinal cord ipsilateral to iritiaplantai injection of Freud's adjuvant (Igwe and
Ning, 1994).
Interestingly PKC may also play a role in the regulation of tedrodotoxin-
insensitive Na+ channels (Thio and Sontheimer, 1993) and Ca^+channels
(McEwan and Mitchell, 1991). Recent evidence suggests that noxious stimulation
may produce an increase in intracellular Ca^+ in spinal cord dorsal horn neurons
that influences nociceptive excitability (Coderre and Melzack, 1992).
Neurotransmitters released in response to noxious stimulation are known to affect
the intracellular levels of Ca^+. Whereas glutamate and aspartate stimulate the
influx of Ca^+ through NMDA receptor operated channels (MacDermott et al,
1986), SP produces an elevation in intracellular Ca^+ by altering its release from
intracellular stores (Womack et al, 1988) as well as increase in Ca^+ influx
through voltage-gated Ca^+ channels (Womack et al, 1989). L-type Ca^+
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channel antagonists inhibit 'wind-up' in turtle spinal cord slices in vitro and are
analgesic in the formalin test of behavioural nociception upon systemic but not
local administration (Russo and Hounsgaard, 1994; Miranda et al, 1992). Low
doses of L-channel blockers applied intrathecally are reported to synergise with
the antinociceptive effects of morphine in the Tail-flick test: N and P-type channel
blockers applied by intrathecal infusion inhibited not only the late phase of
formalin nociceptive behaviour, corresponding to central sensitisation, but also
initial short-latency activity and displayed some motor side effects (Malmberg and
Yaksh, 1994).
In conclusion, under the present circumstances at least, PKC is strongly
implicated as a crucial mediator of the activation of dorsal horn neurons evoked by
a sustained nociceptive challenge. It is clear that PKC activation can result from
NK2 neurokinin receptor mechanisms but likely that both NK^and metabotropic
glutamate receptors also contribute to inflammatory central sensitisation and
hyperalgesia. Therefore blockade of a common intracellular transducer represents
a very important target for new analgesics and may be a much more effective route
than attempting to design a cocktail of receptor antagonists.
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CHAPTER 6:
Mustard Oil-Induced c-fos mRNA Expression
In Rat Spinal Cord.
6.1 AIMS
The aim of these experiments was to use the technique of in situ
hybridisation histochemsitry to examine the expression of c-fos mRNA within the
rat spinal cord. Using cutaneous application of mustard oil as a relatively short-
term model of sustained nociception accompanied by central sensitisation, the
facilitated expression of c-fos was quantified throughout the superficial laminae of
the spinal cord. Control studies were then carried out using peripheral application
of paraffin oil to determine the constitutive and facilitated areas of c-fos
expression. The exclusive mustard-oil facilitated expression of c-fos could now
be established as a marker and used to investigate the effects of intravenous
administration of non-peptide NKq and NK2 tachykinin antagonists on the spinal
changes accompanying cutaneous application of mustard oil.
6.2 MATERIALS
Animals: Male Wistar rats were obtained from Charles River UK Ltd,
Margate, Kent, UK.
Anaesthetics: Alpha-chloralose and methane were obtained from Sigma
Chemical Company, Poole, Dorset, UK; Halothane (flurothane) was obtained
from ICI Pharmaceuticals, Macclesfield, Cheshire, UK.
Molecular Reagents: All laboratory chemicals used were of molecular
biology grade and dry compounds were weighed onto weighboats that had been
cleaned with ethanol or sterile filter paper. Equipment and solutions were
sterilised by autoclaving at 120°C (10 lb/ins pressure) for 1 hour. The reagents
used were as follows: sodium chloride (NaCl), ammonium acetate, poly-L-lysine,
diethyl pyrocarbonate (DEP), dextran sulphate, Haematoxylin, Trizma
Hydrochloride, Trizma Base, yeast tRNA, salmon sperm DNA (sonicated), Bovine
albumin (fatty acid free) (BSA), sodium citrate and dithiothreitol (DTT) were all
obtained from Sigma Chemical Company, Poole, Dorset, UK: Allyl-isothiocyanate
(mustard oil) was purchased from Aldrich Chemical Company Ltd., Gillingham,
Dorset, UK; Paraffin was purchased from Scotlab, Lanarkshire, UK; Terminal
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deoxynucleotidyl transferase and potassium cacodylate tailing buffer were
obtained from Gibco BRL, Paisley, UK; Phenisol developer, fixer and K5
emulsion were obtained from Ilford Scientific Product, Cheshire, UK: Isopentane,
formamide, di-sodium hydrogen orthophosphate, sodium dihydrogen
orthophosphate, paraformaldehyde, Depex mounting medium, potassium
dichromate, silica gel, sulphuric acid, Haematoxylin and Eosin were obtained
from BDH Chemicals Ltd, Poole, Dorset, UK; glycogen and ribonuclease A were
obtained from Boehringer Mannheim, Lewes, East Sussex, UK.
Oligomer Probe: A 48-base oligodeoxyribonucleotide was synthesized
and HPLC-purified by Oswel Chemicals, Edinburgh University Chemistry
Department.
Radiolabeled Compound: Deoxyadenosine 5'-[a 35$] triphosphate
(with specific activity > 1 x 1C)3 Ci/mmol ) was obtained from New England
Nuclear Research Products, Du Pont de Nemours, Dreiech, Germany.
Drugs: RP 67580 was a gift from Dr C Garret, Rhone-Poulenc




Adult male Wistar rats (240-320g) were used as subjects. Animals were
housed in groups of 3 or 4 in standard plastic cages, maintained on 12 hour light:
12 hour dark cycle at 22-23°C; food and water were freely available throughout
experiments.
6.3.2 Treatment and Tissue Preparation
(See Figure 6.1 for a Summary Diagram)
(a) Anaesthetised Paraffin Oil Control.
Rats were briefly anaesthetised with halothane and both hind limbs and
back were shaved, the jugular vein was cannulated and a-chloralose/urethane was
administered as described in Chapter 2. The left hindfoot was painted with
paraffin oil 3 times over 10 minutes and covered up as described in Chapter 3.
After 45 minutes, the rat was killed by cervical dislocation following stunning and
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Figure 6.1
Summary diagram showing the preparation of spinal cord for in situ
hybridisation histochemistry
(a) Tissue Preparation- Adult male rats were anaesthetised with halothane, both
legs were shaved and intravenous cannula inserted for administration of
anaesthetic or antagonists. Over a period of 15 minutes, mustard oil (8%) or
paraffin oil was painted three times over the hindlimb and paw. After 30 minutes,
the spinal cord was removed and rapidly frozen in isopentane at -45°C for 3
minutes.
(b) Hybridisation- 10pm thick fresh-frozen segments of intact spinal cord were
cut on a cryostat and thaw mounted onto subbed slides. The sections were
prepared for in situ hybridisation histochemistry, as outlined.
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In Situ Hybridisation Histochemistry









8% mustard oil or paraffin oil, painted
3X over hindlimb and paw.
4
After 30 mins, spinal cord
quickly removed, frozen at -45 °C
in isopentane for 3 mins.
I
Stored at -70°C until required.
4
10|im thick sections cut on the cryostat,
thaw mounted on 'subbed' slides.
4
Slides stored at -70°C until required.
Tissue sections thawed.
4
Fixed in 4% paraformaldehyde-10 mins
washed 2Xin0.1MPBS.
4





Hybridisation with [35s]-labelled c-fos
oligonucleotide overnight at 37°C, the
hybridisation buffer containing lxl 0^
DPM/slide and 50% formamide.
4
Post-hybridisation washes at 37°C.
2X SSC - 2hrs
IX SSC - 2hrs
0.5X SSC - 2hrs
4
Dehydration through increasing steps




Dipped in Ilford K5 emulsion.
4





Stained in haematoxylin and eosin.
4
Sections examined for positive cells
by light microscope.
4
Silver grain density carried out using an
Optilab Image Analysis System
191
the spinal cord was removed as rapidly as possible, usually 4-5 minutes after
performing a laminectomy (using sterile (boiled) dissection instruments) to reveal
sections L1-L6 of the spinal cord. The dura was carefully removed with fine
forceps and the piece of spinal cord was transversely cut to produce two equal
sized pieces. Each piece was carefully dissected free, dorsal roots removed and
positioned vertically onto a drop of Bright Cryo-M-Bed Embedding Compound on
an autoclaved metal chuck. The free end of the tissue was held lightly with
forceps and the chuck was gently lowered and rapidly frozen for 3 minutes in a
container of isopentane previously cooled to -45 to -50°C on 'dry-ice' bath (solid
carbon dioxide). Care was taken that the temperature was in the correct range to
prevent the tissue from cracking. Each piece of lumbar cord was then wrapped in
cling-film and stored in a sealed sterile pot at -70°C until it was sectioned.
(b) Conscious Paraffin Oil Control.
Experiments were carried out to determine if the anaesthetic used
(Halothane) had any effect on the level of constitutive c-fos expression. Thus
experiments were carried out in an identical manner to those of the anaesthetised
rats. Under halothane anaesthesia, the rats' legs were shaved, paraffin oil was
painted onto the leg three times over 15 minutes before it was bandaged up with
plastic film and sticky tape. However, instead of maintaining anaesthesia for a
further 30 minutes as in the protocol described above, the rat was now put into a
wire mesh restraining cage, where it regained consciousness for a further 30
minutes. It was then killed and the tissue was processed as described above.
(c) Mustard oil Only
Rats were briefly anaesthetised with halothane and both hind limbs and
the back were shaved. The jugular vein was cannulated and then the anaesthetic
was changed from halothane to an a-chloralose / urethane mixture (35mg/kg a-
chloralose and 700mg/kg urethane). This was administered slowly until a regular,
steady respiratory rate was achieved. Anaesthetic levels were continuously
monitored by rate of respiration and corneal reflex; 0.1ml aliquots of anaesthetic
were administered as required. Three applications of 8% mustard oil were painted
onto the left hindfoot and leg over a 10 minute period. The treated leg was then
carefully taped up to prevent cross-contamination of mustard oil to the
contralateral hindlimb.
After 45 minutes the rats were killed by stunning and cervical dislocation
and the tissue was processed as described above.
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(d) Mustard Oil and Non-Peptide Antagonists or Vehicle
Rats were briefly anaesthetised with halothane, both hind-limbs shaved,
jugular vein cannulated and a-chloralose/urethane administered as before. Once a
stable anaesthetised state was maintained, the antagonist or vehicle was given as
an intravenous injection into the jugular vein. The left hindfoot and leg were
painted with mustard oil 3 times over 10 minutes and then taped up as before. For
SR 48968, SR 48965 and vehicle, only one dose was given, however RP 67580
and RP 68651 were given every 15 minutes, due to their shorter half-life (Laird et
al, 1993). After 45 minutes, the spinal cord was removed and tissue frozen as
described above.
6.3.3 Subbing Slides
(See Figure 6.2 for a Summary Diagram)
Glass microscope slides were first cleaned by immersion in a chromic
acid bath for 24 hours. The slides were thoroughly washed to remove all traces of
acid before washing in 2% Decon for 3 hours followed by H2O and then diethyl
pyrocarbonate (DEP) H2O (5-6 drops of DEP in 1 Litre of distilled H2O). The
slides were then soaked in absolute ethanol for 10-15 minutes to remove any
remaining grease. Once dry, the slides were ready for coating. This process
involves firstly, dipping the slides in 0.2M HC1, followed by DEP H2O and
acetone for 3 minutes each before baking in an oven at 50-60°C for 15 minutes to
remove any final RNases. The racks of slides were then dipped in poly-L-lysine
solution (Sigma), twice for 10 seconds each time and then rinsed in DEP H2O for
10 minutes to decrease static and dust attraction. After drying in the oven
overnight at 50-60°C the slides were boxed, sealed tightly and used within 5 to 6
weeks.
6.3.4 Cutting Sections
An OTF/AS Bright cryostat (Bright Instrument Company Ltd.,
Cambridgeshire, UK) was used for sectioning of the rat spinal cord. The
temperature was set to between -18°C and -25°C depending on the tissue mass of
the specimen. A disposable blade was first rinsed in xylene to remove the
lubricant, followed by ethanol to clean and remove any excess grease before being
set at an angle of 5° to the mounted chuck.
The chuck was transported from the freezer to the cryostat on dry ice to
ensure that the -70°C temperature was maintained. It was secured in the cryostat
and left for 1-2 hours to equilibrate to the set temperature.
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Figure 6.2
Summary diagram showing the protocol used for subbing slides
Glass microscope slides were first cleaned with chromic acid and rinsed in
copious amounts of fresh water before being air-dried overnight. Slides were then







Cleaned in chromic Acid- 24hrs.
i
Rinse in H2O overnight.
I
Wash 3 hrs in 2% Decon.
I
Wash in H2O, 1 Day.
I
2 x 15mins, Dep H2O.
i




0.2N NaCl, 3 mins.
I




Dried, 50-60°C, 15 mins.
4.
2 x 10 sec Poly-L-Lysine.
i




Slides boxed and stored with
dessicant.
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The cryostat was initially set to cut 30pm sections and the tissue was
trimmed until a full transverse section of the cord was clearly visible when stained
with methyl blue and viewed at x40 under a light microscope. To minimise
damage to the dorsal horns, which have little surrounding white matter to protect
them during the cutting, the chuck was rotated so that both dorsal horns were the
last part of the cord to be sectioned by the blade. A marker hole was made in the
right ventral horn using a sterile needle, prior to cutting.
The setting was then changed to cut 10pm thick sections and 10 alternate
sections were thaw mounted per poly-L-lysine subbed slide. One section was
taken every 5 sections for histology, stained with methyl blue and viewed under
the light microscope to ensure that the sections had no cracks or edges missing or
were folded. Gloves were always used and the blade was frequently cleaned with
ethanol to minimise RNAse contamination.
The mounted sections were stored in the cryostat until cutting was
finished, then they were transferred on dry ice to the -70°C freezer, where they
were stored in labelled Kartell boxes with silica gel and sealed with electrical tape
to prevent frost accumulating on the slides.
6.3.5 Probe Labelling
A 48-base oligodeoxyribonucleotide was synthesized and HPLC-purified
by Oswel Chemicals, Edinburgh University Chemistry Department. The c-fos
oligomer was complementary to the base sequence 582-630 of the c-fos mRNA
(Curran et al, 1987), (see Figure 6.3). The probe is designed against the base
sequence of the conserved DNA binding domain in Fos-family proteins, therefore
it should be noted that it will not necessarily display specifically c-fos, but also
closely related proteins.
The method for labelling the oligonucleotide involves addition of [-^S]
dATP to the 3' end of the oligonucleotide with the enzyme terminal deoxytidyl
transferase (TdT), followed by extraction of the labelled probe. The following
protocol was followed:-
The purified probe was stored at -70°C, thawed and diluted by 2pl probe :
5.3pl dE^O (14 OD/ml). 2pl of this dilution was taken to give 25pmol probe. To
label the probe, the following were added to a 1.5ml eppendorff tube and heated in
a 32°C waterbath for 15 minutes: 2pl (25pmol) probe; !0|il tailing buffer; 38pl
ddH20 (autoclaved distilled water); 5pl [35s]dATP (>1000Ci/mmol, New
England Nuclear, USA). Once the reaction had reached equilibrium (after 15
mins), 5pl TdT enzyme (Gibco BRL), was added.
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Figure 6.3
Nucleotide Sequence of c-fos (rat)
The nucleotide sequence proceeds in the 5' to 3' direction. The deduced amino
acid sequence from the open reading frame is shown below the nucleotide
sequence. The c-fos probe used was complemetary to bases encoding amino acids
582-629 and is highlighted in a box above the nucleotide sequence.










































The reaction was stopped by placing on ice for 15 minutes and the sample
was then purified through a Nu-Clean D25 Disposable Spun Column (IBI). lpil of
pre- and post- spun samples were pipetted onto small paper squares in plastic
scintillation tubes. 4ml of scintillation fluid was added to each tube and it was
vigorously shaken. Each tube was counted for (3 radioactivity on a scintillation
counter. A successful labelling reaction gave a probe specific activity of 1-2 x 10^
Ci/mmol and a labelling efficiency of >65%. This labelled oligonucleotide was
either used immediately or stored at -20°C overnight.
6.3.6 Hybridisation
(See Figure 6.1 for Summary diagram).
The slides, each holding 10 sections were removed from the -70°C
freezer, put in racks and brought to room temperature for a minimum period of 2
hours. The tissue was first fixed in 4% paraformaldehyde in 0.1M PBS, washed
twice in 0.1M PBS, acetylated to reduce non-specific binding and then dehydrated
through increasing concentrations of buffered alcohol (50,70,80,90 and 100% for
2 minutes each).
Hybridisation was carried out under conditions similar to those described
by Young et al, (1986). It was carried out in plastic containers containing foam
saturated with the following soaking solution (10-15ml per box of 4* standard
sodium citrate (0.03M NaCl and 3mM Tri Sodium Citrate) (4* SSC): de-ionised
formamide. Four slides were placed in each container and 20pl of hybridisation
buffer was carefully dropped onto each section, taking care not to damage the
section. There was 5 x lO^dpm of probe per pi of hybridisation buffer containing
10% (wt/vol.) dextran sulphate, NaCl (600mM, vokvol), bovine serum albumin
(0.1%, vokvol), salmon sperm DNA (0.1%, wt:vol), glycogen (0.005%, wt:vol),
yeast tRNA (0.002%, wt:vol), formamide (50%, vokvol), dithiothreitol (lOpl, 1M
per ml). Each container was sealed and placed in an incubator at 37°C for 20
hours.
After this time post hybridisation washes were carried out over 6 hours at
20°C below the calculated melting temperature for the probe, in decreasing
concentrations of standard sodium citrate (SSC) solution from 30mM NaCl plus
3mM trisodium citrate, to 7.5mM NaCl plus 0.75 mM trisodium citrate. Slides




Ilford K5 emulsion was melted in a waterbath in the darkroom at 45°C for
approximately 45 minutes before being diluted 1:2 (vol:vol) with distilled water.
The slides were dipped in emulsion and air-dried overnight before being boxed
with silica gel and sealed with electrical tape, aluminium foil and black
photographic plastic to eliminate any light.
6.3.8 Developing and Staining Slides
Exposure took place at 6°C for 4-5 weeks. After this time, the slides were
brought to room temperature for >2 hours before being developed in Ilford
Phenisol (diluted 1:4 (vol:vol) with distilled water) in a darkroom. This took 4
minutes with gentle agitation followed by a fixing process in Ilford Hypam Fixer
(diluted 1:4 (vokvol) with distilled water) for 4 minutes. The slides were then
rinsed for five 10 minute periods in copious amounts of fresh distilled water
before being stained.
The slides were then lightly stained with Mayers Haematoxylin (2.5
minutes), washed and then stained with 1% Eosin in 80% alcoholic solution (3
minutes) followed by dehydration through 95% and 100% ethanol (2 minutes each
step). Finally, lipid was extracted in Histoclear (4 minutes) before being mounted
under Depex mounting medium.
6.3.9 Analysis
(a) Primary Examination Under the Light Microscope
Initially each slide was examined carefully by light microscope under x40
magnification to enable a rough estimation of c-fos mRNA to be carried out. Both
sides of the spinal cord were scrutinised on each section and the level of mRNA
expression assessed in both lateral and medial superficial dorsal horn (Laminae I-
II) and additionally, deep dorsal horn (Laminae IV-V). This was achieved by
visually grading the level of mRNA expression from 0-5, with 0 representing no
expression and 5 that of maximum expression, i.e. very dense clustering of black
silver grains around each nucleus.
A diagrammatic 'map' was prepared for each spinal cord section which




An image analysis system was used to evaluate each slide. This consisted
of a Zeiss Axioskop 20 microscope with a CCD video camera attached which
relayed the image from the microscope to an Apple Macintosh Ml298 computer.
The slide under examination was first cleaned with alcohol and then
viewed at x40 under the light microscope. The appropriate section was selected
and the first field was set, this was always at the medial edge of the dorsal horn.
The microscope light was then set to a level for optimum cell and silver grain
display.
The image 144 VDM-F programme was loaded onto the computer and a
'macro' (a pre-determined set of commands that are triggered by the press of a
selected key on the computer panel) was set up to open the 'Excel' programme
within this application, calibrate the image for x40 magnification and to analyse
the labelled particles within the manually set area desired. This was achieved by
first setting the camera 'live' which opens the camera and transmits a live image to
the computer screen. The image was completely defocused to set a 'blank field'
which was consequently subtracted from each image thus minimising any
unwanted background markation.
A second macro was set up to enhance the image and thus make
determination of silver grain density more accurate. This consisted of sharpening
the image, enhancing the contrast followed by a second sharpen. The filed data
was then ready for determination of silver grain density. The three densest
(blackest) areas of silver grain were chosen in each field and then marked onto the
section map. Using the computer mouse a line was drawn around the first region
of interest (ROI).
A third macro was set up to measure this area and to set the density slice
which was then adjusted manually to highlight only the silver grains and not any
background staining. The number of silver grains per pm^ were analysed by the
computer and the values were pasted into the appropriate position on the
spreadsheet.
The ROI area was then moved to an adjacent area of background which
always included an unlabelled nucleus and analysis was carried out as before
taking care not to move the set point of the density slice. The value was pasted




6.4.1 Detection of c-fos mRNA With In Situ Hybridisation Histochemistry-
Confirmation of Technique.
The c-fos mRNA expression detected in both the mustard oil and paraffin
oil treated animals was found in the same general areas of the dorsal horn
observed by other investigators after peripheral nociceptive stimulation (Hunt et
al, 1987; Abbadie and Besson, 1993)
6.4.2 Control Studies
(a) RNAse Controls
RNAse controls were undertaken to ensure that no non-specific labelling
of cells was present when using the In Situ Hybridisation Histochemistry (ISHH)
technique. The results showed that after RNAse treatment, no specific labelling of
c-fos cells was detected, however a low level of non-specific background activity
could be seen.
(b) Paraffin Oil Controls
The effects of unilaterally painting paraffin oil three times onto the
receptive field with a soft paintbrush over 15 minutes was carefully examined in
anaesthetised rats. The levels of c-fos mRNA expression in the superficial layers
(laminae I-II) after unilateral application of paraffin oil to the left hindlimb, were
examined by ISHH, a typical example of this can be seen in Figure 6.4. There was
a low and even distribution of silver grains spread through the spinal cord (both
treated and untreated sides) with no apparent difference between medial and
lateral areas of the superficial layers.
The table in Figure 6.5 demonstrates the mean silver grain density (qm^)
of the superficial layers of the dorsal horn following unilateral paraffin oil
application. This was a mean of 135 regions of interest taken from 3 rats. From
the histogram in Figure 6.6, it can be seen that there is no significant difference
between the experimental (paraffin oil treated) side and the control (untreated)
side of the spinal cord, (P>0.05, Matched Pair Students t-test).
The distribution of c-fos mRNA in the deeper layers of the spinal cord
(Laminae IV-V), although not examined in such great detail, appeared to mirror
the expression pattern of the superficial layers, with no difference between the
'paraffin oil' and 'mustard oil' sides. Thirty five sections, taken from four rats
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Figure 6.4
c-fos mRNA expression in the rat lumbar spinal cord following
cutaneous paraffin oil application.
Low power lightfield photographs showing the typical levels of c-fos mRNA
expression over the superficial dorsal horn following cutaneous application of
paraffin oil, as identified by ISHH. Examples of positively-labelled neurons,
characterised by a dense aggregation of silver grains around haematoxylin-stained
nuclei, are represented by filled arrows. The open arrows demonstrate examples
of non-expressing nuclei with low and evenly distributed background density of
silver grains. A Demonstrates the basal expression, in the side contralateral to the
unilateral application of paraffin oil. Photographs were taken of overlapping areas
and then aligned to show the full mediolateral extent of the superficial region the
dorsal horn. B Demonstrates the expression obtained in the opposite dorsal horn,




Mean density of silver grains (per pm^) in the superficial and deep dorsal
horn following unilateral mustard oil/paraffin oil treatment.
The mean silver grain density per pm^ was significantly increased in the unilateral
mustard oil-treated group compared to the paraffin oil treated group of rats,
calculated from a substantial number of sequential sections rostral to caudal,
covering segments L 3-4 of the spinal cord. The effects of intravenous drug
application were calculated by comparsion of a similar number of sequential















































Histogram demonstrating the c-fos mRNA expression in superficial and deep
dorsal horn of the spinal cord after unilateral mustard oil application
(A) The silver grain density in the superficial layers of the spinal cord after
unilateral application of mustard oil. Unilateral application of mustard oil to the
left hindlimb of 3 anaesthetised rats caused a marked facilitation in c-fos mRNA
expression on the ipsilateral, experimental side of the superficial dorsal horn as
compared to the contralateral, control side. After intravenous injection of the non-
peptide NKj antagonist, RP 67,580 and the non-peptide NK2 antagonist SR
48,968, there was a significant decrease in c-fos mRNA expression on the
experimental side of the cord compared to the experimental side in mustard oil
only treated rats. Interestingly, on the contralateral, control side of the cord
(without mustard oil treatment), intravenous administration of both antagonists,
resulted in a small but significant increase in c-fos mRNA expression compared to
mustard oil only treated rats which had not been given drug. There was no
significant difference between the c-fos mRNA expression on ipsilateral and
contralateral sides of the RP 67,580 or SR 48,986 treated rats.
(B) In the deeper layers of the spinal cord, unilateral application of mustard oil did
not result in such a marked increase in silver grain density as the superficial layers
over the time course examined. Treatment with intravenous RP 67,580 or SR
48,968 did not result in any significant change in silver grain density on the
ipsilateral side of the cord as compared to the mustard oil only treated rats.
However, on the contralateral, control side, after intravenous NKj or NK2
antagonist administration, there is a small, but significant increase in c-fos mRNA
expression as compared to mustard oil only.
Statistical significance of the changes was assessed by the Students Matched
Paired t-Test for comparisons between ipsilateral and contralateral sides of the
same spinal cord and a Students Unmatched Paired t-Test for comparisons
between different spinal cords (*P<0.05, mean ± s.e.m.).
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treated unilaterally with paraffin oil, were examined and the silver grain density
appeared as a low and even expression throughout the deeper layers of both sides
of the spinal cord.
(c) The Effect ofAnaesthetic on Expression of c-fos mRNA
Following unilateral paraffin oil application in a conscious animal, on
both sides of the cord there was a dense pattern of silver grain labelling throughout
every layer. This suggests that the increase in c-fos mRNA expression compared
to anaesthetised control animals, is not substantially due to the treatment of
unilateral paraffin oil and is most likely to be due to stress; in agreement with
Hayes et al, (1976); Rosecrans and Chance, (1976) who have reported that acute
exposure to a stressful event results in increased pain thresholds. The pattern of
bilateral activation to paraffin oil in conscious rats could potentially mask the true
increase in expression caused by mustard oil. It was decided that the conscious
preparation would not give a valid estimation of nociception-induced c-fos mRNA
expression as it would be difficult to separate this from the stress-induced
response.
6.4.3 The Effect of Mustard Oil on c-fos Expression
(a) Peripheral Effects ofMustard Oil
After 15 minutes exposure to topical mustard oil (8%), the painted foot
and leg took on a pink and slightly swollen appearance and after a further 30
minutes of exposure, the treated limb appeared to be additionally swollen. There
was no marked difference in the appearance of limbs between anaesthetised and
conscious animals, however in the latter, behavioural effects indicative of
ipsilateral hyperalgesia could also be observed; raising the treated limb to avoid
weight bearing.
There was no cross-contamination of mustard oil to the contralateral
untreated limb, as the ipsilateral limb was wrapped in cling film and securely
bound with adhesive tape, no detectable changes (such as swelling) were observed
in the contralateral limb.
(b) Effect ofMustard Oil on c-fos mRNA Expression
Unilateral application of mustard oil to the left hindlimb of 3
anaesthetised rats, caused a marked facilitation of c-fos mRNA expression on the
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ipsilateral side of the superficial dorsal horn of the spinal cord, as compared to the
contralateral levels (see Figures 6.5, 6.6 and 6.7).
The expression of silver grains was extremely dense in the superficial
ipsilateral dorsal horn, therefore individual positive cells could not be accurately
resolved. To overcome this, instead of counting positive cells, the silver grain
density per pm^ was measured and the three densest regions of interest in each
field (on both control and experimental side) were taken. There was no significant
difference between the size of the Regions of Interest (ROIs) on control and
experimental sides of the spinal cord. (P>0.05).
After unilateral application of mustard oil, c-fos mRNA was found in the
same laminar distribution pattern as the control, paraffin oil-treated animals i.e.
mainly in the superficial region (Laminae I-II) and deeper in the region of
Laminae IV-V. However, in comparison to the paraffin oil treated sections, the
mustard oil-treated sections showed a much greater increase in silver grain density,
mainly in the lateral edge of the superficial layers of the dorsal horn (see example
in Figure 6.7).
From 3 rats, 135 sections covering lumbar segments L3-4 (within the area
of innervation from the hindfoot) were analysed and a mean silver grain density in
the superficial layers evaluated (see Figures 6.5 and 6.6). A significant and
marked difference in c-fos expression between the control and experimental sides
of the spinal cord was found (P < 0.05, Matched Pair Students t-test). On the
ipsilateral side, the mean silver grain density was 41.0 ±2.1 per prn^, more than
double that of the mean contralateral control side (17.1 ± 1.9 per pm^). After
unilateral mustard oil application under the present conditions, the density of c-fos
mRNA expression in the deeper laminae of the ipsilateral spinal cord was slightly
but not significantly different to that on the contralateral side. From a mean of 45
sections it was observed that on the experimental side of the spinal cord there was
a mean silver grain density of 25.8 ±2.1 whilst on the control side it was 20.1 ±
1.3.
A comparison of the results for the anaesthetised mustard oil treated rats
was made with those of the anaesthetised control (paraffin oil) treated rats (see
Figures 6.4, 6.5 and 6.6). There was a marked and significant (six-fold) increase
in the mean silver grain density between mustard oil and paraffin oil-treated rats in
both superficial and deep spinal cord. In the superficial spinal cord the mean
density on the side ipsilateral to paraffin oil treated side was 6.3 ± 0.3 per pm^,
(mean ± s.e.m.) and that of the ipsilateral mustard oil treated spinal cord 41.0 ±2.1
per pm^, mean ± s.e.m (P < 0.05) (n=15), Unpaired Students t-test. When
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Figure 6.7
c-fos mRNA expression in the rat lumbar spinal cord following
cutaneous mustard oil application.
Low and high power lightfield photographs showing the typical levels of c-fos
mRNA expression over the superficial dorsal horn following cutaneous
application of mustard oil, as identified by ISHH. Examples of positively-labelled
neurons, characterised by a dense aggregation of silver grains around
haematoxylin-stained nuclei, are represented by filled arrows. The open arrows
demonstrate examples of non-expressing nuclei with low and evenly distributed
background density of silver grains. A Demonstrates the basal expression, in the
side contralateral to the unilateral application of 8% mustard oil. Photographs
were taken of overlapping areas and then aligned to show the full mediolateral
extent of the superficial region the dorsal horn. B Demonstrates the facilitated
expression obtained in the opposite dorsal horn, ipsilateral to unilateral application






a direct comparison was made between the contralateral sides of both treatments,
there was a much smaller but still statistically significant increase in the
contralateral side silver grain density (17.1 ± 0.9 per pm% mean ± s.e.m.) for the
mustard oil-treated rats compared to the paraffin oil-treated rats (8.0 ± 0.9 per p
m^, mean ± s.e.m). P<0.05, Unpaired Students t-Test.
In the deep laminae of the spinal cord, a similar pattern of c-fos mRNA
expression could be observed (see Figure 6.7). For the ipsilateral spinal cord
paraffin oil treated side, the mean silver grain density was 6.7 ±1.2 per pm^
(mean ± s.e.m.); whereas the mean silver grain density per pm^ for the side
ipsilateral to mustard oil treatment was significantly increased to 25.8 ±2.1 per p
(mean ± s.e.m.) P<0.05, Unpaired Students t-Test. Similarly when comparing
the contralateral, control sides of mustard oil-treated and paraffin oil-treated deep
spinal cord, the former is significantly raised (20.1 ±1.2 per pm^, mean ± s.e.m.)
compared to the paraffin oil treated sections (9.0 ±1.5 per pm^, mean ± s.e.m.).
P<0.05, Unpaired Students t-Test. This implies that there is a smaller contralateral
increase due to mustard oil application to the ipsilateral rat hindlimb.
6.4.4 The Effect The Non-Peptide NKj Antagonist RP 67580 on Mustard
Oil-Induced c-fos Expression.
The effect of intravenously injected RP 67580 (lmg/kg, injected every 15
minutes throughout the experiment lasting a total of 1 hour and 15 minutes) on c-
fos mRNA expression was investigated in 3 rats, treated unilaterally with mustard
oil as previously described. Comparisons were made firstly between ipsilateral
and contralateral sides of corresponding spinal segments. Secondly, a comparison
was made between the ipsilateral experimental sides of mustard oil only and
mustard oil/ RP 67580-treated spinal segments and a final comparison was made
with the control, paraffin oil-treated group of rats.
(a) Patterns ofc-fos mRNA Expression in Spinal Cord ofRP 67580/
Mustard Oil Treated Rats.
After RP 67580 there was no significant difference in c-fos mRNA
expression, between the ipsilateral and control, contralateral sides of the same
spinal segments in mustard oil-treated rats (see Figure 6.8). The mean expression
of c-fos mRNA was estimated from 135 regions of interest and from the table in
Figure 6.5 and the histogram in Figure 6.6 it can be seen that in the superficial
laminae of the spinal cord, the mean silver grain density on the mustard oil-treated
side was 21.1 ± 5.4 per pm^. There was no significant
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Figure 6.8
Photomicrograph examples of the effects of systemically-applied nonpeptide
tachykinin antagonists on mustard oil-induced c-fos mRNA expression.
Low power lightfield photographs of examples showing the typical levels of c-fos
mRNA expression over the superficial dorsal horn, as identified by ISHH
following systemic administration of nonpeptide tachykinin antagonists.
Examples of positively-labelled neurons, characterised by a dense aggregation of
silver grains around haematoxylin-stained nuclei, are represented by filled arrows.
The open arrows demonstrate examples of non-expressing nuclei with low and
evenly distributed background density of silver grains. The effects on c-fos
mRNA expression are shown for the nonpeptide NK2 antagonist SR 48968 (A
and B) and the nonpeptide NK} antagonist RP 67580 (C and D). The level of
mustard oil-induced c-fos mRNA expression obtained in the presence of these
antagonists (B and D) can be compared with the basal level in their corresponding
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increase in density on the control side at 23.7 ±1.6 per pm^ (P>0.05, Matched
Pair Students t-Test, n=15).
A similar expression pattern was seen upon examination of the deeper
laminae of corresponding spinal segments (see Figures 6.5, 6.6. and 6.8). There
was no significant difference in c-fos mRNA expression between control and
experimental sides of the spinal cord. From a mean of 45 regions of interest
within 135 regions of interest, it was observed that for the experimental side of the
spinal cord there was a mean silver grain density of 25.1 ± 1.4 per pm^ (mean ±
s.e.m.) whilst on the control side there was a slightly but not significantly greater
density at 29.9 ± 2.0 per pm^ ( mean ± s.e.m.). P>0.05, Unpaired Students t-Test.
(b) Comparison Between RP 67580/ Mustard Oil Treated and Mustard
Oil Only Treated Groups.
A second comparison was made between the rats treated with mustard oil
only and rats treated with mustard oil and the non-peptide NKj antagonist RP
67580. In the superficial laminae of the dorsal horn it was seen that in comparison
to the mustard oil only group, both the experimental and control sides of the RP
67580 treated group were significantly changed (see Figures 6.7 and 6.8). The
mean density of the experimental side of the NKj antagonist treated group (21.1 ±
1.0 per pm^) was markedly and significantly decreased from that of the mustard
oil only group (41.0 ± 2.1 per pm^) (P<0.05, Unpaired Students t-Test).
However, when comparing the control sides of the two groups, the results do not
follow the same trend; here the mean contralateral density for the RP 67580,
mustard oil-treated group (24.0 ±1.6 per prn^) was slightly, but significantly
increased, as compared to the contralateral side of the mustard oil only treated
group (174 + 1.9 per pm^)- This suggests that intravenous administration of the
non-peptide NKp antagonist results in a small general increase in c-fos mRNA
expression, whilst specifically inhibiting the increase in c-fos mRNA expression
due to mustard oil application.
An entirely different pattern of c-fos mRNA expression was seen upon
examination of the deeper laminae of the spinal cord. The mean density of the
NKj antagonist plus mustard oil treated side was not significantly changed from
that of the mustard oil only treated side. However in the deeper laminae, the effect
of RP 67580 alone on the density pattern of c-fos mRNA expression seems to
mirror the pattern in the superficial laminae with a slight, but significant increase
in the silver grain density on the RP 67580 plus mustard oil contralateral control
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side (29.0 ±1.9 per pm^) compared to the control contralateral mustard oil only-
treated animals (23.0 ± 2.7 per pm^)(P<0.05, Unpaired Students t-Test).
(c) Comparison Between RP 67580/ Mustard Oil Treated and Paraffin
Oil Control Groups.
A final comparison was made between the RP 67580 plus mustard oil
treated group of rats and the group treated with paraffin oil only. In the superficial
laminae of the dorsal horn it can be seen in Figures 6.4, 6.5, 6.6 and 6.8 that
although intravenous treatment with the non-peptide NK[ antagonist considerably
reduced the mustard oil-induced facilitation in c-fos mRNA expression to 21.1 ±
1.0 per prn^, (mean ± s.e.m.), it did not reduce this expression to the level of the
paraffin oil (control) treated rats (6.3 ± 0.2 per pm% mean ± s.e.m.). When both
the contralateral, control sides of the cord were directly compared, the control side
of the mustard oil plus NKp antagonist-treated sections had a significantly
increased level of c-fos mRNA expression in comparison to the control side of the
paraffin oil-treated sections, (23.7 ±1.1 compared with 7.1 ± 0.3 density per pm^,
mean ± s.e.m.) (P<0.05, Unpaired Students t-Test). Therefore, although the
intravenous NK] antagonist appeared to be inhibiting the mustard oil-induced
facilitation of c-fos expression the residual level of expression was still higher than
in controls devoid of either noxious stimulation or drug treatment.
A similar situation was observed when deeper laminae are compared
under corresponding conditions. From a mean of 45 regions of interest, it was
observed that for the mustard oil plus NKj antagonist-treated side of the spinal
cord there was a mean silver grain density of 25.1 ±1.4 per pm^ (mean ± s.e.m.)
whilst for the side of cord ipsilateral to just paraffin oil-treatment this was
significantly lower at 7.9 ± 0.7 per pm^ (mean ± s.e.m.). P<0.05, Unpaired
Students t-Test. When comparing the contralateral, control sides of the two
treatments, a similar pattern was seen with the c-fos mRNA level for the paraffin
oil treatment having a silver grain density of 10.2 ± 0.8 per pm^ (mean ± s.e.m.)
which was much lower than 29.9 ± 2.0 per pm^ for the mustard oil plus RP 67580
treatment (mean ± s.e.m.). P<0.05, Unpaired Students t-Test.
6.4.5 The Effect of Mustard Oil and The Non-Peptide NK2 Antagonist
SR 48968 on c-fos Expression.
The non-peptide NK2 antagonist SR 48968 was investigated in a similar
manner to RP 67580. Intravenous SR 48968 was administered to unilaterally
mustard oil treated rats and its effect on the expression of c-fos mRNA determined
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by quantifying the silver grain density on the mustard oil and non-treated sides of
the spinal cord. Additionally, the results were compared with the group of rats
which had unilateral mustard oil only and also the control group which were
unilaterally painted with paraffin oil.
(a) Patterns ofc-fos mRNA Expression in Spinal Cord ofSR 48968/
Mustard Oil Treated Rats.
After intravenous SR 48968 (at a dose of lmg/kg every 15 minutes) the
results manifest a similar trend as for the NKq antagonist RP 67580 (see Figures
6.5, 6.5 and 6.8). In the uppermost laminae of the spinal cord sections analysed,
there was no significant difference in mean silver grain density between
corresponding experimental (mustard oil) and non-experiment (control) sides.
(P>0.05, Matched Pair Students t-Test) from the same spinal cord sections i.e. the
SR 48968 had prevented laterally-specific differences due to mustard oil. The
mean expression of c-fos mRNA was calculated from a total of 135 regions of
interest chosen from 3 rats and the results show that after intravenous SR 48968
on the mustard oil-treated side of the cord, the average density of silver grains was
21.7 ± 0.8 per pm^ (mean ± s.e.m.) compared to a control side density of 28.9 ±
1.0 per pm^ (mean ± s.e.m.)(P<0.05, Matched Pair Students t Test).
In the deeper laminae of the spinal cord after analysis of 45 regions of
interest from 3 rats treated with SR 48968, the control side of the cord showed a
slight increase in c-fos mRNA expression to 28.9 ±1.0 per pm^ although it was
not significantly different from the mustard oil treated side (with a density of 23.9
±1.4 per pm^ ).
(b) Comparison Between SR 48968, Mustard Oil Treated and Mustard
Oil Only Treated Groups.
A second comparison was made between the mustard oil only treated
group of rats and the group treated additionally with the highly selective non-
peptide NK2 antagonist SR 48968. From 3 rats, 135 regions of interest in the
superficial dorsal horn were analysed for each group and the results show there
was a marked difference in the mean silver grain density between the mustard oil
treated side for each group (see Figures 6.7 and 6.8). Whereas the mustard oil
only group had a mean density per pm^ of 41.0 ± 1.1, intravenous treatment with
SR 48968 caused a marked decrease in expression density to 21.7 ± 0.8 per pm^.
When the contralateral, control sides were compared for each of the two
treatments the results were different; here the mean contralateral density for the SR
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48968/ mustard oil-treated group (28.9 ± 1.0 per pm^) was slightly, but
significantly increased as compared to the contralateral side of the mustard oil only
treated group (17.1 ± 1.9 per pm^). Similar to the intravenous administration of
RP 67580, this suggests that intravenous administration of the non-peptide NK2
antagonist results in a small general increase in c-fos mRNA expression whilst
specifically inhibiting the increase in c-fos mRNA expression due to mustard oil
application.
Upon examination of the c-fos mRNA pattern in the deeper laminae of
the spinal cord a different pattern of c-fos mRNA expression was seen. The mean
density of the NK2 antagonist/mustard oil-treated side was not significantly
changed from that of the mustard oil only treated side. However in the deeper
laminae, the effect of SR 48968 alone on the density pattern of c-fos mRNA
expression seems to mirror the pattern in the superficial laminae with a slight, but
significant increase in the silver grain density on the SR 48968/mustard oil
contralateral control side (28.9 ±1.4 per pm^) compared to the mustard oil only
control (23.0 ± 2.7 per pm^)(P«0.05, Unpaired Students t-Test).
(c) Comparison Between SR 48968, Mustard Oil Treated and Paraffin
Oil Control Groups.
In a similar manner to the NKj antagonist RP 67580, the non-peptide
NK2 antagonist, although considerably reducing the mustard oil facilitated
expression of c-fos mRNA compared to treatment with mustard oil only, did not
result in a drop to the level of the control expression in the presence of ipsilateral
paraffin oil treatment (see Figures 6.4 and 6.8).
In the superficial laminae of the cord, in comparison to the ipsilateral side
of the paraffin oil only treated animals (with a mean density per pm^ of 6.3 ± 0.2;
mean ± s.e.m.) the SR 48968/ mustard oil-treated sections had a significantly
higher density per pm^ of 21.7 ± 0.8 (mean ± s.e.m.). P<0.05, Unpaired Students
t-Test. This expression pattern was mirrored in the contralateral sides of both
treatments, with a four-fold increase in silver grain density on the mustard oil/ SR
48968 treated segments compared to the paraffin oil only treated segments.
A similar situation was observed when the deeper laminae of the above
two treatments were compared. From a mean of 45 regions of interest, it was
observed that for the ipsilateral side of the mustard oil/ NK2 antagonist-treated
cord there was a mean silver grain density of 23.9 ±1.4 per pm^ (mean ± s.e.m.),
whilst on the side ipsilateral to paraffin oil treatment this was significantly lower at
8.5 ± 0.5 per pm^ (mean ± s.e.m.). P<0.05, Unpaired Students t-Test. When
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comparing the contralateral, control sides of the two treatments, a similar pattern
was seen with the c-fos mRNA level for the paraffin oil treatment having a silver
grain density of 10.2 ± 0.8 per (mean ± s.e.m.) which was much lower than
28.9 ±1.0 per pm^ for the mustard oil/ SR 48968 treatment (mean ± s.e.m.).
P<0.05, Unpaired Students t-Test.
6.5. DISCUSSION
The results presented here demonstrate that cutaneous application of the
chemical algogen mustard oil (known to selectively stimulate C fibres) led to the
facilitation of spinal cord c-fos mRNA expression, detected by in situ
hybridisation histochemistry (ISHH), which was both reproducible and
quantifiable, making it suitable for manipulation as a marker.
RNAse treatments clearly demonstrated the specificity of the ISHH
technique to selectively identify an RNA sequence, indicating that the ISHH
technique employed here was highly likely to be specifically detecting c-fos
mRNA expression. A further control study was undertaken by applying paraffin
oil to identical areas of the hind-limb and foot as for mustard oil. The results
demonstrate a low and even distribution of silver grains spread through the spinal
cord (both treated and untreated sides) with no apparent difference between
medial and lateral areas of the superficial layers and thus representing a basal c-fos
expression. This is in agreement with other studies which have measured c-fos
levels in untreated animals (Abbadie and Besson, 1993) or following non-noxious
brushing of hairs and gentle manipulation of joints (Hunt et al, 1987; Williams et
al, 1989). In the latter studies, following continuous non-noxious brushing and
gentle manipulation of joints for a period of 15 minutes, labelled nuclei were seen
mainly in layers II to V and rarely in layer I, consistent with actions mediated from
the terminals of low-threshold A5 and C primary afferents (Light and Perl, 1977,
1979). However, a few labelled neurons in lamina I were observed here, which
may be explained by either the differences and time scales of the techniques
employed or the low numbers employed in each set of experiments. Further
influencing factors may be the anaesthetics used and level of surgery employed in
each study (see Hunt et al, 1987) or stress-induced c-fos expression suggested by
Sharp et al, (1991).
Following cutaneous application of mustard oil to the hind-foot and limb
of the rat, these ISHH studies demonstrate a marked increase in c-fos mRNA
expression in the superficial laminae of the ipsilateral dorsal horn compared to the
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contralateral side of the dorsal horn. The expression of silver grains was
particularly dense on the lateral edge of the ipsilateral superficial dorsal horn of
lumbar segments 3-5, as is appropriate for this cutaneous input. Most labelled
nuclei were found in layers I (marginal) and II (substantia gelatinosa) where the
majority of unmyelinated afferents terminate (Molander and Grant, 1986), but c-
fos labelled nuclei were also found in layers IV-V and occasionally in layers VI
and VII and around the central canal (layer X).
The general pattern of this facilitation was in agreement with other studies
on the mustard oil-induced facilitation of c-fos mRNA expression in rat lumbar
spinal cord. Although no other groups have used similar ISHH techniques
following mustard oil-induced noxious stimulation, the distribution pattern of cells
expressing c-fos mRNA, closely followed that found previously by other groups
using immunohistochemistry techniques (Hunt et al, 1987; Williams et al, 1989;
Pretel and Piekut, 1991). However, in comparison to the present results (and
those of Pretel and Piekut, 1991) where the principal increase in c-fos mRNA
expression was on the lateral edge of the ipsilateral dorsal horn, others reported
p55c-fos-like immunoreactivity was localised to nuclei in a restricted region of the
ipsilateral medial dorsal horn (Hunt et al, 1987). One possible explanation is the
variability of the precise site of mustard oil application between studies, whereas
we applied the algogen to the entire foot and hind-limb, Hunt et al applied it to an
unspecified region of the hind-limb only.
These experiments established the suitability of using the contralateral
dorsal horn as an internal standard to compare possible effects of tachykinin
antagonists in later experiments. In these experiments the facilitated c-fos mRNA
expression remained generally ipsilateral to the cutaneous mustard oil application,
although compared to paraffin oil there was a small but significant increase in c-
fos mRNA expression on the contralateral side of the spinal cord following
peripheral application of the chemical algogen, entirely in accord with the findings
of other groups (Hunt et al, 1987; Williams et al, 1989; Pretel and Piekut, 1991).
This might be due to a small group of primary afferents which has been shown to
terminate in the contralateral superficial dorsal horn (Light and Perl, 1979) or
alternatively stress-induced (Sharp et al, 1991) or anaesthetic and surgery-induced
c-fos mRNA expression (Hunt et al, 1987).
Mustard oil application led to visibly obvious redness and swelling as
reported to be indicative of development of inflammation, central sensitisation and
hyperalgesia (Treede et al, 1992). Other inflammatory or sustained C fibre
stimulation models have been used to investigate the facilitation of central c-fos
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mRNA expression. Following formalin- or carrageenan- induction of short-term
inflammation and hyperalgesia, a very rapid increase in the levels of c-fos mRNA
or Fos protein has been demonstrated in a somatotopic representation of the
particular nociresponsive neurons stimulated within the dorsal horn (Draisci and
Iadarola, 1989; Williams et al, 1989; Presley et al, 1990; Bullit, 1991; Noguchi et
al, 1991,1992; Leah et al, 1992). Similarly, the expression of c-fos and Fos has
also been demonstrated in rat spinal dorsal horn consistent with the known
nociceptive primary afferent input from the knee following induction of the
longer-term hyperalgesic state of adjuvant-induced arthritis (Menetrey et al, 1989;
Hylden et al, 1992; Abbadie and Besson, 1993; Tolle et al, 1994) and in addition,
the development of a neuroma following nerve injury (Chi et al, 1993).
The tachykinins SP and NKA are two of several transmitters which might
provide input to modulate and regulate the expression of c-fos. SP is known to be
present in small diameter primary afferents (Hokfelt et al, 1975b) and after
cutaneous mustard oil application, which stimulates small diameter afferents, the
majority of c-fos expressing neurons, in laminae I and II of the lumbar spinal cord
also received input from SP immunoreactive neurons (Pretel and Piekut, 1991).
As SP and NKA are derived from the same gene (Nawa et al, 1984), are thought
to be co-localised and are distributed in a similar manner throughout the spinal
cord (Ogawa et al, 1985), it is also feasible that NKA may play a role in regulation
of expression of c-fos in the spinal cord. Indeed, following intrathecal perfusion
of SP or NKA into the sub-arachnoid space, p55c-fos was generated in the
superficial laminae of the dorsal horn (Williams et al, 1989). Therefore the
exclusive mustard oil-facilitated expression of c-fos, established as a marker, was
used to investigate the effects of intravenous administration of non-peptide NKj
and NK2 tachykinin antagonists on the spinal changes accompanying cutaneous
application of mustard oil.
The results presented here indicate that both the NKj and NK2 receptors
accessed here appear to be involved in mediating mustard oil-induced c-fos
mRNA expression within the superficial dorsal horn of the spinal cord. Systemic
application of antagonists to either of these receptor types lead to a significant
inhibition, to very similar levels, in the mustard oil-induced expression of
specifically hybridising material.
RP 67580 is reported to be a highly-selective and potent non-peptide
antagonist for the rat NKj receptor (Garret et al, 1991; Petitet et al, 1993),
indicating that the results obtained with this dmg are likely to represent selective
NKj mediated actions, although unknown side-effects cannot be ruled out. In the
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present studies, RP 67580 administration resulted in a significant decrease in the
mustard oil-evoked facilitation of c-fos mRNA expression on the ipsilateral side of
the spinal cord in comparison to the mustard oil only-treated group of rats.
However, when a comparison is made between the control sides of the two
groups, the results do not follow the same trend, the mean contralateral density for
the RP 67,580 mustard oil-treated group was slightly, but significantly increased
compared to the contralateral side of the mustard oil-treated group. This suggests
that intravenous administration of the non-peptide NK] antagonist results in a
small general increase in c-fos mRNA expression, whilst specifically inhibiting the
increase in c-fos mRNA expression due to mustard oil application. This result
may possibly indicate opposing roles for different NKj receptor sites in this
mustard oil-induced cellular response, although it is possible that this may be a
vehicle-induced effect and ideally we should have been carried out a set of vehicle
or respective enantiomer controls using RP 68651, which reportedly shows no
significant affinity for the NKj binding site (Garrett et al, 1991).
Although intravenous administration of RP 67580 considerably reduced
the ipsilateral mustard oil-induced facilitation in c-fos mRNA expression, it did
not reduce this expression to the level of the ipsilateral paraffin oil- treated
animals. Moreover, the control side of the mustard oil plus NKj antagonist-
treated sections had a significantly increased level of c-fos mRNA expression in
comparison to the control side of the paraffin oil-treated sections. Therefore,
although the intravenous NK4 antagonist appeared to be inhibiting the mustard
oil-induced facilitation of c-fos expression, the residual level of expression was
still higher than in controls devoid of either noxious stimulation or drug treatment.
It may be that other mechanisms or neuropeptides are involved or alternatively that
the full extent of the drug effect is not apparent as RP 67580 is known to have a
short duration of action (Laird et al, 1993). Although repeated doses of drug were
administered every 15 minutes, perhaps the full effect of the selective NKj
antagonist was not being seen as it has been reported that RP 67580 has a low
penetration in the rat CNS (Fardin et al, 1993). However, there certainly was an
effect in this study following repeated doses of RP 67580 and also following a
single application on the nociceptive rat flexor reflex (Laird et al, 1993) on SP-
induced excitation of locus coerulus neurons (Allam et al, 1992) and on SP-
induced extravasation in the dura mater (Moussaoui et al, 1993).
These results are entirely consistent with the results obtained in both
electrophysiological and behavioural studies (see Chapters 2,3,4 and 7) in addition
to a number of other studies which have also revealed that NKj receptors may
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have an important role in mediating sustained nociceptive responses but appear to
be less involved in acute nociception. During the formalin or CFA-induced
inflammation there are increases in the biosynthesis of SP-IR and PPT-1 mRNA
and expression of NKq gene expression and NKq binding sites in the spinal cord
dorsal horn (Minami et al, 1989; Donaldson et al, 1992; Noguchi and Ruda, 1992;
Schafer et al, 1993; Stucky et al, 1993; McCarson and Kruase, 1994). Increased
release of SP-IR into the spinal dorsal horn occurs in models of inflammation and
sustained C fibre activity (Go and Yaksh, 1987; Oku et al, 1987; Kuraishi et al,
1989; Schaible et al, 1990; McCarson and Goldstein, 1991; Garry and Hargreaves,
1992) and the presence of CGRP can act to maintain the levels of SP and promote
its spread through the dorsal horn (Schaible et al, 1990). Just as these changes
suggest, there is compelling evidence that NK] receptors play an increasing role in
nociception following inflammation. NK] antagonists are highly effective
analgesic agents in a variety of behavioural models of sustained and inflammatory
pain (Garrett et al, 1991; Yamamoto and Yaksh, 1991; Birch et al, 1992;
Nagahisa et al, 1992; Chapman and Dickenson, 1993; Yashpal et al, 1993) and
although they are not effective in all cases (Nagahisa et al, 1992; Rupniak et al,
1993), individual drug characteristics may contribute to those particular finding.
The secondary (contralateral) hyperalgesia which develops following heat injury to
one hindpaw of rats, is similarly reversed by an NK} antagonist (Murray et al,
1991). NK4 agonists and conditioning stimulation of the sural nerve both elicit
facilitation of the nociceptive flexor reflex that is sensitive to selective NKj
antagonists (Xu et al, 1991) pointing to a contribution of NKj receptors to the
central sensitisation following sustained C-afferent input. Equally, SP was able to
enhance and a NKq receptor antagonist inhibit the responses of nociceptive dorsal
horn neurons to repetitive C fibre strength stimulation (Kellstein et al, 1990) in
addition to the underlying long-duration postsynaptic dorsal root potentials (Urban
and Randic, 1984). In the ultraviolet burn model, using an in vitro spinal cord-
skin preparation (Thompson et al, 1994), the NKq receptor antagonist CP-96,345
was substantially effective only in the inflamed condition.
SR 48968 has been demonstrated to be a highly potent and selective
antagonist of NK2 receptors (Advenier et al, 1992; Emonds-Alt et al, 1992,1993).
Systemic administration of this selective non-peptide NK2 antagonist resulted in a
very similar outcome to that achieved following administration RP 67580.
Following intravenous administration of SR 48968 there was a significant
decrease in the ipsilateral mustard oil-induced facilitation of c-fos mRNA
expression. However in contrast, SR 48968 increased the number of c-fos
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mRNA-expressing superficial dorsal horn neurons contralateral to unilateral
mustard oil application as compared to the mustard oil only group of controls. As
previously suggested, possible explanations for this spurious result are either a
vehicle-induced effect or opposing roles for different NK2 receptor sites in this
mustard oil-induced cellular response. An alternative suggestion may be that there
are non-specific actions of SR 48968, not related to its action at NK/> receptors.
Indeed, in guinea pig tissue SR 48968 is reported to have activity at NK3 receptors
although in the rat cortical tissue it appears to remain fairly selective for NK/>
receptors (Petitet et al, 1993). However, p agonist actions at higher concentrations
of SR 48968 have been indicated (Martin et al, 1993), although it is not clear how
p agonist actions could increase the c-fos mRNA expression within spinal cord
neurons. Despite this overall increase in c-fos mRNA expression on both sides of
the cord there was a definite and selective inhibition of the mustard oil-induced
facilitation of silver grain density suggestive of an NK2 receptor involvement in
this sustained activation of C-fibres following mustard oil activity.
These results are in close agreement with the electrophysiological,
biochemical and behavioural results discussed in this Thesis. There are also a
variety of other reports indicating that NK2 receptors are extremely important in
mediating sustained spinal nociceptive processing. Adjuvant or formalin-induced
inflammation and hyperalgesia lead to an increased biosynthesis of PPT-1 mRNA
(Minami et al, 1989; Donaldson et al, 1992) and increased release of NKA was
seen following kaolin and carrageenan injection into the knee joint (Hope et al,
1990). Electrophysiological studies demonstrate a role for NK2 receptors in
mediating the flexor reflex facilitation evoked by damaging cutaneous thermal
stimuli (Xu and Wiesenfeld-Hallin, 1992) or following gastrocnemius nerve
conditioning at C fibre strength (Xu et al, 1991). Correspondingly, in the in vitro
UV burn model, the C-fibre evoked ventral root potential was significantly
reduced by a selective NK2 antagonist both pre- and post-inflammation again
providing evidence that NK2 receptors are important in prolonged nociceptive
states.
Our observations indicate that Fos protein is probably induced at least in
part through actions of the neuropeptides SP and NKA. These tachykinins are
known to be present in small diameter afferents (Hokfelt et al, 1975b) which are
the major inputs to these regions of greatest c-fos mRNA expression in the spinal
cord whose laminar distribution is related to the nature of the sensory stimulus.
The significance of the induction in c-fos is unclear, but it is suggested that it is a
rapid response to injury of peripheral tissue and may contribute to long-term
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adaptations of these neurons conceivably through an increase in dynorphin
synthesis. There is strong evidence suggesting that the preprodynorphin gene is a
target for Fos as co-induction of c-fos and preprodynorphin genes is reported to
occur in the same neuronal elements of the spinal cord after noxious thermal
stimulation (Naranjo et al, 1991; Draisci and Iadarola, 1989) and inflammation
(Draisci and Iadarola, 1989; Hylden et al, 1992). The increase in Fos protein after
peripheral inflammation is followed by a large increase in preprodynorphin mRNA
and a subsequent increase in dynorphin peptide (Iadarola et al, 1988). Over 80%
of preprodynorphin expressing neurons in dorsal horn co-localise c-fos mRNA
(Dubner and Ruda, 1992) and in addition, an AP-1 site has been identified in the
preprodynorphin promotor that binds fos/jun proteins (Naranjo et al, 1991)
providing further support that Fos-mediated signalling is coupled to dynorphin
gene transcription. As dynorphin-expressing neurons are thought to be involved in
mechanisms that modulate pain sensations (Iadarola et al, 1988) and it seems
likely that the early induction of c-fos mRNA expression in these cells may fulfil
some role in mediating those responses, such changes may underpin persistent
changes in the sensitivity of nociceptive processing pathways during inflammation
and be integral to the development of lasting hyperalgesia and allodynia.
Moreover, following systemic administration of selective NKq or NK2
antagonists, ISHH studies have demonstrated a contribution of both NKq and
NK2 receptors to the carrageenan-induced expression of preprodynorphin mRNA
in superficial dorsal horn neurons (R.M.C. Parker, unpublished observations).
The precise mechanism through which neurons receive information
signalling the necessity for c-fos production and an increase in dynorphin synthesis
is unclear. However, as both SP and NKA are known to be contained in small
diameter primary afferents (Hokfelt et al, 1975b) and are released upon C fibre
stimulation (Duggan et al, 1987,1988,1990; Hope et al, 1990), following
sustained C fibre activity, these axons could convey the information from the
periphery to spinal cord neurons, depolarise the target neurons and thus induce the
expression of c-fos. Through binding to the AP-1 consensus recognition
sequence, Fos might induce changes in DNA transcription, which could result in
changes of mRNA output and thus changes in synthesis of a peptide such as
dynorphin.
Nevertheless, the tachykinins SP and NKA are not the only
neurotransmitters which may be involved in the transcriptional activation of c-fos.
Although the evidence is somewhat mixed, it is possible that c-fos is induced in
the spinal dorsal horn following Ca^+ entry through NMDA receptor-operated
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Ca^+ channels. It has been demonstrated that noxious stimulation-induced
expression of Fos in the spinal dorsal horn is substantially reduced by pre-
treatment with the NMDA receptor antagonist MK-801 (Kehl et al, 1991),
however others have found that NMDA antagonists do not affect the distribution
of Fos-labelled neurons in spinal cord (Tolle et al, 1991). Alternatively it is
possible that the c-fos-containing neurons might receive input from several
transmitters or from a combination of them depending on the type of stimulation
e.g. noxious or innocuous, indeed Pretel and Piekut (1991) have demonstrated co-






The aim of these experiments was to assess the effects of tachykinin
antagonists on behavioural paradigms of nociception. To do this, the behavioural
responses to rat paw-flick and tail-flick tests were evaluated and these results were
used as 'baseline responses'. The effects of intrathecal administration of NK[ and
NK2 tachykinin antagonists were then assessed in both non-carrageenan treated
rats and those treated with an intraplantar injection of carrageenan (a peripheral
inflammatory stimulus).
7.2 MATERIALS
Male Lister hooded rats were obtained from Glaxo Laboratories, Ware,
Herts, UK. All standard laboratory equipment and chemicals which were used in
these studies were also from Glaxo Laboratories. L-659,874 was purchased from
Cambridge Research Biochemicals; GR 82334 was a gift from Glaxo Group
Research; SR 48968 was a gift from Sanofi Recherche, France and RP 67580 was
a gift from Dr C Garret, Rhone Poulenc, France.
7.3 METHODS
7.3.1 Animals
Rats weighing between 40-80g were used for the intrathecal route of
injection. All animals were housed in suspended steel cages in a colony room
maintained on a 12 hour light : 12 hour dark cycle. Experiments were conducted
at the same time each day. Food and water were available ad libitum throughout
the experiments.
7.3.2 Drug Administration
Drugs were made up in either sterile saline or DMSO on the day of use.
The pH of each drug solution was adjusted to as near 7.0 as possible and
concentrations were made up such that the micro-injection volume of IOjllI
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contained the appropriate drug amount. When 2 drugs were co-administered, the
combination was in a single solution. The following drugs were administered by
this route:- L-659,874 (2,6 and 60nmol, pH 6.5-7.0, prepared from concentrated
stocks dissolved in DMSO (0.5% final concentration)); GR 82334 (2,6 and
60nmol, pH 6.5-7.0, prepared from concentrated stocks dissolved in saline). The
drugs were made up as stock solutions, stored at -20°C over dessicant. Solutions
once thawed were not re-frozen or used again. Vehicle controls used were either
sterile saline or 0.5% DMSO.
An intrathecal injection was used to administer both the peptide
compounds and vehicle controls using the standard protocol of Hylden and
Wilcox, (1980) (see Figure 7.1). All intrathecal injections were performed with
disposable 30 guage 1/2-inch needles mated to a 10pl luer tip syringe. The
injection was initially performed using the highly selective NK4 agonist SPOMe,
known to cause dose-dependent biting and scratching behaviour following its
intrathecal administration (Gamse and Saria, 1986). When the experimenter was
proficient at delivering this NKj agonist accurately (assessed by the ensuing biting
and scratching behaviour), the injection of tachykinin antagonists could be
initiated. The rat was held firmly by the pelvic girdle in one hand, while the
syringe was held in the other hand at an angle of about 20° above the vertebral
column. The needle was inserted into the tissue to one side of the L5 or L6
spinous process so that it slipped into the groove between the spinous and the
transverse processes. The needle was then moved carefully foreword to the
intervertebral space as the angle of the syringe was decreased to about 10°. The
tip of the needle was inserted so that approximately 0.5 cm was within the
vertebral column, the solution was injected and the needle rotated on withdrawal.
The site of injection in these experiments was chosen to be between L5 and L6.
This site represented a compromise to maximise intervertebral accessibility and to
minimise the possibility of spinal damage. Cursory examination of injected rats
showed no evidence of overt motor impairment.
7.3.3 Nociceptive Testing in Non-Carrageenan Treated Animals
Care was taken to ensure that the rats were not overly stressed; this was
achieved by always leaving the rats for at least 30 minutes post transfer to the
laboratory and handling the animals for a minimal period.
The rats were placed in groups of 6, for each dose of the drug to be tested
and their tails pen-marked from 0 to 5 respectively. Each group of six were kept
separately in marked cages between tests. Before injection, each rat was
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Figure 7.1
Schematic Diagram of the Intrathecal Injection.
Diagram showing insertion of the needle into the invertebral; space between L5
and L6.
(From Hylden and Wilcox, 1980)
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consecutively tested, first for tail-flick and then paw-flick, this was repeated three
times and the values were averaged for baseline control values. The animals were
then injected in the same order and the nociceptive tests carried out at 1, 3 and 5
minutes post injection.
Two methods of nociceptive testing were used:-
(a) Tail-flick Test
A Ugo Basile tail-flick unit was used for these studies. This consists of
an infrared (IR) source (50W bulb) whose radiant heat energy of adjustable
intensity is focused by an embodied parabolic mirror on the rat tail.
The tail-flick test was carried out following a standard protocol of
D'Amour and Smith, (1941), whereby the rat was held loosely on the upper panel
(see Figure 7.2) in such a way that its tail, placed over a flush mounted window
received the IR energy. The tail was always placed in exactly the same marked
position prior to testing with the heat stimulus.
When the rat flicked its tail away from the beam, a sensor mounted
coaxially to the infra-red beam detected the lack of energy reflected back by the
tail Via an electronic circuit, this stopped the second counter and switched off the
bulb. Thus the time from the onset of this thermal stimulus to the reflex flick of the
tail away from the light source, was recorded automatically and termed the tail-
flick latency (TFL). An automatic cut-off circuit was provided, which operated
either if the tail was misplaced or moved sideways and thus there was no reflected
energy or, if the animal did not have a tail-flick reaction within the maximum
selected reaction time (23 seconds from initiation of the thermal stimulus).
To test the tail-flick, the rat was restrained in a crouching position under
the cup of the examiner's hand. The tail was held over the infrared source by
loosely holding the end, this allowed any movement of the tail to be sensed by the
examiner. The rat either raised its tail away from the light or moved it to one side
of the beam when it felt discomfort. However, care had to be taken to ensure that
the examiner could distinguish between restless movements of the animal and
movement of the tail due to discomfort.
A 2 minute gap was left between tests to ensure that tissue damage to the
tail and possible ensuing sensitisation of the tail-flick response did not occur,




The rat tail-flick response.
The upper photograph demonstrates positioning of the rat's tail over the IR beam.
The rat was held loosely and the tail positioned in such a was that its tail, placed
over a flush mounted window received the IR energy. The tail then rested freely




(b) Dorsal Paw-flick Test
The dorsal paw-flick test was performed by modification of the Woolfe
and MacDonald, (1944) method on the same Ugo Basile Apparatus as the tail-
flick tests. The examiner held the rat in an elevated position with the left hindlimb
free for testing. The foot was placed over the light source with the paw bent under
in such a manner that the infrared beam was focused on the hairy (dorsal) side of
the foot. Care had to be taken that the foot was only slightly bent so that the paw
could be easily flicked away (see Figure 7.3). A foot operated control was pressed
and when the animal flicked its foot away from the noxious heat source in a brisk
withdrawal type movement, the reaction time was recorded. Thus the time from
the onset of this thermal stimulus to the reflex flick of the paw away from the light
source, was recorded automatically and termed the dorsal paw-flick latency
(DPFL). Again the automatic cut-off point was set to 23.0 seconds from initiation
of the thermal stimulus to avoid damage to the foot if a paw-flick did not occur.
7.3.4 Nociceptive Testing in Carrageenan Treated Animals
The tachykinin antagonists were also tested in rats unilaterally treated
with 2% carrageenan. In the same protocol as the non-carrageenan treated groups,
the rats were placed in groups of 6 for each dose of the drug to be tested. Before
carrageenan injection, each rat was consecutively tested, first for glabrous and then
dorsal paw-flick, this was repeated three times and the values were averaged for
baseline control values. The animals were then unilaterally injected with
carrageenan:
Carrageenan Injection
A 2% solution of lambda carrageenan (Sigma) was made up in sterile
saline and left at 4°C overnight. Under halothane anaesthesia, the left hindpaw of
each animal was injected with carrageenan. The injection was administered under
the dorsal (hairy) surface of the foot by carefully sliding the needle under the skin
surface and injecting 100|il of the 2% solution slowly to avoid any leakage from
the puncture site. The rats were then placed in recovery cages for a minimum
period of 3 hours to allow the inflammation to develop.
Once the inflammation had developed (3-4 hours post-carrageenan), the
paw-flick tests were completed in triplicate and the shift in baseline controls
determined. The animals were then intrathecally injected and the following
nociceptive tests carried out at 1, 3 and 5 minutes post injection.
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Figure 7.3
The dorsal paw-flick response.
The dorsal paw-flick response was performed on the same apparatus as the tail-
flick response. The rat was held in an elevated position and its paw bent under in
such a manner that the infrared beam focused on the hairy side of the foot. The
upper photograph demonstrates the positioning of the foot in this way. The paw
was then unrestrained (the lower photograph) so that the animal was free to flick it
away from the IR beam.
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(a) Dorsal Paw-flick Tests
The dorsal paw-flick tests were carried out in an identical procedure to
that described for the non-carrageenan nociceptive tests (see Figure 7.3).
(b) Glabrous Paw-flick Tests
The rat was held firmly, but gently in one hand with its forelimbs raised,
permitting a free range of movement in the rear quarters of the rat. The foot was
placed over the light source in such a manner that the infrared beam was focused
on the most padded part of the foot and thus presented minimal damage (see
Figure 7.4). A foot operated control was pressed and when the animal flicked its
foot away from the noxious heat source in a brisk withdrawal type movement, the
reaction time was recorded. Thus the time from the onset of this thermal stimulus
to the reflex flick of the paw away from the light source, was recorded
automatically and termed the glabrous paw-flick latency (GPFL). This reflex had
to be discerned from other movements of the rat, such as wriggling or exploratory
type movements. The automatic cut-off point was set to 23.0 seconds to avoid
damage to the foot if a paw-flick did not occur.
7.3.5 Analysis
Paw-flick and tail-flick latencies were calculated in seconds for each rat
under study using the Ugo Basile Apparatus. Six rats were used for each dose of
drug to be examined and control values for paw-flick and tail-flick were calculated
by averaging the control responses for each group of 6 animals.
After intrathecal administration of the tachykinin antagonist(s), the paw-
flick and tail-flick latencies were measured at 1, 3 and 5 minutes post-injection.
The average paw-flick or tail-flick latencies for the 6 rats were calculated for each
timepoint and were expressed as a percentage of the pre-drug control value .
In the carrageenan treated rats, the control values were estimated as
described above, before the intraplantar injection of carrageenan. Four hours after
the carrageenan was administered, the rats were re-tested for paw-flick and tail-
flick latencies and the average value for each group expressed as a percentage of
the control value. The drug was then administered intrathecally and the latencies
tested at 1,3 and 5 minutes post-injection as described above.
The results for each group of 6 rats were meaned and expressed as a
percentage of the total mean control value for all the rats being used in that
particular experiment. This usually was from a total number of 24 rats. The
graphs are shown in Figures 7.5, 7.6 and 7.7.
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Figure 7.4
The glabrous paw-flick response
This photograph demonstrates the positioning used to hold the rat for the glabrous
paw-flick response. The rat was held with its forelimbs raised, permitting a free
range of movements in the rear quarters of the rat. The foot was placed over the
light source in such a manner that the infrared beam was focused on the most
padded part of the foot and thus presented minimal damage.
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To assess statistical significance of changes between the vehicle and drug-
induced response in each test, the students unpaired t-test was employed. When
comparing changes between the non-carrageenan and carrageenan sensitised state,
the statistical significance of changes was assessed by the Mann-Whitney U-test.
This is a non-parametric statistical analysis test which makes no assumptions of a
normal distribution of data and errors. Significance was accepted at probability
values of P<0.05.
7.4 RESULTS
7.4.1 Control Paw-flick And Tail-flick Responses.
After transportation from the animal storage room to the laboratory, the
rats were always left for a minimum period of 30 minutes to enable them to adjust
to the environment. There was free access to diet and water during this period.
Three control responses to both tail-flick and paw-flick, in turn, were obtained for
each rat and from these an average response time was calculated. To minimise
sensitisation of the behavioural responses to the noxious heat stimulus, the paw-
flick and tail-flick responses were alternated over the three control responses and
tests repeated at not less than 2 minute intervals.
7.4.2 Nociceptive Testing in Non-Carrageenan treated Animals.
The effect of two tachykinin antagonists, L-659,874 and GR 82334
(highly selective for NK2 and NKq receptors respectively) were quantified on
nociceptive responses to the tail-flick and dorsal paw-flick tests. The tail-flick test
has previously been widely used for determination of acute nociceptive thresholds
(Cridland and Henry, 1986,1988; Rupniak et al, 1993), although there has been
sparse and conflicting evidence for a role of tachykinins in mediating this response
(Lembeck et al, 1981; Piercey et al, 1981; Yashpal et al, 1982; Gamse and Saria,
1986). The paw-flick test has also been widely used as a method of nociceptive
testing, however most experimenters have relied heavily upon using the glabrous
skin on the ventral surface of the foot. In electrophysiological experiments we
found that this type of skin did not respond to cutaneous application of mustard
oil, which is believed to specifically activate C fibre nociceptors (Lynn and
Carpenter, 1982). As such polymodal C nociceptor afferents are very important in
mediating nociceptive thermal response (Perl, 1984), it was decided to modify the
paw-flick test by focusing the IR beam on the dorsal (hairy) surface of the foot;
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this was achieved by gently bending the foot in such a way that a paw-flick could
easily be achieved (see Figure 7.3).
(a) Effect of Intrathecal L-659,874.
Due to limits on both time and the number of animals available, it was
decided to initially test only one high dose of the selective NK2 antagonist; if a
change in nociceptive latencies for tail-flick or paw-flick occurred then a dose-
response curve could be completed. Six rats were intrathecally injected with L-
659,874 and the tail-flick and dorsal paw-flick tests measured at 1,3 and 5 minutes
post-injection as previously described. The results are graphically expressed in
Figures 7.5 and 7.6 as a percentage of the DMSO control.
(ai) Tail-flick Test
At 1 minute post-intrathecal injection of 3nmol L-659,874, there was a
very small, but insignificant decrease in the tail-flick latency to 88 ± 8% (mean ±
s.e.m.) of the DMSO control (P>0.05, Unmatched Students t-Test). Similarly at
the 3 and 5 minute test points, the 3nmol L-659,874 tail-flick latency was not
significantly different to that of the DMSO control. However, as can be seen in
Figure 7.5a, the intrathecal injection of DMSO gave an increase in Tail-flick
latency. This may be due to either a vehicle effect or more likely, stress-induced
analgesia in this group of 6 rats, so the experiment should be repeated under more
closely controlled stress-free circumstances. When responses in the presence of L-
659,874 were compared with the saline control, there was also no statistically
significant difference in their effects.
(aii) Dorsal Paw-flick Test
As can be seen in Figure 7.6a, the 3nmol intrathecal injection of L-
659,874 resulted in no statistical difference in dorsal paw-flick latency as
compared to the DMSO vehicle control. At each of the time points tested 1,3 and
5 minutes, the dorsal paw-flick latency was 88 ± 9%; 87 ± 11% and 83 ± 10%
(mean ± s.e.m.) of the vehicle control latencies respectively.
The result is surprising as it does not agree with previous
electrophysiological studies on thermal nociception (see Chapters 2 and 4) or with
behavioural experiments carried out by my colleague (Young et al, 1995).under
similar (but not identical) circumstances to the present study. In the latter
experiments it was found that a 3nmol intrathecal injection of L-659,874 caused a
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Figure 7.5
The effect of intrathecal tachykinin antagonists on the rat tail-flick response.
Tail-flick latency is plotted against time for the basal tail-flick latency and then at
1, 3, and 5 minutes post-intrathecal injection of the highly selective tachykinin
antagonists L-659,874 or GR 82334.
(a) Demonstrates the effect of a 3 nmol intrathecal injection of either L-659,874 or
GR 82334 on the rat tail-flick latency. Neither of the selective NKj or NK2
antagonists showed any significant change to their respective saline or DMSO
controls.
(b) Demonstrated the effect of a 0.1, 0.3 and 3nmol intrathecal co-injection of L-
659,874 and GR 82334. The graph demonstrates that the dose-response curves to
the two highest doses of intrathecal drug combination were not significantly
different to that of the vehicle control at any of the time-points tested, however, at
the lowest dose tested (0.1 nmol) there was a slight analgesic type action with a
small but significantly decreased tail-flick from the vehicle control. This is
perhaps a pro-nociceptive action of the drug combination at this dose. Values are
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The effect of intrathecal injection of tachykinin antagonists on the rat dorsal
paw-flick response before and after 2% unilateral intraplantar carrageenan
injection.
The effect of intrathecal injection of the highly selective NKj and NK2
antagonists GR 82334 and L-659,874 on the dorsal paw-flick response were
screened individually at a 3 nmol dose (a), followed by a co-injection of 0.1, 0.3,
and 3.0 nmol of the combination. Four hours after carrageenan had been injected
into the dorsal surface of the left hindpaw, the effect of the NKj and NK2
antagonists on the dorsal were screened individually (c) and in combination (d).
Figure (a) demonstrates that a 3nmol injection of either L-659,874 or GR 82334
was not significantly different to the vehicle controls used (DMSO and saline for
L-659,874 and GR 82334 respectively). However, 4 hours after a 2% carrageenan
injection to the dorsal surface of the foot, an intrathecal injection of 0.1, 0.3 or 3.0
nmol L-659,874 caused a marked and highly significant increase in dorsal paw-
flick latency in comparison to the DMSO control. (Figure (c)). A similar effect
was seen after intrathecal injection of GR 82334, however only at the highest dose
injected was there any significant increase in dorsal paw-flick latency compared to
the saline control.
Figure (b) demonstrates the effect of an intrathecal co-injection of the two drugs
under study on the dorsal paw-flick latency, it can be seen that the lowest dose of
combination had no significant effect on the response whilst the two higher doses
caused a dose-related increase in the paw-flick latency compared to the vehicle
control. The effect of this drug-combination was not investigated in the
carrageenan-sensitised model due to lack of resources available.
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Figure 7.7
The effect of intrathecal injection of tachykinin antagonists on the rat
glabrous paw-flick response before and after 2% unilateral intraplantar
carrageenan injection.
The effect of intrathecal injection of the highly selective NK] and NK2
antagonists GR 82334 and L-659,874 on the glabrous paw-flick response were
screened four hours after carrageenan had been injected into the dorsal surface of
the left hindpaw.Figures (a) and (b) demonstrate that at none of the doses tested
(0.1, 0.3 and 3.0 nmol) did the highly selective NK2 or NKj antagonists result in
any significant change in carrageenan glabrous paw-flick latency. As these drugs
were ineffective in the sensitised state (where it is more likely to see an effect) it
was decided not to test these antagonists on the non-carrageenan glabrous paw-
flick.
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marked increase in paw-flick latency (to a maximal increase of 176% at 3 minutes
post-intrathecal injection) compared to the DMSO control. One plausible
explanation which can be offered is that the sample size used here (n=6) was
much smaller than in the study conducted by colleagues. It seems quite possible
that due to variable controls and the short time available for these studies to be
carried out, the sample was not large enough to reflect a truly representative result.
Another possibility is that variation occurred due to differing assessment methods
and pre-treatment times in the dorsal paw-flick test. In my colleague's behavioural
data, the rat's paw and limb were held flat over the IR source, whereas in this set
of experiments the limb was slightly raised which resulted in a shorter average
paw-flick latency.
(b) Effect of Intrathecal GR 82334.
In an analogous manner to tests for L-659,874, the highly selective NKq
antagonist GR 82334 was intrathecally injected only at one dose before proceeding
with tail-flick and dorsal paw-flick tests. A total of 12 rats were used, 6 for the
drug under investigation and 6 for the saline controls; after intrathecal injection
with L-659,874, the tail-flick and dorsal paw-flick tests were measured at 1,3 and
5 minutes post-injection as previously described. The results are graphically
expressed in Figures 7.5 and 7.6 as a percentage of the saline control.
(bi) Tail-flick Test
It can be observed in Figure 7.5a that the 3nmol intrathecal injection of
the highly selective NKq antagonist GR 82334, resulted in no significant change
in tail-flick latencies at any of the time points tested, compared to the saline
control. At 1, 3, and 5 minutes post-intrathecal injection, the tail-flick latencies
were 96.2 ± 10%; 113 ± 12% and 109.5 ± 13% (mean ± s.e.m.) of the saline
control respectively (P>0.05 Unmatched Students t-Test). At 3 and 5 minutes
post-i.t. injection the curves for both GR 82334 and the saline control are closely
matched.
(bii) Dorsal Paw-flick Test
There was no significant difference between the mean dorsal paw-flick
latencies taken from 6 rats intrathecally injected with GR 82334 and a further 6,
intrathecally injected with the vehicle control, saline. As can be seen in Figure
7.6a, at 1, 3, and 5 minutes post-intrathecal injection the paw-flick latencies for the
GR 82334 treated rats were 86.2 ± 13.8%; 85.8 ± 15.0%; and 92.5 ± 10.6% of the
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(c) Effect of Intrathecal Combination of L-659,874 and GR 82334
It was decided to investigate the possibility of a synergistic interaction
between NKq and NK2 receptors acting to produce a facilitated analgesic action.
This was tested by giving a co-injection of NK] (GR 82334) and NK2 (L-
659,874) receptor antagonists. The effect of intrathecal application of the
combination on dorsal paw-flick and tail-flick was tested in a total of 18 rats, with
6 in each dose group of O.lnmol, 0.3nmol and 3nmol of the combined total drug
concentrations; a further 6 animals were used to test the vehicle control
combination (DMSO and saline). The results are graphically expressed in Figures
7.6 and 7.7 as a percentage of the control for each group. The baseline control
values for each group of animals, whilst not statistically different from the mean
control value, were a little variable. This can most probably be accounted for by
the inexperience of animal handling over the short time available for this project (2
weeks).
(ci) Tail-flick Test
The response curve for the two higher doses of the NK4/NK2
combination (0.3 and 3nmol), followed the same pattern with a small, but
insignificant increase in tail-flick latency at 1 minute post-intrathecal injection (to
115 + 11% and 123 ± 15% of saline controls respectively, mean ± s.e.m.), which
then fell towards baseline values for subsequent tests at 3 and 5 minutes (Figure
7.6b). As the vehicle also caused a similar increase in tail-flick latency at 1 minute
post-intrathecal injection, this suggests this was either due to a vehicle-induced
effect or to the stress of restraint and/ or injection and had no connection with any
analgesic effect of the drugs.
The lower dose of the NK1/NK2 combination (O.lnmol) produced an
entirely different response, showing a small, but significant decrease in tail-flick
latency at 1 minute post-intrathecal injection (to 73 ± 14% of the saline control;
mean ± s.e.m., P<0.01 Mann Whitney U-test). Similarly, at both the 3 and 5
minute time points post-intrathecal injection of the combined drugs, there was a
significant decrease in the tail-flick response, in comparison to the vehicle control
(75 ± 4% and 69 ± 6% respectively).
(cii) Dorsal Paw-flick Test
The vehicle control had no significant effect on paw-flick latencies
compared to baseline. However, each of the three NK4/NK2 drug combination
doses followed the same distinctive response pattern, with a sharp increase in paw
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(cii) Dorsal Paw-flick Test
The vehicle control had no significant effect on paw-flick latencies
compared to baseline. However, each of the three NK4/NK2 drug combination
doses followed the same distinctive response pattern, with a sharp increase in paw
withdrawal latency at 1 minute post-intrathecal injection, which gradually fell
towards control values at the 3 and 5 minute time points (see Figure 7.6b).
The lowest dose (O.lnmol) of the NK1/NK2 antagonist combination
slightly but insignificantly, raised the paw-flick latency above that of the vehicle
control at 1, 3 and 5 minute intervals post-intrathecal injection to a maximum of
119 ± 6% at 1 minute post-intrathecal injection. Although there was no significant
difference at any time-point tested, it did follow the general 'trend' of the higher
doses. This result is most likely to be due to a short lasting action of the low dose
of the drug combination, however, it could possibly be due to stress induced
opioid release (Calcagnetti et al, 1990) as it was only 1 minute post-injection.
The two higher doses of the NK4/NK2 antagonist combination which
were tested (0.3 and 3nmol), raised the paw-flick latency above that of the saline
vehicle at all 3 time points tested (1,3 and 5 minutes post intrathecal injection) in a
dose related manner. The highest dose of drug combination tested (3nmol),
caused a marked and significantly raised dorsal paw-flick latency compared to the
vehicle control. At 1 minute post-intrathecal injection the paw-flick latency was
maximally increased to 178 ± 11% of vehicle control (mean ± s.e.m., P<0.05
Unmatched Students t-Test) and at 3 and 5 minutes post-intrathecal injection it
was still markedly increased from the vehicle control to 175 ± 12% and 146 ± 4%
of vehicle control respectively.
Thus from the above results it can be seen that a 3.0 nmol combination of
L-659,874 and GR 82334 resulted in a significantly greater increase in dorsal paw-
flick latency than either drug alone at the same dose, suggesting a synergistic
interaction between the selective NKq and NK2 antagonists, although it is
possible, but not likely (considering a standard non co-operative form of dose-
dependence) that an equivalent double dose of either drug may have achieved the
same result.
7.4.3 Nociceptive Testing in Carrageenan Treated Animals
The effect of the NKq and NK2 receptor antagonists, GR 82334 and L-
659,874, on nociceptive responses to paw-flick latencies were investigated in rats
unilaterally injected with 2% lamda carrageenan into the dorsal surface of the left
hindpaw. As these experiments aimed to focus on the nociceptive responses before
251
and after tachykinin antagonists in a 'sensitised' state of carrageenan inflammation,
the tail-flick responses were omitted and attention was focused on the dorsal and
glabrous paw-flick responses.
In forty eight rats, the dorsal surface of the foot was injected with 100|il
of 2% carrageenan, which spread to the toes and around the glabrous region of the
foot. After 4 hours, thirty six rats were intrathecally injected with tachykinin
antagonist (18 each of GR 82334 and L-659,874) and a further twelve injected
with vehicle (6 each of DMSO and saline). The dorsal paw-flick was then tested
and a comparison made with glabrous (the ventral surface of the foot traditionally
tested) paw-flick. The glabrous paw-flick was screened on a sensitised response,
because it was more likely to see an effect of drugs in a sensitised state (in view of
previous results with hairy skin- see Chapter 3).
(a) Effect of Intrathecal L-659,874
The effect of intrathecal application of the NK2 antagonist on both dorsal
and glabrous paw-flick was investigated in a total of 18 rats, 6 for each dose of
antagonist (O.lnmol, 0.3nmol and 3nmol) and also a further six were used to
investigate the effect of vehicle in carrageenan-treated animals. The results are
graphically expressed in Figures 7.6 and 7.7 as a percentage of the control for each
group.
(ai) Dorsal Paw-flick Test
As can be seen in Figure 7.6b, 3 hours after carrageenan injection, the
paw-flick latency for each group of rats decreased. Although this value was not
statistically different to the pre-carrageenan control, the general trend was a
decrease in latency consistent with the generation of a hyperalgesic state. The
average response time was decreased from 100 ± 6% in the pre-carrageenan
controls to 82 ± 7% in carrageenan injected animals
All three doses of L-659,874 produced a marked and highly significant
increase in the paw-flick latency at all three time-points investigated. At 1 minute
post-intrathecal injection, each dose of the NK2 antagonist produced its maximum
increase in dorsal paw withdrawal latency (to 225 ± 12%; 249 ± 9%; 255 ± 3% of
vehicle control for O.lnmol, 0.3nmol and 3nmol of L-659,874 respectively; mean
± s.e.m., P<0.05 Unmatched Students t-Test). At 3 and 5 minutes post-intrathecal
injection of L-659,874, the paw-flick latencies were still large and significantly
raised from the DMSO control. Interestingly, at each subsequent time point, there
was a gradual decrease in the mean paw-flick latency compared to the previous
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test. At 3 minutes post-intrathecal injection the paw-flick latencies for each dose
(0.1, 0.3 and 3.0 nmol) were 157 ± 15%; 217 ± 9% and 204 ± 4% of vehicle
control respectively, (mean ± s.e.m., P<0.05 Unmatched Students t-Test) and at 5
minutes post injection the Paw-flick latencies had changed to 181 ± 12%; 213 ±
6% and 220 ± 8% respectively (mean ± s.e.m., P<0.05 Unmatched Students t-
Test).
(aii) Glabrous Paw-flick Test
As can be seen in Figure 7.7a, 3 hours after carrageenan injection, the
glabrous paw-flick latency for each group of rats decreased in a similar manner to
the dorsal paw-flick results. Although this value was not statistically different to
the pre-carrageenan control, the general trend was a decrease in latency consistent
with the generation of a hyperalgesic state. This implies that although the
carrageenan injection had been given into the dorsal surface of the foot, the ventral
side had been similarly affected with both dorsal and ventral paw-flick producing
a similar decrease in paw withdrawal latency post-carrageenan. The average
response time for glabrous paw-withdrawal was decreased from 100 ± 7% in the
pre-carrageenan controls to 68 ± 11% in carrageenan injected animals.
However, despite the redness and swelling associated with the
carrageenan injected hindlimb, suggesting a hyperalgesic state, L-659,874, at all 3
doses tested, was ineffective at producing any significant changes in the glabrous
paw-flick latency compared to control DMSO values. At 1 minute post-intrathecal
injection (where normally a maximum change is observed), the paw-flick latencies
for each of 0.1, 0.3 and 3.0nmol intrathecal injections were 152 ± 33%; 125 ±
13% and 128 ± 4% (mean ± s.e.m.) of vehicle control respectively (P>0.05,
Unmatched Students' t-Test). Although the general shape of each dose response
curve follows a pattern typical of an analgesic-type response, at none of the doses
tested was the response to intrathecal L-659,874 significantly different from the
vehicle control curve. This is perhaps due to the large variability surrounding this
test which is masking the significance of the glabrous paw-flick response to the
NK2 antagonist.
(b) Effect of Intrathecal GR 82334
The effect of intrathecal application of the NK ] antagonist on both dorsal
and glabrous paw-flick was investigated in a total of 18 rats, 6 for each dose of
antagonist (O.lnmol, 0.3nmol and 3nmol) and also a further six were used to
investigate the effect of vehicle in carrageenan-treated animals. The results are
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graphically expressed in Figures 7.6d and 7.7b as a percentage of the control for
each group.
(hi) Dorsal Paw-flick Test
As can be seen in Figure 7.6d, the dose response curve for saline and each
dose of the NK^ antagonist followed the same basic pattern with a decrease in
paw-flick latency after 3 hours of carrageenan. Although this decrease in latency
was not significant for any of the drugs or saline, it is consistent with the
generation of a hyperalgesic state, the average response time was decreased from
100 ± 6% pre-carrageenan control to 82 ± 7% post-carrageenan control. At 1
minute after intrathecal injection, there is an increase in each dose response curve
and although only the highest dose of 3nmol GR 82334 was significantly different
from the saline vehicle control (161 ± 3%, mean ± s.e.m., P<0.05 Unmatched
Students t-Test), the lower two doses obviously follow the same trend. At 3 and 5
minutes post-treatment, the dose response curves fell gradually back towards pre-
carrageenan values with again only the 3nmol dose being significantly different
from the saline control (176 ± 9% and 140 ± 16% respectively, mean ± s.e.m.,
P<0.05 Unmatched Students t-Test). The results are graphically expressed in
Figures 7.6d as a percentage of the control for each group
(bii) Glabrous Paw-flick Test
Figure 7.7b demonstrates that 3 hours after carrageenan injection, the
glabrous paw-flick latency for each group of rats decreased in a similar manner to
the dorsal paw-flick results. Although this value was not statistically different to
the pre-carrageenan control, the general trend was a significant decrease in paw-
flick latency post-carrageenan, indicating that hyperalgesia has developed. This
implies that although the carrageenan injection had been given into the dorsal
surface of the foot, the ventral side had also been affected as there was a similar
decrease in paw withdrawal latency post-carrageenan. The average response time
for glabrous paw-withdrawal was decreased from 100 ± 7.6% in the pre-
carrageenan controls to 81.1 ± 8.9% in carrageenan injected animals.
As can be clearly observed in Figure 7.7b intrathecal injection of the two
lower doses of GR 82334 did not cause any significant change in the dose
response curve as compared to saline control at any of the three time-points tested.
The lowest dose of 0. lnmol GR 82334 caused a small but apparently significant
increase in glabrous paw-flick latency at 1 minute post-intrathecal injection to 118
± 7% of the vehicle control, with no significant effect at the 3 and 5 minute tests.
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As this effect occurred at the lowest dose of drug tested with no significant
changes at higher doses used, it suggests that the increase in paw-flick latency is
not due to a drug-induced effect and is perhaps due to a stress-induced analgesia in
this group of 6 rats. Another explanation is that the effect is vehicle-induced as
the general dose-response pattern follows the same general shape as the two
higher doses.
7.5 DISCUSSION
The experimental models of tail-flick (D'Amour and Smith, 1941) and
glabrous paw-flick (Woolfe and MacDonald, 1944) employed here, have been
previously used by various experimenters and provide reliable and reproducible
methods with which to assess the effects of locally administered tachykinin
receptor antagonists on the spinally-elicited behavioural paradigms of nociception
(Cridland and Henry, 1986, 1988; Lecci et al, 1991; Garces et al, 1992; Picard et
al, 1993; Yashpal et al, 1993). However, in these models, the paw-flick response
has been tested using the thick hind-paw glabrous skin (Lecci et al, 1991; Garces
et al, 1992), on which, paw-withdrawal latencies have been demonstrated to vary,
depending on the precise location of the thermal stimuli applied to different
regions of the glabrous skin (Doucette et al, 1987). Additionally, in previous
studies (see Chapters 3 and 4), we have found that the C-fibre selective chemical
irritant mustard oil is ineffective when painted onto the glabrous skin of the
hindpaw, demonstrating that this skin-type is less sensitive. As such polymodal C
nociceptive afferents are very important in mediating nociceptive thermal
responses, the paw-flick method of nociceptive testing, described by Woolfe and
MacDonald, (1944) was additionally modified such that the foot under
examination was positioned to permit the thinner 'hairy skin' of the hindpaw to rest
over the light beam in such a way that a paw-flick could easily be achieved.
The technique standardly used for intrathecal injection of compounds into
small rats, that of Hylden and Wilcox, (1980), was practised using the selective
NKq antagonist SPOMe, known to cause caudally-directed biting and scratching
behaviour upon its successful intrathecal delivery (Gamse and Saria, 1986), and
only when the experimenter was fully accomplished with this method, were the
experiments initiated. Although it is possible in a few cases that the drug
somehow did not did not reach the spinal cord, generally, puncture of the dura was
reliably indicated by a flick of the tail.
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The results presented here demonstrate that intrathecal administration of
each of the selective NK] antagonist GR 82334 (Hagan et al, 1991) and the
selective NK2 antagonist L-659,874 (McKnight et al, 1988) failed to produce
potent antinociceptive activity in both the acute analgesiometric tests of dorsal
paw-flick and tail-flick. However, the results obtained with the selective NK ]
receptor antagonist in the acute nociceptive tests of paw-flick and tail-flick are not
entirely surprising as mixed reports have been obtained by other groups following
intrathecal administration of selective NK] agonists and antagonists. SP or
selective NK] antagonists (i.t.) have been shown to evoke a classical behavioural
response of compulsive biting, licking and scratching of the corresponding limb,
believed to be indicative of discomfort or pain (Hylden and Wilcox, 1981; Piercey
et al, 1981; Sweeney and Sawynok, 1986; Post and Folkers, 1985; Gamse and
Saria, 1986; Papir-Kricheli et al, 1990; Laneuville et al, 1988; Lecci et al, 1991).
However, the scratching response may not actually be pain-related, but may be a
spinal convulsive state or drug-related side effect (Frenk et al, 1988). Indeed,
although there are some reports that i.t administration of SP or an NK] receptor
agonist can significantly reduce the threshold for eliciting a thermal tail-flick
reflex (Picard et al, 1993; Cridland and Henry, 1986, 1988; Yashpal et al, 1993;
Post and Folkers, 1985) or a paw-pressure test (Sweeney and Sawynok, 1986);
others claim that i.t. SP plays no role in the behavioural responses to tail-flick and
hot plate test in the mouse or rat (Gamse and Saria, 1986; Piercey et al, 1981) or
that i.t. SP can cause hypoalgesia (Doi and Jurna, 1981). Similarly, mixed effects
have been described following i.t. selective NK] antagonists. Behavioural
analgesia in the hot plate and tail-flick tests has been obtained with selective NK]
antagonists (usually in relatively high doses), including some hexapeptide
analogues of SP (i.t.) (Lembeck et al, 1981; Post and Folkers et al, 1985) or the
non-peptide antagonist CP-96,345 (i.t. or i.p.) (Lecci et al, 1991; Picard et al,
1993; Yashpal et al, 1993). However, others have found that CP-96,345 or the
more recently developed NK j antagonist CP-99,994 were ineffective in tail-flick,
paw-flick or paw pinch tests (Elliott et al, 1992; Garces et al, 1992) as well as SP-
mediated biting and scratching (Garces et al, 1992). Further, i.t. RP 67580
(which binds with higher affinity to the rat NK] receptor (Garrett et al, 1991)) was
inactive in rat paw-pressure tests (Rupniak et al, 1993).
In addition, the results obtained behaviourally with NK] antagonists are
in agreement with the electrophysiology experiments described in Chapter 2 which
provided no clear evidence that NK] receptors participate in transducing brief
nociceptive inputs to laminae III-V neurons of the rat spinal dorsal horn. In
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accord, others have reported a similar lack of involvement of NKj receptors in
mediating brief nociceptive inputs (both thermal and mechanical) to deeper dorsal
horn neurons (Duggan et al, 1979; Willcockson et al, 1984; Fleetwood-Walker et
al, 1990). However, again, there are mixed results with reports that i.t.
administration of the highly selective non-peptide NKj antagonist CP-96,345
resulted in inhibition of responses of nociceptive dorsal horn neurons to C fibre
electrical stimuli of the after discharge response to brief noxious pinch and heat
(De Koninck and Henry, 1991; Radhakrishnan and Henry, 1991) with little effect
on the initial phase of excitatory responses to brief heat stimuli and inconsistent
effects on pinch-evoked excitation. It is possible that CP-96,345 is effective only
on late components of nociceptive responses or of more sustained pain states, this
is supported by the observation that CP-96,345 was able to significantly reduce the
ventral root potentials evoked by C-fibre strength electrical stimulation in in vitro
hemisected spinal cords, isolated from rat pups with ultraviolet light-induced
thermal and mechanical hyperalgesia but not in naive, untreated rat spinal cords
(Thompson et al, 1993).
The results obtained following i.t. administration of the selective NK2
receptor antagonist L-659,874 in the acute nociceptive tests were unexpected.
Although far fewer behavioural studies have been carried out for NKA and NK2
receptors than for NK| receptors, the evidence to date suggests that NK2 receptors
are extremely important in mediating thermal nociceptive transmission in the
spinal cord. Intrathecal NKA or selective NK2 agonist results in caudally directed
biting and scratching behaviour (Gamse and Saria, 1986) in addition to dose-
dependent, transient decreases in the tail-flick and paw-flick response latencies to
a noxious thermal stimulus (Cridland and Henry, 1986; Laneuville et al, 1988;
Fleetwood-Walker et al, 1990; Picard et al, 1993), reversed following i.t injection
of selective NK2 antagonists (Fleetwood-Walker et al, 1990; Picard et al, 1993).
Moreover, in electrophysiological studies we have demonstrated a role for NK2
receptors in mediating acute nociceptive thermal (but not mechanical or innocuous
cutaneous sensory responses) following administration of selective NK2 agonists
and antagonists (see Chapters 2 and 4). In agreement, other studies have
demonstrated an important role for NKA and NK2 receptors in mediating acute
nociceptive responses: intracellular recording studies demonstrate that NKA could
elicit a selective depolarisation in capsaicin-sensitive C fibres (Nagy et al, 1993)
and further that the selective NK2 receptor antagonist MEN 10376 inhibited
ventral root potentials evoked by C fibre strength electrical stimulation of
ipsilateral dorsal roots (Thompson et al, 1993). Noxious mechanical and noxious
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thermal stimuli both increase the levels of immunoreactive NKA throughout the
spinal cord (Duggan et al, 1990; Hope et al, 1990) and a role for NK2 receptors in
facilitating the nociceptive spinal flexor reflex has been suggested (Xu et al, 1991;
Xu and Wiesenfeld-Hallin, 1992; Wiesenfeld-Hallin et al, 1994).
The reason for the spurious NK2 results is perhaps due to the small
number (6) of animals in each dose group used; this in combination with the
examiner's inexperience in animal handling conceivably masked any true response
to the selective NK2 antagonist. In addition, although L-659,874 shows extremely
good selectivity for NK/) over NKj and NK3 receptors (McKnight et al, 1988;
Williams et al, 1988), the possibility of unidentified side effects playing a role can
not be ruled out. However, it may be that not all the injections actually reached
the spinal cord (although a tail-flick was generally observed, an indication that the
dura had been ruptured) or that inadequate concentrations were reached to block
the behavioural nociceptive tests in vivo.
There is good evidence that the tachykinins SP and NKA are synthesised
together and co-exist in primary afferents (Carter and Krause, 1990; Dalsgaard et
al, 1985; Helke et al, 1990). Although different patterns of stimuli have been
demonstrated to release each tachykinin (see Duggan et al, 1987,1988,1990; Go
and Yaksh, 1987; Kuraishi et al, 1989; Hope et al, 1990; Lang et al, 1991), it is
possible that the action of each tachykinin can potentiate the action of the other in
order to jointly mediate the responses to acute nociceptive stimuli. Therefore the
behavioural nociceptive thresholds to the tail-flick and paw-flick tests were
measured following an i.t. co-injection of the selective NKj and NK2 antagonists,
GR 82334 and L-659,874 respectively.
The results demonstrate that following the two highest doses of i.t. drug
combination used (0.3 and 3 nmol), there was a small but insignificant increase in
tail-flick latency at 1 minute post-i.t. injection. However, as the vehicle also
caused a similar increase in tail-flick latency at 1 minute post-i.t. injection, this
suggests that this was due to a vehicle-induced effect or to the stress of restraint
(Calcagnetti et al, 1990) and/or injection and had no connection with any
analgesic effect of the drugs. Surprisingly however, the lowest dose of the drug
combination used (0.1 nmol) produced an entirely different response, showing a
small but significant decrease in tail-flick latency at 1, 3 and 5 minute post-
intrathecal injection in comparison to the vehicle control. It is possible that some
distinct and still authentic drug effect is most apparent at lower doses if observed
by side effects at higher doses. However, again in this series of experiments the
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numbers of rats in each dose group was low and therefore before any conclusions
can be drawn this experiment should be repeated using a larger sample.
In contrast to the general lack of effect on the tail-flick response,
following i.t. combination of the NK4/NK2 antagonists GR 82334 and L-659,874,
there was a dose-related increase in dorsal paw-flick latency at each of the time-
points tested. The two higher doses of combination used (0.3 and 3 nmol)
significantly raised the paw-flick latency above that of the saline vehicle, the
highest dose causing a marked and significant augmentation. Although at the
lowest dose of antagonist combination used (0.1 nmol) this increase was
insignificant, it did follow the general trend of the two higher doses, suggesting a
short-lasting action of the low dose. These results demonstrate that although a
singular i.t. injection of either the selective NK4 or the NK/? antagonist used (GR
82334 and L-659,874) has no significant effect on the dorsal paw-flick, when they
are administered as a co-injection (at the same dose) there is a dose-dependent
increase in the paw-flick latency. A plausible explanation for these results is that
the highest singular dose of either NK4 or NK2 antagonist used was subliminal to
elicit any significant effect on the behavioural response to dorsal paw-flick,
however in combination a synergistic effect is produced, sufficient to produce a
significant attenuation of the behavioural response. Although we have not
investigated a possible synergy between NKj and NK2 receptors on acute
electrophysiological responses, in the model of sustained C fibre activity following
cutaneous mustard oil, one neuron was tested with a combination of both NK4
and NK2 antagonists. Whereas singularly, each antagonist only caused a small
inhibition of the mustard oil-induced firing, when ionophoresed in combination, a
marked and long-lasting inhibition of the sustained C-fibre activity was produced.
Although this model is not directly comparable with the behavioural paradigm of
dorsal paw-flick, it does demonstrate the capability of NK] and NK2 receptors to
act in synergy.
The apparent lack of conjoint involvement of NKi and NK2 co-injection
in the tail-flick response can conceivably be explained by the differences in the tail
skin-type compared to the hairy skin of the paw. The glabrous, thick skin on the
tail is likely to contain different proportions of fibre types (and therefore different
combinations of neuropeptides) compared to the thinner hairy skin of the foot
(Treede et al, 1992). This is emphasised by the lack of effect of the C-fibre
selectant algogen, mustard oil, which results in an increased background activity
only on the hairy and not the plantar (glabrous) skin of the hindpaw (see Chapters
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The carrageenan-induced inflammation model used here was modified
from a protocol characterised by others (Iadarola et al, 1988; Draisci and Iadarola,
1989). Rather than the intraplantar injection previously practised, inflammation
was induced in the dorsal (hairy) surface of the hindpaw with a single injection of
2% lambda (X) carrageenan. When inflammation had fully developed, both
glabrous and dorsal paw-flick responses were measured, although the latencies
were not statistically different from the pre-carrageenan controls, the general trend
was a decrease in glabrous as well as dorsal paw-flick latencies consistent with the
generation of a hyperalgesic state.
Despite the redness and swelling associated with the carrageenan-injected
limb, suggestive of development of inflammation which may result in a
hyperalgesic state, L-659,874 (at all 3 doses tested) was ineffective at producing
any significant changes in the glabrous paw-flick latency compared to control
DMSO values. Although this latter result was initially surprising, on close
consideration, it can be seen that even although a 4 hour period was allowed
following carrageenan injection, neither of the observed decreases in glabrous or
the dorsal paw-flick were significant compared to pre-carrageenan controls.
Therefore, if inflammation had not fully developed at the site of carrageenan
injection (on the hairy surface), it is very unlikely that the glabrous side of the paw
would be sensitised sufficiently to observe any changes in paw-flick compared to
the acute state. This experiment should be repeated with local injections of 2% X-
carrageenan to both the dorsal and the glabrous surfaces of the hindpaw, left for
longer periods for inflammation to develop.
In contrast, following carrageenan injection, intrathecal administration of
each of 3 doses of L-659,874 used, produced a marked and highly significant
increase in the dorsal paw-flick latency at all three time points investigated, even
at 5 minutes post-i.t. injection, the paw-flick latencies were still large and
significantly raised from the DMSO control. Although as previously mentioned,
the carrageenan-induced inflammation had not fully developed, there obviously
was a greater level of sensitisation compared to the glabrous skin accounting for
the marked response following i.t. L-659,874.
Although as yet there are no reports of the behavioural responses
mediated by NK2 receptors in sustained nociceptive states these results are in
agreement with electrophysiological models of sustained or chronic pain
associated with inflammation. Sustained activation of lamina IV/V neurons,
induced by repeated peripheral application of the selective C fibre afferent
stimulant, mustard oil (over 10-20 minutes) could be inhibited by ionophoretic
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induced by repeated peripheral application of the selective C fibre afferent
stimulant, mustard oil (over 10-20 minutes) could be inhibited by ionophoretic
application of L-659,874 around these neurons (see Chapter 4). The flexor reflex
facilitation evoked by damaging cutaneous thermal stimuli (80°C for 0.5 seconds)
was significantly potentiated by NKA (i.t.) (Xu and Wiesenfeld-Hallin, 1992).
Likewise, MEN 10207, a selective NK2 receptor antagonist, effectively blocked
the prolonged facilitation of the flexor reflex (lasting for up to 1 hour) that had
been induced by C-fibre strength conditioning stimulation of the gastrocnemius-
muscle nerve (Xu et al, 1991). All these experiments provide evidence that NK2
receptors are indeed important in more prolonged nociception.
Further, in this carrageenan model, there was generally no significant
effects in the glabrous paw-flick test (compared to the saline control) following i.t
administration of GR 82334. As the carrageenan-induced inflammation was not
fully developed (even on the dorsal surface of the paw) it is not surprising that
following i.t. injection of GR 82334, there was no change in glabrous paw-flick
latency compared to acute studies. However, only the highest dose of the selective
NKj antagonist GR 82334 (i.t.) used (3 nmol) produced a marked and highly
significant increase in the dorsal paw-flick latency at all three time points
investigated, which is surprising as previously we have demonstrated that in a
mustard oil-induced model of sensitisation, GR 82334 is highly potent at
antagonising the facilitated sensory responses to both noxious thermal and
innocuous stimuli (see Chapter 4) at relatively low ejection currents. Possible
explanations are firstly that SP-LI is not detectable in the C polymodal nociceptor
units found in the hairy skin (Lawson et al, 1994) but is found in A fibre high
threshold afferents (Lawson et al, 1994). In acute nociceptive testing therefore,
the involvement of SP may be minimal, depending on the properties and location
of the noxious stimulus. However following the hyperalgesia and sensitisation
produced by the inflammatory agent carrageenan, central sensitisation occurs
which causes activity-dependent alterations in dorsal horn neurons such that they
begin to respond in an abnormal or exaggerated way to A8 (and perhaps A [3) and
C afferent inputs (Woolf, 1991). SP is therefore likely to be released in such an
inflammatory state, however, as described earlier, the carrageenan-induced
inflammation had apparently not fully developed and therefore the release of SP
would be minimal and only at the highest dose of NKj antagonist administered
was there likely to be any effect.
In support of this reasoning, previous behavioural models of hyperalgesia
and inflammation have suggested a role for SP and NK, receptors in sensitised
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models of pain (Garret et al, 1991; Birch et al, 1992; Lembeck et al, 1992;
Nagahisa et al, 1992; Chapman and Dickenson, 1993; Yashpal et al, 1993) and
although spurious non-NKj receptor mediated effects may have been involved
with these compounds (Schmidt et al, 1992; Nagahisa et al, 1992; Chapman and
Dickenson, 1993; Rupniak et al, 1993), this suggests a role for NKj receptors in
these hyperalgesic models. In addition, hyperalgesic and inflammatory models
have been shown to increase the biosynthesis of SP-IR, PPT-1 mRNA and NKj
binding sites in the spinal dorsal horn and dorsal root ganglia of rats (Minami et
al, 1989; Donaldson et al, 1992; Noguchi et al, 1992; Schafer et al, 1993; Stucky
et al, 1993; McCarson and Krause, 1994) and increase the release of SP-IR into
the spinal cord (Go and Yaksh, 1987; Oku et al, 1987; Kuraishi et al, 1989;
Schaible et al, 1990; McCarson and Goldstein, 1991; Garry and Hargreaves,
1992).
These results highlight the importance of the tachykinins SP and NKA
(and their respective NKj and NK2 receptors) in the involvement of both acute
and sustained nociceptive transmission. As this was a relatively short (3 week)
project and the numbers of weanling rats available were limited, each dose group
was small, therefore to overcome any unnecessary variability, a larger study should
be completed. In addition, the inflammation produced 4 hours following
carrageenan injection was apparently not fully developed and this series of




This project has used a number of different techniques to investigate the
role of the tachykinin neuropeptides SP and NKA, their respective NKq and NK2
receptor subtypes and some intracellular mediators in both acute and sustained
nociceptive inputs to dorsal horn neurons. Electrophysiological extracellular
recordings from multireceptive laminae III-V dorsal horn neurons were combined
with ionophoresis of selective drugs to address the relative role of NK] and NK2
receptors firstly in brief nociceptive somatosensory prosessing in the dorsal horn,
in addition to the sustained neuronal activity induced by repeated cutaneous
application of the C-fibre selective chemical algogen mustard oil. As the
intracellular mechanisms involved in the sensitisation of spinal dorsal horn
neurons brought about by such sustained nociceptive inputs are unknown,
subsequent electrophysiological recordings and biochemical activation
experiments were carried out to assess whether protein kinase C (PKC) plays a
significant role in sustained neuronal activation by mustard oil and further to
examine sensitivity of the latter to NK2 receptor antagonists. Additional studies
were carried out using the characteristic expression of mustard oil-induced c-fos
mRNA within the superficial dorsal horn as a marker to further assess the possible
tachykinin involvement in this model of sustained C-fibre activity. Finally, the
effects of intrathecal injection of tachykinin antagonists were assessed on
behavioural paradigms of nociception before and after unilateral carrageenan-
induced inflammation.
The results presented here provided no clear evidence that NKq receptors
participate in transducing brief nociceptive inputs to the rat spinal cord in either
behavioural or electrophysiological models. In contrast, in the latter, when NKq
receptor antagonists were ionophoretically applied around the cell, they caused a
modest facilitation of their responses to innocuous brush, suggesting that their lack
of effect on nociceptive responses was not due to failure to reach relevant sites at
effective concentrations. These results are entirely in agreement with previous
studies using cats (Fleetwood-Walker et al, 1987, 1990). However other in vivo
electrophysiology studies have provided very mixed results following ionophoresis
of selective NKq agonists and antagonists. Some groups reporting excitation
(Henry, 1976; Randic and Miletic, 1977; Sastry, 1979; Zieglgansberger and
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Tulloch, 1979; Piercey et al, 1981; Kellstein et al, 1990; Hill et al, 1985; Salter
and Henry, 1991) but others reporting complex mixed excitatory and inhibitory
effects (Davies and Dray, 1980; Murase and Randic, 1984; Willcockson et al,
1984; Ryall and Pini, 1987) suggesting multiple sites or components of action.
Similarly, mixed reports have been obtained from behavioural studies, some
reports indicating that i.t. administration of selective NKj agonists and antagonists
results in dose-dependent nociceptive/ antinociceptive syndromes respectively
(Post and Folkers, 1985; Gamse and Saria, 1986; Sweeney and Sawynok, 1986;
Lecci et al, 1991; Picard et al, 1993; Yashpal et al, 1993), whereas others have
reported that SP plays no role in behavioural responses to nociception (Piercey et
al, 1981; Gamse and Saria, 1986; Garces et al, 1992; Rupniak et al, 1993).
Therefore it is apparent that although SP may play a minor role in transmission of
brief nociceptive responses, it is not likely to be the main transmitter involved. In
the sensitised/ inflamed state however, the actions of SP are clearly different.
The present results clearly demonstrate that following either prolonged
exposure to mustard oil or unilateral intraplantar injection of the inflammatory
agent carrageenan, NKj receptors played an important role in the transmission of
both nociceptive and non-nociceptive responses, in agreement with others who
found that NK] receptor antagonists failed to alter behavioural hyperalgesia
induced in normal rats, but were highly effective analgesic agents in a variety of
behavioural models of sustained/inflammatory pain (Garret et al, 1991; Yamamoto
and Yaksh, 1991; Murray et al, 1991; Birch et al, 1992; Chapman and Dickenson,
1993; Yashpal et al, 1993). Likewise, others found NKj receptors could not be
implicated in normal, baseline nociceptive processing, but were important in
sustained nociceptive states involving damage and central sensitisation
(Wiesenfeld-Hallin et al, 1990; Xu et al, 1992; Laird et al, 1993; Thompson et al,
1993). Similarly, although whilst SP was not released by noxious thermal stimuli
at non-damaging levels (Kuraishi et al, 1989), both increasing the temperature to
elicit chronic inflammatory damage and induction of experimental arthritis with
intra-articular algogens do result in release of SP into dorsal horn (Duggan et al,
1988; Schaible et al, 1990), further suggesting that SP and NK| receptors are
important following prolonged noxious stimulation. Inflammatory models of
formalin and CFA have been shown to increase to biosynthesis of SP-IR, PPT-1
mRNA, NK[ receptor mRNA and corresponding NKj binding sites suggesting
that biosynthesis of SP in the spinal cord and primary sensory neurons can be
increased by a sustained and inflammatory pain state. One possible mechanism
could be a decrease in the rapid degradation of SP which normally occurs in the
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spinal cord. Indeed, SP is normally released into a focal region of the superficial
dorsal horn (Duggan et al, 1987, 1988) but spreads in the presence of peptidase
inhibitors (Duggan et al, 1992). The endogenous neuropeptide CGRP has been
postulated to have attenuate SP degradation, like peptidase inhibitors (le Graves et
al, 1985), indeed CGRP co-localises with SP (Carr and Nagy, 1993; Levine et al,
1993) and its biosynthesis is upregulated during sustained nociceptive conditions
Weihe et al, 1988; Schaible et al, 1994). In addition, CGRP has been shown to be
co-released with SP during carrageenan-induced inflammation (Garry and
Hargreaves, 1992). However, it is not yet clear whether the role in sensitisation of
NK[ receptors that emerges after inflammation is simply due to extra production,
output and spread of SP to NK | sites some way from the release site or whether
the receptors have in addition modified cellular responses to further inputs.
The present results demonstrate that in each of the models used, NK2
receptors and possibly NKA are important mediators of both brief noxious thermal
responses in addition to mustard oil-induced or carrageenan-induced sustained
nociceptive activity. This is in agreement with a number of other studies which
have demonstrated a role for NKA (and NK2 receptors) in both acute and
sustained nociceptive states (Fleetwood-Walker et al, 1987, 1990; Cridland and
Henry, 1986; Xu et al, 1991; Urban et al, 1992; Xu and Wiesenfeld-Hallin, 1992;
Nagy et al, 1993; Laird et al, 1993; Picard et al, 1993; Thompson et al, 1993).
The differences obtained between the results for NKj and NK2 receptors
are at first sight are surprising as there is good evidence that the tachykinins SP
and NKA are synthesised together and co-exist in primary afferents (Dalsgaard et
al, 1985; Carter and Krause, 1990; Helke et al, 1990). However, it is evident that
SP and NKA have very different release (or degradation) patterns and roles in the
spinal cord, both noxious (but not damaging) thermal and mechanical stimuli
being effective stimuli to produce a diffuse and long-lasting release of NKA in the
spinal cord (Duggan et al, 1990; Hope et al, 1990). It may be possible that CGRP,
or another endogenous neuropeptide is tonically released in conjunction with
NKA to limit degredation.
There is also a strong body of evidence suggesting that tachykinins and
excitatory amino acids (EAAs) can act synergistically to facilitate nociceptive
processing. Neuropeptides and EAAs are found to be co-localised in the terminals
of C and some AS primary afferent fibres (De Biasi and Rustioni, 1988) therefore
upon release these transmitters could act either pre- or postsynaptically. Both
presynaptic and postsynaptic actions of neuropeptides on EAA transmission are
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likely, since SP, neurokinin A or CGRP have been found to enhance the release of
glutamate and aspartate from spinal cord dorsal horn (Kangraga and Randic,
1990), while others have found that both SP and NKA could modulate NMDA-
receptor activity in acutely isolated dorsal horn cells (Willcockson et al, 1984;
Dougherty and Willis, 1992; Rusin et al, 1992; Urban et al, 1994). In dorsal horn
cells, membrane currents elicited by NMDA and quisqualate were predominantly
enhanced by SP and NKA, whereas responses to kainate were unaffected by either
of the neurokinins (Urban et al, 1994). However, in experiments with whole
spinal cords, in the in vitro neonatal spinal cord with attatched tail preparation,
these results could be reproduced only with NKA (Urban et al, 1994). When SP
was replaced by the metabolically stable SPOMe or when SP was applied in
presence of endopeptidase inhibitors, both NMDA and quisqualate responses were
enhanced (Urban et al, 1994). The potent effect of antagonists of NKj and NK2
receptors in blocking the enhancement of NMDA responses reinforces the view
for a prominent role for NK receptors in the enhancement of NMDA-receptor
responses (Urban et al, 1994; Rusin et al, 1992).
SP and NMDA interact in an apparently synergistic manner to activate
dorsal horn neurons and facilitate their responses to non-noxious and noxious
mechanical stimuli (Dougherty and Willis, 1991; Rusin et al, 1992; Song and
Zhao, 1994), in potentiation of the nociceptive flexor reflex (Xu et al, 1992) and
in behavioural analgesia (Woolf and Thompson, 1991; Mjellem-Joly et al, 1992).
Conditioning by stimulation of C fibres or by application of SP facilitates NMDA-
and quisqualate-receptor activation (Rusin et al, 1992; Urban et al, 1994;
Dougherty and Willis, 1991) and the interaction can be blocked by various
selective and non-selective NK-receptor antagonists (Rusin et al, 1992; Urban et
al, 1994).
Therefore a selective synergy between NKj/NK2 and EAA receptors may
have an important role in hyperalgesia by maintaining spinal hyperexciteability
through the enhancement of NMDA receptor activity. It has been proposed that
this interaction between NK and EAA receptors involves protein kinase C
activation (Urban et al, 1994) as in both isolated cells (Rusin et al, 1992) and
whole spinal cord (Urban et al, 1994), it was found that staurosporine blocked the
interaction between the NK and EAA receptors but not the responses elicited by
the application of NMDA alone. As staurosporine is a non-selective inhibitor of
protein kinase C, other protein kinases may potentially also be involved, however,
in isolated dorsal horn cells phorbol-12,13-dibutyrate (PDBu), a selective PKC
activator, mimicked the effects of neurokinins on the NMDA-induced currents
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(Rusin et al, 1992), further strengthening the hypothesis. Indeed, NK] and NK2
receptors act through phosphoinositide hydrolysis, calcium mobilisation and
stimulation of PKC. The activated PKC phosphorylates cytosolic and membrane
proteins that might include the NMDA receptor and therefore offers a mechanism
of NMDA-related synaptic transmission (Gerber et al, 1989). A molecular
mechanism whereby PKC activation could promote the function of NMDA
receptor channels has been described, where receptor phosphorylation results in
diminished Mg^+ block and increased conductance at a given membrane potential
(Chen and Huang, 1992). Clearly neurokinin receptors could initiate such a
mechanism, perhaps underpinning the synergistic contribution they make with
NMDA receptors to dorsal horn sensitisation.
Although there is compelling evidence for synergism between NK]/NK2
receptors and for the NMDA receptor operating through PKC, other experiments
have shown that depolarisations of ventral roots, elicited by NKA, were
completely and reversibly blocked by staurosporine whereas SP responses were
unaffected (Urban et al, 1994). This suggests that other second messenger
systems may be more important than PKC in the NK ] receptor-, but not the NK2
receptor-enhancement of NMDA receptors. In this project, selective NK2
receptor antagonists prevented the mustard oil-induced PDBu translocation from
cytosolic to membrane sites, consistent with the possibility that in this model
(which results in hyperalgesia), NK2 receptors may be acting in a PKC-dependent
mechanism to promote NMDA receptor responsiveness. Other mechanisms are of
course possible, PKC and other post-transducers of nociception and sensitisation
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PI35 MUSTARD OIL-EVOKED ACTIVATION OF RAT DORSAL HORN NEURONS IS INHIBITED BY NK2 BUT NOT NKi
RECEPTOR ANTAGONISTS
F.E. Munro, S.M. Fleetwood-Walker, R.M.C. Parker & R. Mitchell1, Department of Preclinical Veterinary Sciences, Royal (Dick)
School of Veterinary Studies, Edinburgh EH9 1QH and 'MRC Brain Metabolism Unit. 1 George Square, Edinburgh EH8 9JZ
We have previously reported that the responses of dorsal horn neurons to brief noxious thermal (but not mechanical) cutaneous stimuli
are inhibited by NK-2 but not NK-1 receptor antagonists (Fleetwood-Walker et al, 1991). In the in vitro spinal cord/dorsal root
preparation, neuronal activity evoked by brief application of capsaicin to the dorsal root ganglia is also inhibited by a selective NK-2
antagonist (Urban et al, 1992). It is not clear, however, whether NK-1 and/or NK-2 receptors are important in the sustained activation
of dorsal hom neurons by prolonged noxious stimulation which results in altered sensitivity and receptive field properties of those
neurons (Woolf and King, 1990). Topical cutaneous application of the chemical irritant 3-isothiocyanato-prop-l-ene (mustard oil)
causes prolonged activation of C- (and briefly also A5-) afferents (Heapy et al, 1987) and brings about a state of increased
responsiveness in dorsal hom neurons (Woolf & King, 1990).
Extracellular recordings were made from laminae IV/V dorsal hom neurons in segments T12 - La of a-chloralose/urethane-
anaesthetised rats, as described previously (Fleetwood-Walker et al, 1991). Neuronal receptive fields were located using brief
innocuous and noxious stimuli and then mustard oil (5 - 20% in paraffin oil) was topically applied to a restricted area (usually about
3 cm2) within this region. Neuronal responses to this stimulus were recorded using the central barrel of a glass microelectrode, with
ionophoresis of drugs from the side barrels. The NK-1 antagonist L-668169 and the NK-2 antagonist L-659874 were prepared as
0.15 mM aqueous solutions with 0.3% dimethylformamide. pH 4.5 - 5.0 (Fleetwood-Walker et al, 1991). Ionophoresis of this vehicle
alone had no effect. The NK 1 antagonist GR 82334 (Hagan et al, 1991) was prepared as a 1 mM aqueous solution, pH 4.5 5.0.
In virtually all multireceptive neurons tested, mustard oil evoked a large and prolonged increase in activity with firing rates of
149 ± 36 fold of background (mean ± s.e. mean) being consistently maintained. In most cases, a steady elevated firing rate was
maintained for at least 30 min by repeated application of mustard oil to the same site. Drags were tested after the mustard oil-evoked
activity was stable and had been continuous for at least 1 - 2 min. In 19 out of 21 neurons tested with L-659874 (10- 80 nA), there
was a clear and maintained inhibition of mustard oil-evoked activity to 52 ± 6% of prior control (mean ± s.e. mean) with an onset
delay of 0 - 120 seconds. Recovery was readily observed after terminating ionophoresis of L-659874 in nearly all cases. In about half
of the cases, this inhibition began to decline after 159 ± 34 s (mean ± s.e. mean) even during continued ionophoresis. In contrast,
L-668169 and GR 82334 (20 - 80 nA) rarely inhibited mustard oil-evoked activity (in 1 out of 8 and 3 out of 9 cases respectively). In
14 cells tested with both NK-2 and NK-1 antagonist, there was only one example where both were effective.
These results provide further evidence for a role of NK-2 receptors in transducing nociceptive afferent inputs to dorsal horn neurons.
NK 2 receptors appear to be important not only in the acute responses of dorsal hom neurons to brief noxious thermal stimuli, but also
in their sustained activation by noxious chemical stimuli.
Fleetwood-Walker, S.M., Hope, P.J., Parker, R.M.C. & Mitchell, R. (1991) Br. J. Pharmacol. 104, 472P.
Hagan, R.M., Ireland, S.J., Bailey, F. McBride, G, Jordon, C.C. & Ward. P. (1991) Br. J. Pharmacol. 102, 168P.
Heapy, C.G., Jamieson, A. & Russell, N.J.W. (1987) Br. J. Pharmacol. 90, 164P.
Urban, L„ Maggi, C.A., Nagy, I. & Dray, A. (1992) Neuropeptides 22, 68.
Woolf, C.J. & King, A.E. (1990) J. Neurosci. 10, 2717-2726.
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Mustard Oil-evoked Activation of Rat Dorsal Horn
Neurons
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Abstract—Previous evidence indicated that brief nociceptive responses of neurons in laminae
IV/V of both rat and cat dorsal horn are more readily inhibited by antagonists at l\IK2 rather
than at NKi neurokinin receptors. Further support for a role of spinal NK2 receptors in nocicep¬
tion has been provided from experiments assessing modulation of the nociceptive flexor
reflex by tachykinins and activation of dorsal horn neurons by brief application of capsaicin to
afferents. The present experiments were designed to compare the contribution of NKi and
NK2 receptors in dorsal horn to the sustained neuronal activity induced by peripheral applica¬
tion of the chemical algogen mustard oil (reported to be a selective activator of C afferents).
In nearly all of the multireceptive laminae IV/V neurons tested, a selective NK2 receptor
antagonist L 659,874 inhibited previously established mustard oil-induced activity. In contrast,
two selective NKi receptor antagonists L 668,169 and GR 82334 were only rarely effective.
These results further underline the apparent importance of NK2 receptors in spinal nociceptive
processing. NK, receptors do not appear to play a major role in the present experimental pro¬
tocol, but they may of course do so under different circumstances.
Introduction
Processing of the precursor for Substance P (SP),
preprotachykinin-1 can lead to the generation of
neurokinin A (NKA) and related sequences which
demonstrate selectivity for the NK2 class of neu-
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rokinin receptor.1-4 In addition to SP, NKA is pre¬
sent in spinal dorsal horn, being largely associated
with fine afferents arriving through the dorsal
roots5-7 and being released into the dorsal horn by
noxious (but not damaging) cutaneous stimuli.8 The
vast majority ofNK2 receptors are present in periph¬
eral non-neural tissue, but recent evidence from radi¬
oligand binding studies and from specific probe
hybridisation to the NK2 receptor mRNA has
revealed very small but significant populations of
NK2 receptors in the CNS and in particular in the
spinal cord.9-11 In contrast, there is strong evidence
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for a major population ofNKi binding sites in super¬
ficial dorsal horn and for the presence ofmoderately
high levels ofNKi receptor mRNA in spinal cord.912
Both SP and NKA are released into superficial
dorsal horn by a regularly repeated noxious pinch
stimulus.13-14 However, whilst SP was not released
by noxious thermal stimuli at non-damaging lev¬
els,13 both increasing the temperature to elicit
chronic inflammatory damage and induction of
experimental arthritis with intra-articular algogens
do result in release of SP into dorsal horn.14-15 Indeed
it has been suggested that SP and NKi receptors may
not be important in brief nociceptive responses but
rather in their potentiation following prolonged nox¬
ious stimulation.16
Functional experiments in our laboratory have
shown that locally-administered NK2 but not NKi
receptor antagonists inhibited the responses of both
rat and cat dorsal horn neurons to briefnoxious ther¬
mal stimuli applied to their cutaneous receptive
field.17-20 Correspondingly, NK2 but not NKi recep¬
tor-selective agonists enhanced neuronal responses
to these noxious stimuli without altering either basal
or other stimulus-evoked activity. Although we
found no evidence in our experiments for a role of
dorsal hom NKi receptors and SP in mediating
responses to brief noxious, thermal, or indeed
mechanical, stimuli, many other groups have pro¬
vided data to strongly implicate some such role in
nociceptive processing.16-21-31
In view of the possibility that SP may play a more
important role in responses to such prolonged noci¬
ceptive inputs we have investigated here the
responses to the sustained activity in C-afferents
elicited by cutaneous application of the chemical
algogen mustard oil.32
Materials and methods
Experiments were carried out on 33 male Wistar rats
(250-340 g), anaesthetised with intravenous (i.v.)
a-chloralose (350 mg kg-1) and urethane (700 mg
kg-1), after induction with halothane. Supplementary
doses of a-chloralose were given as required. Core
temperature was maintained at 37-38°C with a ther¬
mostatically controlled heated blanket, and in the
majority of experiments carotid blood pressure was
monitored throughout the experiment. Oxygen
(0.1 1 min-1) was passed over the end of the tracheal
cannula to enrich the inspired air. The thoraco-lum-
bar spinal column was supported by three pairs of
clamps. A laminectomy (segments L1-L4) was then
carried out and agar injected under the most rostrally
clamped vertebra and then over the whole area of
the laminectomy. A core of agar was removed from
above the recording region, the dura carefully cut
and a pool of liquid paraffin applied to the region.
Electrophysiological methods and ionophoresis
Extracellular recordings were made via the central
barrel (4 M NaCl, pH 4.0^1.5) of a 7-barrelled glass
microelectrode. Electrode tip sizes were 4.0-4.5 pm
and DC resistances were 5-8 MQ. The band-width
of the recording amplifier was 1 Hz-7kHz. One side
barrel contained 1M NaCl (pH 4.0—4.5) for auto¬
matic current balancing and current controls
(Neurophore Ionophoresis System, Medical
Systems Corporation). Another side barrel con¬
tained Pontamine Sky Blue dye (2% in 0.5 M sodium
acetate for marking recording sites by ejection at 10
pA for 10 min). (The laminar locations of recorded
neurons were assessed from Pontamine Sky Blue
spots on 15 pm cryostat sections lightly stained with
eosin). The other barrels of the electrode contained
neurokinin receptor antagonists, vehicle, or 0.1 M
d,l-homocysteic acid (pH 8 in H20) for direct test¬
ing of neuronal excitability. The antagonists L
659,874 and L 668,16933-34 were obtained from
Cambridge Research Biochemicals and prepared as
0.15 mM solutions in 0.3% dimethylformamide in
water (diluted from concentrated stocks in dimethyl¬
formamide). GR 8233435 was prepared as a 1 mM
solution in water. All peptide solutions were either
prepared shortly before use or stored at -20°C in
aliquots. The pH of the antagonist solutions was
adjusted to pH 4.5 and all were ejected using catho¬
dal currents. Retaining currents of— 10 nA were used
to minimise drag leakage between tests. Action
potentials of the recorded cells were clearly dis¬
criminated from other field potentials throughout the
test (Fig. 1). Neuronal firing was recorded on FM
tape (Racal) and firing rates were plotted on-line by
computer (IBM PS/2—70-121) together with mark¬
ers for ionophoresis.
All the neurons recorded were located in dorsal
horn laminae IV/V, had excitatory receptive fields
on the ipsilateral hind limb (excluding glabrous skin)





Fig. 1 Typical example of original oscilloscope records show¬
ing increased firing of the neuron in response to mustard oil and
its inhibition by the NK-2 antagonist L 659,874. Trace A shows
background spontaneous activity of this (multireceptive) neuron
prior to testing. B shows activity 5 min after topical application
of 7% mustard oil to the extent of the brush receptive field of the
cell. In this example, mustard oil-evoked activity was sustained
at this elevated level for a prolonged period without re-applica-
tion. C shows activity 2 min after ionophoresis of L659,874 was
initiated, 18 min following the application ofmustard oil. D shows
recovery, 10 min after L 659,874 ionophoresis was terminated at
the end of test C.
and were multireceptive (i.e. displayed responses to
both noxious and innocuous stimuli). Neurons were
initially found by their responsiveness to widespread
manual brushing of the ipsilateral hindlimb.
Cutaneous fields of the neurons were first localised
by responses to manual brush, then the more
restricted pinch and noxious heat receptive fields
were identified. Interestingly, six neurons which
failed to show a response to noxious heat, gave no
overt response to mustard oil, whereas in virtually
all (> 95%) of other cases there was concurrent
responsiveness to both of these stimuli. The mus¬
tard oil (5-20% in paraffin oil) was applied topically
within the brush receptive field of neurons, with the
intention of covering this firing field (usually about
3 cm2). Thus, the mustard oil application encom¬
passed the noxious heat/pinch receptive fields which
were a sub-set of the brush field.
Experiments were routinely carried out with a
range ofionophoretic currents ofthe antagonists, the
aim being to increase currents stepwise until clear
effects were seen. Drugs were usually ejected for
1-2 min periods in order to assess any maintained
inhibition if present. When currents displaying a
clear inhibition for at least 30 s were reached,
ionophoresis was stopped to look for recovery.
Ejection of apparently inactive compounds was car¬
ried out at ionophoretic currents equal to or greater
than those for active inhibitor. In 17 cells, both NKi
and NKj antagonists were tested, with the former
being first in 12 cases and the latter being first in the
remainder. The chosen order ofapplication appeared
to have no effect on the results. Mustard oil (3-isoth-
iocyanato-prop-l-ene) was obtained from Aldrich
Chemical Company.
Results
The present results were obtained from 35 neurons
located in dorsal horn laminae IV/V. After applica¬
tion ofmustard oil (5-20% in paraffin oil), virtually
all the multireceptive neurons tested (34/35) had a
large and prolonged increase in activity with firing
rates of 138 + 33-fold ofbackground (mean ± SEM)
being consistently maintained in the majority of
cases (28 cells) for at least 28 min. Some cells had
an immediate increase in activity after one applica¬
tion of mustard oil which remained sustained for
more than 7 min (Figs 1, 2B & 3A). However, in
most cases (n = 22), the steady elevated firing rate
was achieved by repeated application ofmustard oil
3-5 times to the same site over a period of 10-15
min. This apparently different sensitivity to mustard
oil had no obvious effects on the pharmacological
results obtained.
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Fig. 2 Typical inhibitory effects of the NK-2 antagonist L 659,874 on mustard oil-evoked activity of laminae IV/V dorsal horn
neurons. The records display raw firing frequency of the neuron (as spikes per sec; R/S) and its activation by either a single appli¬
cation (Fig. IB) or 3 consecutive prior applications (Fig. 1A) of mustard oil. In (A) ionophoretic application of NaCl had no effect,
whereas L 659,874 promptly caused greater than 50% inhibition of evoked activity. After terminating ionophoresis of L 659,874
rapid recovery was observed and the cell readily responded to a presumed direct excitatory stimulus d, I-homocysteic acid (DLF1).
In (B) mustard oil-evoked activity was progressively inhibited (and the inhibition maintained for longer periods) by ionophoresis of
L 659,874 at increasing currents.
200-fold and 250-fold selectivity for NK2 over NKi
and NK3 sites respectively.33 Its even more potent and
selective cyclic congener L 659,87734 was also inves-
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Fig. 3 Typical examples of the generally-observed lack of effect ofNKi antagonists on the mustard oil-evoked activity of laminae
IV/V dorsal hom neurons. The large increases in firing frequency elicited by mustard oil were unaffected by the NKi antagonists L
668,169 (A) and GR 82334 (B) applied after the mustard oil-induced activity had reached a steady state. In each case, the NK; antag¬
onist L 659,874 caused inhibition. This effect was transient in example (A) and more long-lasting in (B), although in the latter exam¬
ple greater recovery was seen after a further delay of 3 min (not shown).
L659 L 659 L 659 L659 L.659
10nA 20nA 30nA 40nA 40nA
tive for NKi and NK2 receptors were tested by
ionophoresis close to the recorded cells. L 659,874
was described by McKnight et al33 to show more than
I M Oil 10% L668 20nA
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Fig. 4 Examples of the occasionally-observed inhibitory effect
of NKi antagonists on mustard oil-evoked activity of laminae
IV/V dorsal horn neurons. A clear-cut inhibition of mustard oil-
evoked firing was seen in 3 out of 11 cases with GR 82334 as in
example (A). Delayed recovery was observed. In only one exam¬
ple, (B), was there any evidence for inhibitory effects ofL 668,169
and even there the inhibition was not closely matched to the time
of drug application.
tigated but could not be tested due to its low solu¬
bility in acceptable vehicles. Drugs were tested after
mustard oil-evoked activity was stable and had been
continuous for at least 1-2 min. In 23 out of 24 cells
tested with the NK2 antagonist L 659,874 (10-80 nA)
there was a clear and relatively maintained inhibition
of mustard oil-evoked activity (Figs 1 & 2) to 50 ±
7% (mean ± SEM) of prior control activity (each
averaged over three 10-second periods). Inhibition
began after an onset delay of 0-120 s (mean = 38 ±
9 s, n = 23). In 19 cases where currents of > 40 nA
were tested, clear inhibition was always apparent
within 30 s. Recovery was observed in 13 out of 17
cases examined after terminating ionophoresis of L
659,874 (Fig. 2A) and in about halfof these cases (n
= 6), inhibition was maintained at its maximal level
for no more than 30-60 s (mean = 48 ± 6 s) even in
the continued presence ofL 659,874 (Figs 2B & 3 A).
Increasing the ejection currents however, produced
a more marked inhibition in 15 out of 19 neurons
tested, with a typical example showing 17, 33 and
85% inhibition at 20, 30 and 40 nA respectively (see
also Fig. 2B). The inhibition was also longer lasting
at higher ionophoretic currents and in all cells tested
with > 40 nA L 659,874 (n = 17) the effect was fully
maintained throughout the ejection period. In 4
examples no recovery was observed, but throughout
this period the cells were still able to generate vig¬
orous responses to manual brush stimuli. Neither cur¬
rent controls (from the NaCl barrel) nor vehicle
controls at equivalent ionophoretic currents had any
discernible effect on mustard oil-evoked activity (n
= 3 in each case).
In contrast, two NKi selective antagonists L
668,169 and GR 82334 (20-80 nA) rarely inhibited
mustard oil-evoked activity (in 1 out of 11 and 3 out
of 11 cases respectively). L 668,169 is reported to
show 80-fold and 25-fold selectivity for NKi over
NK.2 and NK3 receptors respectively33 and equiva¬
lent values for GR 82334 are greater than 170-fold
in each case.35 In 17 cells tested with both NKi and
NK.2 antagonist, there was only one example where
both were clearly effective. The mustard oil-evoked
activity in many cells (n = 15) was unaffected by
NKi antagonists but inhibited by the NK: antagonist
L 659,874 (Fig. 3). In a small number of examples
(n = 4) there was unequivocal inhibition of activity
by NKi antagonists (Fig. 4), although in the one
effective example with L 668,169, inhibition was
not certainly related to the time of administration of
the drug (Fig. 4B). In this example the cell was lost
while waiting for recovery.
Discussion
These results suggest that NK2, but not NKi recep¬
tors, play a crucial role in mediating the sustained
excitation of lamina IV/V dorsal horn neurons
elicited by cutaneous application of mustard oil. As
configured in these experiments, the mustard oil
stimulus represents a medium term prolonged acti¬
vation of nociceptive afferents. Evidence has been
presented that mustard oil elicits activation of
largely C-afferents32'36 although it is possible that
some A5 activation also occurs transiently.37 It is of
interest that stimulation of cutaneous nociceptors
with mustard oil has been described to lead to cen¬
tral sensitisation of dorsal horn neurons and expan¬
sion of their effective receptive fields.38 Those
experiments were designed slightly differently, in
that mustard oil was applied to regions close to but
outwith the overt firing zones. However, the neu¬
rons that exhibited mustard oil-evoked plasticity of
receptive fields or responsiveness were either caused
to fire or displayed increased spontaneous sub¬
threshold activity in response to mustard oil, sug-
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gesting that just as here, a C-fibre mediated input
was important in the responses being investigated.
Both brush and pinch receptive fields and/or neu¬
ronal responsiveness were reported to be increased
by mustard oil application.38 Although dorsal horn
NK2 rather than NKi receptors seem important in
mustard oil-evoked increases in spontaneous activ¬
ity here, it is not clear whether NKi receptors may
play a role in central sensitisation.
It is ofcourse also possible that the localised route
ofadministration ofdrugs here did not allow the NKi
antagonists to access their (perhaps slightly more
distant) sites of action. In tests of behavioural anal¬
gesia, certain peptide and non-peptide NKi antago¬
nists elevate response thresholds.23-26 SP is a potent
excitant of laminae IV/V nociceptive neurons27 and
on intrathecal administration SP produces behaviour
suggestive of noxious irritation.28 Pinch rather than
noxious heat stimuli release SP into dorsal horn1314
and SP-like immunoreactivity has been observed in
identified A 5 as well as C afferents;29 consistent with
the possibility that a somewhat different subset of
nociceptive afferents is involved in pinch-evoked SP
release from those in the heat- and mustard oil-
evoked neuronal activity we have observed to be
sensitive to NK2 antagonists. Nevertheless, neither
brief neuronal responses to pinch17-20 nor nocicep¬
tive flexor reflexes22 appear to be directly prevented
by NKi antagonists. Instead the facilitation of noci¬
ceptive flexor reflexes elicited by conditioning C-
fibre stimulation is inhibited by the antagonist
spantide II22 which shows a modest selectivity for
NKi over NK2 receptors.39 This is consistent with
evidence that SP (NK,) antagonists prevent the sec¬
ondary behavioural hyperalgesia following heat
injury30 and the late prolonged but not the briefepsps
induced in dorsal horn neurons by C-fibre activation
or noxious stimuli.16-31
In view of evidence for differences in the absolute
potency of certain NK, antagonists between species,
we tested GR 82334, which in contrast to L 668,169
(and indeed also spantide II) shows only slightly
reduced potency in the rat bladder compared to
guinea-pig and rabbit tissue bioassays.40-41
Nevertheless, the present results with a medium-term
prolonged chemical algogenic stimulus support pre¬
vious observations on responses to brief noxious
thermal stimuli17-20 in their marked sensitivity to NK,
rather than NK, receptor agents; thereby suggesting
that somewhat different inputs or circumstances are
involved here from those in experiments showing
NKi sensitivity. Consistent with this theme, the facil¬
itation of a nociceptive flexor reflex induced by
intrathecal administration of NKA or by condition¬
ing stimulation of gastrocnemius nerves at C-fibre
intensity42 and the excitation of dorsal horn neurons
evoked by application of capsaicin to the dorsal root
ganglia43 are all inhibited by selective NK2 receptor
antagonists. The detailed characteristics and precise
location of this NK2-like receptor in dorsal horn
remain to be ascertained.
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P82 The Role of NKi and NK: Receptors in
Nociceptive Inputs to Rat Dorsal Horn Lamina
I and Laminae IV/V Neurons
S. Fleetwood-Walker, R. Parker, F. Munro,
M. Young and R. Mitchell*
Royal (Dick) School of Veterinary Studies,
Summerhall, Edinburgh and *MRC Brain Metabolism
Unit, George Square, Edinburgh, UK
Single neurons of chloralose/urethane anaesthetised rats
were extracellularly-recorded and drugs applied by
ionophoresis.1 In lamina I, [Met-OMe"]SP (NKi agonist)
had no effect in 9/10 cells whereas NKA and GR 64349
(NK>) produced a marked but transient excitation in nearly
all cases. However, in laminae IV/V, [Ac-Arg6, Sar9,
Met(02n]SP6-n(NKi), NKA and GR 64349 were all effec¬
tive excitants. In experiments with antagonists on lami¬
nae IV/V neurons, L-659874 (NR>) selectively inhibited
brief thermal nociceptive responses in 9/9 cases but L-
668169 (NKi) had no effect in 7/9. Similar results were
obtained in models of sustained neuronal activation by
mustard oil2 or induction of preprodvnorphin mRNA by
intraplantar carrageenan.3 Our results suggest that NK; but
not NKi receptors may be important in nociceptive
responses of laminae I and IV/V neurons to brief thermal
and modest inflammatory stimuli. NKi receptors may be
more important in profound inflammatory conditions,
since in contrast to NKA, SP is released only by damag¬
ing levels of thermal stimuli.
1. Fleetwood-Walker, S. M., Hope, P. J., Parker, R. M. C. and
Mitchell, R. (1991). Effects of antagonists selective forNKi
and NK> receptors on somatosensory responses of rat dorsal
hom neurons. Br. J. Pharmacol. 104: 472P.
2. Munro, F. E., Fleetwood-Walker, S. M., Parker, R. M. C. and
Mitchell, R. Mustard oil-evoked activation of rat dorsal hom
neurons is inhibited by NK; but not NKi receptor antagonists.
Br. J. Pharmacol (in press).
3. Parker, R. M. C., Fleetwood-Walker. S. M., Rosie, R., Munro,
F. E. and Mitchell, R. Effects ofNK receptor antagonists on
carrageenan-induced expression of preprodynorphin mRNA
in rat dorsal hom lamina I neurons. Br. J. Pharmacol, (in press).
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EVIDENCE FOR THE INVOLVEMENT OF NK? RATHER THAN NKi RECEPTORS IN BOTH ACUTE AND
SUSTAINED NOCICEPTIVE INPUTS TO DORSAL HORN NEURONS
FLEETWOOD-WALKER, S„ PARKER, R„ MUNRO, F„ YOUNG, M. and MITCHELL, R.*
Department of Preclinical Veterinary Sciences, Royal Dick School of Veterinary Sciences, University of Edinburgh. Edinburgh EH9 1QH,
and *MRC Brain Metabolism Unit. University Department ofPharmacology, 1 George Square, Edinburgh EH8 9JZ, UK
Both substance P (SP) and neurokinin A (NKA) are present in fine somatosensory afferents and can be released into spinal dorsal hom by
noxious cutaneous stimuli. However, for thermal stimuli, detectable release of SP is not measured until skin temperatures reach levels
likely to cause inflammatory damage. Here we assessed the role of NK1/NK2 receptors in acute and sustained (inflammatory) nociceptive
inputs to dorsal hom neurons, using ionophoresis of NK receptor drugs. In acute experiments, the NK2 antagonist L-659874 but not L-
668169 (NKi) inhibited thermal nociceptive responses of extracellularly-recorded cells without modifying responses to pinch or brush.
Agonists for both NKi and NK? receptors activated laminae IV/V neurons however, suggesting that under some circumstances SP is likely
to play some role in nociception. Interestingly, only NK2 and not NKi agonists excited lamina I neurons. The sustained activity of laminae
IV/V neurons 'wound-up' by repeated application of mustard oil to the periphery (over 10-30 min) was inhibited by L-659874 but not L-
668169 or GR 82334 (NKi). Neuronal activation elicited by intraplantar carrageenan (6 h) was assessed by in situ hybridisation for
preprodynorphin (PPD) mRNA. The increased expression of PPD mRNA in superficial dorsal hom neurons was inhibited by L-659874 but
not L-668169 or GR 82334. It is clear that NK2 receptors are important in acute thermal nociception and in sustained inflammatory
nociception of moderate intensity. It is not clear whether NKi receptors may be of greater importance in more profound inflammatory
states.
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'RECEPTOR AND CELLULAR MECHANISMS
INVOLVED IN MUSTARD OIL-INDUCED ACTIVA¬
TION OF DORSAL HORN NEURONS. F. Munro. M.
Young, S. Fleetwood-Walker, R. Parker and R.
Mitchell Dept of Preclinical Veterinary Sciences, Royal
(Dick) School of Veterinary Studies, Summerhall,
Edinburgh EH9 1QH and MRC Brain Metabolism Unit,
1 George Square, Edinburgh EH8 9JZ.
Aim of Investigation: The C-fibre-selective chemical
irritant mustard oil produces sustained activity of dorsal
horn neurons upon repeated peripheral application and
long-lasting changes in receptive fields and responsive¬
ness. We addressed the possible role of NKj, NK, and
metabotropic excitatory amino acid receptors and'of
protein kinase C (PKC) in responses to mustard oil.
Methods: Mustard oil was applied to restricted distal
areas of one hindlimb of rats. In some experiments tissue
was taken for biochemical assay of the
translocation/activation of PKC assessed by movement of
[3Hlphorbol dibutyrate Q3H]PDBu) binding sites from
cytosolic to membrane fractions. Extracellular recordings
of single dorsal hom neurons were made in anaesthetised
rats and drugs applied by ionophoresis.
Results: Selective antagonists for NK., and metabo¬
tropic receptors, L-659874 and 1-AP3 reliably inhibited
neuronal activity 'wound-up' by repeated application of
mustard oil (in 19/21 and 6/9 cases respectively). The
NK antagonists, L-668169 and GR 82334 had no effect
in 13/17 cases. The selective PKC inhibitors cheleryth-
rine and GF 109203X caused marked, yet recoverable,
inhibition of activity in 8/9 and 8/8 cases respectively. In
corresponding spinal segments, significantly greater
proportions of [ HJPDBu binding sites were associated
with the membrane fraction on the side ipsilateral to
mustard oil application.
Conclusion: Both NK? and metabotropic receptors
appear to play a role in the sustained activation of dorsal
horn neurons elicited by mustard oil. There is good
evidence that PKC is a crucial mediator of this cellular
activation. NK receptors appear to be of less importance





EVIDENCE FOR A ROLE OF NK, RECEPTORS IN
MEDIATING ACUTE AND SUSTAINED NOCICEP¬
TIVE INPUTS TO DORSAL HORN NEURONS. S,
Fleetwood-Walker. R. Parker, F. Munro, M. Young and
R. Mitchell* (SPON: A. Iggo), Dept. of Preclinical
Veterinary Sciences, Royal (Dick) School of Veterinary
Studies, Summerhall, Edinburgh EH9 1QH and MRC
Brain Metabolism Unit, 1 George Square, Edinburgh
EH8 9JZ.
Aim of Investigation: In view of reports that tachy¬
kinins with selectivity for NK( and NK, receptors (sub¬
stance P and neurokinin A respectively} are contained in
fine somatosensory afferents and can be released upon
noxious stimulation, we assessed the role of these recep¬
tors in nociceptive processing.
Methods: The activation of single dorsal horn neu¬
rons during cutaneous stimulation was investigated in
two models (i) acute natural stimuli to the peripheral
receptive field (over 10-30 s) and (ii) peripheral inflam¬
mation induced by intraplantar injection of carrageenan
(over 6 h). Experiments were carried out in anaesthetised
rats. Neuronal responses were measured in model (i) by
extracellular electrical recording and in model (ii) by in
situ hybridisation histochemistry for preprodynorphin
(PPD) mRNA. Antagonists selective for NK( or NK.,
receptors were delivered by ionophoresis into the spfnal
dorsal horn.
Results: Acute sensory responses to noxious heat but
not innocuous brush or noxious pinch were inhibited by
the NK2 antagonist L-659874 (9/9 cells) but not by L-
668169 (NKjj no effect in 7/9 cells), confirming earlier
work in cats. In 3 out of 3 animals with bilateral carra¬
geenan inflammation, unilateral L-659874 inhibited the
increased expression of PPD mRNA in ipsilateral super¬
ficial dorsal horn whereas L-668169 or GR 82334 were
ineffective.
Conclusion: These results indicate that dorsal horn
NK2 receptors play a more important role than NK] in
the present models of acute and sustained nociception.
However, since laminae IV/V (although not lamina I)
cells are excited by NK! as well as NK2 agonists it seems
likely that NKt receptors do play some role in nocicep¬
tive processing, perhaps under circumstances of more
profound inflammation than assessed here.
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Evidence for a role of tachykinin NK2 receptors in mediating brief
nociceptive inputs to rat dorsal horn (laminae III-V) neurons
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Since the NK2 receptor-selective tachykinin, neurokinin A is present in fine primary afferent neurons in addition to the NK,
receptor-selective tachykinin, substance P, we have addressed the relative role of NK, and NK2 receptors in somatosensory
processing in spinal dorsal horn. Recording extracellularly from rat laminae III-V neurons whilst ionophoresing drugs nearby,
the selective NK, receptor antagonists L 688,169, GR 82334 and [D-Pro4,D-Trp7'9"'Phen]substance P-(4—11) failed to influence
neuronal responses to cutaneous pinch or noxious heat but often enhanced responses to innocuous brush. In contrast, the highly
selective NK2 receptor antagonist L 659,874 profoundly inhibited responses to noxious heat but not pinch or brush. Highly
selective synthetic agonists for both NK, and NK2 receptors ([N-acetyl-Arg'',Sar9,Met(02)"]substance P-(6—11) and GR 64349,
respectively) and also NKA showed the inverse effects on sensory responses to those brought about by their antagonists. At
higher ionophoretic currents, both NK, and NK2 receptor agonists increased spontaneous activity. This increased basal firing
induced by GR 64349 and neurokinin A (but not that due to [N-acetyl-Arg6,Sar9,Met(02)"]substance P-(6—11) appeared to
partially pre-empt further excitatory responses to noxious heat. It is concluded that although both NK, and NK2 receptors can
clearly mediate excitation of dorsal horn neurons, it is not NK,, but rather NK2 receptors that are important as the physiological
transducer of brief thermal nociceptive inputs in this model.
Tachykinins; Neurokinins; Pain; Analgesia; Spinal cord
1. Introduction
The tachykinins substance P and neurokinin A
(which display selectivity for NK, and NK2 receptors
respectively) are both present in fine somatosensory
afferents (Hokfelt et al., 1975; Sundler et al., 1985) and
for some time substance P has been a candidate trans¬
mitter of nociception (Henry, 1976). There is consider¬
able evidence from electrophysiological, behavioural,
biochemical and transmitter release experiments that
substance P is involved in nociception (see Fleetwood-
Walker and Mitchell, 1989, for review). Nevertheless,
the crucial experiments with antagonists have provided
mixed results. Early substance P antagonists [D-
Pro2,D-Trp7'9]substance P and [D-Pro2,D-Phe7,D-
Trp9]substance P failed to reliably reverse the excita-
Correspondence to: S.M. Fleetwood-Walker, Department of Preclin¬
ical Veterinary Sciences, Royal (Dick) School of Veterinary Studies,
University of Edinburgh, Summerhall, Edinburgh EH9 1QH, UK.
Tel. 031 650 6091, fax 031 650 6576.
tory effects of substance P on trigeminal neurons (Hill
et ah, 1985) and [D-Arg'.D-Trp^Leu'^substance P
(spantide) failed to antagonise the substance P facilita¬
tion of the nociceptive flexor reflex in vivo (Wiesen-
feld-Hallin and Duranti, 1987) and only inhibited noci¬
ceptive reflexes in vitro at rather high concentrations
(Otsuka and Yanagisawa, 1988; Brugger et ah, 1990).
However, recent NK, receptor antagonists spantide II
[D-NicLys1,3-Pal3,D-Cl2Phe5,Asn6,D-Trp7'9,Nle11]sub-
stance P (Maggi et ah, 1991b) and CP 96,345 (Snider et
ah, 1991) have been described to block the facilitation
of the flexor reflex and the excitation of dorsal horn
neurons brought about by electrical stimulation of af¬
ferents at C-fibre intensity (Wiesenfeld-Hallin et ah,
1990; De Koninck and Henry, 1991). In behavioural
reflex experiments only certain of the early substance P
antagonists effective elsewhere on smooth muscle
preparations, elevated response thresholds to nocicep¬
tive stimuli (Post and Folkers, 1985; Piercey et ah,
1986), although several newer NK, receptor antago¬
nists were effective in models of inflammatory pain
(Yamamoto and Yaksh, 1991; Murray et ah, 1991;
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Garret et al., 1991; Birch et al., 1992; Boyce et al.,
1992).
Little has been done to address any possible role of
NK2 receptors in dorsal horn, but ionophoretic admin¬
istration of two early NK2 receptor antagonists [D-
Pro4,Lys6,D-Trp7'9,10,Phe11]substance P-(4—11) and [D-
Tyr4,D-Trp7'9,Nleu]substance P-(4—11) (Regoli et al.,
1985) but not an NK, receptor antagonist, spantide,
into the substantia gelatinosa, specifically inhibited the
responses of cat dorsal horn neurons to noxious ther¬
mal, but not other, cutaneous stimuli (Fleetwood-
Walker et al., 1990).
Whilst several reports have described direct excita¬
tory effects of substance P on dorsal horn neurons
(Henry, 1976; Murase et al., 1989; Urban and Dray,
1992), not only the selective NK, receptor agonist
[Met-OMe"]substance P (Fleetwood-Walker et al.,
1990) but also the NK2 receptor agonist neurokinin A
(Salter and Henry, 1991) have been reported to excite
dorsal horn lamina IV/V neurons when ionophoreti-
cally ejected nearby.
The present experiments were carried out with a
range of recently developed agonists and antagonists
which are highly selective for NK, and NK2 receptors
in order to further address their relative contribution
to mediating spinal nociceptive transmission.
2. Materials and methods
2.1. General
Experiments were carried out, broadly as described
previously (Fleetwood-Walker et al., 1991), on male
rats (270-350 g), anaesthetised with intravenous a-
chloralose (60 mg kg-1) and urethane (1.2 mg kg-1),
after induction with halothane. Supplementary doses
of a-chloralose were given as required. Core tempera¬
ture was maintained at 37-38°C with a thermostatically
controlled heated blanket, and in the majority of exper¬
iments carotid blood pressure was monitored through¬
out the experiment. Oxygen (0.1 1 min-1) was passed
over the end of the tracheal cannula to enrich the
inspired air. The thoraco-lumbar spinal column was
supported by three pairs of clamps. A laminectomy
(segments L1-L4) was then carried out and agar in¬
jected under the most rostral clamped vertebra and
then over the whole area of the laminectomy. A core of
agar was removed from above the recording region, the
dura carefully cut and a pool of liquid paraffin applied
to the region.
2.2. Electrophysiological methods and ionophoresis
Extracellular recordings were made via the central
barrel (4 M NaCl, pH 4.0-4.5) of a 7-barrelled glass
microelectrode. Electrode tip sizes were 4.0-4.5 /im
and DC resistances were 5-8 M/2. The band-width of
the recording amplifier was 1 Hz-7 kHz. One side
barrel contained 1 M NaCl (pH 4.0-4.5) for automatic
current balancing and current controls (Neurophore
Ionophoresis System, Medical Systems Corporation).
Another side barrel contained Pontamine Sky Blue dye
(2% in 0.5 M sodium acetate for marking recording
sites by ejection for 100 pA min). The locations of
recording sites in laminae III-V verified histologically
in 15 pm cryostat sections lightly counterstained with
neutral red. Other barrels contained the following neu¬
rokinin receptor agonists and antagonists: neurokinin
A; L 659,874 (acetyl-Leu,Met,Gln,Trp,Phe-NH2), L
668,169 (cyclo(Gln,D-Trp,Me-Phe,(R)Gly[ANC-
2]Leu,Met)2), L 659,877 (cyclo(Gln,Trp,Phe,Gly,Leu,
Met)) (all from Cambridge Research Biochemicals);
[D-Pro4,D-Trp7,9'10,Phen]substance P-(4—11) (from
Bachem UK); GR 82334 ([D-Pro9[spiro-y-lactam]-
Leu10,Trp11]physalaemin-(l-ll) and GR 64349
([Lys3,Gly8-R-"y-lactam-Leu9]neurokinin-(3-10) (gifts
from Glaxo Group Research) and [N-acetyl-Arg6,Sar9,
Met(02)n]substance P-(6-ll) (a gift from Professor D.
Regoli). Solutions were either 1 mM in distilled water
(GR 82334, neurokinin A and GR 64349) or 0.1 mM in
0.3% dimethylformamide, diluted from concentrated
stocks in pure dimethylformamide (other compounds)
and were, adjusted to pH 4.5 with HC1. All peptide
solutions were either freshly made or stored at -20°C
in small (100 p\) aliquots which once thawed were not
refrozen, or used again. All drugs were applied with
cathodal currents. Retaining currents of —10 nA were
used to minimise drug leakage between tests. Action
potentials of the recorded cells were clearly discrimi¬
nated from other field potentials throughout the test.
Neuronal firing was recorded on FM tape (Racal) and
firing rates were plotted on-line by computer (IBM
PS/2-70-121) together with stimulator and ionophore¬
sis markers.
All the neurons recorded were selected as having
cutaneous excitatory receptive fields on the hairy skin
of the ipsilateral hind limb that were multireceptive
(i.e. mediated responses to both noxious and innocuous
stimuli). Receptive fields were initially located by brief
manual brush/pinch stimuli, prior to characterisation
with timed and quantified stimuli, including also nox¬
ious heat. Controlled stimuli were applied to adjacent
cutaneous areas within the receptive field on the dorsal
surface of the paw or the hind limb were regularly
repeated over 3-4 min cycles. The innocuous stimulus
used was a motorised, rotating brush. Noxious stimuli
were provided by a calibrated pinch (serrated forceps
with a graduated controlled displacement) or a thermo¬
couple-controlled radiant heat lamp (giving a skin sur¬
face temperature ramp of 30-48°C). Like the other
stimuli, the noxious heat stimulus was set routinely for
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10 s at 48°C, but in occasional examples for 15 s to
ensure a more robust response. Skin temperatures
never exceeded the 45°C definition of noxious levels
(Duggan et al., 1988) for longer than 1.5 s beyond the
10 or 15 s duration of the pre-set 48°C stimulus. The
marker bars in the figures indicate the period of skin
temperature in excess of 45°C. The cycle of stimuli was
repeated every 3 min, with the ejection of the drugs
initiated 1 min before the start of a cycle and continu¬
ing through that cycle. The different responses and
epochs of spontaneous activity prior to each cycle of
stimuli were integrated over 10-15 s periods as appro¬
priate and compared to pre-drug control values,
meaned from at least two consecutive tests. The stimu¬
lus-evoked responses were always submaximal and ap¬
proximately matched in terms of neuronal firing rates.
Duplicate or triplicate control responses were required
to vary by less than 15-20%.
3. Results
The present results were obtained from a total of 61
neurons which were all located in laminae III—V of the
dorsal horn. Peptide antagonists highly selective for
NK, and NK, receptors (L 668,169/GR 82334/[D-
Pro4,D-Trp7-91(lPhe,,]substance P-(4—11) and L
659,874, respectively; Regoli et al., 1987; McKnight et
al., 1988; Hagan et al., 1991) were tested by ionophore-
sis close to the recorded cells. The vehicle (0.3%
dimethylformamide in water) had no effect on 3 out of
3 neurons when ejected at up to 80 nA for 12 min. The
rather more potent cyclic analogue of L 659,874, L
659,877, could not be tested because of its low solubil¬
ity in acceptable vehicles.
Fig. 1 shows typical results (displayed as raw activity
records) obtained with the NK, receptor antagonist L
668,169 in 6 out of 8 neurons tested. There was little
effect of this antagonist on spontaneous activity or any
sensory-evoked response apart from a small but consis¬
tent enhancement of activity evoked by innocuous brush
(fig. 1, table 2). In the remaining 2 cells there were no
detectable changes. In 4 cells where recovery was as¬
sessed there was 50% (n = 1) and over 85% (n = 3)
reversal of the effect of L 668,169 on brush responses
by 4 and 9-24 min respectively, after cessation of
ionophoresis. Entirely similar results were obtained
with GR 82334 in 5 out of 6 cells, showing a small
increase in responses to brush, but no effect on those
to noxious heat (fig. 2, Table 2). In 2 neurons tested
with [D-Pro4,D-Trp7<U0,Phen]substance P-(4-ll) (30-
40 nA, 6 min) brush responses were increased by 33
and 41% with no consistent change in other activity.
Ionophoretic currents up to 50, 45 and 80 nA were
tested for L 668,169, GR 82334 and [D-Pro\D-



























Fig. 1. Ongoing firing frequency records showing typical effects of
the NK, receptor antagonist L 668,169 on somatosensory responses
of a laminae III—V neuron. A modest facilitation of responses to
innocuous brush was observed in 6 out of 8 neurons tested, with no
other consistent changes. Recovery from drug effects was not exam¬
ined closely, but in 3 out of 4 cells examined, responses to brush had
recovered to within +15% of control levels within 9-24 min after
stopping ionophoresis of the drug. The fourth cell showed approxi¬
mately 50% recovery within 4 min. The inset shows the position of
the cutaneous receptive field on the ipsilateral hind limb. The
duration of each of the stimuli is indicated, in the case of noxious
heat, this representing the period for which the skin temperature
exceeded the generally accepted noxious threshold of 45°C.
ther spike reduction or technical factors prevented
further study. The effects on sensory responses at these
currents were similar to those at lower currents, no¬
tably there still being no consistent inhibition of re-
ponses to noxious heat.
The NK2 receptor antagonist L 659,874 produced a
quite different result: a highly selective inhibition of
responses to noxious thermal stimuli without altering
responses to noxious pinch, innocuous brush or sponta¬
neous activity (fig. 3, table 2). This was seen in 8 out of
10 neurons tested at just 10 nA of L 659,874 (mean
49% inhibition), with no detectable effect in the others.
At a higher ejection current (20 nA) the selective
inhibition was seen in all cells tested (9 out of 9) and
was of a greater degree (mean 66% inhibition) (this
was particularly clear in 4 cases where both currents
were tested on the same cell). In 3 neurons where
recovery was investigated, the inhibition of heat re¬
sponses by L 659,874 had partially recovered (to 50-
85% of controls) within 6-15 min after cessation of
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TABLE 1
Time dependence of the effects of neurokinin receptor antagonists on thermal nociceptive responses.
All values represent evoked activity (corrected for background) and are shown as percentages of the mean stimulus-induced activity occurring
during the stimulus. Values are expressed as mean±S.E.M.
Noxious heat-induced increase in neuronal firing rate (% of control response during stimulus)
During stimulus 0-10 s after stimulus 10-20 s after stimulus
(a) L 668,169 (n = 6)
Control
Drug (20 nA for 6 min)
(b) GR 82334 (n = 5)
Control
Drug (32 ±4 nA for 6 min)
(c) L 659,874 (n = 9)
Control
Drug (20 nA for 6 min)



















ionophoresis. In the majority of cells tested here, re¬
sponses to noxious heat declined rapidly on cessation
of the stimulus (to less than 20% of the response
during the stimulus, within the subsequent 10 s). For
each of the drugs tested there were, however, examples
of relatively prolonged after discharges, retaining
around 50% of the peak activity during the first post-
stimulus period. There was no evidence that effects of
any of the drugs were greater (or in any way different)
in post-stimulus periods than during application of the
heat stimulus (table 1).
A number of NKj and NK2 receptor agonists were
also examined (table 2). The highly selective NK^ re¬
ceptor agonist [N-acetyl-Arg6,Sar9,Met(Oz)1 ']sub-
stance P-(6-ll) (Regoli et al., 1988) was tested either
on neuronal responses to cycled cutaneous stimuli ei¬
ther at low or higher ionophoretic currents. In 9 out of
13 cells [N-acetyl-Arg6,Sar9,Met(02)n [substance P-(6-
11) (when ejected at relatively low currents: mean
31 + 4 nA) caused an inhibition of the activity evoked
by innocuous brush with no apparent effect on sponta¬
neous activity or nociceptive responses. In 6 out of 6
cells, higher ejection currents (mean 57 + 5 nA) of
[N-acetyl-Arg6,Sar9,Met(02)n]substance P-(6—11) in¬
creased spontaneous activity, causing marked and sus¬
tained rises to around 5-fold of pre-drug controls.
Recovery was observed in all 5 cases examined within
5-10 min after terminating ionophoresis and the drug
effect was not replicated in current (NaCl) or vehicle
control tests.
TABLE 2
Summary of the effects of neurokinin receptor antagonists and agonists on laminae III—V neurons.
All values are calculated as a percentage of the mean pre-drug control value and are expressed as the mean±S.E.M. Responses were designated
as being essentially unchanged if they remained within 20% of the mean control value. Neurons in the population tested which were not
influenced in the characteristic predominant fashion illustrated, all showed no (or no consistent) changes in their responses. For the
subpopulations of neurons affected by the drugs, the statistical significance of changes was assessed by Wilcoxon test.
Drug and conditions Stimulus-evoked neuronal firing rate (% of mean pre-drug control)




L 668,169 (NKA 20 nA for 6 min 95+ 7 141 + 9 a 105 + 10 82+ 9 6 8
GR 82334 (NKj) 32 + 4 nA for 6 min 103 ± 8 131 + 8 a _ 91 + 11 5 6
L 659,874 (NK2) 10 nA for 6 min 93 ± 7 103 + 9 99+ 8 51+ 6 a 8 10
20 nA for 6 min 95 + 12 104 + 6 85 + 11 34+ 5 a 9 9
Agonists
[Ac-Arg6,Sar9, Met(02)u]-
substance P-(6—11) (NK |) 31 + 4 nA for 5 ± 1 min 121 + 13 52 + 5 a 98+ 5 92+ 6 9 13
57 + 5 nA for 6 + 2 min 536 + 88 a 67 + 9 a 91 + 14 106+11 6 6
Neurokinin A (NK2) 11 + 5 nA for 7+1 min 112+10 89 + 11 108 + 10 155+13 a 6 6
44 + 4 nA for 6 +1 min 354 + 61a 79 + 19 120 + 21 64+16 a 6 8
GR 64349 (NK2) 66 ± 6 nA for 7 + 1 min 398 + 54 a 111 + 13 88 + 20 75 ± 11a 5 5
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Fig. 2. Ongoing firing frequency records showing typical effects of
the NK, receptor antagonist GR 82334 on somatosensory responses
of a laminae III—"V neuron. Facilitation of responses to innocuous
brush (with no other consistent change) was observed in 5 out of 6
cells examined. The lower trace shows recovery 3 min after termina¬
tion of ionophoresis. Similar effects were observed in 3 further cells
where recovery was assessed. The inset shows the position of the
cutaneous receptive field on the ipsilateral hind limb.
tude of reduction in heat responses. In all other cases
this magnitude of reduction was greater (mean 3-9-
fold) than the actual increase in spontaneous activity.
Recovery was observed within 6-12 min after terminat¬
ing ionophoresis and none of the effects was repro¬
duced in current control tests. In 4 cells where [N-
acetyl-Arg6,Sar9,Met(02)n]substance P-(6—11) and
neurokinin A were each tested, clear excitatory re¬
sponses to both the NK, and NK2 receptor agonist
were seen.
Fig. 4 (representative of 3 out of 3 neurons) shows
the selective facilitation of thermal nociceptive re¬
sponses by a low current of neurokinin A and a reduc¬
tion in those facilitated responses when L 659,874 was
additionally applied. This is consistent with reversal of
the effect of exogenous neurokinin A by the selective
NK2 receptor antagonist but cannot be unequivocal,
since the antagonist alone had inhibitory effects on
thermal nociceptive responses (fig. 3). Analogous re¬
sults were obtained in 3 experiments when the effect of











The NK2 receptor agonists, neurokinin A and the
novel highly selective compound GR 64349 (Hagan et
al., 1991) also increased spontaneous activity of lami¬
nae III-V neurons in a consistent manner. Neurokinin
A (44 + 4 nA) and GR 64349 (66-6 nA) produced
marked and sustained excitation of spontaneous activ¬
ity in 6 out of 8 and 5 out of 5 cases respectively. When
neurokinin A was tested at low currents (mean 11+5
nA) which did not raise spontaneous activity in the
recorded neuron, there was a selective facilitation of
the responses to noxious thermal stimuli (in 6 out of 8
cells). Responses to innocuous brush and noxious pinch
were essentially unaltered. Although one cell showed a
30% increase in the noxious pinch response, this was
not reproduced in the other examples. At the higher
ionophoretic currents of neurokinin A and GR 64349
that increased spontaneous activity, noxious heat-
evoked responses were attenuated when corrected for
the elevated baseline. Other responses were essentially
unaltered. In 2 cases with neurokinin A, the increment














Fig. 3. Ongoing firing frequency records showing typical effects of
the NK2 receptor antagonist L 659,874 on somatosensory responses
of a laminae III—V neuron. A marked attentuation of responses to
noxious heat but not other stimuli or spontaneous activity was seen
in all 11 neurons tested at currents of 15-20 nA. Recovery from drug
effects was not examined closely, but in 3 out of 3 cells examined
there was recovery of the noxious heat response to within 50-85% of
control at 6-15 min after terminating ionophoresis of the drug. The
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Fig. 4. Ongoing firing frequency records showing typical effects of
the NK2 receptor agonist neurokinin A, in the absence or presence
of the NK2 receptor antagonist L 659,874 on the somatosensory
responses of a laminae III—V neuron. Neurokinin A caused a selec¬
tive facilitation of responses to thermal but not mechanical noxious
stimuli. Responses to innocuous brush (not shown here) were also
unaltered (see table 2). Results were typical of 6 neurons tested with
low currents of neurokinin A. After the middle trace had been
recorded, ionophoresis of L 659,874 was begun in addition to neu¬
rokinin A. A marked attenuation of the neurokinin A-amplified
response to noxious heat to below control levels was observed in all 3
cells so tested. The inset shows the position of the cutaneous
receptive field on the ipsilateral hind limb.
brush responses induced by low currents of [N-acetyl-
Arg6,Sar9,Met(02)u]substance P-(6—11). Effects of an¬
tagonists on the increases in spontaneous activity
brought about by high ejection currents of NK, and
NK2 receptor agonists were not investigated in the
present study.
4. Discussion
These experiments provided no clear evidence that
NK, receptors participate in transducing brief nocicep¬
tive inputs to laminae III-V neurons of rat spinal
dorsal horn under the present conditions. Since the
potency of some NK, receptor antagonists, including L
668,169, is reduced in rodent bioassays compared to
those in other species (Pattachini et al., 1992), we also
tested GR 82334 (which retains high potency at rat
NK, receptors; Beresford et al., 1992) and [D-Pro4,D-
jrp7,9,io phgHjsubstance P-(4-ll) (which is effectively
antinociceptive in the mouse formalin model; Murray
et al., 1991). The NK, receptor antagonists L 668,169,
GR 82334 and [D-Pro4,D-Trp7910Phen]substance P-
(4-11) had no significant effect on nociceptive re¬
sponses in any neurons tested, but in contrast caused a
modest facilitation of their responses to innocuous
brush in the majority of cells. This suggests that their
lack of effect on nociceptive responses was not due to
failure to reach relevant sites at effective concentra¬
tions. Conviction that this effect of L 668,169, GR
82334, and [D-Pro4,D-Trp7'9'10,Pheu]substance P-(4-
11) was due to NK, receptor antagonism is strength¬
ened by that being the common property of structurally
quite distinct compounds, by the low ionophoretic cur¬
rents required, by the observation that NK, receptor
agonists produce precisely the inverse effect (table 2)
and by the apparent reduction in the effect of [N-
acetyl-Arg6,Sar6,Met(02)H] substance P-(6-ll) in the
presence of GR 82334.
The simplest interpretation of the facilitation of
brush responses by NK, receptor antagonists seems to
be that NK, receptors are responsible for an attenuat¬
ing influence on non-nociceptive inputs to these cells
and that the antagonist is acting to reverse the action
of the endogenous NK, receptor agonist, substance P,
which has been released during the course of our
experimental procedure. The factors leading to sub¬
stance P release here are unclear (see below), but
substance P does not appear to be responsible for
acutely mediating the increased activity elicited by brief
thermal or mechanical noxious stimuli. It is of course
possible that the antagonists have unknown side effects
or that more complex interactions are occurring. The
NK, receptor agonist [N-acetyl-Arg6,Sar9,Met(02)H]
substance P-(6-ll) clearly increased the spontaneous
activity of laminae III-V neurons here (table 2), indi¬
cating that NK, receptors can exert a direct (or at least
a general modality-independent) influence on activity
of these cells. The data indicating that NK, receptor
activation can excite these cells, but seems not to
participate in nociceptive responses and instead atten¬
uates non-nociceptive tactile responses (in at least a
subpopulation of cells) are entirely consistent, in our
hands, between rat and cat. Somewhat in contrast to
the present results, Radhakrishnan and Henry (1991)
reported inhibition by CP-96,345 of the after-discharge
following brief noxious mechanical or thermal stimuli.
There was little effect on the initial phase of excitatory
responses to brief heat stimuli and inconsistent effects
on pinch-evoked excitation. It is possible that CP-96,345
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is effective only on late components of nociceptive
responses or that actions of this compound other than
on NK, receptors may be involved. Indeed, there is
new evidence that CP-96,345 is a potent antagonist of
'L'-type Ca2+ channels (Schmidt et al., 1992) and fur¬
thermore that such compounds are effective antinoci¬
ceptive agents (Miranda et al., 1992). Although both
peptide and non-peptide NK, receptor antagonists
have been reported to block the late prolonged but not
the brief excitatory postsynaptic potentials induced in
dorsal horn neurons by C-fibre activation or by noxious
stimuli (Urban and Randic, 1984; De Koninck and
Henry, 1991), in our experiments, there was no evi¬
dence that NK, receptor antagonists were any more
effective in the 20 s of afterdischarge following a nox¬
ious heat stimulus than they were during the response
itself (table 1).
In experiments designed to examine adequate stim¬
uli for the release of substance P into spinal cord, it
has been reported that noxious pinch, intraplantar
formalin, topical methylene chloride and flexion of a
kaolin/carrageenan-inflamed knee-joint were effective
(Duggan et al., 1988; Kuraishi et al., 1989; Schaible et
al., 1990). Thermal cutaneous stimuli, however, were
only effective at skin temperatures considered to result
in inflammatory cutaneous lesions (Duggan et al., 1988;
Kuraishi et al., 1989). In contrast, both noxious me¬
chanical stimuli and noxious thermal stimuli (at skin
temperatures below those producing inflammatory
damage) were effective in releasing neurokinin A
(Duggan et al., 1990). Behavioural reports have de¬
scribed inhibition by CP-96,345 of the second (in¬
flammation-supported) phase of the response to intra¬
plantar formalin (Yamamoto and Yaksh, 1991) and
inhibition by [Arg',D-Pro2,D-Phe7,D-His9]substance P
of the secondary contralateral hyperalgesia following
heat injury (Coderre and Melzack, 1991). Correspond¬
ingly, only the facilitation of nociceptive flexor reflex
by substance P or C-afferent conditioning stimuli (and
not the reflex itself) was inhibited by the NK, receptor
antagonist spantide II (Wiesenfeld-Hallin et al., 1990).
Thus, our evidence and the data from behavioural and
release experiments point towards the involvement of
substance P in mediating inflammation-supported noci¬
ception rather than responses to brief noxious stimuli.
In contrast to the results concerning NK, receptors,
the NK2 receptor antagonist L 659,874 caused a
marked and highly consistent inhibition of nociceptive
responses without affecting spontaneous activity or re¬
sponses to innocuous brush. Inhibition by the NK2
receptor antagonist showed a striking selectively for
thermal rather than mechanical nociceptive stimuli, a
result also noted in cat with the moderately selective
NK2 receptor antagonist [D-Pro4,Lys6,D-Trp7'9'10,
Phe"]substance P-(4—11) (Fleetwood-Walker et al.,
1990). The mechanistic basis for this is unclear, since
polymodal C-afferents are likely to contribute greatly
to both responses. Nevertheless, small dorsal root gan¬
glion cells are very heterogeneous in terms of their
neuropeptide content and there is evidence that ther¬
mal/mechanical noxious stimuli can differentially elicit
release of neuropeptides into spinal perfusates
(Kuraishi et al., 1989). Consistent with a role of an
NK2 receptor agonist such as neurokinin A in thermal,
but not mechanical nociception is its selective facilita¬
tion of thermal nociceptive responses (fig. 4, a result
also seen in cat with neurokinin A and other agonists
with NK2 receptor selectively (Fleetwood-Walker et
al., 1990). In the current experiments, both neurokinin
A and the highly selective NK2 receptor agonist GR
64349 further caused marked and consistent increases
in spontaneous activity of laminae III—V neurons, con¬
sistent with the idea that NK2 receptor activation is an
important element in the transduction of thermal noci¬
ceptive inputs. It is of course possible that co-factors
may also subserve an important role. Interestingly,
although both NK, and NK2 receptor agonists in¬
crease the spontaneous activity in laminae 111—V cells,
the situation is quite different in lamina I where only
NK2 but not NK, receptor agonists are effective
(Fleetwood-Walker et al., 1992).
There is increasing biochemical evidence that NK2
receptors (although generally at much lower abun¬
dance than NK, or NK3 receptor sites) are present in
the CNS and in particular in the dorsal horn of the
spinal cord (Yashpal et al., 1990; Poosch et al., 1991;
Takeda and Krause, 1991). Additionally functional
studies from other groups are now beginning to sup¬
port a role for NK2 receptors in spinal nociception. Xu
et al. (1991) described that the NK2 receptor antago¬
nist, [Tyr5,D-Trp6A9,Arg10]neurokini"n A-(4-10) (MEN
10207) selectively reversed the facilitation by neu¬
rokinin A (but not substance P) of the spinal nocicep¬
tive flexor reflex. Furthermore, a congener with further
reduced partial efficacy [Tyr5,D-Trp6'8'9,Lys1()]neuro-
kinin A-(4-10) (MEN 10376; Maggi et al., 1991a) inhib¬
ited the synaptic excitation of dorsal horn neurons
evoked by capsaicin administration to the dorsal root
ganglia (but not that evoked by an NK, receptor ago¬
nist) in a spinal cord slice with attached dorsal roots
(Urban et al., 1992).
The pharmacological properties of the small, but
functionally important population of NK2 receptors in
dorsal horn remain to be investigated in detail.
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Abstract
The intracellular mechanisms involved in the sensitisation of spinal dorsal horn neurons brought about by sustained or repeated
nociceptive inputs are unknown. The present experiments addressed any role of protein kinase (PKC) in sustained nociceptive
responses of rat dorsal horn neurons by: (i) ionophoretic administration of PKC inhibitors whilst recording activity evoked by
repeated cutaneous application of mustard oil; and (ii) assessing subcellular translocation of PKC evoked in spinal cord by cutaneous
application of mustard oil. Both marked attenuation of mustard oil-induced neuronal activity by PKC inhibitors and selective
translocation of PKC in spinal cord tissue ipsilateral to mustard oil application strongly supported a critical role of PKC in sustained
nociceptive responses to mustard oil.
Key words: Protein kinase C; Phorbol ester; Spinal cord; Dorsal horn; Nociception; Hyperalgesia
Sustained or repetitive activation of nociceptive affer-
ents brings about a state of hyperalgesia which is partly
due to a sensitisation of central neurons in the dorsal
horn of the spinal cord [20-22]. Peripheral administra¬
tion of the C fibre-selective chemical algogen, mustard
oil (3-isothiocyanato-prop-l-ene) [8,22] results in dorsal
horn neurons displaying receptive field expansion and
increased responsiveness to fixed stimuli [21]. We have
shown previously that repeated cutaneous application of
mustard oil (7-20%; 2-5 x 5 min intervals to the same
site) leads to an intense activation of dorsal horn neurons
which is then largely maintained over many tens of min¬
utes [13]. Both neurokinin-2 (NK2) and metabotropic
glutamate (mGlu) receptors appear to participate in me¬
diating such sustained mustard oil-evoked activity
[13,23],
The increased responsiveness and prolonged after-dis¬
charges induced by repetitive C afferent stimulation
('wind-up') or by intraplantar formalin can be reversed
""Corresponding author.
by Wmethyl-D-aspartate (NMDA) receptor antagonists
[4,7], The intracellular mechanisms by which neuroki¬
nins and excitatory amino acids might bring about sensi¬
tisation of dorsal horn neurons are not clear. Since both
NK2 receptors and some subtypes of mGlu receptors
appear to act largely through phosphoinositide hydroly¬
sis [2,16], the present experiments were carried out to
assess whether protein kinase C (PKC) plays a signifi¬
cant role in sustained neuronal activation by mustard oil.
Extracellular recordings were made from histologi-
cally-identified laminae IV/V neurons in segments LI -L4
of male Wistar rats (260-320 g), anaesthetised with intra¬
venous ct-chloralose (60 mg/kg) and urethane (1.2 g/kg)
as described previously [5,13]. Electrode side barrels con¬
tained selective PKC inhibitors (Novabiochem, Notting¬
ham, Notts, UK): chelerythrine [9] (1 mM, pH 4.5-5.0)
and GF 109203X [18] (0.2 mM in 0.2% dimethylforma-
mide (DMF), pH 4.5-5.0) for ionophoresis. Other bar¬
rels contained 1 M NaCl for automatic current balancing
or current controls, 0.2% DMF for vehicle controls and
2% Pontamine sky blue in 0.5 M sodium acetate for
marking recording sites. All of the neurons tested were
0304-3940/94/57.00 © 1994 Elsevier Science Ireland Ltd. All rights reserved
SSDI 0304-3940(94)00128-W






Fig. 1. Typical effects of protein kinase C (PKC) inhibitors, chelerythrine and GF 109203X on stimulus-evoked activation of multireceptive dorsal
horn neurons. Continuous records of firing frequency (responses/s; R/S, bin width 1000 ms) are plotted against time. Prior to testing, all neurons
examined showed a low spontaneous firing rate (<0.1 Hz). Activity was evoked in (a) and (b) by mustard oil (8.5%) applied to the receptive field
4x5 min intervals until a steady elevated firing rate was maintained or in (c) by motorised brush applied continuously to an equivalent receptive
field area without mustard oil treatment. Drugs were applied ionophoretically at the indicated currents (maintained until the subsequent marker)
and at all other times were subject to a retention current of - 10 nA. Results are typical of 8 out of 8 cells and 4 out of 5 cells tested with GF 109203X
(GF) in (a) and (c) respectively, and of 8 out of 9 cells tested with chelerythrine (Chel) in (b).
multireceptive (responding to brush, pinch and noxious
48°C heat) and had excitatory receptive fields on the
hairy skin of the distal ipsilateral hindlimb. After char¬
acterising the field manually, mustard oil (Aldrich
Chemical Co., Gillingham, Dorset) as a 7.5-10% solu¬
tion in paraffin oil was applied (2-5 x 5 rnin intervals) to
a restricted area (usually about 3 cm2) within this region
which had been shaved. In some experiments, responses
to innocuous stimulation by continuous brushing were
also examined.
Biochemical experiments were carried out to examine
the effect of mustard oil on the subcellular translocation
of [20-3H(N)]phorbol 12,13-dibutyrate ([3H]PDBu)
binding sites from cytosolic to membrane compartments,
which can be taken as an index of PKC activation in
response to stimulation of cell surface receptors [11].
Male Wistar rats were anaesthetised with halothane and
mustard oil (8% in paraffin oil) was applied 3x5 min
intervals to an extensive area of shaved skin distal from
the thigh on one hindlimb. The affected area was covered
and after a further 30 min, the animal was killed by
cervical fracture and spinal segments L2-L5 were care¬
fully removed and hemisected on the midline for analy¬
sis. Tissue was homogenised and centrifuged before spe¬
cific binding of [3H]PDBu was determined as described
previously [11].
PKC antagonists profoundly inhibited the mustard
oil-evoked activity of dorsal horn neurons; generally
within 1 minute of ionophoresis (Fig. 1). The inhibitory
effects were defined at the 10 s period of greatest inhibi¬
tion and were expressed as a percentage of control mus¬
tard oil-evoked activity in the 10 s period prior to drug
administration. In 8 out of 9 cells tested with GF
109203X (20-60 nA), marked inhibition by 58 ± 9%
(mean ± S.E.M.; range 34-99%) was seen. In 8 out of 8
cells tested with chelerythrine (10-80 nA) mustard oil-
evoked activity was similarly inhibited by 70 ± 10%
(mean ± S.E.M.; range 42-100%). In 4 out of 5 cells
where GF 109203X was tested on brush-evoked activity,
there was no discernible effect, with only a small inhibi¬
tion (< 15%) in the fifth cell. Chelerythrine was not exam¬
ined on brush-evoked activity. In all cases recovery oc¬
curred rapidly within 1 min of removing the inhibitor,
presumably indicating a requirement for ongoing PKC
































Fig. 2. The effect of unilateral mustard oil application to the skin of a
distal hindlimb on the subcellular distribution of [3H]phorbol 12,13-
dibutyrate ([3H]PDBu) binding sites in spinal cord. Specific binding of
['HjPDBu was determined in homogenates of hemisected spinal cord
(segments L2-L5). On the control side of spinal cord (contralateral to
mustard oil) this represented 12,000-15,000 dpm/assay (>85% specific)
in the cytosolic fraction and 4000-5000 dpm/assay (>75% specific) in
the membrane fraction. On the test side of spinal cord (ipsilateral to
mustard oil application), the absolute specific binding in the membrane
fraction was increased on average by 55 ± 15% (mean + S.E.M., n = 9)
and that in the cytosolic fraction fell by 50 ± 13%, such that the total
recovered specific binding was only slightly reduced (< 10%) from that
on the control side. The proportion of specific binding recovered in the
membrane fraction on the test side was significantly greater than the
corresponding value on the control side (P < 0.05, Mann-Whitney IJ-
test).
activity in mediating the mustard oil response rather
than a role for long-lasting phosphorylation events. In
3 out of 3 cells tested, ionophoresis of vehicle or NaCl
at up to 80 nA had no detectable effect on neuronal
responses to cutaneous stimuli.
In the biochemical experiments, tissue was successfully
obtained from 9 preparations and demonstrated a
marked translocation of [3H]PDBu binding sites from
cytosolic to membrane fractions on the side ipsilateral to
mustard oil compared to contralateral control (Fig. 2).
The present results show that cutaneous stimulation
with mustard oil leads to translocation/activation of
PKC in ipsilateral spinal cord and that the correspond¬
ing activation of ipsilateral dorsal horn neurons is con¬
sistently reversed by selective PKC inhibitors. Other
groups have provided evidence consistent with a role of
PKC in central sensitisation. In dorsal horn slices in
vitro, phorbol esters facilitated depolarising responses to
NMDA (in the presence of tetrodotoxin) and also in¬
creased the release of excitatory (and other) amino acids
evoked by dorsal root stimulation [6], The potentiation
of depolarising NMDA responses produced by neuroki¬
nins in isolated dorsal horn neurons is mimicked by the
PKC activator PDBu (but also by activators of other
kinases) and inhibited by the non-selective kinase inhibi¬
tor staurosporine [15]. The nociceptive behaviour in rats
following intraplantar injection of formalin was pro¬
moted by intrathecal administration of a phorbol ester
and reduced by a non-selective kinase inhibitor H7 [3],
In contrast, in neonatal rat spinal cord in vitro the facil¬
itation by neurokinin A of ventral root potentials evoked
by bath-applied NMDA was unaffected by stauro¬
sporine [19], Long-term increases in the levels of
[3H]PDBu binding sites have also been reported ipsi¬
lateral (and to a lesser extent also contralateral) to exper¬
imental constrictive neuropathy and to monoarthritis in¬
duced by Complete Freund's Adjuvant; consistent with
an involvement of PKC in long-term central changes
elicited by inflammation [12,17]. Interestingly the in¬
creased expression of preprodynorphin mRNA in ipsi¬
lateral superficial dorsal horn elicited by intraplantar
carrageenan (like mustard oil-induced activation here
[13]), is blocked by NK; receptor antagonists [14], again
consistent with a role of a signal resulting from phospho-
inositide hydrolysis such as PKC activation.
In conclusion, under the present circumstances at
least, PKC is strongly implicated as a crucial mediator
of the activation of dorsal horn neurons evoked by a
sustained nociceptive challenge. It is not yet clear
whether PKC activation results predominantly from
neurokinin, excitatory amino acid or other receptor
mechanisms. Although PKC activation is reported to
diminish voltage-sensitive Mg2+ block of the NMDA
channel [1] and may in some situations facilitate excita¬
tory amino acid release [6,10], the PKC-dependent mech¬
anisms underlying sustained activation here are un¬
known.
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Summary
Since not only substance P (SP) but also neurokinin A (NKA)
appears to be released from fine primary afferents upon
noxious cutaneous stimulation we have addressed the role of
their preferential targets (NK, and NK2 receptors respec¬
tively) in mediating nociceptive responses of spinal dorsal
hom neurons. By making extracellular recordings of neurons
in anaesthetised rats (and cats) whilst applying drugs locally
by ionophoresis it was shown that NIC, agonists facilitate and
NK, antagonists prevent responses to brief thermal noxious
stimuli in a highly selective manner. NK, receptor drugs had
no marked effect, although NK, agonists could readily excite
laminae 1V/V but not lamina I neurons. NK, agonists excited
both deep and superficial cells, apparently producing a selec¬
tive desensitising block of thermal nociception in lamina I.
NK, and NK, receptor drugs were also assessed in two
models of sustained C-afferent input associated with periph¬
eral inflammation, hyperalgesia and increased responsive¬
ness of dorsal horn. Neuronal activity wind-up over tens of
minutes by cutaneous application ofmustard oil was inhibited
by NK, but not NK, antagonists. Expression of mRNA for
preprodynorphin elicited over 6 hours by intraplantar injec¬
tion of X.-carrageenan was similarly affected.
Experiments with another peptide released from fine noci¬
ceptive afferents, somatostatin (SS) indicated that just like
NK, receptors, the SS2 subtype of SS receptor may well be an
essential component in mediation of brief thermal nocicep¬
tive inputs.
The interrelations between the roles played by NK,, SS,
and NK, receptors (and indeed receptors for other factors co-
released from nociceptive afferents) will be important to
elucidate.
Introduction
For a number of years there has been strong interest in the
possibility that substance P (SP) is a transmitter mediating the
input from fine primary afferent C fibres to dorsal horn
neurons. In support of this hypothesis there is a body of early
work describing prominent excitatory effects of SP on dorsal
horn neurons, especially those responding to nociceptive
inputs (see [1] for review). More recent work with in vitro
preparations describes facilitation by SP of responses to
excitatory amino acids [2]. In behavioural experiments,
intrathecally-applied SP and NK, receptor agonists elicit a
localised biting/scratching response, perhaps consistent with
irritation or pain [3] while some but not all NK, antagonists
produce behavioural analgesia [4,5]. However, when the
release of tachykinins into dorsal horn has been examined by
antibody microprobe or push-pull cannula techniques, it is
clear that SP is released by noxious levels of mechanical
stimulation but surprisingly not by noxious thermal stimula
tion at temperatures which selectively activate polymodal C-
afferents [6,7], Higher skin temperatures however which are
likely to cause inflammatory damage, do release SP [8], In
contrast, both noxious pinch and heat cause release of neuro¬
kinin A (NKA) which originates in dorsal horn very largely
from primary afferents [9] where it is generated by alternative
splicing of the mRNA for the SP precursor [10].
At the level of sensory responses of single neurons or
nociceptive reflexes there has been relatively little decisive
data implicating tachykinins as mediators of nociception; due
in large part to the low specificity and potency of the early
antagonists. Although SP was reported [11] to excite only
those neurons that received nociceptive inputs, this has not
been observed by other workers [12]. Only recently with the
advent of non-peptide NK, antagonists has solid evidence
been presented for an actual role of NK, receptors in mediat¬
ing responses of single neurons to high intensity afferent
stimulation or peripheral noxious stimuli [13,14]. More ex¬
tensive studies are needed because these new agents have
been found to exert prominent and very relevant effects on
Ca2+ channels [15]. Facilitation of a flexor reflex elicited
either by SP or by conditioning stimulation of sural nerve was
prevented by an improved peptide antagonist, Spantide II (a
more potent blocker of NK, than NK, or NK3 receptors) [16].
Our earlier studies, carried out on single neurons of anaes¬
thetised cats, pointed clearly to a role of NK, rather than NK,
receptors in mediating brief responses to noxious thermal
stimuli [17], NKA and other NK, agonists specifically facili¬
tated such responses, whereas the early NK, antagonists
[D-Pro4,Lys6,D-Trp7'9'10,Phe"]SPJ ,, and ~[D-Tyr4,D-
Trp7-9,Nle"]SP41, abrogated thermal nociceptive responses,
reversed the effect of NKA on these responses and demon¬
strated behavioural analgesia in rat tail flick and hot plate
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tests. Interestingly, selective NK^ agonists had no effect on
dorsal horn neurons in those studies whereas NK, agonists
merely inhibited nonnociceptive responses, without modify¬
ing thermal or mechanical nociceptive responses; despite
clear evidence [6] that noxious pinch releases SP into dorsal
hom.
The experiments described here were carried out to further
investigate the relative importance of NK, and NK. receptors
in spinal nociceptive processing. There is evidence that ligand
binding sites and mRNA corresponding to both NK, and to a
lesser extent NK, receptors are present in superficial dorsal
hom [18-20].
Methods
Experiments were carried out in chloralose/urethane-anaes-
thetised rats examining the responses of single dorsal hom
neurons during localised ionophoresis ofNK receptor antago¬
nists and employing a range of sensory stimuli. Some experi¬
ments, particularly comparing the effects of tachykinins and
somatostatin (SS; shown to be released into dorsal hom by
noxious, but not damaging levels of thermal stimuli [6,7])
were carried out in cats. The detailed methods, and sources
and specificity of the relevant pharmacological agents are
described in the publications indicated.
Results
In lamina I, NK, agonists reliably produced a marked yet
transient excitation and the declining phase of this (desensi-
tisation?) coincided remarkably with a selective diminution
of responses to noxious heat. NK, agonists were without










Fraction of cells excited
(mean fold increase in firing rate)
Lamina / Laminae IV7V
6/6 (x5.4 fold)
2/11 (<0.6 fold) 4/4 (x3.9 fold)
9/11 (xl 1.2 fold) 6/8 (x3.5 fold)
7/9 (x7.8 fold) 5/5 (x4.0 fold)
Experiments were carried out in anaesthetised rats and drugs were applied by
microtonophoresis (10-80 nA for 3-12 min) from side barrels of the mulribarrelled
extracellular recording electrode.
In the first series of experiments, novel and highly selective
NK, and NK, antagonists were tested on the nociceptive/non-
nociceptive responses of rat laminae IV/V neurons [21222]. In
17 out of 19 neurons tested with the NK. antagonist L-659874
there was clear and selective inhibition of thermal (but not
mechanical) nociceptive responses. In contrast, the NK, an¬
tagonists L-668169 and GR 82334 were without effect on
nociception in 6 out of 8 and 4 out of 6 cases respectively, yet
caused facilitation of non-nociceptive responses in over 75%
of the cells. It seems clear that not only in cat but also in rat,
NK. receptors play an important role in thermal (if not
mechanical) nociception.
One possible reason for the lack of forthcoming evidence
for a role of NK, receptors is that they are not present at a
location accessible to the drugs as applied. To address this
issue we carried out experiments with agonists. Drugs were
applied ionophoretically close to laminae FV/V neurons and
as a comparison, lamina I neurons [22,23], The ascending
cells of lamina I were of interest for two reasons; (i) they are
reported to show a greater predominance of nociceptive cells
and (ii) they are reported to receive direct synaptic contacts
from fine primary afferents (including some SP reactive
terminals). In laminae IV/V, selective NK, and NK, agonists
produced clear excitatory effects of a similar order of magni¬
tude which gradually declined despite continued ionophoresis.
Table 1. Effects ofNK receptor agonists on spontaneous electrical
activity of multireceptive neurons in lamina I and laminae IV/V.
Since the sensory models investigated relied on very brief
(10 sec) cutaneous stimuli, we carried out further experiments
utilising models of sustained inflammatory nociceptive input
to ascertain whether these in contrast would provide evidence
for a role of NK, over NK. receptors. Two models were
selected: (i) electrical recording of cells during topical appli¬
cation of mustard oil (a C-tlbre selective chemical irritant) to
the cutaneous receptive field, and (ii) measurement of the
expression of preprodynorphin (PPD) mRNA in dorsal hom
neurons (using in situ hybridisation histochemistry) follow¬
ing localised inflammation induced by intraplantar injection
of ^.-carrageenan. These models provide sustained C-afferent
input for relatively prolonged periods and covered the experi¬
mental time domains of tens of minutes and six hours respec¬
tively. NK receptor antagonists were administered locally to
the spinal dorsal hom by ionophoresis in each case (Table 2).
In the mustard oil model, several NK. but not NK, antagonists
again prevented mustard oil-induced excitation of spontane¬
ous neuronal activity [24,25]. In the carrageenan model, the
same profile was apparent [26.27] with no discernible evi¬
dence for a role of NK, receptors. It is possible that more
profound or qualitatively different inflammatory stimuli would
reveal a contribution from NK, receptors, but (at least in the
present experimental conditions) it appears that NK, receptors
have a more prominent role in mediating nociception. Thus,
there is evidence mainly from release studies to suggest that
NK, receptors may play a greater role in nociception elicited
by prolonged mechanical stimuli, noxious cold or formalin
[6,7,28,29].
Since release experiments [6,7] have shown that in contrast
to SP, SS (as well as NKA [9]) is released into dorsal hom by
noxious heat, we compared the effects of agonists and antago¬
nists for neurokinin [17,21,22] and somatostatin [30] receptors
on brief sensory responses of laminae IV/V neurons (Table 3).
Whilst SS-14 had broad antinociceptive effects on responses
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Antagonist Proportion of neurons Mean percentage inhibition
inhibited in affected cells (± s.e. mean)
L 668169 (NK,) l/l I
GR 82334 (NK,). 3/11 (31 ± 14)
L 659874 (NIC) 23/24 50 ± 7
MEN 10376 (NKJ 4/4 38 ±6
R 396 (NIC) ' 3/3 44 ± 10
Electrical activity of multireceptive laminae iV/V neurons was recorded (as in Table 1)
during topical application of mustard oil (5-20% in paraffin oil); a C-fibre selective
chemical irritant [24.25]. One to five repeated applications over 10-15 min caused
marked increases in firing rate (138 +/- 33 fold ofbackground, mean +/- s.e. mean) which
were sustained for more than 20 min and allowed testing of NK antagonists by
ionophoresis (10-80 nA for 1-6 min).
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The expression of preprodynorphin mRNA in lamina I neurons of anaesthetised rats
subjected to bilateral intraplantar injection of the inflammatory agent A-carrageenan
(150pl of 1.4% in saline; n=*12) was measured by in situ hybridisation histochemistry
[26.27]. Neurokinin receptor antagonists were continuously ionophoresed unilaterally
into the superficial dorsal horn of spinal segments shown to display corresponding
receptive field areas. Drugs were ejected (50nA) for 1 hour prior to and then throughout
the 6 hours of carrageenan stimulation. Drug effects were observed over about700pm
centred on the ejection site; the data shown are for the 200pm in closest proximity to the
electrode.
b) Carrageenan-induced PPD mRNA expression
Table 2. Effects of NK receptor antagonists on the responses




Predominant effects on sensory responses
(proportion ofcells so injluenced)
heat pinch brush
a) Agonists
SS-14 (SS, > SS,) >(9/11) >(5/5) 0(10/12)
SS-28 (SS, > SS{) "(5/6) 0(5/5) 0(6/6)
[D-Trp*,D-Cys14]SS-14 "(5/6) 0(5/6) 0(5/6)
(SS, > SS.?)
[Met-Ome"]SP 0(13/16) 0(6/9) >(12/16)
(NK. >NK,)
NKA "(17/18) 0(11/14) 0(16/18)
(NK. > NK,)
b) Antagonists
cyclo-(7-aminoheptanoyl. >(7/10) 0(8/10) 0(10/11)
Phe,D-Trp.Lys.O-benzyl-Thr]
(SS./SS,?)
[D-Argi,D-Trp:,.Leu1']SP 0(10/12) 0(9/10) 0(10/12)
(NK, > NK,)
[ D-Pro4,Lys6,D-Trp:-9W- >(11/13) 0(8/9) 0(11/13)
Phe»]SPwl
(NK, > NK,)
Experiments were earned out as described previously [17.30] on anaesthensed cats,
applying drugs by microionophoresis from a multibarreiled electrode located in lamina
II immediately dorsal to the recording electrode. Since the required diffusion distances
in the cat are much greater than in the rat. ionophoresis was at higher currents (350-400
nA for 6-15 mm), which in ejection of 1M NaCl were shown to have no discernible effect
alone on neuronal activity.
to both thermal and mechanical noxious stimuli (just as in rat
[30]), SS-28 and [D-Trps, D-Cys,4]SS-14 selectively facili¬
tated solely thermal nociceptive responses. This is analogous
to the effect of the NK. agonist NKA and the parallel between
effects ofNKA and SS-28 is further indicated by the identical
effects of their antagonists ([D-Pro4,Lys6X)-Trp7'9 l0,Pheil]SP^ll
and cyclo-[7-aminoheptanoyl,Phe,D-Trp,Lys-0-benzyl-Thr]
respectively) in selective abrogation of thermal nociception.
As in the other experimental models described above, there
was little evidence for a significant role of NK, receptors.
Discussion
The present results provide strong support for a functionally-
important role of dorsal horn NK, receptors in thermal
nociception. Although present at much lower levels than NK,
receptors, both ligand binding sites and mRNA for NK,
receptors are present in spinal cord [18,20]. In support of our
contention, the flexor reflex facilitation elicited by NKA or by
conditioning stimulation of the gastrocnemius nerve is pre¬
vented by selective NK, antagonists [31]. Furthermore, the
excitation of dorsal horn neurons brought about by capsaicin
applied to the dorsal roots of an in vitro spinal cord/dorsal root
preparation is similarly prevented by NK, and not NK,
antagonists [32],
NK, receptors may be more important in nociception which
may rely more on different classes of fine afferent inputs, for
example high threshold mechanoreceptive afferents in pro¬
longed and severe pinch-mediated responses. Both noxious
cold [7] and profoundly damaging inflammatory stimuli such
as intraplantar formalin [29] or ultraviolet radiation-induced
burning [33] may invoke a greater NK, contribution.
It is clear that the two main processing variants from
preprosomatostatin (SS-14 and SS-28) exert quite different
effects on somatosensory processing. Both are present in
dorsal horn [34], show selectivity for the two subtypes of SS
receptor (SS, and SS,, respectively [35]) and have been shown
in other CNS regions to exert quite distinct electrophysiological
effects [36], It appears that just like NKA, SS-28 may act as
a transmitter of thermal nociceptive afferents. Whilst the
antagonist experiments show each is necessary for main¬
tained mediation of inputs, the full range of consequences of
a thermal nociceptive input may not be felt by dorsal horn
neurons unless they receive combined signals from NKA, SS-
28 and possibly other co-released factors.
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INTRODUCTION
For many years substance P (SP) has been a prominent candidate for the
transmitter of primary afferent nociceptive fibers (Henry 1976). Although
considerable evidence suggests a role for SP (and NK, receptors) in nocicep¬
tive transmission (Coderre et al. 1993; Maggi et al. 1993), it is unlikely to be
the only relevant transmitter. SP together with neurokinin A (NKA) and
excitatory amino acids (EAAs) are released into the dorsal horn by noxious or
high-intensity stimulation of afferents (Duggan et al. 1990; Skilling et al.
1988; Petermann et al. 1986). Evidence from both electrophysiological and
reflex studies suggests that transmitters such as NKA and EAAs also may be
crucial to nociception through their actions at NK2, NMDA, and non-NMDA
receptors (Coderre et al. 1993).
Several lines of evidence point to a role for NKA in nociceptive transmis¬
sion. Ligand binding (Yashpal et al. 1990) and mRNA hybridization studies
(Takeda and Krause 1991) have confirmed that there are NK2 receptors in the
spinal cord. NKA is present in primary sensory neurons (Ogawa et al. 1985)
end is released by capsaicin from primary afferent terminals (Saria et al.
337
338 F.E. M.UNRO ET AL.
1986). In a model of acute nociception, we have previously shown that
responses of dorsal horn neurons to brief thermal (but not mechanical) r
ious cutaneous stimuli are inhibited by selective NK2 but not NK[ recej
antagonists (Fleetwood-Walker et al. 1990, 1992a). Also in an in vitro sp
cord/dorsal root preparation, neuronal activity evoked by brief applicatioi
capsaicin to the dorsal root ganglion is inhibited by a selective NK2 antago
(Urban et al. 1992). Following both noxious mechanical and noxious ther
stimuli, release of NKA-immunoreactive material is detected throughout
dorsal horn in a diffuse pattern (Duggan et al. 1990; Hope et al. 1990)
intrathecal administration of NKA gives rise to behavioral responses indi
tive of pain (Cridland and Henry 1986; Fleetwood-Walker et al. 1990).
The EAA glutamate is present at high levels in local interneurons of
dorsal hom (Rizzoli 1968; Fagg and Foster 1983; Storm-Mathisen and Otter
1987) as well as in primary afferent terminals, as demonstrated
immunolabeling of granular vesicles following rhizotomy (DeBiasi and Rusti
1988). Upon noxious cutaneous stimulation or low- or high-intensity elec
cal stimulation to peripheral nerves, glutamate is released (Skilling et
1988), where it may act via several receptors (Schoepp et al. 1990a; Watk
et al. 1990). The ionotropic group of receptors, including a-amino-3-hydro
5-isoxazole-4-propionate (AMPA) and N-methyl-D-aspartate (NMDA) typ
have been extensively studied and it is now well established that the NM1
receptor is involved in hypersensitized states such as long-term potentiat
(LTP) in the hippocampus (Collingridge 1992) and wind-up in the spinal ci
(Davies and Lodge 1987; Dickenson and Sullivan 1987, 1990; Thompson
al. 1990). A metabotropic group of glutamate receptors (mGlu), linked
G-proteins, also may be involved in such transmission. Studies have derm
strated a role for mGlu receptors, including a role in an NMDA recept
independent model of LTP (Bortolotto and Collingridge 1993). Previous stud
have demonstrated that l-amino-cyclopentane-l,3-dicarboxylic acid (ACPI
a metabotropic glutamate receptor agonist (Irving et al. 1990), can augmi
the actions of ionotropic agonist-induced activity in spinal cord preparatic
(Cerne and Randic 1992; Bleakman et al. 1992), although the cellular mecl
nism responsible has yet to be elucidated.
In our study, we used a prolonged noxious chemical stimulus to inve:
gate the involvement of NKh NK2, mGlu receptors, and protein kinase
(PKC) in the sustained activation of dorsal hom neurons. The model used
topical cutaneous application of mustard oil (allyl isothiocyanate), a chemii
irritant that selectively activates C (and occasionally some A-delta) affert
fibers (Heapy et al. 1987).
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METHODS
ELECTROPHYSIOLOGY
We conducted experiments on male Wistar rats (250-340 g) anaesthetized
with intravenous a-chloralose (60 mg/kg) and urethane (1200 mg/kg) after
induction with halothane. Supplementary doses of a-chloralose were given as
required. Rectal temperature was continuously monitored and maintained be¬
tween 37-38°C. The rats respired spontaneously, but oxygen was supplied to
the area of the tracheal cannula to enrich the inspired air.
The thoraco-lumbar spinal column was supported by clamps under the
lateral processes and a laminectomy (segments L1-L4) was performed. To
increase the recording stability, a 2% agar solution was injected under the
spinal bone at the rostral end of the laminectomy and then poured over the
exposed cord. A core of agar was removed from above the recording region,
the dura carefully cut, and a pool of liquid paraffin applied to the region.
Extracellular recordings were made via the central barrel (4 M NaCl pH
4.0-4.5) of a seven-barreled glass microelectrode. One side barrel contained
1 M NaCl (pH 4.0-4.5) for automatic current balancing and current controls.
Another side barrel contained Pontamine Sky Blue (2% in 0.5 M sodium
acetate) for determination of neuronal location by ejection at the recording
site followed by histological examination. The other barrels of the electrode
contained NK,, NK2 or mGlu receptor antagonists or PKC inhibitors, which
were applied locally by ionophoresis over a range of currents (10-80nA) for
several minutes. NK, (L668,169) and NK2 (L659,874) antagonists were pre¬
pared as 0.15 mM solutions in distilled water with 0.3% dimethylformamide,
and the NK, antagonist GR82334 was a 1 mM aqueous solution; all were pH
4.5-5.0. Metabotropic glutamate (mGlu) antagonists (L- and D-2-amino-3-
phosphoproprionate, L- and D-AP3) and (RS)4-carboxy-3-hydroxyphenylglycine
(CHPG) were 10 mM aqueous solutions pH 8.0-8.5. PKC inhibitors
chelerythrine (1 mM aqueous solution) and GF109203X (0.2 mM aqueous
solution with 0.2% dimethylformamide) were pH 4.0.
All neurons were located in dorsal hom laminae IV/V, had excitatory
receptive fields on the ipsilateral hindlimb (excluding glabrous skin), and
were multireceptive (i.e., displayed responses to both noxious and innocuous
stimuli). Neurons were initially found by their responsiveness to widespread
manual brushing of the ipsilateral hindlimb. Cutaneous receptive fields of the










Fig. 1. Typical inhibitory effects of the NK; antagonist L659.874 on mustard oil-evoked
activity of laminae IV/V dorsal horn neurons. Ionophoretic application of NaCI had no
effect, whereas L659.874 consistently caused greater than 50% inhibition of evoked
activity.
neurons were First localized by responses to manual brush, then the more
restricted pinch and noxious heat fields were identified. The mustard oil (5—20%
in paraffin oil) was applied topically with a paintbrush to the receptive fields.
BIOCHEMISTRY
To examine the subcellular translocation of protein kinase C (PKC, a
facet of its activation in response to external stimuli), we performed the fol¬
lowing [3H]PDBu binding assay in spinal cord tissue ipsilateral/contralateral
to mustard oil stimulation.
Male Wistar rats (273-330 g) were briefly anaesthetized with halothane,
and mustard oil (7-20%) was applied three times to the left hindfoot and leg
over a 15-minute period. This treated leg was bandaged to avoid cross-
contamination and after one hour the rats were killed and the spinal cords
removed and hemisected.
Each side of the spinal cord was separately homogenized in 0.4 ml of ice-
cold buffer containing 20 mM Tris-HCl at pH 7.5, 50 mM 2-mercaptoethanol,
2 mM EDTA and 1 mM phenylmethylsulphonylfluoride with 0.01% leupeptin
and 20 pM trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (E-64).
The samples were then centrifuged at 25,000 X g for 20 minutes at 4°C. The
supernatant and pellet were carefully separated and the pellet was
rehomogenized in 0.3 ml Tris-BSA (50 mM Tris HC1, pH 7.4), with 4 mg/ml
essential fatty acid-free bovine serum albumin. While membrane binding was
carried out in Tris-BSA, cytosolic binding assays additionally contained
1 mM CaCl2 and 75 mM magnesium acetate and 1.35 mg/ml sonicated
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Fig. 2. An example of the inhibition of mustard oil-induced firing of a dorsal horn neuron
by the metabotropic glutamate receptor antagonist CHPG. In this case recovery was
observed within two minutes of termination of ionophoresis of the antagonist.
phosphatidylserine, sodium salt. Assays were conducted in a total volume of
275 pi (30 min, 37°C), with 5 nM [3H]PDBu (approximately 0.03 pCi per
tube) and dimethylformamide (0.5% final) or 10 pM PDBu in dimethylformnmide
for total and nonspecific binding measurements, respectively. Tissue samples
gave a total binding of less than 10% of total radioactivity present. Protein
was precipitated at 4°C by the addition of 100 pi of 12 mg/ml bovine gamma
globulin and 300 pi of 24% polyethyleneglycol 8000 in 50 mM Tris-HCl
(pH 7.4). After 20 minutes on ice, assay tubes were centrifuged (12,000 X g,
5 min, 4°C), the supernatant aspirated, and the [3H] radioactivity in each
pellet determined after solubilization.
All laboratory chemicals were from Sigma Chemical Co., Poole, Dorset,
UK, except phosphatidyl serine from Lipid Products Ltd., Nutfield, Sussex,
UK. Radioligand was from Du Pont NEN, Stevenage, Herts., UK. Drugs
were from Cambridge Research Biochemicals Ltd., Northwich, Cheshire, UK;
Calbiochem-Novabiochem, Nottingham, Notts., UK; Tocris Neuramin,
Churchill Building, Langford House, Langford, Bristol, Avon, UK; or were
gifts from Merck, Sharp and Dohme and Glaxo Group Research.
RESULTS
After application of the C-nociceptor-selective chemical algogen mustard
oil, virtually all the multireceptive neurons showed a large and prolonged
increase in activity (149 ± 36-fold of background, mean ± S.E.M.). In most
cases, the steady elevated firing rate was achieved by repeated application of
mustard oil 3-5 times to the same site over a period of 10-15 minutes.
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Fig. 3. The selective PKC inhibitors (A) chelerythrine and (B) GF109203X caused
marked, yet recoverable inhibition of mustard oil-evoked activity.
The selective NK2 antagonist L-659,874 (10-80 nA) caused a clear and
maintained inhibition of the elevated activity, to 50 ± 7% mean ± S.E.M., of
prior control level in 23 of 24 cells (Fig. 1). Recovery was observed in 13 of
17 cases examined after terminating ionophoresis of L659,874. In contrast,
the two selective NK[ antagonists L668,169 and GR82334 (20-80 nA) rarely
inhibited mustard oil-evoked activity (in 1 of 11 and 3 of 11 cases, respectively).
The mustard oil—evoked activity in many cells (n = 15) was unaffected by
NK[ antagonists but was inhibited by the NK2 antagonist L659.874 (Munro et
al. 1993).
Selective antagonists for mGlu (L-AP3 and CHPG) and NK2 (L659,874)
receptors also reliably inhibited the mustard oil-induced wind-up of neuronal
activity. L-AP3 (-15 to -50 nA) and CHPG (-15 to -55 nA) inhibited the
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Table I
Mustard oil-induced translocation of specific [3H] PDBu binding sites
(% of total specific binding on control contralateral side)
Cystolic Fraction Membrane Fraction
Control (contralateral to mustard oil) 73.7 ± 2.5 26.2 ± 2.4
Test (ipsilaterai to mustard oil) 37.6 ± 5.0 40.5 ± 4.8
Note: The proportion of f3H] PDBu binding sites in the membrane fraction was significantly greater on
the test side (mean 52%) than on the control side (mean 26%) P < 0.05, Wilcoxon test). Values are the
means ± S.E.M. from nine separate experiments.
mustard oil-evoked activity (by 68 ± 7% and 56 ± 9% mean ± S.E.M.) in 11
of 16 and 7 of 8 cells, respectively (Fig. 2). Recovery was sometimes but not
always observed. The stereoisomer of L-AP3, D-AP3 (which has a much
lower affinity for mGlu receptors; Schoepp et al. 1990b) (-15 to -55 nA) had
no effect in 5 of 5 cells.
The selective PKC inhibitors chelerythrine and GF109203X caused marked
inhibition of mustard oil-induced activity in 8 of 9 and 8 of 8 cases respec¬
tively (Fig. 3). Rapid recovery was seen in the majority of cases after removal
of the PKC inhibitor. In contrast, activity evoked by continuous innocuous
brushing was completely unaffected by the PKC inhibitors (data not shown,
n = 5).
In rats treated with mustard oil to one distal hindlimb, a significant trans¬
location of specific [3H]PDBu binding sites from the cytosolic to membrane
fraction was observed in ipsilaterai spinal segments L1-L5 in comparison
with the contralateral (control) side (Table I).
DISCUSSION
These results indicate that both NK2 and mGlu receptors play a crucial
role in mediating the sustained excitation of lamina IV/V dorsal horn neurons
elicited by cutaneous application of mustard oil. As mustard oil excites largely
C-fibers (Heapy et al. 1987), this implies a role for NK2 and mGlu receptors
in the transmission of nociceptive information. For tachykinins, this finding
agrees with our previous studies showing that ionophoretic administration of
NK2 but not NK[ receptor antagonists inhibited the responses of both rat and
cat dorsal hom neurons to brief noxious thermal stimuli applied to their cuta¬
neous receptive fields (Fleetwood-Walker et al. 1990, 1991, 1992a,b).
This evidence for a role of mGlu receptors in sustained cutaneous noci¬
ceptive inputs that lead to hyperalgesia is novel and contrasts with data from
Thompson et al. (1992) who found no evidence for inhibition by L-AP3 of
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ventral root potentials evoked by high-intensity stimulation of dorsal roots in
an in vitro spinal cord preparation. Despite several reports of the attenuation
of wind-up by NMDA receptor antagonists (Davies and Lodge 1987; Dickenson
and Sullivan 1987, 1990; Thompson et al. 1990), we found no evidence for
attenuation of mustard oil-evoked responses by the D-isomer of AP3 (which
is a weak antagonist at the NMDA receptor [Schoepp et al. 1990b]). This
may simply be a consequence of low potency of the antagonist or it may
indicate a genuine mechanistic difference in the present case.
We also carried out a preliminary investigation of the intracellular mecha¬
nisms underlying the sensitization of spinal dorsal horn neurons brought about
by the repeated application of mustard oil. The role of PKC in this model was
clearly indicated by two separate approaches: (1) the inhibition of electro¬
physiological responses by ionophoretic administration of selective PKC in¬
hibitors, and (2) translocation/activation of PKC in response to mustard oil.
Although many other mechanisms may contribute to the processing of sus¬
tained nociceptive inputs and the integral sensitization of dorsal horn neurons
which they bring about, this preliminary evidence clearly identifies a crucial
role of PKC. Since both NK> and some mGlu receptors bring about hydrolysis
of phosphoinositides, it seems likely that either or both of these receptors
could well contribute to PKC activation by means of elevation of cellular
diglyceride contact.
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